Datasets:
Upload folder using huggingface_hub
Browse files- README.md +361 -0
- heart_failure/hlt004_baseline.csv +401 -0
- heart_failure/hlt004_events.csv +1970 -0
- heart_failure/hlt004_longitudinal.csv +0 -0
- nsclc/hlt004_baseline.csv +401 -0
- nsclc/hlt004_events.csv +1944 -0
- nsclc/hlt004_longitudinal.csv +0 -0
README.md
ADDED
|
@@ -0,0 +1,361 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
---
|
| 2 |
+
license: cc-by-nc-4.0
|
| 3 |
+
task_categories:
|
| 4 |
+
- tabular-classification
|
| 5 |
+
- tabular-regression
|
| 6 |
+
- time-series-forecasting
|
| 7 |
+
language:
|
| 8 |
+
- en
|
| 9 |
+
tags:
|
| 10 |
+
- synthetic
|
| 11 |
+
- healthcare
|
| 12 |
+
- disease-progression
|
| 13 |
+
- longitudinal
|
| 14 |
+
- survival-analysis
|
| 15 |
+
- oncology
|
| 16 |
+
- cardiology
|
| 17 |
+
- nsclc
|
| 18 |
+
- lung-cancer
|
| 19 |
+
- heart-failure
|
| 20 |
+
- seer
|
| 21 |
+
- tnm-staging
|
| 22 |
+
- nyha
|
| 23 |
+
- recist
|
| 24 |
+
- ctcae
|
| 25 |
+
- biomarkers
|
| 26 |
+
- kaplan-meier
|
| 27 |
+
- competing-risk
|
| 28 |
+
- fine-gray
|
| 29 |
+
- markov-chain
|
| 30 |
+
- gaussian-process
|
| 31 |
+
- treatment-response
|
| 32 |
+
- progression-free-survival
|
| 33 |
+
- overall-survival
|
| 34 |
+
pretty_name: HLT-004 Synthetic Disease Progression Dataset — NSCLC + Heart Failure (Sample Preview)
|
| 35 |
+
size_categories:
|
| 36 |
+
- 10K<n<100K
|
| 37 |
+
---
|
| 38 |
+
|
| 39 |
+
# HLT-004 — Synthetic Disease Progression Dataset (Sample Preview)
|
| 40 |
+
|
| 41 |
+
**A free, schema-identical preview of the full HLT-004 commercial product from [XpertSystems.ai](https://xpertsystems.ai).**
|
| 42 |
+
|
| 43 |
+
A **fully synthetic** longitudinal disease progression dataset combining patient-level baseline records, visit-level biomarker trajectories, and structured event logs across **two clinically distinct disease modules**: NSCLC (oncology survival) and Heart Failure (chronic cardiovascular progression). Calibrated to SEER 5-year survival, AJCC TNM 8th Edition staging, NYHA Functional Classification, RECIST 1.1 response criteria, CTCAE v5.0 adverse events, and Fine-Gray competing-risk survival outcomes.
|
| 44 |
+
|
| 45 |
+
> ⚠️ **PRIVACY & SYNTHETIC NATURE**
|
| 46 |
+
> Every record in this dataset is **100% synthetic**. **No real patient data, no PHI, no re-identifiable records.** Stage-specific survival distributions and treatment response rates match published SEER / clinical trial benchmarks but the patients are computationally generated.
|
| 47 |
+
|
| 48 |
+
---
|
| 49 |
+
|
| 50 |
+
## What's in this sample
|
| 51 |
+
|
| 52 |
+
Two disease modules, each with three CSVs:
|
| 53 |
+
|
| 54 |
+
### `nsclc/` — Non-Small Cell Lung Cancer (TNM 8th Edition staging)
|
| 55 |
+
|
| 56 |
+
| File | Rows | Cols | Description |
|
| 57 |
+
|---|---|---|---|
|
| 58 |
+
| `hlt004_baseline.csv` | 400 | 37 | Patient-level: demographics, ECOG PS, CCI, stage at dx, OS/PFS, death cause, 1L treatment arm, best overall response (CR/PR/SD/PD) |
|
| 59 |
+
| `hlt004_longitudinal.csv` | 3,323 | 33 | Visit-level: ~8.3 visits/patient × 5yr follow-up; CEA biomarker trajectory, labs, AEs, on-treatment flag, RECIST per imaging visit |
|
| 60 |
+
| `hlt004_events.csv` | 1,943 | 4 | Event log: diagnosis / treatment_start_1L / treatment_end_1L / response_assessment / progression / os_endpoint |
|
| 61 |
+
|
| 62 |
+
### `heart_failure/` — Heart Failure (NYHA Class I-IV)
|
| 63 |
+
|
| 64 |
+
| File | Rows | Cols | Description |
|
| 65 |
+
|---|---|---|---|
|
| 66 |
+
| `hlt004_baseline.csv` | 400 | 37 | Patient-level: demographics, ECOG-equivalent ambulation, CCI, NYHA Class at dx, OS/PFS-equivalent, death cause, 1L therapy arm (GDMT/Ivabradine/LVAD) |
|
| 67 |
+
| `hlt004_longitudinal.csv` | 4,502 | 33 | Visit-level: ~11.3 visits/patient over 5yr; NT-proBNP biomarker, labs, AEs |
|
| 68 |
+
| `hlt004_events.csv` | 1,969 | 4 | Event log analogous to NSCLC structure |
|
| 69 |
+
|
| 70 |
+
**Total:** ~12,500 rows across 8 CSVs + 2 generator summaries = ~2.2 MB.
|
| 71 |
+
|
| 72 |
+
---
|
| 73 |
+
|
| 74 |
+
## Schema highlights
|
| 75 |
+
|
| 76 |
+
### Baseline (37 columns, patient-level)
|
| 77 |
+
|
| 78 |
+
**Identity:** `patient_id`, `disease_type`, `diagnosis_date`
|
| 79 |
+
|
| 80 |
+
**Demographics:** `age_at_dx`, `sex`, `race_ethnicity`, `bmi_baseline`, `smoking_ever`, `pack_years`, `insurance_type`
|
| 81 |
+
|
| 82 |
+
**Clinical scoring:** `ecog_ps_baseline` (0-4), `cci_at_dx` (Charlson Comorbidity Index), `stage_at_dx`, `stage_idx_at_dx` (numeric)
|
| 83 |
+
|
| 84 |
+
**Survival (Fine-Gray competing risk):** `os_days`, `os_event` (death/censored), `pfs_days`, `pfs_event`, `censoring_reason`, `death_cause`, `last_contact_days`
|
| 85 |
+
|
| 86 |
+
**Treatment:** `treatment_arm_1L` (regimen code), `best_overall_response` (CR/PR/SD/PD per RECIST 1.1), `response_day_from_dx`, `progression_day_from_dx`
|
| 87 |
+
|
| 88 |
+
### Longitudinal (33 columns, visit-level)
|
| 89 |
+
|
| 90 |
+
**Visit metadata:** `patient_id`, `visit_id`, `visit_number`, `visit_date`, `days_from_dx`, `visit_type` (baseline/imaging/routine_lab/urgent/hospitalization)
|
| 91 |
+
|
| 92 |
+
**Disease state:** `stage_current`, `stage_idx_current`, `stage_changed_flag` (Markov transitions)
|
| 93 |
+
|
| 94 |
+
**Biomarker (disease-specific):** NSCLC → `cea_value` (CEA, ng/mL); HF → `ntprobnp_value` (NT-proBNP, pg/mL); plus `*_units`
|
| 95 |
+
|
| 96 |
+
**Treatment state:** `on_treatment_flag`, `treatment_line`, `treatment_arm`
|
| 97 |
+
|
| 98 |
+
**RECIST 1.1:** `recist_response_visit` (CR/PR/SD/PD/N/A per imaging visit, derived from marker change)
|
| 99 |
+
|
| 100 |
+
**Labs (10 panels):** `wbc`, `hgb`, `plt`, `anc`, `creatinine`, `bun`, `alt`, `ast`, `albumin`, `bilirubin`
|
| 101 |
+
|
| 102 |
+
**Adverse events (CTCAE v5.0):** `ae_count_grade1`, `ae_count_grade2`, `ae_count_grade3`, `ae_count_grade4`
|
| 103 |
+
|
| 104 |
+
### Events (4 columns, sparse event log)
|
| 105 |
+
|
| 106 |
+
`patient_id`, `event_type` ∈ {diagnosis, treatment_start_1L, treatment_end_1L, response_assessment, progression, os_endpoint}, `event_day` (days from dx), `event_detail`
|
| 107 |
+
|
| 108 |
+
---
|
| 109 |
+
|
| 110 |
+
## Coverage
|
| 111 |
+
|
| 112 |
+
**2 fully-calibrated disease modules** demonstrated:
|
| 113 |
+
- **NSCLC** (oncology) — TNM 8th Edition, SEER-calibrated OS by stage, CEA biomarker, 4 treatment regimens (Carboplatin/Pemetrexed/Pembrolizumab, Carboplatin/Paclitaxel, Pembrolizumab mono, Docetaxel 2L)
|
| 114 |
+
- **Heart Failure** (chronic CV) — NYHA Class I-IV, 3 treatment lines (GDMT, Ivabradine add-on, LVAD)
|
| 115 |
+
|
| 116 |
+
**Survival modeling:**
|
| 117 |
+
- Weibull-distributed time-to-event with shape parameter 1.2
|
| 118 |
+
- Stage-specific median OS calibrated to SEER (NSCLC) and Pocock et al. 2013 (HF)
|
| 119 |
+
- Competing-risk death cause assignment (Fine-Gray framework)
|
| 120 |
+
- Administrative censoring at follow-up end
|
| 121 |
+
|
| 122 |
+
**Biomarker dynamics:**
|
| 123 |
+
- Gaussian-process trajectories with stage-mean drift
|
| 124 |
+
- Response-driven dips (CR/PR) and progression-driven rises
|
| 125 |
+
- Disease-specific markers calibrated to clinical literature
|
| 126 |
+
|
| 127 |
+
**Stage transitions:**
|
| 128 |
+
- Markov-chain time-inhomogeneous transitions
|
| 129 |
+
- Stage 1→2→3→4 progression probabilities tied to PFS days
|
| 130 |
+
|
| 131 |
+
**Adverse events:**
|
| 132 |
+
- CTCAE v5.0 grade 1-4 counts per visit
|
| 133 |
+
- On-treatment elevation, ECOG-driven baseline rates
|
| 134 |
+
|
| 135 |
+
**Missing data:**
|
| 136 |
+
- MAR rate 10% + MCAR rate 2% applied to biomarker/lab columns
|
| 137 |
+
|
| 138 |
+
---
|
| 139 |
+
|
| 140 |
+
## Calibration source story
|
| 141 |
+
|
| 142 |
+
The full HLT-004 generator anchors all distributions to authoritative oncology and cardiology references:
|
| 143 |
+
|
| 144 |
+
- **SEER (Surveillance, Epidemiology, End Results) Program** — 5-year overall survival benchmarks by cancer stage (NSCLC Stage I=63%, II=37%, III=15%, IV=6%)
|
| 145 |
+
- **AJCC TNM 8th Edition (2017)** — Cancer staging anatomical definitions
|
| 146 |
+
- **NYHA Functional Classification (1994 update)** — Heart Failure stages I-IV with associated 1-year mortality 5%/15%/30%/50%
|
| 147 |
+
- **Roche et al. (2020) Lancet** — Advanced NSCLC median OS 10-14 months with platinum chemotherapy
|
| 148 |
+
- **Pocock et al. (2013)** — MAGGIC heart failure risk model; chronic HF mortality predictors
|
| 149 |
+
- **RECIST 1.1 (Eisenhauer et al. 2009)** — Response Evaluation Criteria In Solid Tumors
|
| 150 |
+
- **CTCAE v5.0 (NCI)** — Common Terminology Criteria for Adverse Events
|
| 151 |
+
- **Fine & Gray (1999)** — Competing risk regression for cause-specific mortality
|
| 152 |
+
- **CONSORT 2010** — Longitudinal data hygiene conventions
|
| 153 |
+
|
| 154 |
+
### Sample-scale validation scorecard
|
| 155 |
+
|
| 156 |
+
| Metric | Observed | Target | Tolerance | Status | Source |
|
| 157 |
+
|---|---|---|---|---|---|
|
| 158 |
+
| NSCLC overall mortality rate | 76.5% | 77% | ±10% | ✅ PASS | Roche et al. (2020) |
|
| 159 |
+
| NSCLC median OS (months) | 13.8 | 12.0 | ±4.0 | ✅ PASS | SEER 2021 |
|
| 160 |
+
| HF overall mortality rate | 62.5% | 63% | ±10% | ✅ PASS | Pocock et al. (2013) |
|
| 161 |
+
| HF median OS (months) | 19.5 | 18.0 | ±6.0 | ✅ PASS | Pocock et al. (2013) |
|
| 162 |
+
| RECIST response categories | 4 | 4 | — | ✅ PASS | RECIST 1.1 |
|
| 163 |
+
| TNM stage diversity | 4 | 4 | — | ✅ PASS | AJCC TNM 8th |
|
| 164 |
+
| Longitudinal temporal monotonicity | 100% | 100% | ±2% | ✅ PASS | CONSORT |
|
| 165 |
+
| PFS ≤ OS invariant | 100% | 100% | ±2% | ✅ PASS | Fine & Gray (1999) |
|
| 166 |
+
| Event log completeness | 100% | 100% | ±5% | ✅ PASS | Data hygiene |
|
| 167 |
+
| Missing data rate | 11.8% | 12% | ±6% | ✅ PASS | MAR 10% + MCAR 2% |
|
| 168 |
+
|
| 169 |
+
**Grade: A+ (100/100) — verified across 6 random seeds (42, 7, 123, 2024, 99, 1).**
|
| 170 |
+
|
| 171 |
+
---
|
| 172 |
+
|
| 173 |
+
## Loading examples
|
| 174 |
+
|
| 175 |
+
### Pandas
|
| 176 |
+
|
| 177 |
+
```python
|
| 178 |
+
import pandas as pd
|
| 179 |
+
|
| 180 |
+
base = pd.read_csv("nsclc/hlt004_baseline.csv")
|
| 181 |
+
long = pd.read_csv("nsclc/hlt004_longitudinal.csv")
|
| 182 |
+
events = pd.read_csv("nsclc/hlt004_events.csv")
|
| 183 |
+
|
| 184 |
+
print(f"Patients: {len(base)}")
|
| 185 |
+
print(f"Visits: {len(long)}")
|
| 186 |
+
print(f"Events: {len(events)}")
|
| 187 |
+
|
| 188 |
+
# Survival by stage
|
| 189 |
+
print("\nNSCLC OS by stage (event rate, median OS days):")
|
| 190 |
+
for stage, grp in base.groupby("stage_at_dx"):
|
| 191 |
+
events_only = grp[grp["os_event"] == 1]
|
| 192 |
+
if len(events_only):
|
| 193 |
+
print(f" {stage}: n={len(grp)} "
|
| 194 |
+
f"event_rate={grp['os_event'].mean():.2%} "
|
| 195 |
+
f"median_os={events_only['os_days'].median():.0f}d")
|
| 196 |
+
```
|
| 197 |
+
|
| 198 |
+
### Hugging Face Datasets
|
| 199 |
+
|
| 200 |
+
```python
|
| 201 |
+
from datasets import load_dataset
|
| 202 |
+
|
| 203 |
+
ds = load_dataset("xpertsystems/hlt004-sample", data_files={
|
| 204 |
+
"nsclc_baseline": "nsclc/hlt004_baseline.csv",
|
| 205 |
+
"nsclc_longitudinal": "nsclc/hlt004_longitudinal.csv",
|
| 206 |
+
"nsclc_events": "nsclc/hlt004_events.csv",
|
| 207 |
+
"hf_baseline": "heart_failure/hlt004_baseline.csv",
|
| 208 |
+
"hf_longitudinal": "heart_failure/hlt004_longitudinal.csv",
|
| 209 |
+
"hf_events": "heart_failure/hlt004_events.csv",
|
| 210 |
+
})
|
| 211 |
+
print(ds)
|
| 212 |
+
```
|
| 213 |
+
|
| 214 |
+
### Kaplan-Meier survival curve
|
| 215 |
+
|
| 216 |
+
```python
|
| 217 |
+
import pandas as pd
|
| 218 |
+
import matplotlib.pyplot as plt
|
| 219 |
+
# Optional: pip install lifelines
|
| 220 |
+
from lifelines import KaplanMeierFitter
|
| 221 |
+
|
| 222 |
+
base = pd.read_csv("nsclc/hlt004_baseline.csv")
|
| 223 |
+
fig, ax = plt.subplots(figsize=(8, 5))
|
| 224 |
+
for stage, grp in base.groupby("stage_at_dx"):
|
| 225 |
+
kmf = KaplanMeierFitter()
|
| 226 |
+
kmf.fit(grp["os_days"], event_observed=grp["os_event"], label=stage)
|
| 227 |
+
kmf.plot_survival_function(ax=ax)
|
| 228 |
+
ax.set_xlabel("Days from diagnosis"); ax.set_ylabel("Overall Survival")
|
| 229 |
+
ax.set_title("NSCLC OS by TNM Stage")
|
| 230 |
+
plt.show()
|
| 231 |
+
```
|
| 232 |
+
|
| 233 |
+
### Time-varying covariate Cox model
|
| 234 |
+
|
| 235 |
+
```python
|
| 236 |
+
import pandas as pd
|
| 237 |
+
from lifelines import CoxTimeVaryingFitter
|
| 238 |
+
|
| 239 |
+
long = pd.read_csv("nsclc/hlt004_longitudinal.csv")
|
| 240 |
+
base = pd.read_csv("nsclc/hlt004_baseline.csv")[["patient_id", "os_days", "os_event"]]
|
| 241 |
+
|
| 242 |
+
# Build start/stop format for time-varying biomarker
|
| 243 |
+
long_sorted = long.sort_values(["patient_id", "days_from_dx"])
|
| 244 |
+
long_sorted["start"] = long_sorted.groupby("patient_id")["days_from_dx"].shift(0)
|
| 245 |
+
long_sorted["stop"] = long_sorted.groupby("patient_id")["days_from_dx"].shift(-1)
|
| 246 |
+
long_sorted = long_sorted.merge(base, on="patient_id")
|
| 247 |
+
long_sorted["event_at_stop"] = (long_sorted["stop"] >= long_sorted["os_days"]) & (long_sorted["os_event"] == 1)
|
| 248 |
+
long_sorted = long_sorted.dropna(subset=["stop", "cea_value"])
|
| 249 |
+
|
| 250 |
+
ctv = CoxTimeVaryingFitter()
|
| 251 |
+
ctv.fit(long_sorted[["patient_id", "start", "stop", "event_at_stop", "cea_value"]]
|
| 252 |
+
.rename(columns={"event_at_stop": "event"}),
|
| 253 |
+
id_col="patient_id", event_col="event", start_col="start", stop_col="stop")
|
| 254 |
+
ctv.print_summary()
|
| 255 |
+
```
|
| 256 |
+
|
| 257 |
+
---
|
| 258 |
+
|
| 259 |
+
## Suggested use cases
|
| 260 |
+
|
| 261 |
+
- **Survival modeling** — Cox proportional hazards, Kaplan-Meier, accelerated failure time, parametric survival (Weibull, log-normal, log-logistic)
|
| 262 |
+
- **Time-varying covariate analysis** — joint longitudinal-survival models using biomarker trajectories
|
| 263 |
+
- **Competing-risk regression** — Fine-Gray subdistribution hazard models on `death_cause` field
|
| 264 |
+
- **Stage transition modeling** — multi-state Markov models on `stage_current` evolution
|
| 265 |
+
- **Biomarker trajectory clustering** — latent class growth analysis on CEA / NT-proBNP series
|
| 266 |
+
- **Treatment effect estimation** — propensity score / inverse probability weighting from observational treatment_arm_1L assignment
|
| 267 |
+
- **RECIST response prediction** — predict CR/PR/SD/PD from baseline + early biomarker dynamics
|
| 268 |
+
- **Adverse event hazard modeling** — predict Grade 3+ AE onset from on-treatment patient state
|
| 269 |
+
- **Missing data methodology** — develop MAR/MCAR/MNAR imputation strategies on flagged data
|
| 270 |
+
- **ML model pretraining** — pretrain healthcare survival models before fine-tuning on real registry data (SEER, CIBMTR, etc.)
|
| 271 |
+
|
| 272 |
+
---
|
| 273 |
+
|
| 274 |
+
## Sample vs. full product
|
| 275 |
+
|
| 276 |
+
| Aspect | This sample | Full HLT-004 product |
|
| 277 |
+
|---|---|---|
|
| 278 |
+
| Disease modules | 2 (NSCLC + HF) | 4 fully-calibrated + 11 templated (15 total) |
|
| 279 |
+
| Patients per disease | 400 | 10,000+ (default) up to 100K |
|
| 280 |
+
| Follow-up window | 5 years | Configurable 1-15 years |
|
| 281 |
+
| Schema | identical | identical |
|
| 282 |
+
| Calibration | identical | identical |
|
| 283 |
+
| License | CC-BY-NC-4.0 | Commercial license |
|
| 284 |
+
|
| 285 |
+
The full product includes:
|
| 286 |
+
- **All 4 fully-calibrated diseases**: NSCLC, Heart Failure, CKD, and Breast Cancer (after stage-distribution fix)
|
| 287 |
+
- **11 additional disease modules** (Colorectal, Prostate, Ovarian, COPD, T2DM Progressive, Multiple Sclerosis, Alzheimer's, Hepatocellular Carcinoma, AML, Rheumatoid Arthritis, HIV/AIDS) — these currently use NSCLC defaults as templates pending per-disease calibration
|
| 288 |
+
- **Up to 100K patients per disease** for production-grade model training
|
| 289 |
+
- **Configurable follow-up windows** up to 15 years
|
| 290 |
+
|
| 291 |
+
**Contact us for the full product and calibration roadmap.**
|
| 292 |
+
|
| 293 |
+
---
|
| 294 |
+
|
| 295 |
+
## Limitations & honest disclosures
|
| 296 |
+
|
| 297 |
+
- **Sample is preview-only.** 400 patients per disease × 5yr follow-up is enough to demonstrate schema, calibration, and survival shape, but is **not statistically sufficient** for serious prognostic model training, especially for rare death-cause analysis or biomarker discovery. Use the full product (10K+ patients per disease) for serious work.
|
| 298 |
+
- **Two disease modules in this sample, not all 15.** The full HLT-004 catalogue lists 15 disease keys, but currently only 4 (NSCLC, Heart Failure, CKD, Breast Cancer) have per-disease calibration; the remaining 11 use NSCLC defaults as placeholder templates. This sample includes the 2 most-requested modules (NSCLC for oncology, Heart Failure for chronic CV).
|
| 299 |
+
- **`breast_cancer` module has a known stage-distribution normalization bug** in the current generator release (`stage_dist_dx` sums to 0.94 instead of 1.0, causing a NumPy ValueError when sampling). This is a single one-line fix in the generator's catalogue but is not yet patched in the version distributed with this sample. We excluded breast_cancer from this preview rather than patch around it. Will be addressed in the next generator release.
|
| 300 |
+
- **Visit-level `recist_response_visit` is change-detection, not best-response.** RECIST 1.1 best response per patient is in `baseline.csv → best_overall_response`. The visit-level field compares consecutive biomarker readings to flag changes during follow-up; it rarely yields "CR" since CR requires lesion disappearance (not capturable from a single marker comparison). Use `best_overall_response` for cohort-level response analysis.
|
| 301 |
+
- **Biomarker trajectories are simulation, not real labs.** Stage-specific drift and response/progression-driven trajectories follow published clinical patterns (CEA elevation with NSCLC progression, NT-proBNP elevation with HF decompensation) but do NOT capture the full noise structure, batch effects, or measurement variability of real lab data. Use for ML algorithm development; validate on real registry data.
|
| 302 |
+
- **Treatment assignment is propensity-weighted, not randomized.** Treatment arms are assigned based on stage, ECOG PS, CCI, and insurance — a *non-randomized* mechanism reflecting real-world prescribing. Causal effect estimation requires propensity score adjustment, IPW, or G-methods.
|
| 303 |
+
- **Stage transitions are Markov, not informative.** Stage changes follow a memoryless transition kernel; the full real-world progression dynamics include informative censoring patterns not captured here.
|
| 304 |
+
- **Death causes are simplified.** `death_cause` field includes the primary cause; real death certificates have ICD-10 underlying + contributing causes which are not in this sample.
|
| 305 |
+
- **CCI (Charlson) score is baseline only.** Real comorbidity index evolves over follow-up; the sample treats it as fixed at diagnosis.
|
| 306 |
+
|
| 307 |
+
---
|
| 308 |
+
|
| 309 |
+
## Ethical use guidance
|
| 310 |
+
|
| 311 |
+
This dataset is designed for:
|
| 312 |
+
- Survival analysis methodology development
|
| 313 |
+
- Healthcare ML model pretraining
|
| 314 |
+
- Educational use in oncology biostatistics and HF outcomes research
|
| 315 |
+
- Synthetic data validation methodology research
|
| 316 |
+
- ETL pipeline testing for clinical registries (SEER-conformant schemas)
|
| 317 |
+
|
| 318 |
+
This dataset is **not appropriate for**:
|
| 319 |
+
- Making decisions about real individual patients
|
| 320 |
+
- Clinical prognosis claims of any kind
|
| 321 |
+
- Drug efficacy or treatment comparisons in regulatory submissions
|
| 322 |
+
- Training models that produce real clinical recommendations
|
| 323 |
+
- Discriminatory analyses on protected demographic groups
|
| 324 |
+
|
| 325 |
+
---
|
| 326 |
+
|
| 327 |
+
## Companion datasets in the Healthcare vertical
|
| 328 |
+
|
| 329 |
+
- [HLT-001](https://huggingface.co/datasets/xpertsystems/hlt001-sample) — Synthetic Patient Population (5K patients × 79 cols, CDC/NHANES calibrated)
|
| 330 |
+
- [HLT-002](https://huggingface.co/datasets/xpertsystems/hlt002-sample) — Synthetic EHR Dataset (4K encounters + FHIR R4 bundles)
|
| 331 |
+
- [HLT-003](https://huggingface.co/datasets/xpertsystems/hlt003-sample) — Synthetic Clinical Trial Dataset (3 endpoint types + power sweep)
|
| 332 |
+
- **HLT-004** — Synthetic Disease Progression Dataset (you are here)
|
| 333 |
+
|
| 334 |
+
Use **HLT-001 → HLT-004 together** for population → encounter → trial → longitudinal-progression healthcare ML workflows.
|
| 335 |
+
|
| 336 |
+
---
|
| 337 |
+
|
| 338 |
+
## Citation
|
| 339 |
+
|
| 340 |
+
If you use this dataset, please cite:
|
| 341 |
+
|
| 342 |
+
```bibtex
|
| 343 |
+
@dataset{xpertsystems_hlt004_sample_2026,
|
| 344 |
+
author = {XpertSystems.ai},
|
| 345 |
+
title = {HLT-004 Synthetic Disease Progression Dataset (Sample Preview)},
|
| 346 |
+
year = 2026,
|
| 347 |
+
publisher = {Hugging Face},
|
| 348 |
+
url = {https://huggingface.co/datasets/xpertsystems/hlt004-sample}
|
| 349 |
+
}
|
| 350 |
+
```
|
| 351 |
+
|
| 352 |
+
---
|
| 353 |
+
|
| 354 |
+
## Contact
|
| 355 |
+
|
| 356 |
+
- **Web:** [https://xpertsystems.ai](https://xpertsystems.ai)
|
| 357 |
+
- **Email:** [pradeep@xpertsystems.ai](mailto:pradeep@xpertsystems.ai)
|
| 358 |
+
- **Full product catalog:** Cybersecurity, Insurance & Risk, Materials & Energy, Oil & Gas, Healthcare, and more
|
| 359 |
+
|
| 360 |
+
**Sample License:** CC-BY-NC-4.0 (Creative Commons Attribution-NonCommercial 4.0)
|
| 361 |
+
**Full product License:** Commercial — please contact for pricing.
|
heart_failure/hlt004_baseline.csv
ADDED
|
@@ -0,0 +1,401 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
patient_id,disease_type,cohort_label,staging_system,diagnosis_date,age_at_dx,sex,race_ethnicity,ecog_ps_baseline,smoking_ever,smoking_pack_years,bmi_at_dx,cci_at_dx,insurance_type,adi_percentile,education_level,stage_at_dx,stage_idx_at_dx,os_days,os_event,pfs_days,pfs_event,censoring_reason,death_cause,last_contact_days,treatment_arm_1L,best_overall_response,response_day_from_dx,progression_day_from_dx
|
| 2 |
+
HLT004-0000001,heart_failure,Heart Failure,NYHA Class I-IV,2016-12-29,75,Male,Hispanic_Latino,0,True,6.1,34.0,1,Uninsured,48.8,HS_Diploma,NYHA_IV,3,448,1,37,1,death,disease,448,lvad,PR,49.0,
|
| 3 |
+
HLT004-0000002,heart_failure,Heart Failure,NYHA Class I-IV,2014-04-04,59,Female,White,1,False,0.0,19.6,0,Commercial,25.2,Less_than_HS,NYHA_III,2,576,1,576,1,death,disease,576,ivabradine,PR,41.0,
|
| 4 |
+
HLT004-0000003,heart_failure,Heart Failure,NYHA Class I-IV,2023-05-19,81,Male,Black_AA,1,False,0.0,25.9,0,Medicare,24.9,Bachelors_Plus,NYHA_II,1,1825,0,974,1,administrative,censored,1825,gdmt_core,PD,,974.0
|
| 5 |
+
HLT004-0000004,heart_failure,Heart Failure,NYHA Class I-IV,2023-02-28,83,Female,White,0,True,16.0,33.3,2,Medicare,13.7,Bachelors_Plus,NYHA_III,2,1125,0,1125,0,lost_to_follow_up,censored,1125,gdmt_core,SD,,791.0
|
| 6 |
+
HLT004-0000005,heart_failure,Heart Failure,NYHA Class I-IV,2015-09-23,48,Female,White,0,True,41.0,25.3,1,Medicare,65.3,Bachelors_Plus,NYHA_II,1,1825,0,1106,1,administrative,censored,1825,lvad,PD,,1106.0
|
| 7 |
+
HLT004-0000006,heart_failure,Heart Failure,NYHA Class I-IV,2017-02-10,56,Male,White,0,False,0.0,19.1,1,Commercial,89.0,Less_than_HS,NYHA_II,1,155,1,155,0,death,other_cause,155,gdmt_core,PR,54.0,
|
| 8 |
+
HLT004-0000007,heart_failure,Heart Failure,NYHA Class I-IV,2021-06-02,73,Male,White,2,False,0.0,33.2,3,Commercial,74.1,HS_Diploma,NYHA_II,1,772,0,772,0,lost_to_follow_up,censored,772,lvad,SD,,565.0
|
| 9 |
+
HLT004-0000008,heart_failure,Heart Failure,NYHA Class I-IV,2020-08-08,68,Male,Black_AA,1,True,23.1,36.1,1,Medicare,15.9,Less_than_HS,NYHA_IV,3,66,0,52,1,lost_to_follow_up,censored,66,ivabradine,PR,52.0,
|
| 10 |
+
HLT004-0000009,heart_failure,Heart Failure,NYHA Class I-IV,2019-10-24,71,Female,Hispanic_Latino,0,True,37.7,28.8,1,Commercial,69.3,Bachelors_Plus,NYHA_IV,3,351,1,126,1,death,disease,351,gdmt_core,PR,67.0,
|
| 11 |
+
HLT004-0000010,heart_failure,Heart Failure,NYHA Class I-IV,2023-11-20,61,Female,White,2,False,0.0,16.9,0,Medicare,12.7,Some_College,NYHA_III,2,1414,0,551,1,lost_to_follow_up,censored,1414,lvad,PR,55.0,
|
| 12 |
+
HLT004-0000011,heart_failure,Heart Failure,NYHA Class I-IV,2020-04-17,82,Male,White,1,True,34.0,33.5,1,Medicare,15.6,Some_College,NYHA_I,0,1758,1,1758,0,death,other_cause,1758,gdmt_core,PR,62.0,
|
| 13 |
+
HLT004-0000012,heart_failure,Heart Failure,NYHA Class I-IV,2020-09-09,81,Female,White,1,True,3.7,18.8,3,Medicare,61.4,Some_College,NYHA_II,1,68,1,68,0,death,other_cause,68,lvad,PR,82.0,
|
| 14 |
+
HLT004-0000013,heart_failure,Heart Failure,NYHA Class I-IV,2019-01-07,72,Male,Hispanic_Latino,3,True,10.8,31.0,2,Medicare,25.1,HS_Diploma,NYHA_II,1,596,1,596,1,death,disease,596,lvad,SD,,430.0
|
| 15 |
+
HLT004-0000014,heart_failure,Heart Failure,NYHA Class I-IV,2019-04-01,85,Female,White,0,False,0.0,23.6,1,Commercial,23.2,Some_College,NYHA_IV,3,253,1,253,1,death,disease,253,gdmt_core,SD,,152.0
|
| 16 |
+
HLT004-0000015,heart_failure,Heart Failure,NYHA Class I-IV,2016-11-28,77,Female,Black_AA,0,False,0.0,21.9,1,Uninsured,67.5,Less_than_HS,NYHA_I,0,1108,1,1108,1,death,other_cause,1108,ivabradine,PR,56.0,
|
| 17 |
+
HLT004-0000016,heart_failure,Heart Failure,NYHA Class I-IV,2019-03-17,61,Female,White,1,False,0.0,26.4,1,Commercial,13.6,Some_College,NYHA_I,0,836,1,836,1,death,disease,836,ivabradine,PR,74.0,
|
| 18 |
+
HLT004-0000017,heart_failure,Heart Failure,NYHA Class I-IV,2023-03-06,76,Female,White,0,False,0.0,28.0,0,Medicare,68.9,Bachelors_Plus,NYHA_III,2,1312,0,318,1,lost_to_follow_up,censored,1312,lvad,PD,,318.0
|
| 19 |
+
HLT004-0000018,heart_failure,Heart Failure,NYHA Class I-IV,2017-10-07,60,Female,Black_AA,1,False,0.0,25.1,0,Commercial,50.4,Some_College,NYHA_II,1,863,1,793,1,death,other_cause,863,ivabradine,PR,51.0,
|
| 20 |
+
HLT004-0000019,heart_failure,Heart Failure,NYHA Class I-IV,2015-05-02,82,Male,Black_AA,0,False,0.0,32.7,0,Commercial,79.1,HS_Diploma,NYHA_III,2,1016,1,642,1,death,disease,1016,ivabradine,SD,,439.0
|
| 21 |
+
HLT004-0000020,heart_failure,Heart Failure,NYHA Class I-IV,2019-12-30,71,Male,White,0,False,0.0,26.3,1,Commercial,73.1,Bachelors_Plus,NYHA_I,0,468,1,468,1,death,disease,468,lvad,CR,87.0,
|
| 22 |
+
HLT004-0000021,heart_failure,Heart Failure,NYHA Class I-IV,2021-11-05,69,Male,Hispanic_Latino,0,False,0.0,35.2,1,Medicare,59.1,Some_College,NYHA_III,2,50,0,50,0,lost_to_follow_up,censored,50,gdmt_core,SD,,44.0
|
| 23 |
+
HLT004-0000022,heart_failure,Heart Failure,NYHA Class I-IV,2023-08-01,63,Male,NHOPI,1,False,0.0,30.8,0,Commercial,45.9,HS_Diploma,NYHA_I,0,598,1,598,0,death,other_cause,598,ivabradine,PR,31.0,
|
| 24 |
+
HLT004-0000023,heart_failure,Heart Failure,NYHA Class I-IV,2019-06-02,86,Female,White,0,True,52.2,24.8,1,Medicare,25.1,HS_Diploma,NYHA_I,0,1825,0,142,1,administrative,censored,1825,gdmt_core,PR,86.0,
|
| 25 |
+
HLT004-0000024,heart_failure,Heart Failure,NYHA Class I-IV,2021-11-16,70,Female,White,0,False,0.0,23.7,0,Commercial,44.4,Some_College,NYHA_II,1,1825,0,329,1,administrative,censored,1825,ivabradine,PR,37.0,
|
| 26 |
+
HLT004-0000025,heart_failure,Heart Failure,NYHA Class I-IV,2016-07-03,66,Female,White,2,False,0.0,18.9,0,Commercial,86.1,HS_Diploma,NYHA_II,1,1269,1,1240,1,death,disease,1269,ivabradine,CR,75.0,
|
| 27 |
+
HLT004-0000026,heart_failure,Heart Failure,NYHA Class I-IV,2018-03-29,67,Male,Hispanic_Latino,0,True,5.0,30.9,4,Medicare,56.5,Less_than_HS,NYHA_III,2,673,0,338,1,lost_to_follow_up,censored,673,lvad,SD,,273.0
|
| 28 |
+
HLT004-0000027,heart_failure,Heart Failure,NYHA Class I-IV,2018-03-10,78,Female,White,1,False,0.0,26.9,2,Medicare,72.6,HS_Diploma,NYHA_I,0,253,0,253,0,lost_to_follow_up,censored,253,ivabradine,CR,73.0,
|
| 29 |
+
HLT004-0000028,heart_failure,Heart Failure,NYHA Class I-IV,2017-04-28,76,Male,White,0,True,19.8,15.0,1,Medicare,55.8,HS_Diploma,NYHA_I,0,801,0,801,0,lost_to_follow_up,censored,801,gdmt_core,PR,39.0,
|
| 30 |
+
HLT004-0000029,heart_failure,Heart Failure,NYHA Class I-IV,2021-02-26,76,Male,White,1,True,16.5,25.8,1,Medicare,36.6,Some_College,NYHA_III,2,333,1,333,1,death,disease,333,lvad,PR,60.0,
|
| 31 |
+
HLT004-0000030,heart_failure,Heart Failure,NYHA Class I-IV,2022-10-30,77,Female,Hispanic_Latino,0,False,0.0,23.5,4,Medicare,31.6,Some_College,NYHA_II,1,1249,1,1249,0,death,other_cause,1249,lvad,PR,88.0,
|
| 32 |
+
HLT004-0000031,heart_failure,Heart Failure,NYHA Class I-IV,2017-04-07,95,Female,White,1,True,17.2,38.9,3,Medicare,39.4,HS_Diploma,NYHA_III,2,616,1,616,1,death,other_cause,616,lvad,PR,52.0,
|
| 33 |
+
HLT004-0000032,heart_failure,Heart Failure,NYHA Class I-IV,2015-05-11,67,Female,Black_AA,0,False,0.0,18.5,2,Medicare,30.3,Some_College,NYHA_III,2,151,1,151,1,death,disease,151,lvad,SD,,120.0
|
| 34 |
+
HLT004-0000033,heart_failure,Heart Failure,NYHA Class I-IV,2022-04-01,65,Male,White,2,False,0.0,20.2,0,Medicaid,60.1,HS_Diploma,NYHA_I,0,485,1,485,1,death,disease,485,ivabradine,CR,67.0,
|
| 35 |
+
HLT004-0000034,heart_failure,Heart Failure,NYHA Class I-IV,2022-06-28,62,Female,Asian,3,False,0.0,36.0,0,Commercial,4.5,HS_Diploma,NYHA_III,2,1167,1,232,1,death,disease,1167,lvad,PR,52.0,
|
| 36 |
+
HLT004-0000035,heart_failure,Heart Failure,NYHA Class I-IV,2023-05-06,79,Male,White,0,True,1.0,37.5,1,Medicare,51.2,HS_Diploma,NYHA_II,1,983,1,983,0,death,other_cause,983,gdmt_core,SD,,754.0
|
| 37 |
+
HLT004-0000036,heart_failure,Heart Failure,NYHA Class I-IV,2016-07-20,85,Female,White,0,True,65.6,24.5,2,Commercial,37.6,Bachelors_Plus,NYHA_II,1,906,1,563,1,death,other_cause,906,gdmt_core,PR,40.0,
|
| 38 |
+
HLT004-0000037,heart_failure,Heart Failure,NYHA Class I-IV,2021-03-09,70,Female,Hispanic_Latino,0,True,10.1,25.2,0,Medicaid,77.1,Bachelors_Plus,NYHA_I,0,45,1,45,0,death,other_cause,45,lvad,PR,49.0,
|
| 39 |
+
HLT004-0000038,heart_failure,Heart Failure,NYHA Class I-IV,2021-02-25,61,Male,Asian,1,True,10.0,32.9,1,Medicare,39.9,Some_College,NYHA_III,2,983,1,927,1,death,disease,983,lvad,PD,,927.0
|
| 40 |
+
HLT004-0000039,heart_failure,Heart Failure,NYHA Class I-IV,2021-11-23,62,Male,White,0,False,0.0,15.0,2,Uninsured,57.8,Less_than_HS,NYHA_III,2,1123,1,661,1,death,disease,1123,gdmt_core,PR,81.0,
|
| 41 |
+
HLT004-0000040,heart_failure,Heart Failure,NYHA Class I-IV,2022-01-21,79,Male,White,2,False,0.0,17.6,2,Commercial,50.2,HS_Diploma,NYHA_II,1,1095,1,1095,1,death,disease,1095,gdmt_core,PR,79.0,
|
| 42 |
+
HLT004-0000041,heart_failure,Heart Failure,NYHA Class I-IV,2023-07-09,80,Female,Hispanic_Latino,2,True,24.5,27.4,1,Medicare,41.7,HS_Diploma,NYHA_IV,3,1064,1,43,1,death,disease,1064,lvad,CR,47.0,
|
| 43 |
+
HLT004-0000042,heart_failure,Heart Failure,NYHA Class I-IV,2018-10-08,78,Male,Hispanic_Latino,2,False,0.0,38.7,3,Commercial,42.8,Bachelors_Plus,NYHA_II,1,484,0,484,0,lost_to_follow_up,censored,484,gdmt_core,CR,31.0,
|
| 44 |
+
HLT004-0000043,heart_failure,Heart Failure,NYHA Class I-IV,2014-10-05,64,Female,White,1,True,3.3,26.4,0,Medicare,21.9,Less_than_HS,NYHA_IV,3,366,1,167,1,death,disease,366,gdmt_core,PD,,167.0
|
| 45 |
+
HLT004-0000044,heart_failure,Heart Failure,NYHA Class I-IV,2015-12-03,74,Female,White,4,True,16.2,29.7,1,Medicare,17.3,Bachelors_Plus,NYHA_III,2,39,1,39,1,death,other_cause,39,gdmt_core,SD,,30.0
|
| 46 |
+
HLT004-0000045,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-11,73,Female,Hispanic_Latino,0,True,2.3,36.1,2,Medicare,41.2,Some_College,NYHA_IV,3,92,1,92,1,death,disease,92,gdmt_core,PR,64.0,
|
| 47 |
+
HLT004-0000046,heart_failure,Heart Failure,NYHA Class I-IV,2022-06-11,74,Male,Hispanic_Latino,1,False,0.0,42.2,0,Commercial,35.0,Some_College,NYHA_IV,3,502,1,380,1,death,disease,502,gdmt_core,SD,,322.0
|
| 48 |
+
HLT004-0000047,heart_failure,Heart Failure,NYHA Class I-IV,2014-02-10,82,Female,Hispanic_Latino,0,False,0.0,25.5,1,Medicare,39.8,Bachelors_Plus,NYHA_IV,3,151,1,144,1,death,disease,151,lvad,SD,,118.0
|
| 49 |
+
HLT004-0000048,heart_failure,Heart Failure,NYHA Class I-IV,2017-09-03,74,Male,White,3,True,38.8,29.0,4,Medicare,39.7,Less_than_HS,NYHA_I,0,1591,1,1591,1,death,disease,1591,ivabradine,PR,88.0,
|
| 50 |
+
HLT004-0000049,heart_failure,Heart Failure,NYHA Class I-IV,2016-06-13,80,Female,White,1,False,0.0,40.4,1,Medicaid,64.9,Bachelors_Plus,NYHA_III,2,1274,0,970,1,lost_to_follow_up,censored,1274,ivabradine,CR,53.0,
|
| 51 |
+
HLT004-0000050,heart_failure,Heart Failure,NYHA Class I-IV,2017-03-16,72,Female,Hispanic_Latino,2,False,0.0,19.7,2,Medicaid,50.2,Less_than_HS,NYHA_III,2,198,1,198,1,death,disease,198,lvad,PD,,198.0
|
| 52 |
+
HLT004-0000051,heart_failure,Heart Failure,NYHA Class I-IV,2020-05-20,75,Female,Hispanic_Latino,0,False,0.0,35.5,0,Medicaid,13.3,Bachelors_Plus,NYHA_III,2,116,0,116,0,lost_to_follow_up,censored,116,ivabradine,PR,38.0,
|
| 53 |
+
HLT004-0000052,heart_failure,Heart Failure,NYHA Class I-IV,2019-02-05,79,Female,Hispanic_Latino,3,True,25.0,22.8,0,VA,26.6,Some_College,NYHA_II,1,1825,0,1825,0,administrative,censored,1825,lvad,PR,55.0,
|
| 54 |
+
HLT004-0000053,heart_failure,Heart Failure,NYHA Class I-IV,2018-10-22,54,Male,White,1,True,12.8,29.7,0,Medicare,54.8,Less_than_HS,NYHA_IV,3,89,1,89,1,death,disease,89,ivabradine,PD,,89.0
|
| 55 |
+
HLT004-0000054,heart_failure,Heart Failure,NYHA Class I-IV,2018-05-08,68,Male,White,1,False,0.0,27.6,3,Uninsured,40.8,Bachelors_Plus,NYHA_II,1,1076,1,1076,1,death,disease,1076,ivabradine,PD,,1076.0
|
| 56 |
+
HLT004-0000055,heart_failure,Heart Failure,NYHA Class I-IV,2020-05-30,66,Male,Hispanic_Latino,3,True,35.0,23.2,1,Commercial,6.5,Less_than_HS,NYHA_II,1,45,0,45,0,lost_to_follow_up,censored,45,lvad,PR,88.0,
|
| 57 |
+
HLT004-0000056,heart_failure,Heart Failure,NYHA Class I-IV,2020-10-29,64,Male,White,1,False,0.0,23.0,1,Uninsured,41.7,HS_Diploma,NYHA_II,1,1077,0,213,1,lost_to_follow_up,censored,1077,lvad,SD,,183.0
|
| 58 |
+
HLT004-0000057,heart_failure,Heart Failure,NYHA Class I-IV,2014-06-08,68,Male,AIAN,1,False,0.0,30.8,1,Medicare,48.9,Bachelors_Plus,NYHA_II,1,1397,1,1397,1,death,disease,1397,lvad,PR,59.0,
|
| 59 |
+
HLT004-0000058,heart_failure,Heart Failure,NYHA Class I-IV,2015-05-16,89,Male,White,1,True,13.5,35.3,1,Commercial,57.5,Some_College,NYHA_III,2,445,1,445,1,death,other_cause,445,lvad,CR,30.0,
|
| 60 |
+
HLT004-0000059,heart_failure,Heart Failure,NYHA Class I-IV,2017-05-30,61,Male,Black_AA,0,False,0.0,28.3,1,Commercial,60.1,Bachelors_Plus,NYHA_I,0,914,0,914,0,lost_to_follow_up,censored,914,gdmt_core,SD,,580.0
|
| 61 |
+
HLT004-0000060,heart_failure,Heart Failure,NYHA Class I-IV,2018-05-10,83,Male,Hispanic_Latino,0,False,0.0,29.5,5,Commercial,50.7,Some_College,NYHA_III,2,542,0,542,0,lost_to_follow_up,censored,542,lvad,SD,,438.0
|
| 62 |
+
HLT004-0000061,heart_failure,Heart Failure,NYHA Class I-IV,2023-12-16,51,Male,White,0,False,0.0,32.6,2,Medicare,3.8,Some_College,NYHA_III,2,839,1,794,1,death,disease,839,lvad,CR,56.0,
|
| 63 |
+
HLT004-0000062,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-29,67,Female,White,0,False,0.0,23.1,0,VA,63.8,HS_Diploma,NYHA_II,1,650,0,330,1,lost_to_follow_up,censored,650,gdmt_core,SD,,286.0
|
| 64 |
+
HLT004-0000063,heart_failure,Heart Failure,NYHA Class I-IV,2020-06-26,73,Female,Black_AA,2,False,0.0,33.7,1,Uninsured,11.9,HS_Diploma,NYHA_III,2,1694,1,299,1,death,other_cause,1694,lvad,PR,88.0,
|
| 65 |
+
HLT004-0000064,heart_failure,Heart Failure,NYHA Class I-IV,2014-05-12,79,Male,White,1,False,0.0,34.2,1,VA,16.1,Bachelors_Plus,NYHA_II,1,1015,1,1015,1,death,other_cause,1015,gdmt_core,SD,,807.0
|
| 66 |
+
HLT004-0000065,heart_failure,Heart Failure,NYHA Class I-IV,2015-01-03,80,Male,White,1,False,0.0,45.2,1,Commercial,61.6,Less_than_HS,NYHA_III,2,1459,1,594,1,death,disease,1459,gdmt_core,PR,72.0,
|
| 67 |
+
HLT004-0000066,heart_failure,Heart Failure,NYHA Class I-IV,2018-07-28,81,Male,Black_AA,1,False,0.0,26.8,3,Commercial,55.5,Some_College,NYHA_IV,3,499,1,499,1,death,disease,499,lvad,SD,,344.0
|
| 68 |
+
HLT004-0000067,heart_failure,Heart Failure,NYHA Class I-IV,2019-11-13,67,Female,Asian,1,False,0.0,26.3,2,Medicare,9.8,HS_Diploma,NYHA_II,1,1825,0,1310,1,administrative,censored,1825,gdmt_core,PD,,1310.0
|
| 69 |
+
HLT004-0000068,heart_failure,Heart Failure,NYHA Class I-IV,2020-08-07,66,Male,White,1,True,120.0,33.9,1,Medicaid,34.7,HS_Diploma,NYHA_III,2,567,1,410,1,death,disease,567,ivabradine,PD,,410.0
|
| 70 |
+
HLT004-0000069,heart_failure,Heart Failure,NYHA Class I-IV,2015-06-03,82,Male,White,3,True,4.5,34.2,1,Commercial,56.9,Some_College,NYHA_II,1,1214,0,974,1,lost_to_follow_up,censored,1214,ivabradine,SD,,795.0
|
| 71 |
+
HLT004-0000070,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-15,69,Male,White,3,True,2.7,25.8,2,Medicare,48.6,Bachelors_Plus,NYHA_III,2,867,1,747,1,death,disease,867,lvad,PR,75.0,
|
| 72 |
+
HLT004-0000071,heart_failure,Heart Failure,NYHA Class I-IV,2018-12-06,56,Male,White,1,False,0.0,26.6,1,Medicare,45.3,Bachelors_Plus,NYHA_III,2,740,0,206,1,lost_to_follow_up,censored,740,ivabradine,SD,,125.0
|
| 73 |
+
HLT004-0000072,heart_failure,Heart Failure,NYHA Class I-IV,2019-12-08,58,Male,White,0,False,0.0,32.5,2,Commercial,21.7,Bachelors_Plus,NYHA_II,1,1825,0,831,1,administrative,censored,1825,lvad,CR,50.0,
|
| 74 |
+
HLT004-0000073,heart_failure,Heart Failure,NYHA Class I-IV,2014-05-24,60,Female,White,1,False,0.0,24.0,0,Commercial,54.0,HS_Diploma,NYHA_III,2,1545,0,359,1,lost_to_follow_up,censored,1545,lvad,PD,,359.0
|
| 75 |
+
HLT004-0000074,heart_failure,Heart Failure,NYHA Class I-IV,2022-03-29,77,Female,Black_AA,1,True,8.4,26.6,3,Medicare,53.6,Some_College,NYHA_II,1,539,0,539,0,lost_to_follow_up,censored,539,ivabradine,PR,83.0,
|
| 76 |
+
HLT004-0000075,heart_failure,Heart Failure,NYHA Class I-IV,2019-06-06,73,Female,White,1,False,0.0,29.7,1,Medicare,79.3,Less_than_HS,NYHA_II,1,860,0,850,1,lost_to_follow_up,censored,860,lvad,PR,47.0,
|
| 77 |
+
HLT004-0000076,heart_failure,Heart Failure,NYHA Class I-IV,2016-03-23,80,Female,Asian,1,False,0.0,35.3,2,Medicaid,18.7,Bachelors_Plus,NYHA_IV,3,280,1,138,1,death,disease,280,lvad,PD,,138.0
|
| 78 |
+
HLT004-0000077,heart_failure,Heart Failure,NYHA Class I-IV,2017-03-09,66,Female,White,1,True,6.2,25.4,1,Medicaid,35.7,HS_Diploma,NYHA_I,0,1568,1,1130,1,death,disease,1568,ivabradine,SD,,800.0
|
| 79 |
+
HLT004-0000078,heart_failure,Heart Failure,NYHA Class I-IV,2017-07-11,73,Male,White,0,False,0.0,17.7,2,Medicaid,45.1,Some_College,NYHA_III,2,349,1,349,1,death,disease,349,lvad,CR,36.0,
|
| 80 |
+
HLT004-0000079,heart_failure,Heart Failure,NYHA Class I-IV,2014-04-09,79,Female,Hispanic_Latino,0,False,0.0,17.2,1,Commercial,41.6,HS_Diploma,NYHA_II,1,55,1,55,1,death,other_cause,55,ivabradine,PR,51.0,
|
| 81 |
+
HLT004-0000080,heart_failure,Heart Failure,NYHA Class I-IV,2023-06-01,68,Female,Hispanic_Latino,1,False,0.0,21.3,0,Commercial,60.2,Bachelors_Plus,NYHA_III,2,651,1,651,1,death,disease,651,gdmt_core,SD,,450.0
|
| 82 |
+
HLT004-0000081,heart_failure,Heart Failure,NYHA Class I-IV,2022-01-09,77,Male,White,0,True,9.2,21.0,2,Medicare,34.5,Bachelors_Plus,NYHA_III,2,599,1,599,1,death,other_cause,599,gdmt_core,CR,45.0,
|
| 83 |
+
HLT004-0000082,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-08,64,Female,White,0,False,0.0,28.1,2,Medicare,38.7,Bachelors_Plus,NYHA_II,1,793,1,377,1,death,other_cause,793,ivabradine,PR,89.0,
|
| 84 |
+
HLT004-0000083,heart_failure,Heart Failure,NYHA Class I-IV,2017-07-14,67,Male,White,1,False,0.0,21.7,1,Commercial,28.8,Less_than_HS,NYHA_II,1,1661,0,142,1,lost_to_follow_up,censored,1661,gdmt_core,PR,35.0,
|
| 85 |
+
HLT004-0000084,heart_failure,Heart Failure,NYHA Class I-IV,2019-07-30,67,Male,White,1,False,0.0,24.7,3,Commercial,76.5,Bachelors_Plus,NYHA_II,1,1656,0,869,1,lost_to_follow_up,censored,1656,ivabradine,SD,,761.0
|
| 86 |
+
HLT004-0000085,heart_failure,Heart Failure,NYHA Class I-IV,2018-07-31,57,Female,White,0,False,0.0,24.3,0,Commercial,43.1,HS_Diploma,NYHA_IV,3,169,0,169,0,lost_to_follow_up,censored,169,gdmt_core,SD,,143.0
|
| 87 |
+
HLT004-0000086,heart_failure,Heart Failure,NYHA Class I-IV,2018-10-02,77,Female,White,1,False,0.0,26.4,3,Medicare,21.4,HS_Diploma,NYHA_II,1,871,0,871,0,lost_to_follow_up,censored,871,ivabradine,PD,,871.0
|
| 88 |
+
HLT004-0000087,heart_failure,Heart Failure,NYHA Class I-IV,2019-11-20,66,Female,White,2,True,13.7,37.3,3,Commercial,45.6,HS_Diploma,NYHA_II,1,8,1,8,0,death,other_cause,8,gdmt_core,SD,,7.0
|
| 89 |
+
HLT004-0000088,heart_failure,Heart Failure,NYHA Class I-IV,2018-07-05,72,Male,White,0,False,0.0,33.2,2,Medicare,16.6,HS_Diploma,NYHA_III,2,1065,1,1065,1,death,other_cause,1065,lvad,CR,80.0,
|
| 90 |
+
HLT004-0000089,heart_failure,Heart Failure,NYHA Class I-IV,2021-09-23,77,Male,Asian,2,False,0.0,29.2,1,Medicare,55.9,Some_College,NYHA_II,1,374,0,374,0,lost_to_follow_up,censored,374,ivabradine,PD,,374.0
|
| 91 |
+
HLT004-0000090,heart_failure,Heart Failure,NYHA Class I-IV,2014-08-03,77,Female,Black_AA,3,False,0.0,26.2,3,Commercial,46.1,HS_Diploma,NYHA_II,1,458,1,458,1,death,disease,458,gdmt_core,PD,,458.0
|
| 92 |
+
HLT004-0000091,heart_failure,Heart Failure,NYHA Class I-IV,2015-12-05,79,Male,White,1,True,19.5,26.4,1,Medicare,53.1,HS_Diploma,NYHA_II,1,1606,1,1167,1,death,disease,1606,ivabradine,PR,77.0,
|
| 93 |
+
HLT004-0000092,heart_failure,Heart Failure,NYHA Class I-IV,2022-12-02,70,Female,White,1,False,0.0,31.1,0,Medicare,22.9,Some_College,NYHA_II,1,76,1,76,1,death,other_cause,76,ivabradine,PR,66.0,
|
| 94 |
+
HLT004-0000093,heart_failure,Heart Failure,NYHA Class I-IV,2022-10-26,66,Male,White,0,False,0.0,32.7,1,Medicare,35.3,Bachelors_Plus,NYHA_III,2,935,1,341,1,death,disease,935,ivabradine,PR,65.0,
|
| 95 |
+
HLT004-0000094,heart_failure,Heart Failure,NYHA Class I-IV,2022-03-06,71,Male,White,3,True,52.4,23.5,1,Medicare,48.8,Some_College,NYHA_IV,3,328,1,328,1,death,disease,328,ivabradine,SD,,230.0
|
| 96 |
+
HLT004-0000095,heart_failure,Heart Failure,NYHA Class I-IV,2017-09-07,51,Male,Hispanic_Latino,1,False,0.0,29.3,1,Medicare,18.5,Some_College,NYHA_IV,3,386,1,298,1,death,disease,386,gdmt_core,PR,49.0,
|
| 97 |
+
HLT004-0000096,heart_failure,Heart Failure,NYHA Class I-IV,2018-07-24,54,Female,Hispanic_Latino,3,True,8.1,16.5,1,Commercial,31.9,HS_Diploma,NYHA_IV,3,477,1,275,1,death,disease,477,lvad,SD,,220.0
|
| 98 |
+
HLT004-0000097,heart_failure,Heart Failure,NYHA Class I-IV,2014-04-03,56,Male,Hispanic_Latino,1,False,0.0,30.4,0,Medicare,15.1,Bachelors_Plus,NYHA_II,1,1399,1,917,1,death,other_cause,1399,ivabradine,SD,,585.0
|
| 99 |
+
HLT004-0000098,heart_failure,Heart Failure,NYHA Class I-IV,2016-10-16,60,Male,NHOPI,0,False,0.0,33.8,2,Medicaid,47.3,Less_than_HS,NYHA_II,1,264,0,264,0,lost_to_follow_up,censored,264,gdmt_core,SD,,212.0
|
| 100 |
+
HLT004-0000099,heart_failure,Heart Failure,NYHA Class I-IV,2021-04-05,76,Male,NHOPI,0,True,7.8,27.4,5,Commercial,57.2,HS_Diploma,NYHA_III,2,1270,0,827,1,lost_to_follow_up,censored,1270,lvad,CR,50.0,
|
| 101 |
+
HLT004-0000100,heart_failure,Heart Failure,NYHA Class I-IV,2017-06-05,61,Male,Asian,1,False,0.0,40.4,2,Medicare,6.3,Less_than_HS,NYHA_IV,3,635,1,359,1,death,disease,635,ivabradine,PR,51.0,
|
| 102 |
+
HLT004-0000101,heart_failure,Heart Failure,NYHA Class I-IV,2018-10-19,67,Male,White,1,True,11.8,23.6,0,Commercial,43.1,Some_College,NYHA_III,2,793,1,793,1,death,disease,793,ivabradine,PR,42.0,
|
| 103 |
+
HLT004-0000102,heart_failure,Heart Failure,NYHA Class I-IV,2015-03-26,87,Female,White,0,False,0.0,30.4,0,Medicaid,15.7,HS_Diploma,NYHA_II,1,1825,0,1464,1,administrative,censored,1825,ivabradine,CR,35.0,
|
| 104 |
+
HLT004-0000103,heart_failure,Heart Failure,NYHA Class I-IV,2018-12-17,67,Male,White,2,False,0.0,28.9,3,Medicare,57.5,Some_College,NYHA_III,2,235,0,235,0,lost_to_follow_up,censored,235,ivabradine,PR,79.0,
|
| 105 |
+
HLT004-0000104,heart_failure,Heart Failure,NYHA Class I-IV,2021-03-19,80,Female,White,2,False,0.0,28.5,1,Medicare,10.4,HS_Diploma,NYHA_III,2,576,1,576,1,death,disease,576,lvad,PR,55.0,
|
| 106 |
+
HLT004-0000105,heart_failure,Heart Failure,NYHA Class I-IV,2019-09-20,60,Female,White,1,True,15.9,28.4,6,Commercial,34.5,Some_College,NYHA_IV,3,814,1,283,1,death,disease,814,gdmt_core,SD,,215.0
|
| 107 |
+
HLT004-0000106,heart_failure,Heart Failure,NYHA Class I-IV,2019-07-25,69,Male,Hispanic_Latino,1,True,19.6,29.8,0,Medicaid,59.7,Some_College,NYHA_III,2,1211,1,435,1,death,disease,1211,gdmt_core,PR,43.0,
|
| 108 |
+
HLT004-0000107,heart_failure,Heart Failure,NYHA Class I-IV,2023-02-21,60,Male,Black_AA,0,False,0.0,34.4,0,Commercial,43.5,Less_than_HS,NYHA_II,1,1807,0,1403,1,lost_to_follow_up,censored,1807,lvad,PR,65.0,
|
| 109 |
+
HLT004-0000108,heart_failure,Heart Failure,NYHA Class I-IV,2016-05-04,67,Female,White,2,False,0.0,37.6,1,Medicare,28.5,Some_College,NYHA_II,1,754,0,562,1,lost_to_follow_up,censored,754,lvad,PR,53.0,
|
| 110 |
+
HLT004-0000109,heart_failure,Heart Failure,NYHA Class I-IV,2016-12-28,82,Male,White,0,False,0.0,29.1,0,Medicare,12.1,Some_College,NYHA_II,1,1825,0,538,1,administrative,censored,1825,ivabradine,SD,,479.0
|
| 111 |
+
HLT004-0000110,heart_failure,Heart Failure,NYHA Class I-IV,2020-03-23,51,Male,White,2,True,0.4,34.2,1,Medicare,34.2,Some_College,NYHA_II,1,343,0,343,0,lost_to_follow_up,censored,343,ivabradine,PR,61.0,
|
| 112 |
+
HLT004-0000111,heart_failure,Heart Failure,NYHA Class I-IV,2018-10-19,77,Female,White,1,True,15.0,24.7,4,Uninsured,45.1,Less_than_HS,NYHA_IV,3,172,0,110,1,lost_to_follow_up,censored,172,lvad,PR,72.0,
|
| 113 |
+
HLT004-0000112,heart_failure,Heart Failure,NYHA Class I-IV,2023-10-15,74,Female,Hispanic_Latino,1,False,0.0,33.8,1,Medicare,94.6,Some_College,NYHA_II,1,1825,0,1171,1,administrative,censored,1825,gdmt_core,SD,,958.0
|
| 114 |
+
HLT004-0000113,heart_failure,Heart Failure,NYHA Class I-IV,2014-08-06,64,Female,White,0,True,105.0,24.4,2,Medicare,64.5,HS_Diploma,NYHA_II,1,764,0,764,0,lost_to_follow_up,censored,764,gdmt_core,PR,56.0,
|
| 115 |
+
HLT004-0000114,heart_failure,Heart Failure,NYHA Class I-IV,2015-03-23,54,Male,Hispanic_Latino,0,True,39.4,35.9,2,Medicare,32.4,Less_than_HS,NYHA_II,1,465,1,465,1,death,other_cause,465,gdmt_core,SD,,332.0
|
| 116 |
+
HLT004-0000115,heart_failure,Heart Failure,NYHA Class I-IV,2017-06-02,72,Female,White,2,False,0.0,42.8,1,Commercial,70.1,HS_Diploma,NYHA_III,2,489,0,489,0,lost_to_follow_up,censored,489,lvad,PD,,489.0
|
| 117 |
+
HLT004-0000116,heart_failure,Heart Failure,NYHA Class I-IV,2018-08-01,65,Female,White,1,True,80.2,28.3,1,Medicare,34.5,Some_College,NYHA_II,1,472,1,472,1,death,disease,472,ivabradine,PR,59.0,
|
| 118 |
+
HLT004-0000117,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-25,74,Male,White,1,False,0.0,15.5,1,Medicaid,45.7,HS_Diploma,NYHA_I,0,568,0,426,1,lost_to_follow_up,censored,568,gdmt_core,PR,56.0,
|
| 119 |
+
HLT004-0000118,heart_failure,Heart Failure,NYHA Class I-IV,2018-12-09,72,Female,Hispanic_Latino,3,True,43.6,25.7,1,Uninsured,76.6,Some_College,NYHA_IV,3,434,1,177,1,death,disease,434,gdmt_core,SD,,114.0
|
| 120 |
+
HLT004-0000119,heart_failure,Heart Failure,NYHA Class I-IV,2018-05-15,91,Male,Hispanic_Latino,3,False,0.0,36.7,1,Medicaid,19.2,HS_Diploma,NYHA_II,1,1258,1,951,1,death,disease,1258,lvad,SD,,747.0
|
| 121 |
+
HLT004-0000120,heart_failure,Heart Failure,NYHA Class I-IV,2015-09-01,69,Male,White,2,False,0.0,32.5,0,Medicaid,28.5,Bachelors_Plus,NYHA_II,1,1825,0,440,1,administrative,censored,1825,lvad,PD,,440.0
|
| 122 |
+
HLT004-0000121,heart_failure,Heart Failure,NYHA Class I-IV,2018-05-05,59,Male,Asian,0,False,0.0,30.6,1,Medicare,48.5,HS_Diploma,NYHA_II,1,1825,0,133,1,administrative,censored,1825,lvad,SD,,118.0
|
| 123 |
+
HLT004-0000122,heart_failure,Heart Failure,NYHA Class I-IV,2019-04-25,74,Male,White,1,True,46.5,35.4,4,Medicaid,66.7,Some_College,NYHA_III,2,1429,1,366,1,death,other_cause,1429,gdmt_core,PD,,366.0
|
| 124 |
+
HLT004-0000123,heart_failure,Heart Failure,NYHA Class I-IV,2019-11-01,74,Male,Hispanic_Latino,2,False,0.0,32.1,0,Commercial,45.5,Bachelors_Plus,NYHA_III,2,278,0,278,0,lost_to_follow_up,censored,278,lvad,PR,81.0,
|
| 125 |
+
HLT004-0000124,heart_failure,Heart Failure,NYHA Class I-IV,2020-01-21,88,Female,White,1,False,0.0,36.6,3,Medicaid,66.2,HS_Diploma,NYHA_IV,3,97,1,25,1,death,disease,97,lvad,PD,,25.0
|
| 126 |
+
HLT004-0000125,heart_failure,Heart Failure,NYHA Class I-IV,2018-04-18,82,Female,White,0,True,7.4,34.8,2,Medicaid,77.1,Less_than_HS,NYHA_I,0,1112,1,1112,0,death,other_cause,1112,ivabradine,PR,66.0,
|
| 127 |
+
HLT004-0000126,heart_failure,Heart Failure,NYHA Class I-IV,2015-07-29,76,Female,Hispanic_Latino,2,True,4.5,38.5,0,Commercial,78.4,Some_College,NYHA_IV,3,362,1,216,1,death,disease,362,gdmt_core,PR,68.0,
|
| 128 |
+
HLT004-0000127,heart_failure,Heart Failure,NYHA Class I-IV,2015-07-12,89,Female,White,1,True,18.3,31.3,1,Medicare,49.5,Bachelors_Plus,NYHA_III,2,125,1,125,1,death,disease,125,lvad,CR,74.0,
|
| 129 |
+
HLT004-0000128,heart_failure,Heart Failure,NYHA Class I-IV,2015-07-19,57,Female,White,1,False,0.0,34.7,3,Medicare,47.3,Bachelors_Plus,NYHA_II,1,775,1,775,1,death,disease,775,ivabradine,PR,65.0,
|
| 130 |
+
HLT004-0000129,heart_failure,Heart Failure,NYHA Class I-IV,2020-03-07,64,Male,White,4,False,0.0,27.2,1,Commercial,68.9,HS_Diploma,NYHA_II,1,331,1,331,1,death,disease,331,gdmt_core,CR,71.0,
|
| 131 |
+
HLT004-0000130,heart_failure,Heart Failure,NYHA Class I-IV,2022-07-23,60,Male,White,1,False,0.0,25.4,0,Commercial,23.2,Bachelors_Plus,NYHA_II,1,1825,0,989,1,administrative,censored,1825,gdmt_core,PR,67.0,
|
| 132 |
+
HLT004-0000131,heart_failure,Heart Failure,NYHA Class I-IV,2022-10-29,67,Male,Black_AA,1,False,0.0,39.7,1,Commercial,29.7,HS_Diploma,NYHA_IV,3,153,1,131,1,death,other_cause,153,lvad,PR,38.0,
|
| 133 |
+
HLT004-0000132,heart_failure,Heart Failure,NYHA Class I-IV,2017-02-10,55,Male,Hispanic_Latino,1,False,0.0,30.4,0,Uninsured,35.9,HS_Diploma,NYHA_II,1,445,1,445,1,death,other_cause,445,ivabradine,PR,86.0,
|
| 134 |
+
HLT004-0000133,heart_failure,Heart Failure,NYHA Class I-IV,2014-10-18,79,Female,Hispanic_Latino,1,False,0.0,34.1,1,Medicare,51.9,Some_College,NYHA_II,1,864,1,864,1,death,disease,864,lvad,PR,70.0,
|
| 135 |
+
HLT004-0000134,heart_failure,Heart Failure,NYHA Class I-IV,2020-04-19,69,Male,White,0,False,0.0,29.9,0,VA,27.3,Some_College,NYHA_III,2,401,0,401,0,lost_to_follow_up,censored,401,ivabradine,CR,73.0,
|
| 136 |
+
HLT004-0000135,heart_failure,Heart Failure,NYHA Class I-IV,2014-05-21,54,Male,White,2,False,0.0,25.5,0,Commercial,62.3,Some_College,NYHA_IV,3,151,1,151,1,death,other_cause,151,ivabradine,PR,57.0,
|
| 137 |
+
HLT004-0000136,heart_failure,Heart Failure,NYHA Class I-IV,2020-04-06,59,Male,White,2,True,1.4,29.2,2,Medicaid,35.9,Bachelors_Plus,NYHA_III,2,212,1,64,1,death,other_cause,212,gdmt_core,PR,36.0,
|
| 138 |
+
HLT004-0000137,heart_failure,Heart Failure,NYHA Class I-IV,2017-10-30,75,Male,White,0,False,0.0,38.0,1,Medicare,25.3,HS_Diploma,NYHA_III,2,640,0,640,0,lost_to_follow_up,censored,640,ivabradine,PR,51.0,
|
| 139 |
+
HLT004-0000138,heart_failure,Heart Failure,NYHA Class I-IV,2022-05-21,82,Female,White,0,False,0.0,32.5,3,Medicare,17.3,Some_College,NYHA_II,1,53,1,53,1,death,disease,53,gdmt_core,PR,88.0,
|
| 140 |
+
HLT004-0000139,heart_failure,Heart Failure,NYHA Class I-IV,2020-04-01,95,Male,Asian,2,True,24.7,18.5,1,Medicaid,64.9,HS_Diploma,NYHA_IV,3,176,1,176,1,death,disease,176,ivabradine,PR,84.0,
|
| 141 |
+
HLT004-0000140,heart_failure,Heart Failure,NYHA Class I-IV,2021-05-24,95,Male,Hispanic_Latino,0,False,0.0,27.8,6,Commercial,29.4,Less_than_HS,NYHA_II,1,550,1,273,1,death,disease,550,gdmt_core,PR,36.0,
|
| 142 |
+
HLT004-0000141,heart_failure,Heart Failure,NYHA Class I-IV,2018-01-20,76,Male,Hispanic_Latino,1,True,84.3,40.2,2,Medicare,38.0,HS_Diploma,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,ivabradine,PR,54.0,
|
| 143 |
+
HLT004-0000142,heart_failure,Heart Failure,NYHA Class I-IV,2022-05-27,60,Male,White,1,False,0.0,27.8,2,Medicare,10.4,Bachelors_Plus,NYHA_IV,3,602,1,261,1,death,disease,602,ivabradine,PR,81.0,
|
| 144 |
+
HLT004-0000143,heart_failure,Heart Failure,NYHA Class I-IV,2019-04-01,46,Female,White,1,False,0.0,17.9,1,Medicaid,36.1,Some_College,NYHA_II,1,1825,0,282,1,administrative,censored,1825,gdmt_core,SD,,218.0
|
| 145 |
+
HLT004-0000144,heart_failure,Heart Failure,NYHA Class I-IV,2020-04-01,75,Male,White,0,False,0.0,40.8,0,Medicare,17.4,Less_than_HS,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,gdmt_core,PR,53.0,
|
| 146 |
+
HLT004-0000145,heart_failure,Heart Failure,NYHA Class I-IV,2017-08-09,62,Male,White,1,True,27.3,33.3,0,Medicaid,53.1,Some_College,NYHA_III,2,1224,1,1224,1,death,disease,1224,lvad,SD,,780.0
|
| 147 |
+
HLT004-0000146,heart_failure,Heart Failure,NYHA Class I-IV,2018-06-29,67,Male,White,1,True,7.9,28.7,2,Medicare,27.4,Bachelors_Plus,NYHA_II,1,798,1,798,1,death,disease,798,gdmt_core,PR,48.0,
|
| 148 |
+
HLT004-0000147,heart_failure,Heart Failure,NYHA Class I-IV,2022-05-25,64,Female,White,1,True,11.2,26.8,1,Medicaid,45.4,Bachelors_Plus,NYHA_I,0,160,1,160,0,death,other_cause,160,gdmt_core,PR,70.0,
|
| 149 |
+
HLT004-0000148,heart_failure,Heart Failure,NYHA Class I-IV,2017-12-07,70,Female,White,0,True,8.0,35.8,0,Commercial,5.9,Some_College,NYHA_III,2,1104,1,438,1,death,disease,1104,gdmt_core,CR,39.0,
|
| 150 |
+
HLT004-0000149,heart_failure,Heart Failure,NYHA Class I-IV,2014-03-20,84,Female,Asian,1,True,34.5,25.7,3,Medicaid,59.4,HS_Diploma,NYHA_III,2,582,1,582,1,death,other_cause,582,ivabradine,PD,,582.0
|
| 151 |
+
HLT004-0000150,heart_failure,Heart Failure,NYHA Class I-IV,2017-10-15,73,Female,White,1,True,7.9,36.2,1,Medicare,31.7,Some_College,NYHA_III,2,1825,0,384,1,administrative,censored,1825,lvad,PD,,384.0
|
| 152 |
+
HLT004-0000151,heart_failure,Heart Failure,NYHA Class I-IV,2017-12-01,70,Female,Asian,0,False,0.0,32.5,0,Medicaid,19.0,Bachelors_Plus,NYHA_II,1,262,0,262,0,lost_to_follow_up,censored,262,gdmt_core,PR,59.0,
|
| 153 |
+
HLT004-0000152,heart_failure,Heart Failure,NYHA Class I-IV,2018-03-08,59,Male,White,0,True,37.5,30.6,6,Uninsured,90.1,Bachelors_Plus,NYHA_III,2,719,1,472,1,death,disease,719,ivabradine,SD,,288.0
|
| 154 |
+
HLT004-0000153,heart_failure,Heart Failure,NYHA Class I-IV,2014-09-15,51,Male,White,0,True,22.8,30.0,0,Medicaid,34.1,Bachelors_Plus,NYHA_III,2,74,0,74,0,lost_to_follow_up,censored,74,ivabradine,PR,35.0,
|
| 155 |
+
HLT004-0000154,heart_failure,Heart Failure,NYHA Class I-IV,2015-04-17,66,Male,White,0,False,0.0,28.0,0,Uninsured,28.4,Some_College,NYHA_II,1,557,1,557,0,death,other_cause,557,ivabradine,PR,89.0,
|
| 156 |
+
HLT004-0000155,heart_failure,Heart Failure,NYHA Class I-IV,2017-03-28,71,Male,White,0,False,0.0,35.6,0,Medicaid,15.1,Less_than_HS,NYHA_II,1,425,0,425,0,lost_to_follow_up,censored,425,lvad,SD,,380.0
|
| 157 |
+
HLT004-0000156,heart_failure,Heart Failure,NYHA Class I-IV,2018-03-28,93,Female,White,3,False,0.0,23.7,0,Medicare,43.4,Some_College,NYHA_I,0,1685,0,1685,0,lost_to_follow_up,censored,1685,lvad,SD,,1318.0
|
| 158 |
+
HLT004-0000157,heart_failure,Heart Failure,NYHA Class I-IV,2014-04-16,73,Male,White,1,False,0.0,19.0,2,Commercial,56.8,HS_Diploma,NYHA_II,1,88,0,88,0,lost_to_follow_up,censored,88,gdmt_core,SD,,70.0
|
| 159 |
+
HLT004-0000158,heart_failure,Heart Failure,NYHA Class I-IV,2017-11-22,83,Female,Asian,2,False,0.0,32.9,1,Medicaid,39.3,Less_than_HS,NYHA_II,1,13,1,13,1,death,disease,13,ivabradine,PR,47.0,
|
| 160 |
+
HLT004-0000159,heart_failure,Heart Failure,NYHA Class I-IV,2017-03-14,66,Female,White,3,False,0.0,33.0,2,Medicare,68.7,Some_College,NYHA_III,2,1072,0,583,1,lost_to_follow_up,censored,1072,gdmt_core,PR,45.0,
|
| 161 |
+
HLT004-0000160,heart_failure,Heart Failure,NYHA Class I-IV,2014-05-07,57,Male,Black_AA,0,False,0.0,32.1,0,Medicare,46.0,Some_College,NYHA_IV,3,137,1,137,1,death,disease,137,gdmt_core,PR,38.0,
|
| 162 |
+
HLT004-0000161,heart_failure,Heart Failure,NYHA Class I-IV,2016-07-02,60,Female,White,1,False,0.0,31.6,1,Medicare,63.8,Bachelors_Plus,NYHA_II,1,680,0,680,0,lost_to_follow_up,censored,680,ivabradine,SD,,458.0
|
| 163 |
+
HLT004-0000162,heart_failure,Heart Failure,NYHA Class I-IV,2016-10-01,63,Female,White,2,False,0.0,27.1,3,Medicare,18.8,Bachelors_Plus,NYHA_III,2,1079,1,789,1,death,disease,1079,lvad,PR,59.0,
|
| 164 |
+
HLT004-0000163,heart_failure,Heart Failure,NYHA Class I-IV,2015-06-08,95,Female,White,1,True,20.6,34.0,2,Uninsured,28.8,Bachelors_Plus,NYHA_II,1,676,1,351,1,death,disease,676,ivabradine,PR,87.0,
|
| 165 |
+
HLT004-0000164,heart_failure,Heart Failure,NYHA Class I-IV,2021-07-07,62,Male,White,1,False,0.0,28.8,2,Medicaid,43.5,Bachelors_Plus,NYHA_I,0,452,1,349,1,death,other_cause,452,gdmt_core,PR,51.0,
|
| 166 |
+
HLT004-0000165,heart_failure,Heart Failure,NYHA Class I-IV,2014-09-22,82,Male,Two_Plus,1,True,17.6,26.1,0,Medicare,21.8,Some_College,NYHA_III,2,1049,1,1049,1,death,disease,1049,gdmt_core,CR,80.0,
|
| 167 |
+
HLT004-0000166,heart_failure,Heart Failure,NYHA Class I-IV,2019-10-11,61,Male,Hispanic_Latino,0,False,0.0,27.2,1,VA,39.9,Less_than_HS,NYHA_II,1,282,1,282,1,death,other_cause,282,lvad,SD,,204.0
|
| 168 |
+
HLT004-0000167,heart_failure,Heart Failure,NYHA Class I-IV,2020-08-25,83,Male,Hispanic_Latino,1,True,16.6,41.6,0,VA,15.1,Some_College,NYHA_IV,3,28,1,28,1,death,disease,28,lvad,PR,74.0,
|
| 169 |
+
HLT004-0000168,heart_failure,Heart Failure,NYHA Class I-IV,2022-01-21,76,Male,White,4,True,29.2,18.3,0,VA,54.2,HS_Diploma,NYHA_III,2,570,1,166,1,death,disease,570,gdmt_core,PD,,166.0
|
| 170 |
+
HLT004-0000169,heart_failure,Heart Failure,NYHA Class I-IV,2019-06-15,70,Female,White,3,True,7.7,32.2,2,Medicare,11.7,Less_than_HS,NYHA_II,1,143,1,143,1,death,other_cause,143,lvad,PR,38.0,
|
| 171 |
+
HLT004-0000170,heart_failure,Heart Failure,NYHA Class I-IV,2019-06-04,71,Female,Asian,0,False,0.0,18.7,2,Medicaid,95.1,HS_Diploma,NYHA_II,1,1825,0,871,1,administrative,censored,1825,ivabradine,PR,30.0,
|
| 172 |
+
HLT004-0000171,heart_failure,Heart Failure,NYHA Class I-IV,2021-08-08,64,Male,White,1,True,47.4,28.4,2,Medicare,51.2,Bachelors_Plus,NYHA_II,1,709,1,709,1,death,disease,709,lvad,SD,,634.0
|
| 173 |
+
HLT004-0000172,heart_failure,Heart Failure,NYHA Class I-IV,2022-07-15,77,Male,White,0,False,0.0,26.4,2,Medicare,59.8,Bachelors_Plus,NYHA_IV,3,398,1,135,1,death,disease,398,ivabradine,PD,,135.0
|
| 174 |
+
HLT004-0000173,heart_failure,Heart Failure,NYHA Class I-IV,2016-02-09,66,Male,White,2,False,0.0,16.2,3,Uninsured,46.0,Bachelors_Plus,NYHA_III,2,957,1,638,1,death,disease,957,lvad,SD,,413.0
|
| 175 |
+
HLT004-0000174,heart_failure,Heart Failure,NYHA Class I-IV,2021-12-15,57,Male,Hispanic_Latino,0,True,17.0,31.5,0,Medicaid,13.4,Bachelors_Plus,NYHA_II,1,1720,1,108,1,death,disease,1720,gdmt_core,PD,,108.0
|
| 176 |
+
HLT004-0000175,heart_failure,Heart Failure,NYHA Class I-IV,2018-08-15,56,Female,Black_AA,3,False,0.0,26.7,1,Medicare,27.1,Bachelors_Plus,NYHA_II,1,157,0,157,0,lost_to_follow_up,censored,157,ivabradine,PR,50.0,
|
| 177 |
+
HLT004-0000176,heart_failure,Heart Failure,NYHA Class I-IV,2014-12-25,74,Male,Hispanic_Latino,2,True,13.5,16.1,1,Medicare,35.7,HS_Diploma,NYHA_III,2,720,1,720,1,death,other_cause,720,lvad,SD,,442.0
|
| 178 |
+
HLT004-0000177,heart_failure,Heart Failure,NYHA Class I-IV,2020-02-14,90,Male,Hispanic_Latino,0,True,120.0,34.3,2,Medicaid,59.4,Bachelors_Plus,NYHA_III,2,17,1,17,1,death,disease,17,gdmt_core,SD,,15.0
|
| 179 |
+
HLT004-0000178,heart_failure,Heart Failure,NYHA Class I-IV,2023-10-07,73,Female,White,0,False,0.0,38.0,0,Commercial,16.2,Bachelors_Plus,NYHA_I,0,1360,1,1360,0,death,other_cause,1360,gdmt_core,SD,,1134.0
|
| 180 |
+
HLT004-0000179,heart_failure,Heart Failure,NYHA Class I-IV,2015-05-29,70,Male,Asian,2,False,0.0,38.3,1,Medicare,58.8,Bachelors_Plus,NYHA_I,0,1096,1,1096,1,death,other_cause,1096,lvad,PR,33.0,
|
| 181 |
+
HLT004-0000180,heart_failure,Heart Failure,NYHA Class I-IV,2014-02-23,75,Male,White,0,True,26.3,31.3,1,Commercial,79.0,HS_Diploma,NYHA_I,0,434,0,434,0,lost_to_follow_up,censored,434,lvad,SD,,338.0
|
| 182 |
+
HLT004-0000181,heart_failure,Heart Failure,NYHA Class I-IV,2023-02-28,87,Female,Black_AA,1,False,0.0,29.4,1,Medicare,43.6,Less_than_HS,NYHA_II,1,1473,1,249,1,death,disease,1473,lvad,PD,,249.0
|
| 183 |
+
HLT004-0000182,heart_failure,Heart Failure,NYHA Class I-IV,2019-12-19,74,Female,White,3,True,4.1,37.3,2,Medicare,3.5,Bachelors_Plus,NYHA_II,1,567,1,567,1,death,other_cause,567,lvad,CR,48.0,
|
| 184 |
+
HLT004-0000183,heart_failure,Heart Failure,NYHA Class I-IV,2016-03-10,67,Female,Two_Plus,1,False,0.0,39.5,4,Medicaid,69.0,HS_Diploma,NYHA_I,0,219,1,219,0,death,other_cause,219,lvad,PR,70.0,
|
| 185 |
+
HLT004-0000184,heart_failure,Heart Failure,NYHA Class I-IV,2021-12-02,85,Female,White,1,False,0.0,36.1,3,Medicare,26.7,HS_Diploma,NYHA_II,1,1404,1,1404,1,death,other_cause,1404,gdmt_core,SD,,1247.0
|
| 186 |
+
HLT004-0000185,heart_failure,Heart Failure,NYHA Class I-IV,2017-12-07,77,Male,White,1,False,0.0,23.3,0,Medicaid,28.9,Some_College,NYHA_II,1,712,0,712,0,lost_to_follow_up,censored,712,ivabradine,PR,59.0,
|
| 187 |
+
HLT004-0000186,heart_failure,Heart Failure,NYHA Class I-IV,2017-04-26,90,Female,White,0,False,0.0,30.3,1,Medicaid,72.0,HS_Diploma,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,lvad,CR,45.0,
|
| 188 |
+
HLT004-0000187,heart_failure,Heart Failure,NYHA Class I-IV,2016-11-23,74,Female,White,3,True,2.0,31.8,1,Commercial,17.5,Less_than_HS,NYHA_IV,3,762,1,468,1,death,disease,762,lvad,PR,65.0,
|
| 189 |
+
HLT004-0000188,heart_failure,Heart Failure,NYHA Class I-IV,2019-12-25,57,Female,White,0,False,0.0,17.9,0,Medicare,8.0,Bachelors_Plus,NYHA_III,2,48,1,48,1,death,other_cause,48,gdmt_core,PR,51.0,
|
| 190 |
+
HLT004-0000189,heart_failure,Heart Failure,NYHA Class I-IV,2015-05-07,55,Female,Black_AA,0,False,0.0,32.0,2,Medicaid,34.9,Bachelors_Plus,NYHA_II,1,1177,0,1177,0,lost_to_follow_up,censored,1177,gdmt_core,SD,,998.0
|
| 191 |
+
HLT004-0000190,heart_failure,Heart Failure,NYHA Class I-IV,2017-08-14,91,Female,White,0,False,0.0,43.2,0,Commercial,84.4,Bachelors_Plus,NYHA_II,1,845,0,845,0,lost_to_follow_up,censored,845,lvad,PR,50.0,
|
| 192 |
+
HLT004-0000191,heart_failure,Heart Failure,NYHA Class I-IV,2017-01-18,92,Female,Asian,3,True,36.1,33.1,2,Uninsured,26.1,HS_Diploma,NYHA_II,1,203,0,203,0,lost_to_follow_up,censored,203,ivabradine,SD,,169.0
|
| 193 |
+
HLT004-0000192,heart_failure,Heart Failure,NYHA Class I-IV,2014-08-10,69,Male,White,0,False,0.0,38.2,2,Medicare,46.9,HS_Diploma,NYHA_IV,3,82,1,82,1,death,other_cause,82,gdmt_core,SD,,54.0
|
| 194 |
+
HLT004-0000193,heart_failure,Heart Failure,NYHA Class I-IV,2021-08-17,67,Female,Black_AA,2,False,0.0,30.2,3,Medicare,37.5,Some_College,NYHA_III,2,61,1,61,1,death,other_cause,61,lvad,SD,,53.0
|
| 195 |
+
HLT004-0000194,heart_failure,Heart Failure,NYHA Class I-IV,2014-01-31,89,Male,White,1,True,23.5,28.6,0,Medicare,43.0,Some_College,NYHA_II,1,355,0,355,0,lost_to_follow_up,censored,355,ivabradine,PR,55.0,
|
| 196 |
+
HLT004-0000195,heart_failure,Heart Failure,NYHA Class I-IV,2023-08-04,58,Female,Black_AA,2,True,64.3,31.5,2,Medicare,28.3,Less_than_HS,NYHA_IV,3,337,1,3,1,death,disease,337,gdmt_core,PD,,3.0
|
| 197 |
+
HLT004-0000196,heart_failure,Heart Failure,NYHA Class I-IV,2014-12-13,61,Female,White,3,False,0.0,24.0,2,Medicaid,28.9,Bachelors_Plus,NYHA_III,2,1476,1,880,1,death,disease,1476,gdmt_core,CR,72.0,
|
| 198 |
+
HLT004-0000197,heart_failure,Heart Failure,NYHA Class I-IV,2017-07-31,79,Female,White,2,False,0.0,23.1,0,Commercial,44.7,Bachelors_Plus,NYHA_III,2,151,1,151,1,death,disease,151,gdmt_core,SD,,97.0
|
| 199 |
+
HLT004-0000198,heart_failure,Heart Failure,NYHA Class I-IV,2014-12-26,67,Female,Asian,3,True,31.4,37.0,0,Medicaid,17.9,Some_College,NYHA_II,1,728,1,728,1,death,other_cause,728,lvad,SD,,539.0
|
| 200 |
+
HLT004-0000199,heart_failure,Heart Failure,NYHA Class I-IV,2017-09-01,71,Male,White,0,False,0.0,37.6,1,Medicaid,60.2,HS_Diploma,NYHA_II,1,43,0,43,0,lost_to_follow_up,censored,43,ivabradine,PD,,43.0
|
| 201 |
+
HLT004-0000200,heart_failure,Heart Failure,NYHA Class I-IV,2020-02-08,70,Female,White,2,False,0.0,23.0,4,Medicare,20.6,HS_Diploma,NYHA_III,2,330,1,203,1,death,disease,330,gdmt_core,PD,,203.0
|
| 202 |
+
HLT004-0000201,heart_failure,Heart Failure,NYHA Class I-IV,2014-11-16,76,Female,Black_AA,1,False,0.0,35.1,0,Commercial,83.8,Less_than_HS,NYHA_II,1,969,0,969,0,lost_to_follow_up,censored,969,ivabradine,PD,,969.0
|
| 203 |
+
HLT004-0000202,heart_failure,Heart Failure,NYHA Class I-IV,2019-04-04,88,Male,Hispanic_Latino,1,False,0.0,28.6,1,Commercial,48.9,HS_Diploma,NYHA_III,2,1414,1,443,1,death,disease,1414,gdmt_core,CR,75.0,
|
| 204 |
+
HLT004-0000203,heart_failure,Heart Failure,NYHA Class I-IV,2021-09-18,73,Male,White,2,False,0.0,31.2,0,Commercial,66.7,Some_College,NYHA_III,2,91,1,91,1,death,other_cause,91,gdmt_core,PD,,91.0
|
| 205 |
+
HLT004-0000204,heart_failure,Heart Failure,NYHA Class I-IV,2018-07-21,79,Male,White,3,False,0.0,32.0,1,Commercial,38.7,Some_College,NYHA_II,1,30,0,30,0,lost_to_follow_up,censored,30,ivabradine,SD,,23.0
|
| 206 |
+
HLT004-0000205,heart_failure,Heart Failure,NYHA Class I-IV,2015-02-15,47,Female,Hispanic_Latino,1,False,0.0,35.3,1,Commercial,29.1,Some_College,NYHA_II,1,655,1,655,1,death,other_cause,655,ivabradine,CR,81.0,
|
| 207 |
+
HLT004-0000206,heart_failure,Heart Failure,NYHA Class I-IV,2020-11-30,71,Male,Hispanic_Latino,1,False,0.0,29.6,3,Medicare,28.1,Bachelors_Plus,NYHA_II,1,690,1,690,1,death,other_cause,690,gdmt_core,CR,48.0,
|
| 208 |
+
HLT004-0000207,heart_failure,Heart Failure,NYHA Class I-IV,2015-11-12,61,Female,Two_Plus,1,False,0.0,37.8,2,Commercial,45.3,HS_Diploma,NYHA_II,1,266,1,266,1,death,disease,266,ivabradine,PD,,266.0
|
| 209 |
+
HLT004-0000208,heart_failure,Heart Failure,NYHA Class I-IV,2014-03-03,57,Male,White,1,False,0.0,31.0,1,Medicare,35.9,Less_than_HS,NYHA_III,2,590,1,524,1,death,disease,590,ivabradine,PD,,524.0
|
| 210 |
+
HLT004-0000209,heart_failure,Heart Failure,NYHA Class I-IV,2018-05-14,61,Female,Black_AA,1,False,0.0,33.0,0,Medicare,61.4,Less_than_HS,NYHA_III,2,555,1,555,1,death,disease,555,ivabradine,PD,,555.0
|
| 211 |
+
HLT004-0000210,heart_failure,Heart Failure,NYHA Class I-IV,2016-09-16,67,Male,White,1,True,3.0,23.9,1,Commercial,58.6,HS_Diploma,NYHA_II,1,1825,0,1642,1,administrative,censored,1825,gdmt_core,PR,40.0,
|
| 212 |
+
HLT004-0000211,heart_failure,Heart Failure,NYHA Class I-IV,2014-04-14,82,Female,Asian,0,False,0.0,42.5,2,Medicare,56.1,Some_College,NYHA_III,2,800,0,800,0,lost_to_follow_up,censored,800,gdmt_core,PR,36.0,
|
| 213 |
+
HLT004-0000212,heart_failure,Heart Failure,NYHA Class I-IV,2021-10-08,56,Male,White,0,False,0.0,32.0,0,Medicaid,60.0,Bachelors_Plus,NYHA_II,1,1537,1,926,1,death,disease,1537,gdmt_core,PD,,926.0
|
| 214 |
+
HLT004-0000213,heart_failure,Heart Failure,NYHA Class I-IV,2019-12-30,72,Female,Hispanic_Latino,2,False,0.0,33.5,1,Medicare,53.7,Bachelors_Plus,NYHA_III,2,816,1,816,1,death,disease,816,ivabradine,SD,,588.0
|
| 215 |
+
HLT004-0000214,heart_failure,Heart Failure,NYHA Class I-IV,2023-02-04,66,Female,White,1,False,0.0,19.1,1,Medicare,35.6,Some_College,NYHA_II,1,1268,1,1268,1,death,disease,1268,lvad,CR,54.0,
|
| 216 |
+
HLT004-0000215,heart_failure,Heart Failure,NYHA Class I-IV,2018-10-20,68,Female,White,3,False,0.0,24.0,0,Commercial,23.8,Some_College,NYHA_III,2,451,1,451,1,death,disease,451,gdmt_core,SD,,365.0
|
| 217 |
+
HLT004-0000216,heart_failure,Heart Failure,NYHA Class I-IV,2018-05-19,84,Female,Black_AA,1,False,0.0,36.8,3,Medicare,28.4,HS_Diploma,NYHA_III,2,1825,0,395,1,administrative,censored,1825,lvad,CR,39.0,
|
| 218 |
+
HLT004-0000217,heart_failure,Heart Failure,NYHA Class I-IV,2022-06-03,78,Male,White,0,False,0.0,30.9,2,Commercial,48.9,Some_College,NYHA_II,1,1052,1,278,1,death,disease,1052,lvad,PR,36.0,
|
| 219 |
+
HLT004-0000218,heart_failure,Heart Failure,NYHA Class I-IV,2014-10-25,88,Male,Hispanic_Latino,0,True,22.9,17.2,0,Medicare,23.6,HS_Diploma,NYHA_III,2,214,0,214,0,lost_to_follow_up,censored,214,gdmt_core,PD,,214.0
|
| 220 |
+
HLT004-0000219,heart_failure,Heart Failure,NYHA Class I-IV,2017-08-13,70,Male,White,0,True,5.5,35.5,0,Commercial,53.4,Bachelors_Plus,NYHA_IV,3,258,1,26,1,death,disease,258,gdmt_core,SD,,16.0
|
| 221 |
+
HLT004-0000220,heart_failure,Heart Failure,NYHA Class I-IV,2021-12-25,63,Male,Black_AA,3,True,12.2,25.7,1,Medicaid,16.1,Some_College,NYHA_II,1,993,0,993,0,lost_to_follow_up,censored,993,gdmt_core,SD,,705.0
|
| 222 |
+
HLT004-0000221,heart_failure,Heart Failure,NYHA Class I-IV,2016-12-03,69,Female,White,0,True,18.9,37.9,1,Commercial,51.6,HS_Diploma,NYHA_III,2,583,1,131,1,death,disease,583,gdmt_core,PR,64.0,
|
| 223 |
+
HLT004-0000222,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-05,74,Female,White,1,False,0.0,28.6,3,Medicare,43.3,HS_Diploma,NYHA_IV,3,152,1,152,1,death,disease,152,ivabradine,CR,57.0,
|
| 224 |
+
HLT004-0000223,heart_failure,Heart Failure,NYHA Class I-IV,2016-11-02,74,Female,White,3,False,0.0,30.4,1,Medicare,23.1,HS_Diploma,NYHA_IV,3,1165,1,430,1,death,disease,1165,gdmt_core,SD,,377.0
|
| 225 |
+
HLT004-0000224,heart_failure,Heart Failure,NYHA Class I-IV,2018-02-18,58,Female,White,3,False,0.0,36.4,1,Medicare,16.9,Bachelors_Plus,NYHA_II,1,786,0,786,0,lost_to_follow_up,censored,786,lvad,PR,68.0,
|
| 226 |
+
HLT004-0000225,heart_failure,Heart Failure,NYHA Class I-IV,2022-12-20,73,Female,White,0,True,89.7,23.5,2,Medicare,75.0,Less_than_HS,NYHA_III,2,1366,0,986,1,lost_to_follow_up,censored,1366,ivabradine,PR,63.0,
|
| 227 |
+
HLT004-0000226,heart_failure,Heart Failure,NYHA Class I-IV,2016-06-07,74,Female,Black_AA,0,False,0.0,22.9,0,Medicare,45.0,Less_than_HS,NYHA_IV,3,99,0,99,0,lost_to_follow_up,censored,99,ivabradine,PR,64.0,
|
| 228 |
+
HLT004-0000227,heart_failure,Heart Failure,NYHA Class I-IV,2023-09-04,95,Male,Black_AA,0,True,2.9,27.9,2,Commercial,19.9,HS_Diploma,NYHA_III,2,832,0,217,1,lost_to_follow_up,censored,832,lvad,PR,86.0,
|
| 229 |
+
HLT004-0000228,heart_failure,Heart Failure,NYHA Class I-IV,2014-06-10,94,Male,Black_AA,0,False,0.0,34.2,2,Commercial,73.0,Bachelors_Plus,NYHA_I,0,117,0,117,0,lost_to_follow_up,censored,117,ivabradine,PD,,117.0
|
| 230 |
+
HLT004-0000229,heart_failure,Heart Failure,NYHA Class I-IV,2016-08-28,61,Female,White,0,True,72.7,20.8,1,Commercial,70.1,Some_College,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,lvad,PR,76.0,
|
| 231 |
+
HLT004-0000230,heart_failure,Heart Failure,NYHA Class I-IV,2019-11-28,68,Female,White,1,False,0.0,18.8,3,Medicare,53.5,Some_College,NYHA_III,2,344,1,344,1,death,disease,344,lvad,CR,74.0,
|
| 232 |
+
HLT004-0000231,heart_failure,Heart Failure,NYHA Class I-IV,2019-12-09,54,Male,White,3,True,42.8,34.2,3,Medicare,19.9,HS_Diploma,NYHA_II,1,1492,0,1492,0,lost_to_follow_up,censored,1492,ivabradine,PR,38.0,
|
| 233 |
+
HLT004-0000232,heart_failure,Heart Failure,NYHA Class I-IV,2023-02-04,64,Male,Hispanic_Latino,1,False,0.0,25.4,3,Commercial,28.0,Less_than_HS,NYHA_II,1,1601,1,1601,1,death,disease,1601,gdmt_core,SD,,1186.0
|
| 234 |
+
HLT004-0000233,heart_failure,Heart Failure,NYHA Class I-IV,2023-08-05,75,Female,Hispanic_Latino,1,False,0.0,26.7,1,Commercial,4.3,Bachelors_Plus,NYHA_II,1,606,1,606,1,death,disease,606,ivabradine,SD,,458.0
|
| 235 |
+
HLT004-0000234,heart_failure,Heart Failure,NYHA Class I-IV,2020-10-10,86,Male,White,0,False,0.0,17.6,2,Medicare,20.2,HS_Diploma,NYHA_III,2,812,1,812,1,death,disease,812,gdmt_core,CR,33.0,
|
| 236 |
+
HLT004-0000235,heart_failure,Heart Failure,NYHA Class I-IV,2020-08-05,63,Male,Black_AA,2,True,52.5,24.9,2,Commercial,31.7,Less_than_HS,NYHA_II,1,970,1,970,1,death,disease,970,ivabradine,SD,,763.0
|
| 237 |
+
HLT004-0000236,heart_failure,Heart Failure,NYHA Class I-IV,2017-03-03,64,Female,White,1,False,0.0,29.1,0,Medicare,43.2,Some_College,NYHA_IV,3,616,1,325,1,death,disease,616,gdmt_core,CR,52.0,
|
| 238 |
+
HLT004-0000237,heart_failure,Heart Failure,NYHA Class I-IV,2022-01-19,46,Female,White,2,False,0.0,34.9,2,Commercial,57.6,Less_than_HS,NYHA_III,2,824,1,824,1,death,disease,824,ivabradine,SD,,656.0
|
| 239 |
+
HLT004-0000238,heart_failure,Heart Failure,NYHA Class I-IV,2020-06-04,70,Male,White,3,False,0.0,24.3,5,VA,24.0,Less_than_HS,NYHA_IV,3,507,1,242,1,death,disease,507,lvad,SD,,175.0
|
| 240 |
+
HLT004-0000239,heart_failure,Heart Failure,NYHA Class I-IV,2014-03-29,59,Female,White,0,False,0.0,39.4,0,Commercial,8.3,Bachelors_Plus,NYHA_IV,3,441,1,323,1,death,disease,441,gdmt_core,PR,64.0,
|
| 241 |
+
HLT004-0000240,heart_failure,Heart Failure,NYHA Class I-IV,2022-04-26,65,Male,Black_AA,0,False,0.0,24.9,1,Medicaid,13.5,Some_College,NYHA_II,1,584,0,418,1,lost_to_follow_up,censored,584,ivabradine,PR,33.0,
|
| 242 |
+
HLT004-0000241,heart_failure,Heart Failure,NYHA Class I-IV,2017-08-05,61,Female,Asian,0,True,69.4,24.9,1,Medicare,53.0,HS_Diploma,NYHA_III,2,1825,0,1111,1,administrative,censored,1825,ivabradine,CR,80.0,
|
| 243 |
+
HLT004-0000242,heart_failure,Heart Failure,NYHA Class I-IV,2018-10-03,70,Male,White,1,True,82.0,38.6,1,Medicaid,68.9,HS_Diploma,NYHA_I,0,1411,1,1411,1,death,disease,1411,lvad,PR,67.0,
|
| 244 |
+
HLT004-0000243,heart_failure,Heart Failure,NYHA Class I-IV,2018-11-10,50,Female,White,3,True,62.0,30.4,0,Commercial,31.0,Bachelors_Plus,NYHA_IV,3,231,1,195,1,death,disease,231,lvad,SD,,140.0
|
| 245 |
+
HLT004-0000244,heart_failure,Heart Failure,NYHA Class I-IV,2022-03-12,54,Male,Black_AA,1,True,39.3,25.7,0,Medicare,42.6,Less_than_HS,NYHA_II,1,208,1,208,1,death,disease,208,gdmt_core,SD,,168.0
|
| 246 |
+
HLT004-0000245,heart_failure,Heart Failure,NYHA Class I-IV,2016-09-04,95,Male,Asian,2,False,0.0,28.1,2,Commercial,67.2,Less_than_HS,NYHA_III,2,1186,1,729,1,death,disease,1186,lvad,CR,76.0,
|
| 247 |
+
HLT004-0000246,heart_failure,Heart Failure,NYHA Class I-IV,2017-12-01,56,Female,Black_AA,1,False,0.0,37.5,2,Commercial,33.3,Some_College,NYHA_III,2,204,0,204,0,lost_to_follow_up,censored,204,gdmt_core,PR,50.0,
|
| 248 |
+
HLT004-0000247,heart_failure,Heart Failure,NYHA Class I-IV,2014-05-23,58,Male,White,0,False,0.0,38.2,1,Medicaid,32.8,Some_College,NYHA_II,1,1732,1,90,1,death,other_cause,1732,lvad,SD,,72.0
|
| 249 |
+
HLT004-0000248,heart_failure,Heart Failure,NYHA Class I-IV,2017-06-26,94,Male,Black_AA,0,False,0.0,24.0,1,Medicare,55.5,Bachelors_Plus,NYHA_III,2,666,1,192,1,death,disease,666,ivabradine,PR,88.0,
|
| 250 |
+
HLT004-0000249,heart_failure,Heart Failure,NYHA Class I-IV,2014-11-19,95,Male,White,1,False,0.0,28.8,0,Commercial,57.8,HS_Diploma,NYHA_I,0,1734,0,1165,1,lost_to_follow_up,censored,1734,ivabradine,SD,,910.0
|
| 251 |
+
HLT004-0000250,heart_failure,Heart Failure,NYHA Class I-IV,2019-10-29,57,Female,AIAN,1,False,0.0,29.7,4,Medicare,34.8,Less_than_HS,NYHA_II,1,10,1,10,1,death,other_cause,10,lvad,CR,46.0,
|
| 252 |
+
HLT004-0000251,heart_failure,Heart Failure,NYHA Class I-IV,2022-12-05,67,Female,White,1,False,0.0,23.0,2,Medicaid,53.4,Some_College,NYHA_II,1,1055,0,1055,0,lost_to_follow_up,censored,1055,lvad,PR,67.0,
|
| 253 |
+
HLT004-0000252,heart_failure,Heart Failure,NYHA Class I-IV,2018-08-24,76,Female,Black_AA,0,True,52.9,28.8,1,Uninsured,23.5,Some_College,NYHA_II,1,1825,0,992,1,administrative,censored,1825,lvad,PR,75.0,
|
| 254 |
+
HLT004-0000253,heart_failure,Heart Failure,NYHA Class I-IV,2023-02-12,92,Male,White,1,False,0.0,29.1,1,Medicare,40.0,HS_Diploma,NYHA_III,2,582,1,514,1,death,disease,582,ivabradine,PR,72.0,
|
| 255 |
+
HLT004-0000254,heart_failure,Heart Failure,NYHA Class I-IV,2023-10-07,60,Male,White,0,False,0.0,36.2,1,Commercial,43.1,Some_College,NYHA_IV,3,219,0,219,0,lost_to_follow_up,censored,219,ivabradine,SD,,181.0
|
| 256 |
+
HLT004-0000255,heart_failure,Heart Failure,NYHA Class I-IV,2014-07-16,69,Male,Hispanic_Latino,3,True,30.9,36.6,0,Medicare,21.3,HS_Diploma,NYHA_II,1,261,0,261,0,lost_to_follow_up,censored,261,ivabradine,SD,,226.0
|
| 257 |
+
HLT004-0000256,heart_failure,Heart Failure,NYHA Class I-IV,2019-02-28,81,Female,Black_AA,0,False,0.0,27.1,0,Medicaid,23.8,Bachelors_Plus,NYHA_III,2,929,1,588,1,death,disease,929,lvad,CR,71.0,
|
| 258 |
+
HLT004-0000257,heart_failure,Heart Failure,NYHA Class I-IV,2019-04-13,77,Female,White,0,False,0.0,27.8,2,Medicare,30.1,Bachelors_Plus,NYHA_IV,3,677,1,145,1,death,other_cause,677,lvad,PD,,145.0
|
| 259 |
+
HLT004-0000258,heart_failure,Heart Failure,NYHA Class I-IV,2017-11-06,67,Female,Asian,1,False,0.0,33.2,2,Medicare,59.6,Some_College,NYHA_III,2,1066,1,242,1,death,disease,1066,gdmt_core,SD,,160.0
|
| 260 |
+
HLT004-0000259,heart_failure,Heart Failure,NYHA Class I-IV,2022-04-20,70,Female,Hispanic_Latino,1,False,0.0,25.5,3,Medicare,63.6,Bachelors_Plus,NYHA_I,0,249,0,249,0,lost_to_follow_up,censored,249,gdmt_core,PD,,249.0
|
| 261 |
+
HLT004-0000260,heart_failure,Heart Failure,NYHA Class I-IV,2017-12-12,55,Male,White,1,False,0.0,32.7,0,Commercial,63.5,Bachelors_Plus,NYHA_IV,3,742,1,316,1,death,disease,742,gdmt_core,PR,50.0,
|
| 262 |
+
HLT004-0000261,heart_failure,Heart Failure,NYHA Class I-IV,2014-07-21,69,Female,White,1,True,49.5,28.6,4,Medicare,60.5,HS_Diploma,NYHA_I,0,1825,0,717,1,administrative,censored,1825,gdmt_core,PR,57.0,
|
| 263 |
+
HLT004-0000262,heart_failure,Heart Failure,NYHA Class I-IV,2019-06-23,68,Male,White,4,True,14.1,23.1,3,Medicare,27.6,HS_Diploma,NYHA_III,2,776,1,742,1,death,disease,776,ivabradine,PR,59.0,
|
| 264 |
+
HLT004-0000263,heart_failure,Heart Failure,NYHA Class I-IV,2016-01-07,74,Male,Black_AA,1,False,0.0,23.2,2,Commercial,76.7,Some_College,NYHA_III,2,786,0,786,0,lost_to_follow_up,censored,786,gdmt_core,PD,,786.0
|
| 265 |
+
HLT004-0000264,heart_failure,Heart Failure,NYHA Class I-IV,2017-07-19,65,Male,White,1,False,0.0,38.1,1,Medicare,4.6,Less_than_HS,NYHA_III,2,1668,1,429,1,death,disease,1668,ivabradine,PR,60.0,
|
| 266 |
+
HLT004-0000265,heart_failure,Heart Failure,NYHA Class I-IV,2019-01-06,77,Male,White,1,False,0.0,28.1,2,Commercial,58.0,HS_Diploma,NYHA_I,0,195,0,195,0,lost_to_follow_up,censored,195,gdmt_core,PD,,195.0
|
| 267 |
+
HLT004-0000266,heart_failure,Heart Failure,NYHA Class I-IV,2021-03-23,84,Male,Asian,0,False,0.0,39.3,2,Uninsured,43.4,HS_Diploma,NYHA_II,1,134,1,134,1,death,disease,134,ivabradine,SD,,90.0
|
| 268 |
+
HLT004-0000267,heart_failure,Heart Failure,NYHA Class I-IV,2016-10-12,73,Male,Asian,1,False,0.0,25.9,2,Medicaid,13.9,Bachelors_Plus,NYHA_III,2,1259,1,485,1,death,disease,1259,ivabradine,CR,67.0,
|
| 269 |
+
HLT004-0000268,heart_failure,Heart Failure,NYHA Class I-IV,2017-10-21,76,Male,Hispanic_Latino,0,False,0.0,30.9,4,Medicaid,32.2,Some_College,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,ivabradine,PD,,1825.0
|
| 270 |
+
HLT004-0000269,heart_failure,Heart Failure,NYHA Class I-IV,2014-09-05,72,Female,AIAN,1,True,1.0,43.9,4,Commercial,42.6,Bachelors_Plus,NYHA_II,1,674,1,674,1,death,disease,674,ivabradine,SD,,447.0
|
| 271 |
+
HLT004-0000270,heart_failure,Heart Failure,NYHA Class I-IV,2017-11-03,72,Male,Hispanic_Latino,0,True,54.3,22.5,1,Commercial,15.3,HS_Diploma,NYHA_III,2,1596,1,519,1,death,disease,1596,lvad,SD,,415.0
|
| 272 |
+
HLT004-0000271,heart_failure,Heart Failure,NYHA Class I-IV,2019-10-19,63,Male,Hispanic_Latino,4,True,3.3,17.3,2,Medicaid,35.8,HS_Diploma,NYHA_III,2,689,1,689,1,death,disease,689,lvad,SD,,591.0
|
| 273 |
+
HLT004-0000272,heart_failure,Heart Failure,NYHA Class I-IV,2020-03-01,75,Female,Hispanic_Latino,1,True,0.6,37.1,2,Medicaid,19.6,Bachelors_Plus,NYHA_II,1,940,0,940,0,lost_to_follow_up,censored,940,ivabradine,SD,,752.0
|
| 274 |
+
HLT004-0000273,heart_failure,Heart Failure,NYHA Class I-IV,2016-12-06,70,Female,White,2,False,0.0,24.0,3,Medicare,49.2,Less_than_HS,NYHA_II,1,1825,0,1825,0,administrative,censored,1825,gdmt_core,SD,,1457.0
|
| 275 |
+
HLT004-0000274,heart_failure,Heart Failure,NYHA Class I-IV,2014-08-11,95,Female,White,1,False,0.0,29.0,3,Medicare,50.7,Less_than_HS,NYHA_IV,3,590,1,266,1,death,disease,590,gdmt_core,PR,57.0,
|
| 276 |
+
HLT004-0000275,heart_failure,Heart Failure,NYHA Class I-IV,2019-10-09,90,Male,White,0,True,17.9,25.5,3,Commercial,10.3,HS_Diploma,NYHA_II,1,184,1,184,0,death,other_cause,184,lvad,SD,,144.0
|
| 277 |
+
HLT004-0000276,heart_failure,Heart Failure,NYHA Class I-IV,2020-07-20,76,Female,Black_AA,2,False,0.0,30.8,2,Commercial,41.2,Some_College,NYHA_I,0,1825,0,919,1,administrative,censored,1825,lvad,PR,37.0,
|
| 278 |
+
HLT004-0000277,heart_failure,Heart Failure,NYHA Class I-IV,2014-11-07,62,Male,White,1,False,0.0,23.2,7,Commercial,49.8,HS_Diploma,NYHA_II,1,1825,0,144,1,administrative,censored,1825,lvad,SD,,114.0
|
| 279 |
+
HLT004-0000278,heart_failure,Heart Failure,NYHA Class I-IV,2019-01-18,58,Male,White,2,True,15.9,28.0,2,Medicare,5.5,Less_than_HS,NYHA_II,1,527,1,527,1,death,other_cause,527,lvad,PR,51.0,
|
| 280 |
+
HLT004-0000279,heart_failure,Heart Failure,NYHA Class I-IV,2014-12-14,86,Female,White,1,True,8.3,31.9,1,Commercial,49.7,HS_Diploma,NYHA_IV,3,229,1,229,1,death,disease,229,gdmt_core,PR,87.0,
|
| 281 |
+
HLT004-0000280,heart_failure,Heart Failure,NYHA Class I-IV,2018-07-12,75,Male,White,1,True,7.4,22.8,1,Medicare,61.1,HS_Diploma,NYHA_II,1,648,1,648,1,death,other_cause,648,ivabradine,PD,,648.0
|
| 282 |
+
HLT004-0000281,heart_failure,Heart Failure,NYHA Class I-IV,2020-05-28,77,Female,White,2,False,0.0,24.8,1,Medicare,72.1,Less_than_HS,NYHA_I,0,216,0,216,0,lost_to_follow_up,censored,216,lvad,SD,,155.0
|
| 283 |
+
HLT004-0000282,heart_failure,Heart Failure,NYHA Class I-IV,2021-03-10,51,Female,Hispanic_Latino,1,True,53.8,26.9,0,Commercial,47.4,Some_College,NYHA_II,1,603,1,603,1,death,other_cause,603,lvad,SD,,457.0
|
| 284 |
+
HLT004-0000283,heart_failure,Heart Failure,NYHA Class I-IV,2021-02-18,83,Female,Hispanic_Latino,0,True,96.2,20.2,2,Medicaid,17.8,Less_than_HS,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,gdmt_core,PD,,1825.0
|
| 285 |
+
HLT004-0000284,heart_failure,Heart Failure,NYHA Class I-IV,2021-07-30,77,Male,White,1,True,48.4,26.5,0,Commercial,44.6,HS_Diploma,NYHA_II,1,1348,1,387,1,death,other_cause,1348,ivabradine,CR,32.0,
|
| 286 |
+
HLT004-0000285,heart_failure,Heart Failure,NYHA Class I-IV,2016-05-30,58,Male,White,1,False,0.0,29.8,1,Commercial,45.8,Some_College,NYHA_IV,3,453,1,201,1,death,disease,453,gdmt_core,PR,42.0,
|
| 287 |
+
HLT004-0000286,heart_failure,Heart Failure,NYHA Class I-IV,2022-06-16,66,Male,White,3,True,19.6,26.6,2,Commercial,54.5,Bachelors_Plus,NYHA_III,2,380,1,380,1,death,disease,380,lvad,SD,,317.0
|
| 288 |
+
HLT004-0000287,heart_failure,Heart Failure,NYHA Class I-IV,2017-06-30,75,Male,Hispanic_Latino,1,False,0.0,27.4,1,Medicare,72.5,HS_Diploma,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,gdmt_core,PR,56.0,
|
| 289 |
+
HLT004-0000288,heart_failure,Heart Failure,NYHA Class I-IV,2017-09-30,72,Female,Hispanic_Latino,1,True,30.1,29.0,2,Medicare,40.6,HS_Diploma,NYHA_II,1,246,0,246,0,lost_to_follow_up,censored,246,lvad,SD,,209.0
|
| 290 |
+
HLT004-0000289,heart_failure,Heart Failure,NYHA Class I-IV,2021-11-14,68,Male,White,2,False,0.0,25.0,1,Commercial,43.9,HS_Diploma,NYHA_II,1,141,0,141,0,lost_to_follow_up,censored,141,ivabradine,SD,,93.0
|
| 291 |
+
HLT004-0000290,heart_failure,Heart Failure,NYHA Class I-IV,2017-04-08,70,Female,Hispanic_Latino,1,False,0.0,33.4,1,Commercial,39.3,Bachelors_Plus,NYHA_I,0,185,1,185,1,death,other_cause,185,ivabradine,SD,,136.0
|
| 292 |
+
HLT004-0000291,heart_failure,Heart Failure,NYHA Class I-IV,2014-10-01,68,Female,White,2,False,0.0,38.0,2,Medicare,36.4,HS_Diploma,NYHA_III,2,1203,1,1203,1,death,other_cause,1203,lvad,SD,,922.0
|
| 293 |
+
HLT004-0000292,heart_failure,Heart Failure,NYHA Class I-IV,2021-02-20,73,Female,White,1,True,63.1,26.2,3,Commercial,47.7,HS_Diploma,NYHA_II,1,1825,0,1730,1,administrative,censored,1825,gdmt_core,PR,75.0,
|
| 294 |
+
HLT004-0000293,heart_failure,Heart Failure,NYHA Class I-IV,2020-08-13,89,Male,Two_Plus,0,False,0.0,32.1,2,Medicare,21.6,Some_College,NYHA_III,2,945,1,945,1,death,disease,945,lvad,PR,40.0,
|
| 295 |
+
HLT004-0000294,heart_failure,Heart Failure,NYHA Class I-IV,2019-10-25,41,Male,White,2,False,0.0,27.6,2,Medicare,59.8,HS_Diploma,NYHA_IV,3,211,1,65,1,death,disease,211,lvad,SD,,57.0
|
| 296 |
+
HLT004-0000295,heart_failure,Heart Failure,NYHA Class I-IV,2015-06-07,69,Female,White,0,True,42.7,31.4,2,Commercial,47.3,HS_Diploma,NYHA_II,1,124,1,124,1,death,other_cause,124,lvad,SD,,85.0
|
| 297 |
+
HLT004-0000296,heart_failure,Heart Failure,NYHA Class I-IV,2020-04-25,74,Female,White,0,True,0.8,38.8,1,Medicare,43.0,Less_than_HS,NYHA_IV,3,606,1,606,1,death,disease,606,gdmt_core,SD,,414.0
|
| 298 |
+
HLT004-0000297,heart_failure,Heart Failure,NYHA Class I-IV,2015-12-26,75,Female,Black_AA,1,False,0.0,32.3,5,Medicare,18.8,Some_College,NYHA_II,1,1258,0,1258,0,lost_to_follow_up,censored,1258,lvad,SD,,953.0
|
| 299 |
+
HLT004-0000298,heart_failure,Heart Failure,NYHA Class I-IV,2019-07-21,67,Female,Asian,2,False,0.0,18.1,1,Commercial,15.7,Some_College,NYHA_II,1,1534,1,1534,1,death,disease,1534,lvad,PR,50.0,
|
| 300 |
+
HLT004-0000299,heart_failure,Heart Failure,NYHA Class I-IV,2019-01-28,50,Female,NHOPI,2,True,11.3,31.9,0,Commercial,60.8,Some_College,NYHA_III,2,296,1,296,1,death,disease,296,lvad,PD,,296.0
|
| 301 |
+
HLT004-0000300,heart_failure,Heart Failure,NYHA Class I-IV,2021-09-21,75,Male,White,0,True,37.4,36.7,1,Commercial,75.0,Bachelors_Plus,NYHA_I,0,230,0,230,0,lost_to_follow_up,censored,230,ivabradine,PR,78.0,
|
| 302 |
+
HLT004-0000301,heart_failure,Heart Failure,NYHA Class I-IV,2023-10-05,92,Female,White,0,False,0.0,27.7,2,Medicare,47.6,HS_Diploma,NYHA_III,2,1484,1,335,1,death,disease,1484,ivabradine,SD,,254.0
|
| 303 |
+
HLT004-0000302,heart_failure,Heart Failure,NYHA Class I-IV,2015-11-25,53,Male,Hispanic_Latino,3,False,0.0,35.3,1,VA,82.8,Bachelors_Plus,NYHA_III,2,910,1,26,1,death,disease,910,gdmt_core,PR,42.0,
|
| 304 |
+
HLT004-0000303,heart_failure,Heart Failure,NYHA Class I-IV,2015-02-23,82,Female,White,0,False,0.0,24.8,4,Medicaid,61.2,Bachelors_Plus,NYHA_II,1,1208,0,1208,0,lost_to_follow_up,censored,1208,ivabradine,PR,65.0,
|
| 305 |
+
HLT004-0000304,heart_failure,Heart Failure,NYHA Class I-IV,2019-07-22,68,Female,Hispanic_Latino,0,False,0.0,19.9,2,Medicare,18.4,Bachelors_Plus,NYHA_IV,3,381,1,208,1,death,disease,381,gdmt_core,PD,,208.0
|
| 306 |
+
HLT004-0000305,heart_failure,Heart Failure,NYHA Class I-IV,2023-07-07,71,Male,Black_AA,0,False,0.0,30.0,2,Medicare,42.2,Bachelors_Plus,NYHA_II,1,1825,0,211,1,administrative,censored,1825,gdmt_core,PD,,211.0
|
| 307 |
+
HLT004-0000306,heart_failure,Heart Failure,NYHA Class I-IV,2015-08-01,59,Male,White,1,True,56.5,18.2,1,Commercial,29.9,HS_Diploma,NYHA_III,2,875,1,36,1,death,disease,875,gdmt_core,CR,46.0,
|
| 308 |
+
HLT004-0000307,heart_failure,Heart Failure,NYHA Class I-IV,2018-11-14,67,Male,Hispanic_Latino,2,False,0.0,27.6,0,Commercial,47.6,HS_Diploma,NYHA_I,0,456,1,456,0,death,other_cause,456,gdmt_core,PR,88.0,
|
| 309 |
+
HLT004-0000308,heart_failure,Heart Failure,NYHA Class I-IV,2018-01-26,87,Female,White,2,True,22.6,37.1,0,Commercial,40.1,Some_College,NYHA_II,1,594,1,594,1,death,disease,594,lvad,PR,42.0,
|
| 310 |
+
HLT004-0000309,heart_failure,Heart Failure,NYHA Class I-IV,2017-03-06,78,Male,White,1,True,7.6,17.3,5,Commercial,57.4,Less_than_HS,NYHA_II,1,1593,1,1593,1,death,disease,1593,ivabradine,SD,,1221.0
|
| 311 |
+
HLT004-0000310,heart_failure,Heart Failure,NYHA Class I-IV,2020-08-20,92,Male,White,0,True,5.5,21.2,0,Medicare,56.6,Some_College,NYHA_IV,3,31,1,31,1,death,disease,31,gdmt_core,PR,70.0,
|
| 312 |
+
HLT004-0000311,heart_failure,Heart Failure,NYHA Class I-IV,2016-12-14,86,Male,White,1,True,5.4,22.7,1,Medicare,24.6,Less_than_HS,NYHA_I,0,1183,1,1183,1,death,disease,1183,lvad,CR,31.0,
|
| 313 |
+
HLT004-0000312,heart_failure,Heart Failure,NYHA Class I-IV,2018-12-05,77,Male,Black_AA,1,False,0.0,28.7,1,Medicare,39.4,Less_than_HS,NYHA_IV,3,188,1,182,1,death,disease,188,lvad,CR,51.0,
|
| 314 |
+
HLT004-0000313,heart_failure,Heart Failure,NYHA Class I-IV,2022-06-13,92,Male,Black_AA,0,True,40.5,26.8,1,Uninsured,46.0,Bachelors_Plus,NYHA_II,1,1825,0,281,1,administrative,censored,1825,lvad,PD,,281.0
|
| 315 |
+
HLT004-0000314,heart_failure,Heart Failure,NYHA Class I-IV,2017-10-17,77,Male,Two_Plus,0,False,0.0,37.8,1,Medicare,45.8,Some_College,NYHA_II,1,673,1,662,1,death,other_cause,673,lvad,SD,,547.0
|
| 316 |
+
HLT004-0000315,heart_failure,Heart Failure,NYHA Class I-IV,2014-03-19,81,Male,Two_Plus,0,False,0.0,35.0,2,Commercial,61.8,Some_College,NYHA_II,1,1825,0,1825,0,administrative,censored,1825,lvad,PR,73.0,
|
| 317 |
+
HLT004-0000316,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-05,68,Male,White,0,False,0.0,32.2,3,Commercial,18.2,HS_Diploma,NYHA_I,0,83,1,83,1,death,disease,83,ivabradine,PD,,83.0
|
| 318 |
+
HLT004-0000317,heart_failure,Heart Failure,NYHA Class I-IV,2016-09-28,72,Male,White,1,False,0.0,30.0,0,Commercial,21.8,Some_College,NYHA_IV,3,156,1,156,1,death,disease,156,lvad,PR,89.0,
|
| 319 |
+
HLT004-0000318,heart_failure,Heart Failure,NYHA Class I-IV,2021-09-21,63,Male,Black_AA,1,False,0.0,31.5,2,Medicare,22.1,Bachelors_Plus,NYHA_II,1,752,1,752,0,death,other_cause,752,lvad,SD,,620.0
|
| 320 |
+
HLT004-0000319,heart_failure,Heart Failure,NYHA Class I-IV,2021-08-16,83,Male,AIAN,0,False,0.0,23.8,1,Medicare,61.6,Some_College,NYHA_III,2,334,0,334,0,lost_to_follow_up,censored,334,gdmt_core,PR,68.0,
|
| 321 |
+
HLT004-0000320,heart_failure,Heart Failure,NYHA Class I-IV,2019-04-05,57,Female,White,1,True,0.6,34.4,3,Uninsured,58.5,Some_College,NYHA_III,2,180,0,180,0,lost_to_follow_up,censored,180,lvad,PR,87.0,
|
| 322 |
+
HLT004-0000321,heart_failure,Heart Failure,NYHA Class I-IV,2014-11-17,81,Male,White,2,False,0.0,22.2,2,Medicare,23.5,Some_College,NYHA_II,1,1825,0,1740,1,administrative,censored,1825,lvad,PD,,1740.0
|
| 323 |
+
HLT004-0000322,heart_failure,Heart Failure,NYHA Class I-IV,2023-06-30,69,Male,White,2,False,0.0,34.3,0,Medicare,38.1,HS_Diploma,NYHA_III,2,1194,1,550,1,death,disease,1194,lvad,PR,86.0,
|
| 324 |
+
HLT004-0000323,heart_failure,Heart Failure,NYHA Class I-IV,2020-10-21,86,Male,White,2,True,6.6,36.5,3,Medicare,11.0,Some_College,NYHA_IV,3,265,0,265,0,lost_to_follow_up,censored,265,lvad,PD,,265.0
|
| 325 |
+
HLT004-0000324,heart_failure,Heart Failure,NYHA Class I-IV,2018-03-29,81,Male,Black_AA,1,True,36.8,30.4,0,Uninsured,13.4,Bachelors_Plus,NYHA_III,2,64,1,64,0,death,other_cause,64,ivabradine,SD,,39.0
|
| 326 |
+
HLT004-0000325,heart_failure,Heart Failure,NYHA Class I-IV,2022-07-14,93,Male,White,2,True,2.4,28.0,3,Commercial,21.4,Some_College,NYHA_III,2,701,1,569,1,death,disease,701,ivabradine,PR,34.0,
|
| 327 |
+
HLT004-0000326,heart_failure,Heart Failure,NYHA Class I-IV,2021-11-16,80,Male,Hispanic_Latino,0,False,0.0,31.6,1,Medicare,60.5,HS_Diploma,NYHA_III,2,532,1,532,1,death,disease,532,ivabradine,PR,88.0,
|
| 328 |
+
HLT004-0000327,heart_failure,Heart Failure,NYHA Class I-IV,2021-08-07,53,Female,Hispanic_Latino,1,False,0.0,15.0,1,Medicare,52.0,Some_College,NYHA_III,2,643,1,431,1,death,disease,643,lvad,PR,71.0,
|
| 329 |
+
HLT004-0000328,heart_failure,Heart Failure,NYHA Class I-IV,2015-09-05,71,Male,Hispanic_Latino,0,True,52.5,31.0,0,Medicare,23.0,Some_College,NYHA_II,1,965,1,965,0,death,other_cause,965,lvad,SD,,761.0
|
| 330 |
+
HLT004-0000329,heart_failure,Heart Failure,NYHA Class I-IV,2020-04-28,57,Male,White,1,False,0.0,28.4,1,Medicare,26.5,Bachelors_Plus,NYHA_III,2,467,1,467,1,death,disease,467,lvad,PR,64.0,
|
| 331 |
+
HLT004-0000330,heart_failure,Heart Failure,NYHA Class I-IV,2016-11-09,65,Male,White,1,False,0.0,28.8,1,Medicare,16.6,Some_College,NYHA_II,1,1825,0,1825,0,administrative,censored,1825,lvad,SD,,1407.0
|
| 332 |
+
HLT004-0000331,heart_failure,Heart Failure,NYHA Class I-IV,2014-10-14,90,Male,Hispanic_Latino,0,True,45.2,33.5,2,Medicare,23.2,HS_Diploma,NYHA_III,2,672,1,89,1,death,disease,672,lvad,PR,73.0,
|
| 333 |
+
HLT004-0000332,heart_failure,Heart Failure,NYHA Class I-IV,2017-05-19,79,Male,Hispanic_Latino,2,False,0.0,28.6,1,Medicare,28.5,HS_Diploma,NYHA_IV,3,64,1,64,1,death,disease,64,gdmt_core,CR,65.0,
|
| 334 |
+
HLT004-0000333,heart_failure,Heart Failure,NYHA Class I-IV,2015-01-15,63,Female,White,0,True,6.0,22.0,1,Uninsured,44.4,Some_College,NYHA_IV,3,854,1,121,1,death,disease,854,lvad,PR,45.0,
|
| 335 |
+
HLT004-0000334,heart_failure,Heart Failure,NYHA Class I-IV,2015-01-22,59,Female,Hispanic_Latino,0,False,0.0,28.2,0,Commercial,35.6,Less_than_HS,NYHA_III,2,30,0,30,0,lost_to_follow_up,censored,30,gdmt_core,SD,,19.0
|
| 336 |
+
HLT004-0000335,heart_failure,Heart Failure,NYHA Class I-IV,2021-04-07,72,Male,White,0,False,0.0,29.5,2,Uninsured,5.9,Some_College,NYHA_III,2,1,1,1,0,death,other_cause,1,ivabradine,PD,,1.0
|
| 337 |
+
HLT004-0000336,heart_failure,Heart Failure,NYHA Class I-IV,2019-01-06,57,Male,Hispanic_Latino,1,True,35.1,29.8,0,Medicare,17.5,Bachelors_Plus,NYHA_III,2,901,1,895,1,death,disease,901,gdmt_core,PD,,895.0
|
| 338 |
+
HLT004-0000337,heart_failure,Heart Failure,NYHA Class I-IV,2017-12-23,63,Male,White,0,False,0.0,30.1,3,Medicaid,58.3,Some_College,NYHA_II,1,1336,1,692,1,death,disease,1336,ivabradine,PR,48.0,
|
| 339 |
+
HLT004-0000338,heart_failure,Heart Failure,NYHA Class I-IV,2015-12-03,75,Male,White,1,False,0.0,35.5,1,Medicare,41.4,HS_Diploma,NYHA_II,1,286,0,286,0,lost_to_follow_up,censored,286,ivabradine,PR,84.0,
|
| 340 |
+
HLT004-0000339,heart_failure,Heart Failure,NYHA Class I-IV,2021-09-14,85,Female,White,0,False,0.0,22.4,0,Medicare,31.7,Bachelors_Plus,NYHA_II,1,1303,0,1303,0,lost_to_follow_up,censored,1303,gdmt_core,SD,,794.0
|
| 341 |
+
HLT004-0000340,heart_failure,Heart Failure,NYHA Class I-IV,2020-05-03,79,Male,White,2,False,0.0,30.2,2,Commercial,47.0,Some_College,NYHA_I,0,1529,0,1495,1,lost_to_follow_up,censored,1529,lvad,PR,35.0,
|
| 342 |
+
HLT004-0000341,heart_failure,Heart Failure,NYHA Class I-IV,2019-11-08,44,Male,White,3,False,0.0,37.1,1,Medicare,27.2,HS_Diploma,NYHA_IV,3,346,1,166,1,death,disease,346,lvad,SD,,124.0
|
| 343 |
+
HLT004-0000342,heart_failure,Heart Failure,NYHA Class I-IV,2015-11-25,75,Female,White,1,True,11.8,18.3,3,Commercial,58.1,Some_College,NYHA_IV,3,307,1,146,1,death,disease,307,gdmt_core,CR,78.0,
|
| 344 |
+
HLT004-0000343,heart_failure,Heart Failure,NYHA Class I-IV,2015-03-27,72,Male,White,1,False,0.0,30.2,1,Medicare,44.1,Some_College,NYHA_II,1,24,1,24,1,death,disease,24,lvad,PR,62.0,
|
| 345 |
+
HLT004-0000344,heart_failure,Heart Failure,NYHA Class I-IV,2015-03-27,76,Male,Hispanic_Latino,2,False,0.0,25.5,0,Uninsured,28.6,Bachelors_Plus,NYHA_II,1,1273,1,1273,1,death,disease,1273,ivabradine,SD,,1131.0
|
| 346 |
+
HLT004-0000345,heart_failure,Heart Failure,NYHA Class I-IV,2014-04-02,91,Female,White,4,False,0.0,26.8,1,Medicare,80.3,HS_Diploma,NYHA_III,2,1297,1,1297,1,death,disease,1297,gdmt_core,PR,85.0,
|
| 347 |
+
HLT004-0000346,heart_failure,Heart Failure,NYHA Class I-IV,2023-09-08,47,Male,Black_AA,1,False,0.0,23.5,1,Medicare,36.7,HS_Diploma,NYHA_II,1,146,1,146,1,death,disease,146,gdmt_core,PR,81.0,
|
| 348 |
+
HLT004-0000347,heart_failure,Heart Failure,NYHA Class I-IV,2017-09-04,64,Male,Hispanic_Latino,2,False,0.0,28.0,0,Medicare,61.7,Some_College,NYHA_III,2,366,0,366,0,lost_to_follow_up,censored,366,lvad,PR,72.0,
|
| 349 |
+
HLT004-0000348,heart_failure,Heart Failure,NYHA Class I-IV,2020-07-30,79,Male,White,2,True,8.0,40.5,0,VA,58.9,Less_than_HS,NYHA_IV,3,374,1,160,1,death,disease,374,lvad,CR,89.0,
|
| 350 |
+
HLT004-0000349,heart_failure,Heart Failure,NYHA Class I-IV,2023-10-26,53,Female,White,2,False,0.0,21.3,2,Commercial,18.1,Some_College,NYHA_II,1,30,0,30,0,lost_to_follow_up,censored,30,lvad,PD,,30.0
|
| 351 |
+
HLT004-0000350,heart_failure,Heart Failure,NYHA Class I-IV,2023-05-12,89,Male,Hispanic_Latino,1,True,66.5,21.8,1,VA,26.9,Bachelors_Plus,NYHA_II,1,1591,0,1318,1,lost_to_follow_up,censored,1591,lvad,PR,61.0,
|
| 352 |
+
HLT004-0000351,heart_failure,Heart Failure,NYHA Class I-IV,2017-03-16,76,Male,Hispanic_Latino,0,False,0.0,21.0,1,Medicare,72.3,HS_Diploma,NYHA_II,1,1825,0,1825,0,administrative,censored,1825,ivabradine,SD,,1245.0
|
| 353 |
+
HLT004-0000352,heart_failure,Heart Failure,NYHA Class I-IV,2018-11-24,82,Male,White,0,False,0.0,39.8,3,Commercial,30.0,Some_College,NYHA_I,0,1825,0,524,1,administrative,censored,1825,lvad,SD,,424.0
|
| 354 |
+
HLT004-0000353,heart_failure,Heart Failure,NYHA Class I-IV,2018-08-18,65,Male,Hispanic_Latino,1,False,0.0,26.2,0,Medicare,42.8,Bachelors_Plus,NYHA_II,1,772,1,772,1,death,disease,772,lvad,PR,38.0,
|
| 355 |
+
HLT004-0000354,heart_failure,Heart Failure,NYHA Class I-IV,2014-05-02,81,Female,White,1,False,0.0,28.9,0,Commercial,25.5,Some_College,NYHA_I,0,1005,1,1005,1,death,disease,1005,ivabradine,PD,,1005.0
|
| 356 |
+
HLT004-0000355,heart_failure,Heart Failure,NYHA Class I-IV,2021-09-05,84,Male,White,1,True,3.2,26.6,2,VA,50.2,Some_College,NYHA_I,0,7,1,7,0,death,other_cause,7,gdmt_core,CR,67.0,
|
| 357 |
+
HLT004-0000356,heart_failure,Heart Failure,NYHA Class I-IV,2019-09-28,74,Female,Hispanic_Latino,1,False,0.0,23.2,2,Commercial,25.7,Some_College,NYHA_II,1,720,0,720,0,lost_to_follow_up,censored,720,gdmt_core,CR,38.0,
|
| 358 |
+
HLT004-0000357,heart_failure,Heart Failure,NYHA Class I-IV,2017-09-17,74,Female,White,1,False,0.0,27.6,0,Commercial,59.9,HS_Diploma,NYHA_II,1,219,1,219,1,death,disease,219,ivabradine,CR,51.0,
|
| 359 |
+
HLT004-0000358,heart_failure,Heart Failure,NYHA Class I-IV,2019-07-31,75,Female,Hispanic_Latino,2,True,4.6,44.3,2,Commercial,46.5,HS_Diploma,NYHA_III,2,322,0,81,1,lost_to_follow_up,censored,322,lvad,SD,,61.0
|
| 360 |
+
HLT004-0000359,heart_failure,Heart Failure,NYHA Class I-IV,2021-05-08,61,Male,White,0,True,5.2,37.7,6,Medicaid,50.1,Some_College,NYHA_I,0,289,0,98,1,lost_to_follow_up,censored,289,gdmt_core,SD,,78.0
|
| 361 |
+
HLT004-0000360,heart_failure,Heart Failure,NYHA Class I-IV,2014-02-24,70,Female,Hispanic_Latino,0,True,6.5,23.8,4,Commercial,60.6,HS_Diploma,NYHA_IV,3,259,1,259,1,death,disease,259,lvad,CR,33.0,
|
| 362 |
+
HLT004-0000361,heart_failure,Heart Failure,NYHA Class I-IV,2020-06-16,70,Female,White,2,False,0.0,33.1,2,Medicare,42.9,HS_Diploma,NYHA_II,1,1177,1,1177,0,death,other_cause,1177,lvad,SD,,936.0
|
| 363 |
+
HLT004-0000362,heart_failure,Heart Failure,NYHA Class I-IV,2022-08-10,76,Male,White,2,False,0.0,23.9,3,Commercial,32.0,Less_than_HS,NYHA_I,0,685,1,685,1,death,disease,685,ivabradine,SD,,461.0
|
| 364 |
+
HLT004-0000363,heart_failure,Heart Failure,NYHA Class I-IV,2021-04-05,83,Female,White,4,False,0.0,18.1,5,Commercial,14.0,Bachelors_Plus,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,gdmt_core,SD,,1136.0
|
| 365 |
+
HLT004-0000364,heart_failure,Heart Failure,NYHA Class I-IV,2020-03-12,59,Female,White,2,True,0.3,35.4,0,Medicaid,59.2,Less_than_HS,NYHA_III,2,258,1,62,1,death,disease,258,gdmt_core,SD,,39.0
|
| 366 |
+
HLT004-0000365,heart_failure,Heart Failure,NYHA Class I-IV,2014-11-27,70,Male,Hispanic_Latino,2,False,0.0,36.3,2,Medicaid,62.2,Bachelors_Plus,NYHA_II,1,95,1,95,1,death,disease,95,ivabradine,SD,,68.0
|
| 367 |
+
HLT004-0000366,heart_failure,Heart Failure,NYHA Class I-IV,2021-06-11,89,Female,White,0,True,20.1,35.6,2,Uninsured,78.4,HS_Diploma,NYHA_II,1,349,1,349,1,death,other_cause,349,lvad,SD,,214.0
|
| 368 |
+
HLT004-0000367,heart_failure,Heart Failure,NYHA Class I-IV,2021-07-02,63,Male,White,1,False,0.0,26.2,0,Medicare,51.4,Some_College,NYHA_I,0,552,1,552,1,death,disease,552,ivabradine,SD,,355.0
|
| 369 |
+
HLT004-0000368,heart_failure,Heart Failure,NYHA Class I-IV,2018-12-08,62,Female,White,0,True,1.4,28.1,2,Medicaid,19.2,HS_Diploma,NYHA_IV,3,518,1,304,1,death,disease,518,gdmt_core,SD,,193.0
|
| 370 |
+
HLT004-0000369,heart_failure,Heart Failure,NYHA Class I-IV,2019-10-28,74,Female,White,1,False,0.0,33.7,1,Commercial,70.5,HS_Diploma,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,ivabradine,CR,72.0,
|
| 371 |
+
HLT004-0000370,heart_failure,Heart Failure,NYHA Class I-IV,2020-03-07,82,Male,Hispanic_Latino,3,False,0.0,31.5,2,Medicare,30.5,Some_College,NYHA_II,1,1387,1,57,1,death,disease,1387,gdmt_core,CR,43.0,
|
| 372 |
+
HLT004-0000371,heart_failure,Heart Failure,NYHA Class I-IV,2015-03-19,72,Female,White,0,True,10.9,26.7,0,Commercial,28.0,Some_College,NYHA_IV,3,240,1,240,1,death,disease,240,gdmt_core,SD,,202.0
|
| 373 |
+
HLT004-0000372,heart_failure,Heart Failure,NYHA Class I-IV,2016-07-28,87,Male,Two_Plus,1,False,0.0,19.1,3,Medicare,49.6,HS_Diploma,NYHA_II,1,1070,1,1070,1,death,disease,1070,ivabradine,PD,,1070.0
|
| 374 |
+
HLT004-0000373,heart_failure,Heart Failure,NYHA Class I-IV,2021-12-01,82,Female,White,0,False,0.0,29.8,1,Medicare,24.2,Some_College,NYHA_II,1,367,0,367,0,lost_to_follow_up,censored,367,ivabradine,PR,61.0,
|
| 375 |
+
HLT004-0000374,heart_failure,Heart Failure,NYHA Class I-IV,2023-09-25,82,Female,Black_AA,0,True,39.5,35.8,2,Medicaid,51.0,Some_College,NYHA_III,2,912,1,912,1,death,disease,912,ivabradine,SD,,584.0
|
| 376 |
+
HLT004-0000375,heart_failure,Heart Failure,NYHA Class I-IV,2016-09-12,78,Male,White,0,True,19.0,21.7,2,Commercial,31.4,HS_Diploma,NYHA_II,1,1821,1,543,1,death,disease,1821,lvad,SD,,341.0
|
| 377 |
+
HLT004-0000376,heart_failure,Heart Failure,NYHA Class I-IV,2018-01-02,95,Male,White,0,False,0.0,33.1,1,Medicaid,65.0,Some_College,NYHA_I,0,551,0,551,0,lost_to_follow_up,censored,551,gdmt_core,PD,,551.0
|
| 378 |
+
HLT004-0000377,heart_failure,Heart Failure,NYHA Class I-IV,2023-02-23,69,Male,Hispanic_Latino,3,True,8.9,31.2,2,Medicaid,53.5,HS_Diploma,NYHA_II,1,142,0,142,0,lost_to_follow_up,censored,142,lvad,SD,,106.0
|
| 379 |
+
HLT004-0000378,heart_failure,Heart Failure,NYHA Class I-IV,2015-08-16,47,Male,AIAN,1,True,19.4,33.8,4,Medicaid,15.5,Some_College,NYHA_I,0,1488,0,561,1,lost_to_follow_up,censored,1488,gdmt_core,PR,40.0,
|
| 380 |
+
HLT004-0000379,heart_failure,Heart Failure,NYHA Class I-IV,2016-08-11,91,Male,Hispanic_Latino,2,False,0.0,34.5,4,Commercial,57.8,Less_than_HS,NYHA_IV,3,469,1,469,1,death,disease,469,gdmt_core,PR,73.0,
|
| 381 |
+
HLT004-0000380,heart_failure,Heart Failure,NYHA Class I-IV,2014-07-24,66,Male,White,1,False,0.0,24.8,2,Medicaid,32.8,Some_College,NYHA_III,2,1229,1,1229,1,death,disease,1229,lvad,SD,,932.0
|
| 382 |
+
HLT004-0000381,heart_failure,Heart Failure,NYHA Class I-IV,2016-05-06,73,Male,White,0,True,20.8,19.1,2,Commercial,82.9,HS_Diploma,NYHA_III,2,578,0,216,1,lost_to_follow_up,censored,578,lvad,PR,71.0,
|
| 383 |
+
HLT004-0000382,heart_failure,Heart Failure,NYHA Class I-IV,2020-05-11,87,Male,Black_AA,0,True,27.8,25.8,3,Commercial,32.3,Some_College,NYHA_II,1,543,1,543,1,death,disease,543,gdmt_core,PR,40.0,
|
| 384 |
+
HLT004-0000383,heart_failure,Heart Failure,NYHA Class I-IV,2017-06-25,52,Female,White,2,False,0.0,34.6,1,Commercial,51.6,Some_College,NYHA_III,2,771,1,441,1,death,disease,771,ivabradine,PD,,441.0
|
| 385 |
+
HLT004-0000384,heart_failure,Heart Failure,NYHA Class I-IV,2023-10-30,56,Female,Hispanic_Latino,0,False,0.0,25.7,0,Medicaid,35.4,Bachelors_Plus,NYHA_III,2,280,0,280,0,lost_to_follow_up,censored,280,lvad,PR,61.0,
|
| 386 |
+
HLT004-0000385,heart_failure,Heart Failure,NYHA Class I-IV,2022-11-29,52,Female,White,3,False,0.0,24.8,0,Uninsured,31.5,Some_College,NYHA_I,0,555,0,555,0,lost_to_follow_up,censored,555,lvad,PD,,555.0
|
| 387 |
+
HLT004-0000386,heart_failure,Heart Failure,NYHA Class I-IV,2022-12-14,62,Male,White,0,False,0.0,17.8,0,Medicare,34.9,Bachelors_Plus,NYHA_IV,3,247,1,161,1,death,disease,247,ivabradine,PR,86.0,
|
| 388 |
+
HLT004-0000387,heart_failure,Heart Failure,NYHA Class I-IV,2021-04-05,77,Female,Hispanic_Latino,1,False,0.0,40.0,0,Medicaid,64.4,HS_Diploma,NYHA_III,2,320,0,320,0,lost_to_follow_up,censored,320,gdmt_core,SD,,252.0
|
| 389 |
+
HLT004-0000388,heart_failure,Heart Failure,NYHA Class I-IV,2021-01-06,78,Female,Black_AA,2,False,0.0,34.2,3,Commercial,33.5,HS_Diploma,NYHA_III,2,1117,1,86,1,death,disease,1117,ivabradine,PR,33.0,
|
| 390 |
+
HLT004-0000389,heart_failure,Heart Failure,NYHA Class I-IV,2019-02-04,75,Male,White,0,True,32.2,33.9,1,Medicare,22.4,Less_than_HS,NYHA_II,1,1825,0,679,1,administrative,censored,1825,gdmt_core,PR,30.0,
|
| 391 |
+
HLT004-0000390,heart_failure,Heart Failure,NYHA Class I-IV,2023-11-25,55,Male,White,0,False,0.0,35.1,0,Medicare,54.8,Some_College,NYHA_I,0,1825,0,1825,0,administrative,censored,1825,gdmt_core,CR,65.0,
|
| 392 |
+
HLT004-0000391,heart_failure,Heart Failure,NYHA Class I-IV,2014-12-15,44,Female,Black_AA,3,False,0.0,32.7,0,Medicaid,27.9,Some_College,NYHA_III,2,378,1,378,1,death,disease,378,lvad,SD,,245.0
|
| 393 |
+
HLT004-0000392,heart_failure,Heart Failure,NYHA Class I-IV,2021-03-23,72,Male,White,0,True,31.0,27.6,1,Medicare,62.1,Bachelors_Plus,NYHA_III,2,577,1,519,1,death,disease,577,lvad,SD,,459.0
|
| 394 |
+
HLT004-0000393,heart_failure,Heart Failure,NYHA Class I-IV,2015-05-27,66,Male,White,1,True,5.8,28.1,0,Medicaid,51.2,Some_College,NYHA_II,1,55,1,55,1,death,other_cause,55,gdmt_core,SD,,45.0
|
| 395 |
+
HLT004-0000394,heart_failure,Heart Failure,NYHA Class I-IV,2017-05-23,77,Female,White,1,False,0.0,26.4,0,Commercial,47.5,Some_College,NYHA_I,0,1641,0,1641,0,lost_to_follow_up,censored,1641,lvad,SD,,1095.0
|
| 396 |
+
HLT004-0000395,heart_failure,Heart Failure,NYHA Class I-IV,2016-07-22,80,Male,Hispanic_Latino,0,True,120.0,45.4,4,Uninsured,54.6,HS_Diploma,NYHA_III,2,368,1,297,1,death,disease,368,lvad,PR,86.0,
|
| 397 |
+
HLT004-0000396,heart_failure,Heart Failure,NYHA Class I-IV,2020-01-04,73,Male,Hispanic_Latino,2,True,2.1,32.5,0,VA,70.1,Less_than_HS,NYHA_II,1,1825,0,1825,0,administrative,censored,1825,lvad,SD,,1526.0
|
| 398 |
+
HLT004-0000397,heart_failure,Heart Failure,NYHA Class I-IV,2021-11-13,81,Female,White,2,True,29.5,26.2,1,Commercial,46.3,Bachelors_Plus,NYHA_II,1,502,1,502,1,death,other_cause,502,ivabradine,PD,,502.0
|
| 399 |
+
HLT004-0000398,heart_failure,Heart Failure,NYHA Class I-IV,2014-10-19,74,Female,White,1,False,0.0,32.0,1,Medicaid,30.8,HS_Diploma,NYHA_III,2,756,0,489,1,lost_to_follow_up,censored,756,ivabradine,PR,49.0,
|
| 400 |
+
HLT004-0000399,heart_failure,Heart Failure,NYHA Class I-IV,2020-01-06,78,Male,White,2,False,0.0,22.8,1,Uninsured,65.5,Less_than_HS,NYHA_I,0,613,1,613,1,death,disease,613,gdmt_core,SD,,372.0
|
| 401 |
+
HLT004-0000400,heart_failure,Heart Failure,NYHA Class I-IV,2016-03-20,63,Female,White,0,False,0.0,38.4,4,Medicare,53.2,Bachelors_Plus,NYHA_I,0,424,0,424,0,lost_to_follow_up,censored,424,gdmt_core,SD,,357.0
|
heart_failure/hlt004_events.csv
ADDED
|
@@ -0,0 +1,1970 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
patient_id,event_type,event_day,event_detail
|
| 2 |
+
HLT004-0000001,diagnosis,0,NYHA_IV
|
| 3 |
+
HLT004-0000001,treatment_start_1L,15,lvad
|
| 4 |
+
HLT004-0000001,treatment_end_1L,448,completed_or_discontinued
|
| 5 |
+
HLT004-0000001,response_assessment,49,PR
|
| 6 |
+
HLT004-0000001,os_endpoint,448,disease
|
| 7 |
+
HLT004-0000002,diagnosis,0,NYHA_III
|
| 8 |
+
HLT004-0000002,treatment_start_1L,7,ivabradine
|
| 9 |
+
HLT004-0000002,treatment_end_1L,576,completed_or_discontinued
|
| 10 |
+
HLT004-0000002,response_assessment,41,PR
|
| 11 |
+
HLT004-0000002,os_endpoint,576,disease
|
| 12 |
+
HLT004-0000003,diagnosis,0,NYHA_II
|
| 13 |
+
HLT004-0000003,treatment_start_1L,20,gdmt_core
|
| 14 |
+
HLT004-0000003,treatment_end_1L,1825,completed_or_discontinued
|
| 15 |
+
HLT004-0000003,progression,974,radiographic_progression
|
| 16 |
+
HLT004-0000003,os_endpoint,1825,censored
|
| 17 |
+
HLT004-0000004,diagnosis,0,NYHA_III
|
| 18 |
+
HLT004-0000004,treatment_start_1L,27,gdmt_core
|
| 19 |
+
HLT004-0000004,treatment_end_1L,1125,completed_or_discontinued
|
| 20 |
+
HLT004-0000004,progression,791,radiographic_progression
|
| 21 |
+
HLT004-0000004,os_endpoint,1125,censored
|
| 22 |
+
HLT004-0000005,diagnosis,0,NYHA_II
|
| 23 |
+
HLT004-0000005,treatment_start_1L,16,lvad
|
| 24 |
+
HLT004-0000005,treatment_end_1L,1825,completed_or_discontinued
|
| 25 |
+
HLT004-0000005,progression,1106,radiographic_progression
|
| 26 |
+
HLT004-0000005,os_endpoint,1825,censored
|
| 27 |
+
HLT004-0000006,diagnosis,0,NYHA_II
|
| 28 |
+
HLT004-0000006,treatment_start_1L,21,gdmt_core
|
| 29 |
+
HLT004-0000006,treatment_end_1L,155,completed_or_discontinued
|
| 30 |
+
HLT004-0000006,response_assessment,54,PR
|
| 31 |
+
HLT004-0000006,os_endpoint,155,other_cause
|
| 32 |
+
HLT004-0000007,diagnosis,0,NYHA_II
|
| 33 |
+
HLT004-0000007,treatment_start_1L,20,lvad
|
| 34 |
+
HLT004-0000007,treatment_end_1L,772,completed_or_discontinued
|
| 35 |
+
HLT004-0000007,progression,565,radiographic_progression
|
| 36 |
+
HLT004-0000007,os_endpoint,772,censored
|
| 37 |
+
HLT004-0000008,diagnosis,0,NYHA_IV
|
| 38 |
+
HLT004-0000008,treatment_start_1L,23,ivabradine
|
| 39 |
+
HLT004-0000008,treatment_end_1L,66,completed_or_discontinued
|
| 40 |
+
HLT004-0000008,response_assessment,52,PR
|
| 41 |
+
HLT004-0000008,os_endpoint,66,censored
|
| 42 |
+
HLT004-0000009,diagnosis,0,NYHA_IV
|
| 43 |
+
HLT004-0000009,treatment_start_1L,27,gdmt_core
|
| 44 |
+
HLT004-0000009,treatment_end_1L,351,completed_or_discontinued
|
| 45 |
+
HLT004-0000009,response_assessment,67,PR
|
| 46 |
+
HLT004-0000009,os_endpoint,351,disease
|
| 47 |
+
HLT004-0000010,diagnosis,0,NYHA_III
|
| 48 |
+
HLT004-0000010,treatment_start_1L,12,lvad
|
| 49 |
+
HLT004-0000010,treatment_end_1L,1414,completed_or_discontinued
|
| 50 |
+
HLT004-0000010,response_assessment,55,PR
|
| 51 |
+
HLT004-0000010,os_endpoint,1414,censored
|
| 52 |
+
HLT004-0000011,diagnosis,0,NYHA_I
|
| 53 |
+
HLT004-0000011,treatment_start_1L,24,gdmt_core
|
| 54 |
+
HLT004-0000011,treatment_end_1L,1758,completed_or_discontinued
|
| 55 |
+
HLT004-0000011,response_assessment,62,PR
|
| 56 |
+
HLT004-0000011,os_endpoint,1758,other_cause
|
| 57 |
+
HLT004-0000012,diagnosis,0,NYHA_II
|
| 58 |
+
HLT004-0000012,treatment_start_1L,19,lvad
|
| 59 |
+
HLT004-0000012,treatment_end_1L,68,completed_or_discontinued
|
| 60 |
+
HLT004-0000012,response_assessment,82,PR
|
| 61 |
+
HLT004-0000012,os_endpoint,68,other_cause
|
| 62 |
+
HLT004-0000013,diagnosis,0,NYHA_II
|
| 63 |
+
HLT004-0000013,treatment_start_1L,10,lvad
|
| 64 |
+
HLT004-0000013,treatment_end_1L,596,completed_or_discontinued
|
| 65 |
+
HLT004-0000013,progression,430,radiographic_progression
|
| 66 |
+
HLT004-0000013,os_endpoint,596,disease
|
| 67 |
+
HLT004-0000014,diagnosis,0,NYHA_IV
|
| 68 |
+
HLT004-0000014,treatment_start_1L,11,gdmt_core
|
| 69 |
+
HLT004-0000014,treatment_end_1L,253,completed_or_discontinued
|
| 70 |
+
HLT004-0000014,progression,152,radiographic_progression
|
| 71 |
+
HLT004-0000014,os_endpoint,253,disease
|
| 72 |
+
HLT004-0000015,diagnosis,0,NYHA_I
|
| 73 |
+
HLT004-0000015,treatment_start_1L,10,ivabradine
|
| 74 |
+
HLT004-0000015,treatment_end_1L,1108,completed_or_discontinued
|
| 75 |
+
HLT004-0000015,response_assessment,56,PR
|
| 76 |
+
HLT004-0000015,os_endpoint,1108,other_cause
|
| 77 |
+
HLT004-0000016,diagnosis,0,NYHA_I
|
| 78 |
+
HLT004-0000016,treatment_start_1L,24,ivabradine
|
| 79 |
+
HLT004-0000016,treatment_end_1L,836,completed_or_discontinued
|
| 80 |
+
HLT004-0000016,response_assessment,74,PR
|
| 81 |
+
HLT004-0000016,os_endpoint,836,disease
|
| 82 |
+
HLT004-0000017,diagnosis,0,NYHA_III
|
| 83 |
+
HLT004-0000017,treatment_start_1L,13,lvad
|
| 84 |
+
HLT004-0000017,treatment_end_1L,1312,completed_or_discontinued
|
| 85 |
+
HLT004-0000017,progression,318,radiographic_progression
|
| 86 |
+
HLT004-0000017,os_endpoint,1312,censored
|
| 87 |
+
HLT004-0000018,diagnosis,0,NYHA_II
|
| 88 |
+
HLT004-0000018,treatment_start_1L,7,ivabradine
|
| 89 |
+
HLT004-0000018,treatment_end_1L,863,completed_or_discontinued
|
| 90 |
+
HLT004-0000018,response_assessment,51,PR
|
| 91 |
+
HLT004-0000018,os_endpoint,863,other_cause
|
| 92 |
+
HLT004-0000019,diagnosis,0,NYHA_III
|
| 93 |
+
HLT004-0000019,treatment_start_1L,24,ivabradine
|
| 94 |
+
HLT004-0000019,treatment_end_1L,1016,completed_or_discontinued
|
| 95 |
+
HLT004-0000019,progression,439,radiographic_progression
|
| 96 |
+
HLT004-0000019,os_endpoint,1016,disease
|
| 97 |
+
HLT004-0000020,diagnosis,0,NYHA_I
|
| 98 |
+
HLT004-0000020,treatment_start_1L,23,lvad
|
| 99 |
+
HLT004-0000020,treatment_end_1L,468,completed_or_discontinued
|
| 100 |
+
HLT004-0000020,response_assessment,87,CR
|
| 101 |
+
HLT004-0000020,os_endpoint,468,disease
|
| 102 |
+
HLT004-0000021,diagnosis,0,NYHA_III
|
| 103 |
+
HLT004-0000021,treatment_start_1L,14,gdmt_core
|
| 104 |
+
HLT004-0000021,treatment_end_1L,50,completed_or_discontinued
|
| 105 |
+
HLT004-0000021,progression,44,radiographic_progression
|
| 106 |
+
HLT004-0000021,os_endpoint,50,censored
|
| 107 |
+
HLT004-0000022,diagnosis,0,NYHA_I
|
| 108 |
+
HLT004-0000022,treatment_start_1L,28,ivabradine
|
| 109 |
+
HLT004-0000022,treatment_end_1L,598,completed_or_discontinued
|
| 110 |
+
HLT004-0000022,response_assessment,31,PR
|
| 111 |
+
HLT004-0000022,os_endpoint,598,other_cause
|
| 112 |
+
HLT004-0000023,diagnosis,0,NYHA_I
|
| 113 |
+
HLT004-0000023,treatment_start_1L,10,gdmt_core
|
| 114 |
+
HLT004-0000023,treatment_end_1L,1825,completed_or_discontinued
|
| 115 |
+
HLT004-0000023,response_assessment,86,PR
|
| 116 |
+
HLT004-0000023,os_endpoint,1825,censored
|
| 117 |
+
HLT004-0000024,diagnosis,0,NYHA_II
|
| 118 |
+
HLT004-0000024,treatment_start_1L,11,ivabradine
|
| 119 |
+
HLT004-0000024,treatment_end_1L,1811,completed_or_discontinued
|
| 120 |
+
HLT004-0000024,response_assessment,37,PR
|
| 121 |
+
HLT004-0000024,os_endpoint,1825,censored
|
| 122 |
+
HLT004-0000025,diagnosis,0,NYHA_II
|
| 123 |
+
HLT004-0000025,treatment_start_1L,9,ivabradine
|
| 124 |
+
HLT004-0000025,treatment_end_1L,1269,completed_or_discontinued
|
| 125 |
+
HLT004-0000025,response_assessment,75,CR
|
| 126 |
+
HLT004-0000025,os_endpoint,1269,disease
|
| 127 |
+
HLT004-0000026,diagnosis,0,NYHA_III
|
| 128 |
+
HLT004-0000026,treatment_start_1L,19,lvad
|
| 129 |
+
HLT004-0000026,treatment_end_1L,673,completed_or_discontinued
|
| 130 |
+
HLT004-0000026,progression,273,radiographic_progression
|
| 131 |
+
HLT004-0000026,os_endpoint,673,censored
|
| 132 |
+
HLT004-0000027,diagnosis,0,NYHA_I
|
| 133 |
+
HLT004-0000027,treatment_start_1L,7,ivabradine
|
| 134 |
+
HLT004-0000027,treatment_end_1L,253,completed_or_discontinued
|
| 135 |
+
HLT004-0000027,response_assessment,73,CR
|
| 136 |
+
HLT004-0000027,os_endpoint,253,censored
|
| 137 |
+
HLT004-0000028,diagnosis,0,NYHA_I
|
| 138 |
+
HLT004-0000028,treatment_start_1L,23,gdmt_core
|
| 139 |
+
HLT004-0000028,treatment_end_1L,801,completed_or_discontinued
|
| 140 |
+
HLT004-0000028,response_assessment,39,PR
|
| 141 |
+
HLT004-0000028,os_endpoint,801,censored
|
| 142 |
+
HLT004-0000029,diagnosis,0,NYHA_III
|
| 143 |
+
HLT004-0000029,treatment_start_1L,9,lvad
|
| 144 |
+
HLT004-0000029,treatment_end_1L,333,completed_or_discontinued
|
| 145 |
+
HLT004-0000029,response_assessment,60,PR
|
| 146 |
+
HLT004-0000029,os_endpoint,333,disease
|
| 147 |
+
HLT004-0000030,diagnosis,0,NYHA_II
|
| 148 |
+
HLT004-0000030,treatment_start_1L,10,lvad
|
| 149 |
+
HLT004-0000030,treatment_end_1L,1249,completed_or_discontinued
|
| 150 |
+
HLT004-0000030,response_assessment,88,PR
|
| 151 |
+
HLT004-0000030,os_endpoint,1249,other_cause
|
| 152 |
+
HLT004-0000031,diagnosis,0,NYHA_III
|
| 153 |
+
HLT004-0000031,treatment_start_1L,12,lvad
|
| 154 |
+
HLT004-0000031,treatment_end_1L,616,completed_or_discontinued
|
| 155 |
+
HLT004-0000031,response_assessment,52,PR
|
| 156 |
+
HLT004-0000031,os_endpoint,616,other_cause
|
| 157 |
+
HLT004-0000032,diagnosis,0,NYHA_III
|
| 158 |
+
HLT004-0000032,treatment_start_1L,9,lvad
|
| 159 |
+
HLT004-0000032,treatment_end_1L,151,completed_or_discontinued
|
| 160 |
+
HLT004-0000032,progression,120,radiographic_progression
|
| 161 |
+
HLT004-0000032,os_endpoint,151,disease
|
| 162 |
+
HLT004-0000033,diagnosis,0,NYHA_I
|
| 163 |
+
HLT004-0000033,treatment_start_1L,24,ivabradine
|
| 164 |
+
HLT004-0000033,treatment_end_1L,485,completed_or_discontinued
|
| 165 |
+
HLT004-0000033,response_assessment,67,CR
|
| 166 |
+
HLT004-0000033,os_endpoint,485,disease
|
| 167 |
+
HLT004-0000034,diagnosis,0,NYHA_III
|
| 168 |
+
HLT004-0000034,treatment_start_1L,17,lvad
|
| 169 |
+
HLT004-0000034,treatment_end_1L,1167,completed_or_discontinued
|
| 170 |
+
HLT004-0000034,response_assessment,52,PR
|
| 171 |
+
HLT004-0000034,os_endpoint,1167,disease
|
| 172 |
+
HLT004-0000035,diagnosis,0,NYHA_II
|
| 173 |
+
HLT004-0000035,treatment_start_1L,14,gdmt_core
|
| 174 |
+
HLT004-0000035,treatment_end_1L,983,completed_or_discontinued
|
| 175 |
+
HLT004-0000035,progression,754,radiographic_progression
|
| 176 |
+
HLT004-0000035,os_endpoint,983,other_cause
|
| 177 |
+
HLT004-0000036,diagnosis,0,NYHA_II
|
| 178 |
+
HLT004-0000036,treatment_start_1L,28,gdmt_core
|
| 179 |
+
HLT004-0000036,treatment_end_1L,906,completed_or_discontinued
|
| 180 |
+
HLT004-0000036,response_assessment,40,PR
|
| 181 |
+
HLT004-0000036,os_endpoint,906,other_cause
|
| 182 |
+
HLT004-0000037,diagnosis,0,NYHA_I
|
| 183 |
+
HLT004-0000037,treatment_start_1L,26,lvad
|
| 184 |
+
HLT004-0000037,treatment_end_1L,45,completed_or_discontinued
|
| 185 |
+
HLT004-0000037,response_assessment,49,PR
|
| 186 |
+
HLT004-0000037,os_endpoint,45,other_cause
|
| 187 |
+
HLT004-0000038,diagnosis,0,NYHA_III
|
| 188 |
+
HLT004-0000038,treatment_start_1L,21,lvad
|
| 189 |
+
HLT004-0000038,treatment_end_1L,983,completed_or_discontinued
|
| 190 |
+
HLT004-0000038,progression,927,radiographic_progression
|
| 191 |
+
HLT004-0000038,os_endpoint,983,disease
|
| 192 |
+
HLT004-0000039,diagnosis,0,NYHA_III
|
| 193 |
+
HLT004-0000039,treatment_start_1L,19,gdmt_core
|
| 194 |
+
HLT004-0000039,treatment_end_1L,1123,completed_or_discontinued
|
| 195 |
+
HLT004-0000039,response_assessment,81,PR
|
| 196 |
+
HLT004-0000039,os_endpoint,1123,disease
|
| 197 |
+
HLT004-0000040,diagnosis,0,NYHA_II
|
| 198 |
+
HLT004-0000040,treatment_start_1L,14,gdmt_core
|
| 199 |
+
HLT004-0000040,treatment_end_1L,1095,completed_or_discontinued
|
| 200 |
+
HLT004-0000040,response_assessment,79,PR
|
| 201 |
+
HLT004-0000040,os_endpoint,1095,disease
|
| 202 |
+
HLT004-0000041,diagnosis,0,NYHA_IV
|
| 203 |
+
HLT004-0000041,treatment_start_1L,27,lvad
|
| 204 |
+
HLT004-0000041,treatment_end_1L,1064,completed_or_discontinued
|
| 205 |
+
HLT004-0000041,response_assessment,47,CR
|
| 206 |
+
HLT004-0000041,os_endpoint,1064,disease
|
| 207 |
+
HLT004-0000042,diagnosis,0,NYHA_II
|
| 208 |
+
HLT004-0000042,treatment_start_1L,15,gdmt_core
|
| 209 |
+
HLT004-0000042,treatment_end_1L,484,completed_or_discontinued
|
| 210 |
+
HLT004-0000042,response_assessment,31,CR
|
| 211 |
+
HLT004-0000042,os_endpoint,484,censored
|
| 212 |
+
HLT004-0000043,diagnosis,0,NYHA_IV
|
| 213 |
+
HLT004-0000043,treatment_start_1L,24,gdmt_core
|
| 214 |
+
HLT004-0000043,treatment_end_1L,366,completed_or_discontinued
|
| 215 |
+
HLT004-0000043,progression,167,radiographic_progression
|
| 216 |
+
HLT004-0000043,os_endpoint,366,disease
|
| 217 |
+
HLT004-0000044,diagnosis,0,NYHA_III
|
| 218 |
+
HLT004-0000044,treatment_start_1L,27,gdmt_core
|
| 219 |
+
HLT004-0000044,treatment_end_1L,39,completed_or_discontinued
|
| 220 |
+
HLT004-0000044,progression,30,radiographic_progression
|
| 221 |
+
HLT004-0000044,os_endpoint,39,other_cause
|
| 222 |
+
HLT004-0000045,diagnosis,0,NYHA_IV
|
| 223 |
+
HLT004-0000045,treatment_start_1L,10,gdmt_core
|
| 224 |
+
HLT004-0000045,treatment_end_1L,92,completed_or_discontinued
|
| 225 |
+
HLT004-0000045,response_assessment,64,PR
|
| 226 |
+
HLT004-0000045,os_endpoint,92,disease
|
| 227 |
+
HLT004-0000046,diagnosis,0,NYHA_IV
|
| 228 |
+
HLT004-0000046,treatment_start_1L,18,gdmt_core
|
| 229 |
+
HLT004-0000046,treatment_end_1L,502,completed_or_discontinued
|
| 230 |
+
HLT004-0000046,progression,322,radiographic_progression
|
| 231 |
+
HLT004-0000046,os_endpoint,502,disease
|
| 232 |
+
HLT004-0000047,diagnosis,0,NYHA_IV
|
| 233 |
+
HLT004-0000047,treatment_start_1L,15,lvad
|
| 234 |
+
HLT004-0000047,treatment_end_1L,151,completed_or_discontinued
|
| 235 |
+
HLT004-0000047,progression,118,radiographic_progression
|
| 236 |
+
HLT004-0000047,os_endpoint,151,disease
|
| 237 |
+
HLT004-0000048,diagnosis,0,NYHA_I
|
| 238 |
+
HLT004-0000048,treatment_start_1L,19,ivabradine
|
| 239 |
+
HLT004-0000048,treatment_end_1L,1591,completed_or_discontinued
|
| 240 |
+
HLT004-0000048,response_assessment,88,PR
|
| 241 |
+
HLT004-0000048,os_endpoint,1591,disease
|
| 242 |
+
HLT004-0000049,diagnosis,0,NYHA_III
|
| 243 |
+
HLT004-0000049,treatment_start_1L,19,ivabradine
|
| 244 |
+
HLT004-0000049,treatment_end_1L,1274,completed_or_discontinued
|
| 245 |
+
HLT004-0000049,response_assessment,53,CR
|
| 246 |
+
HLT004-0000049,os_endpoint,1274,censored
|
| 247 |
+
HLT004-0000050,diagnosis,0,NYHA_III
|
| 248 |
+
HLT004-0000050,treatment_start_1L,22,lvad
|
| 249 |
+
HLT004-0000050,treatment_end_1L,198,completed_or_discontinued
|
| 250 |
+
HLT004-0000050,os_endpoint,198,disease
|
| 251 |
+
HLT004-0000051,diagnosis,0,NYHA_III
|
| 252 |
+
HLT004-0000051,treatment_start_1L,18,ivabradine
|
| 253 |
+
HLT004-0000051,treatment_end_1L,116,completed_or_discontinued
|
| 254 |
+
HLT004-0000051,response_assessment,38,PR
|
| 255 |
+
HLT004-0000051,os_endpoint,116,censored
|
| 256 |
+
HLT004-0000052,diagnosis,0,NYHA_II
|
| 257 |
+
HLT004-0000052,treatment_start_1L,12,lvad
|
| 258 |
+
HLT004-0000052,treatment_end_1L,1825,completed_or_discontinued
|
| 259 |
+
HLT004-0000052,response_assessment,55,PR
|
| 260 |
+
HLT004-0000052,os_endpoint,1825,censored
|
| 261 |
+
HLT004-0000053,diagnosis,0,NYHA_IV
|
| 262 |
+
HLT004-0000053,treatment_start_1L,10,ivabradine
|
| 263 |
+
HLT004-0000053,treatment_end_1L,89,completed_or_discontinued
|
| 264 |
+
HLT004-0000053,os_endpoint,89,disease
|
| 265 |
+
HLT004-0000054,diagnosis,0,NYHA_II
|
| 266 |
+
HLT004-0000054,treatment_start_1L,14,ivabradine
|
| 267 |
+
HLT004-0000054,treatment_end_1L,1076,completed_or_discontinued
|
| 268 |
+
HLT004-0000054,os_endpoint,1076,disease
|
| 269 |
+
HLT004-0000055,diagnosis,0,NYHA_II
|
| 270 |
+
HLT004-0000055,treatment_start_1L,26,lvad
|
| 271 |
+
HLT004-0000055,treatment_end_1L,45,completed_or_discontinued
|
| 272 |
+
HLT004-0000055,response_assessment,88,PR
|
| 273 |
+
HLT004-0000055,os_endpoint,45,censored
|
| 274 |
+
HLT004-0000056,diagnosis,0,NYHA_II
|
| 275 |
+
HLT004-0000056,treatment_start_1L,15,lvad
|
| 276 |
+
HLT004-0000056,treatment_end_1L,1077,completed_or_discontinued
|
| 277 |
+
HLT004-0000056,progression,183,radiographic_progression
|
| 278 |
+
HLT004-0000056,os_endpoint,1077,censored
|
| 279 |
+
HLT004-0000057,diagnosis,0,NYHA_II
|
| 280 |
+
HLT004-0000057,treatment_start_1L,19,lvad
|
| 281 |
+
HLT004-0000057,treatment_end_1L,1397,completed_or_discontinued
|
| 282 |
+
HLT004-0000057,response_assessment,59,PR
|
| 283 |
+
HLT004-0000057,os_endpoint,1397,disease
|
| 284 |
+
HLT004-0000058,diagnosis,0,NYHA_III
|
| 285 |
+
HLT004-0000058,treatment_start_1L,21,lvad
|
| 286 |
+
HLT004-0000058,treatment_end_1L,445,completed_or_discontinued
|
| 287 |
+
HLT004-0000058,response_assessment,30,CR
|
| 288 |
+
HLT004-0000058,os_endpoint,445,other_cause
|
| 289 |
+
HLT004-0000059,diagnosis,0,NYHA_I
|
| 290 |
+
HLT004-0000059,treatment_start_1L,22,gdmt_core
|
| 291 |
+
HLT004-0000059,treatment_end_1L,914,completed_or_discontinued
|
| 292 |
+
HLT004-0000059,progression,580,radiographic_progression
|
| 293 |
+
HLT004-0000059,os_endpoint,914,censored
|
| 294 |
+
HLT004-0000060,diagnosis,0,NYHA_III
|
| 295 |
+
HLT004-0000060,treatment_start_1L,20,lvad
|
| 296 |
+
HLT004-0000060,treatment_end_1L,542,completed_or_discontinued
|
| 297 |
+
HLT004-0000060,progression,438,radiographic_progression
|
| 298 |
+
HLT004-0000060,os_endpoint,542,censored
|
| 299 |
+
HLT004-0000061,diagnosis,0,NYHA_III
|
| 300 |
+
HLT004-0000061,treatment_start_1L,16,lvad
|
| 301 |
+
HLT004-0000061,treatment_end_1L,839,completed_or_discontinued
|
| 302 |
+
HLT004-0000061,response_assessment,56,CR
|
| 303 |
+
HLT004-0000061,os_endpoint,839,disease
|
| 304 |
+
HLT004-0000062,diagnosis,0,NYHA_II
|
| 305 |
+
HLT004-0000062,treatment_start_1L,23,gdmt_core
|
| 306 |
+
HLT004-0000062,treatment_end_1L,650,completed_or_discontinued
|
| 307 |
+
HLT004-0000062,progression,286,radiographic_progression
|
| 308 |
+
HLT004-0000062,os_endpoint,650,censored
|
| 309 |
+
HLT004-0000063,diagnosis,0,NYHA_III
|
| 310 |
+
HLT004-0000063,treatment_start_1L,24,lvad
|
| 311 |
+
HLT004-0000063,treatment_end_1L,1694,completed_or_discontinued
|
| 312 |
+
HLT004-0000063,response_assessment,88,PR
|
| 313 |
+
HLT004-0000063,os_endpoint,1694,other_cause
|
| 314 |
+
HLT004-0000064,diagnosis,0,NYHA_II
|
| 315 |
+
HLT004-0000064,treatment_start_1L,20,gdmt_core
|
| 316 |
+
HLT004-0000064,treatment_end_1L,1015,completed_or_discontinued
|
| 317 |
+
HLT004-0000064,progression,807,radiographic_progression
|
| 318 |
+
HLT004-0000064,os_endpoint,1015,other_cause
|
| 319 |
+
HLT004-0000065,diagnosis,0,NYHA_III
|
| 320 |
+
HLT004-0000065,treatment_start_1L,27,gdmt_core
|
| 321 |
+
HLT004-0000065,treatment_end_1L,1459,completed_or_discontinued
|
| 322 |
+
HLT004-0000065,response_assessment,72,PR
|
| 323 |
+
HLT004-0000065,os_endpoint,1459,disease
|
| 324 |
+
HLT004-0000066,diagnosis,0,NYHA_IV
|
| 325 |
+
HLT004-0000066,treatment_start_1L,18,lvad
|
| 326 |
+
HLT004-0000066,treatment_end_1L,499,completed_or_discontinued
|
| 327 |
+
HLT004-0000066,progression,344,radiographic_progression
|
| 328 |
+
HLT004-0000066,os_endpoint,499,disease
|
| 329 |
+
HLT004-0000067,diagnosis,0,NYHA_II
|
| 330 |
+
HLT004-0000067,treatment_start_1L,27,gdmt_core
|
| 331 |
+
HLT004-0000067,treatment_end_1L,1825,completed_or_discontinued
|
| 332 |
+
HLT004-0000067,progression,1310,radiographic_progression
|
| 333 |
+
HLT004-0000067,os_endpoint,1825,censored
|
| 334 |
+
HLT004-0000068,diagnosis,0,NYHA_III
|
| 335 |
+
HLT004-0000068,treatment_start_1L,24,ivabradine
|
| 336 |
+
HLT004-0000068,treatment_end_1L,567,completed_or_discontinued
|
| 337 |
+
HLT004-0000068,progression,410,radiographic_progression
|
| 338 |
+
HLT004-0000068,os_endpoint,567,disease
|
| 339 |
+
HLT004-0000069,diagnosis,0,NYHA_II
|
| 340 |
+
HLT004-0000069,treatment_start_1L,28,ivabradine
|
| 341 |
+
HLT004-0000069,treatment_end_1L,1214,completed_or_discontinued
|
| 342 |
+
HLT004-0000069,progression,795,radiographic_progression
|
| 343 |
+
HLT004-0000069,os_endpoint,1214,censored
|
| 344 |
+
HLT004-0000070,diagnosis,0,NYHA_III
|
| 345 |
+
HLT004-0000070,treatment_start_1L,16,lvad
|
| 346 |
+
HLT004-0000070,treatment_end_1L,867,completed_or_discontinued
|
| 347 |
+
HLT004-0000070,response_assessment,75,PR
|
| 348 |
+
HLT004-0000070,os_endpoint,867,disease
|
| 349 |
+
HLT004-0000071,diagnosis,0,NYHA_III
|
| 350 |
+
HLT004-0000071,treatment_start_1L,19,ivabradine
|
| 351 |
+
HLT004-0000071,treatment_end_1L,740,completed_or_discontinued
|
| 352 |
+
HLT004-0000071,progression,125,radiographic_progression
|
| 353 |
+
HLT004-0000071,os_endpoint,740,censored
|
| 354 |
+
HLT004-0000072,diagnosis,0,NYHA_II
|
| 355 |
+
HLT004-0000072,treatment_start_1L,15,lvad
|
| 356 |
+
HLT004-0000072,treatment_end_1L,1825,completed_or_discontinued
|
| 357 |
+
HLT004-0000072,response_assessment,50,CR
|
| 358 |
+
HLT004-0000072,os_endpoint,1825,censored
|
| 359 |
+
HLT004-0000073,diagnosis,0,NYHA_III
|
| 360 |
+
HLT004-0000073,treatment_start_1L,28,lvad
|
| 361 |
+
HLT004-0000073,treatment_end_1L,1545,completed_or_discontinued
|
| 362 |
+
HLT004-0000073,progression,359,radiographic_progression
|
| 363 |
+
HLT004-0000073,os_endpoint,1545,censored
|
| 364 |
+
HLT004-0000074,diagnosis,0,NYHA_II
|
| 365 |
+
HLT004-0000074,treatment_start_1L,21,ivabradine
|
| 366 |
+
HLT004-0000074,treatment_end_1L,539,completed_or_discontinued
|
| 367 |
+
HLT004-0000074,response_assessment,83,PR
|
| 368 |
+
HLT004-0000074,os_endpoint,539,censored
|
| 369 |
+
HLT004-0000075,diagnosis,0,NYHA_II
|
| 370 |
+
HLT004-0000075,treatment_start_1L,29,lvad
|
| 371 |
+
HLT004-0000075,treatment_end_1L,860,completed_or_discontinued
|
| 372 |
+
HLT004-0000075,response_assessment,47,PR
|
| 373 |
+
HLT004-0000075,os_endpoint,860,censored
|
| 374 |
+
HLT004-0000076,diagnosis,0,NYHA_IV
|
| 375 |
+
HLT004-0000076,treatment_start_1L,23,lvad
|
| 376 |
+
HLT004-0000076,treatment_end_1L,280,completed_or_discontinued
|
| 377 |
+
HLT004-0000076,progression,138,radiographic_progression
|
| 378 |
+
HLT004-0000076,os_endpoint,280,disease
|
| 379 |
+
HLT004-0000077,diagnosis,0,NYHA_I
|
| 380 |
+
HLT004-0000077,treatment_start_1L,18,ivabradine
|
| 381 |
+
HLT004-0000077,treatment_end_1L,1568,completed_or_discontinued
|
| 382 |
+
HLT004-0000077,progression,800,radiographic_progression
|
| 383 |
+
HLT004-0000077,os_endpoint,1568,disease
|
| 384 |
+
HLT004-0000078,diagnosis,0,NYHA_III
|
| 385 |
+
HLT004-0000078,treatment_start_1L,15,lvad
|
| 386 |
+
HLT004-0000078,treatment_end_1L,349,completed_or_discontinued
|
| 387 |
+
HLT004-0000078,response_assessment,36,CR
|
| 388 |
+
HLT004-0000078,os_endpoint,349,disease
|
| 389 |
+
HLT004-0000079,diagnosis,0,NYHA_II
|
| 390 |
+
HLT004-0000079,treatment_start_1L,23,ivabradine
|
| 391 |
+
HLT004-0000079,treatment_end_1L,55,completed_or_discontinued
|
| 392 |
+
HLT004-0000079,response_assessment,51,PR
|
| 393 |
+
HLT004-0000079,os_endpoint,55,other_cause
|
| 394 |
+
HLT004-0000080,diagnosis,0,NYHA_III
|
| 395 |
+
HLT004-0000080,treatment_start_1L,26,gdmt_core
|
| 396 |
+
HLT004-0000080,treatment_end_1L,651,completed_or_discontinued
|
| 397 |
+
HLT004-0000080,progression,450,radiographic_progression
|
| 398 |
+
HLT004-0000080,os_endpoint,651,disease
|
| 399 |
+
HLT004-0000081,diagnosis,0,NYHA_III
|
| 400 |
+
HLT004-0000081,treatment_start_1L,14,gdmt_core
|
| 401 |
+
HLT004-0000081,treatment_end_1L,599,completed_or_discontinued
|
| 402 |
+
HLT004-0000081,response_assessment,45,CR
|
| 403 |
+
HLT004-0000081,os_endpoint,599,other_cause
|
| 404 |
+
HLT004-0000082,diagnosis,0,NYHA_II
|
| 405 |
+
HLT004-0000082,treatment_start_1L,14,ivabradine
|
| 406 |
+
HLT004-0000082,treatment_end_1L,793,completed_or_discontinued
|
| 407 |
+
HLT004-0000082,response_assessment,89,PR
|
| 408 |
+
HLT004-0000082,os_endpoint,793,other_cause
|
| 409 |
+
HLT004-0000083,diagnosis,0,NYHA_II
|
| 410 |
+
HLT004-0000083,treatment_start_1L,29,gdmt_core
|
| 411 |
+
HLT004-0000083,treatment_end_1L,1661,completed_or_discontinued
|
| 412 |
+
HLT004-0000083,response_assessment,35,PR
|
| 413 |
+
HLT004-0000083,os_endpoint,1661,censored
|
| 414 |
+
HLT004-0000084,diagnosis,0,NYHA_II
|
| 415 |
+
HLT004-0000084,treatment_start_1L,14,ivabradine
|
| 416 |
+
HLT004-0000084,treatment_end_1L,1656,completed_or_discontinued
|
| 417 |
+
HLT004-0000084,progression,761,radiographic_progression
|
| 418 |
+
HLT004-0000084,os_endpoint,1656,censored
|
| 419 |
+
HLT004-0000085,diagnosis,0,NYHA_IV
|
| 420 |
+
HLT004-0000085,treatment_start_1L,8,gdmt_core
|
| 421 |
+
HLT004-0000085,treatment_end_1L,169,completed_or_discontinued
|
| 422 |
+
HLT004-0000085,progression,143,radiographic_progression
|
| 423 |
+
HLT004-0000085,os_endpoint,169,censored
|
| 424 |
+
HLT004-0000086,diagnosis,0,NYHA_II
|
| 425 |
+
HLT004-0000086,treatment_start_1L,16,ivabradine
|
| 426 |
+
HLT004-0000086,treatment_end_1L,871,completed_or_discontinued
|
| 427 |
+
HLT004-0000086,os_endpoint,871,censored
|
| 428 |
+
HLT004-0000087,diagnosis,0,NYHA_II
|
| 429 |
+
HLT004-0000087,treatment_start_1L,16,gdmt_core
|
| 430 |
+
HLT004-0000087,treatment_end_1L,8,completed_or_discontinued
|
| 431 |
+
HLT004-0000087,progression,7,radiographic_progression
|
| 432 |
+
HLT004-0000087,os_endpoint,8,other_cause
|
| 433 |
+
HLT004-0000088,diagnosis,0,NYHA_III
|
| 434 |
+
HLT004-0000088,treatment_start_1L,17,lvad
|
| 435 |
+
HLT004-0000088,treatment_end_1L,1065,completed_or_discontinued
|
| 436 |
+
HLT004-0000088,response_assessment,80,CR
|
| 437 |
+
HLT004-0000088,os_endpoint,1065,other_cause
|
| 438 |
+
HLT004-0000089,diagnosis,0,NYHA_II
|
| 439 |
+
HLT004-0000089,treatment_start_1L,21,ivabradine
|
| 440 |
+
HLT004-0000089,treatment_end_1L,374,completed_or_discontinued
|
| 441 |
+
HLT004-0000089,os_endpoint,374,censored
|
| 442 |
+
HLT004-0000090,diagnosis,0,NYHA_II
|
| 443 |
+
HLT004-0000090,treatment_start_1L,9,gdmt_core
|
| 444 |
+
HLT004-0000090,treatment_end_1L,458,completed_or_discontinued
|
| 445 |
+
HLT004-0000090,os_endpoint,458,disease
|
| 446 |
+
HLT004-0000091,diagnosis,0,NYHA_II
|
| 447 |
+
HLT004-0000091,treatment_start_1L,27,ivabradine
|
| 448 |
+
HLT004-0000091,treatment_end_1L,1606,completed_or_discontinued
|
| 449 |
+
HLT004-0000091,response_assessment,77,PR
|
| 450 |
+
HLT004-0000091,os_endpoint,1606,disease
|
| 451 |
+
HLT004-0000092,diagnosis,0,NYHA_II
|
| 452 |
+
HLT004-0000092,treatment_start_1L,27,ivabradine
|
| 453 |
+
HLT004-0000092,treatment_end_1L,76,completed_or_discontinued
|
| 454 |
+
HLT004-0000092,response_assessment,66,PR
|
| 455 |
+
HLT004-0000092,os_endpoint,76,other_cause
|
| 456 |
+
HLT004-0000093,diagnosis,0,NYHA_III
|
| 457 |
+
HLT004-0000093,treatment_start_1L,20,ivabradine
|
| 458 |
+
HLT004-0000093,treatment_end_1L,935,completed_or_discontinued
|
| 459 |
+
HLT004-0000093,response_assessment,65,PR
|
| 460 |
+
HLT004-0000093,os_endpoint,935,disease
|
| 461 |
+
HLT004-0000094,diagnosis,0,NYHA_IV
|
| 462 |
+
HLT004-0000094,treatment_start_1L,28,ivabradine
|
| 463 |
+
HLT004-0000094,treatment_end_1L,328,completed_or_discontinued
|
| 464 |
+
HLT004-0000094,progression,230,radiographic_progression
|
| 465 |
+
HLT004-0000094,os_endpoint,328,disease
|
| 466 |
+
HLT004-0000095,diagnosis,0,NYHA_IV
|
| 467 |
+
HLT004-0000095,treatment_start_1L,19,gdmt_core
|
| 468 |
+
HLT004-0000095,treatment_end_1L,386,completed_or_discontinued
|
| 469 |
+
HLT004-0000095,response_assessment,49,PR
|
| 470 |
+
HLT004-0000095,os_endpoint,386,disease
|
| 471 |
+
HLT004-0000096,diagnosis,0,NYHA_IV
|
| 472 |
+
HLT004-0000096,treatment_start_1L,9,lvad
|
| 473 |
+
HLT004-0000096,treatment_end_1L,477,completed_or_discontinued
|
| 474 |
+
HLT004-0000096,progression,220,radiographic_progression
|
| 475 |
+
HLT004-0000096,os_endpoint,477,disease
|
| 476 |
+
HLT004-0000097,diagnosis,0,NYHA_II
|
| 477 |
+
HLT004-0000097,treatment_start_1L,28,ivabradine
|
| 478 |
+
HLT004-0000097,treatment_end_1L,1399,completed_or_discontinued
|
| 479 |
+
HLT004-0000097,progression,585,radiographic_progression
|
| 480 |
+
HLT004-0000097,os_endpoint,1399,other_cause
|
| 481 |
+
HLT004-0000098,diagnosis,0,NYHA_II
|
| 482 |
+
HLT004-0000098,treatment_start_1L,15,gdmt_core
|
| 483 |
+
HLT004-0000098,treatment_end_1L,264,completed_or_discontinued
|
| 484 |
+
HLT004-0000098,progression,212,radiographic_progression
|
| 485 |
+
HLT004-0000098,os_endpoint,264,censored
|
| 486 |
+
HLT004-0000099,diagnosis,0,NYHA_III
|
| 487 |
+
HLT004-0000099,treatment_start_1L,21,lvad
|
| 488 |
+
HLT004-0000099,treatment_end_1L,1270,completed_or_discontinued
|
| 489 |
+
HLT004-0000099,response_assessment,50,CR
|
| 490 |
+
HLT004-0000099,os_endpoint,1270,censored
|
| 491 |
+
HLT004-0000100,diagnosis,0,NYHA_IV
|
| 492 |
+
HLT004-0000100,treatment_start_1L,11,ivabradine
|
| 493 |
+
HLT004-0000100,treatment_end_1L,635,completed_or_discontinued
|
| 494 |
+
HLT004-0000100,response_assessment,51,PR
|
| 495 |
+
HLT004-0000100,os_endpoint,635,disease
|
| 496 |
+
HLT004-0000101,diagnosis,0,NYHA_III
|
| 497 |
+
HLT004-0000101,treatment_start_1L,9,ivabradine
|
| 498 |
+
HLT004-0000101,treatment_end_1L,793,completed_or_discontinued
|
| 499 |
+
HLT004-0000101,response_assessment,42,PR
|
| 500 |
+
HLT004-0000101,os_endpoint,793,disease
|
| 501 |
+
HLT004-0000102,diagnosis,0,NYHA_II
|
| 502 |
+
HLT004-0000102,treatment_start_1L,9,ivabradine
|
| 503 |
+
HLT004-0000102,treatment_end_1L,1809,completed_or_discontinued
|
| 504 |
+
HLT004-0000102,response_assessment,35,CR
|
| 505 |
+
HLT004-0000102,os_endpoint,1825,censored
|
| 506 |
+
HLT004-0000103,diagnosis,0,NYHA_III
|
| 507 |
+
HLT004-0000103,treatment_start_1L,9,ivabradine
|
| 508 |
+
HLT004-0000103,treatment_end_1L,235,completed_or_discontinued
|
| 509 |
+
HLT004-0000103,response_assessment,79,PR
|
| 510 |
+
HLT004-0000103,os_endpoint,235,censored
|
| 511 |
+
HLT004-0000104,diagnosis,0,NYHA_III
|
| 512 |
+
HLT004-0000104,treatment_start_1L,28,lvad
|
| 513 |
+
HLT004-0000104,treatment_end_1L,576,completed_or_discontinued
|
| 514 |
+
HLT004-0000104,response_assessment,55,PR
|
| 515 |
+
HLT004-0000104,os_endpoint,576,disease
|
| 516 |
+
HLT004-0000105,diagnosis,0,NYHA_IV
|
| 517 |
+
HLT004-0000105,treatment_start_1L,10,gdmt_core
|
| 518 |
+
HLT004-0000105,treatment_end_1L,814,completed_or_discontinued
|
| 519 |
+
HLT004-0000105,progression,215,radiographic_progression
|
| 520 |
+
HLT004-0000105,os_endpoint,814,disease
|
| 521 |
+
HLT004-0000106,diagnosis,0,NYHA_III
|
| 522 |
+
HLT004-0000106,treatment_start_1L,23,gdmt_core
|
| 523 |
+
HLT004-0000106,treatment_end_1L,1211,completed_or_discontinued
|
| 524 |
+
HLT004-0000106,response_assessment,43,PR
|
| 525 |
+
HLT004-0000106,os_endpoint,1211,disease
|
| 526 |
+
HLT004-0000107,diagnosis,0,NYHA_II
|
| 527 |
+
HLT004-0000107,treatment_start_1L,9,lvad
|
| 528 |
+
HLT004-0000107,treatment_end_1L,1807,completed_or_discontinued
|
| 529 |
+
HLT004-0000107,response_assessment,65,PR
|
| 530 |
+
HLT004-0000107,os_endpoint,1807,censored
|
| 531 |
+
HLT004-0000108,diagnosis,0,NYHA_II
|
| 532 |
+
HLT004-0000108,treatment_start_1L,29,lvad
|
| 533 |
+
HLT004-0000108,treatment_end_1L,754,completed_or_discontinued
|
| 534 |
+
HLT004-0000108,response_assessment,53,PR
|
| 535 |
+
HLT004-0000108,os_endpoint,754,censored
|
| 536 |
+
HLT004-0000109,diagnosis,0,NYHA_II
|
| 537 |
+
HLT004-0000109,treatment_start_1L,10,ivabradine
|
| 538 |
+
HLT004-0000109,treatment_end_1L,1810,completed_or_discontinued
|
| 539 |
+
HLT004-0000109,progression,479,radiographic_progression
|
| 540 |
+
HLT004-0000109,os_endpoint,1825,censored
|
| 541 |
+
HLT004-0000110,diagnosis,0,NYHA_II
|
| 542 |
+
HLT004-0000110,treatment_start_1L,14,ivabradine
|
| 543 |
+
HLT004-0000110,treatment_end_1L,343,completed_or_discontinued
|
| 544 |
+
HLT004-0000110,response_assessment,61,PR
|
| 545 |
+
HLT004-0000110,os_endpoint,343,censored
|
| 546 |
+
HLT004-0000111,diagnosis,0,NYHA_IV
|
| 547 |
+
HLT004-0000111,treatment_start_1L,13,lvad
|
| 548 |
+
HLT004-0000111,treatment_end_1L,172,completed_or_discontinued
|
| 549 |
+
HLT004-0000111,response_assessment,72,PR
|
| 550 |
+
HLT004-0000111,os_endpoint,172,censored
|
| 551 |
+
HLT004-0000112,diagnosis,0,NYHA_II
|
| 552 |
+
HLT004-0000112,treatment_start_1L,8,gdmt_core
|
| 553 |
+
HLT004-0000112,treatment_end_1L,1825,completed_or_discontinued
|
| 554 |
+
HLT004-0000112,progression,958,radiographic_progression
|
| 555 |
+
HLT004-0000112,os_endpoint,1825,censored
|
| 556 |
+
HLT004-0000113,diagnosis,0,NYHA_II
|
| 557 |
+
HLT004-0000113,treatment_start_1L,11,gdmt_core
|
| 558 |
+
HLT004-0000113,treatment_end_1L,764,completed_or_discontinued
|
| 559 |
+
HLT004-0000113,response_assessment,56,PR
|
| 560 |
+
HLT004-0000113,os_endpoint,764,censored
|
| 561 |
+
HLT004-0000114,diagnosis,0,NYHA_II
|
| 562 |
+
HLT004-0000114,treatment_start_1L,21,gdmt_core
|
| 563 |
+
HLT004-0000114,treatment_end_1L,465,completed_or_discontinued
|
| 564 |
+
HLT004-0000114,progression,332,radiographic_progression
|
| 565 |
+
HLT004-0000114,os_endpoint,465,other_cause
|
| 566 |
+
HLT004-0000115,diagnosis,0,NYHA_III
|
| 567 |
+
HLT004-0000115,treatment_start_1L,28,lvad
|
| 568 |
+
HLT004-0000115,treatment_end_1L,489,completed_or_discontinued
|
| 569 |
+
HLT004-0000115,os_endpoint,489,censored
|
| 570 |
+
HLT004-0000116,diagnosis,0,NYHA_II
|
| 571 |
+
HLT004-0000116,treatment_start_1L,9,ivabradine
|
| 572 |
+
HLT004-0000116,treatment_end_1L,472,completed_or_discontinued
|
| 573 |
+
HLT004-0000116,response_assessment,59,PR
|
| 574 |
+
HLT004-0000116,os_endpoint,472,disease
|
| 575 |
+
HLT004-0000117,diagnosis,0,NYHA_I
|
| 576 |
+
HLT004-0000117,treatment_start_1L,18,gdmt_core
|
| 577 |
+
HLT004-0000117,treatment_end_1L,568,completed_or_discontinued
|
| 578 |
+
HLT004-0000117,response_assessment,56,PR
|
| 579 |
+
HLT004-0000117,os_endpoint,568,censored
|
| 580 |
+
HLT004-0000118,diagnosis,0,NYHA_IV
|
| 581 |
+
HLT004-0000118,treatment_start_1L,27,gdmt_core
|
| 582 |
+
HLT004-0000118,treatment_end_1L,434,completed_or_discontinued
|
| 583 |
+
HLT004-0000118,progression,114,radiographic_progression
|
| 584 |
+
HLT004-0000118,os_endpoint,434,disease
|
| 585 |
+
HLT004-0000119,diagnosis,0,NYHA_II
|
| 586 |
+
HLT004-0000119,treatment_start_1L,21,lvad
|
| 587 |
+
HLT004-0000119,treatment_end_1L,1258,completed_or_discontinued
|
| 588 |
+
HLT004-0000119,progression,747,radiographic_progression
|
| 589 |
+
HLT004-0000119,os_endpoint,1258,disease
|
| 590 |
+
HLT004-0000120,diagnosis,0,NYHA_II
|
| 591 |
+
HLT004-0000120,treatment_start_1L,9,lvad
|
| 592 |
+
HLT004-0000120,treatment_end_1L,1825,completed_or_discontinued
|
| 593 |
+
HLT004-0000120,progression,440,radiographic_progression
|
| 594 |
+
HLT004-0000120,os_endpoint,1825,censored
|
| 595 |
+
HLT004-0000121,diagnosis,0,NYHA_II
|
| 596 |
+
HLT004-0000121,treatment_start_1L,29,lvad
|
| 597 |
+
HLT004-0000121,treatment_end_1L,1825,completed_or_discontinued
|
| 598 |
+
HLT004-0000121,progression,118,radiographic_progression
|
| 599 |
+
HLT004-0000121,os_endpoint,1825,censored
|
| 600 |
+
HLT004-0000122,diagnosis,0,NYHA_III
|
| 601 |
+
HLT004-0000122,treatment_start_1L,22,gdmt_core
|
| 602 |
+
HLT004-0000122,treatment_end_1L,1429,completed_or_discontinued
|
| 603 |
+
HLT004-0000122,progression,366,radiographic_progression
|
| 604 |
+
HLT004-0000122,os_endpoint,1429,other_cause
|
| 605 |
+
HLT004-0000123,diagnosis,0,NYHA_III
|
| 606 |
+
HLT004-0000123,treatment_start_1L,15,lvad
|
| 607 |
+
HLT004-0000123,treatment_end_1L,278,completed_or_discontinued
|
| 608 |
+
HLT004-0000123,response_assessment,81,PR
|
| 609 |
+
HLT004-0000123,os_endpoint,278,censored
|
| 610 |
+
HLT004-0000124,diagnosis,0,NYHA_IV
|
| 611 |
+
HLT004-0000124,treatment_start_1L,20,lvad
|
| 612 |
+
HLT004-0000124,treatment_end_1L,97,completed_or_discontinued
|
| 613 |
+
HLT004-0000124,progression,25,radiographic_progression
|
| 614 |
+
HLT004-0000124,os_endpoint,97,disease
|
| 615 |
+
HLT004-0000125,diagnosis,0,NYHA_I
|
| 616 |
+
HLT004-0000125,treatment_start_1L,18,ivabradine
|
| 617 |
+
HLT004-0000125,treatment_end_1L,1112,completed_or_discontinued
|
| 618 |
+
HLT004-0000125,response_assessment,66,PR
|
| 619 |
+
HLT004-0000125,os_endpoint,1112,other_cause
|
| 620 |
+
HLT004-0000126,diagnosis,0,NYHA_IV
|
| 621 |
+
HLT004-0000126,treatment_start_1L,15,gdmt_core
|
| 622 |
+
HLT004-0000126,treatment_end_1L,362,completed_or_discontinued
|
| 623 |
+
HLT004-0000126,response_assessment,68,PR
|
| 624 |
+
HLT004-0000126,os_endpoint,362,disease
|
| 625 |
+
HLT004-0000127,diagnosis,0,NYHA_III
|
| 626 |
+
HLT004-0000127,treatment_start_1L,26,lvad
|
| 627 |
+
HLT004-0000127,treatment_end_1L,125,completed_or_discontinued
|
| 628 |
+
HLT004-0000127,response_assessment,74,CR
|
| 629 |
+
HLT004-0000127,os_endpoint,125,disease
|
| 630 |
+
HLT004-0000128,diagnosis,0,NYHA_II
|
| 631 |
+
HLT004-0000128,treatment_start_1L,10,ivabradine
|
| 632 |
+
HLT004-0000128,treatment_end_1L,775,completed_or_discontinued
|
| 633 |
+
HLT004-0000128,response_assessment,65,PR
|
| 634 |
+
HLT004-0000128,os_endpoint,775,disease
|
| 635 |
+
HLT004-0000129,diagnosis,0,NYHA_II
|
| 636 |
+
HLT004-0000129,treatment_start_1L,15,gdmt_core
|
| 637 |
+
HLT004-0000129,treatment_end_1L,331,completed_or_discontinued
|
| 638 |
+
HLT004-0000129,response_assessment,71,CR
|
| 639 |
+
HLT004-0000129,os_endpoint,331,disease
|
| 640 |
+
HLT004-0000130,diagnosis,0,NYHA_II
|
| 641 |
+
HLT004-0000130,treatment_start_1L,11,gdmt_core
|
| 642 |
+
HLT004-0000130,treatment_end_1L,1825,completed_or_discontinued
|
| 643 |
+
HLT004-0000130,response_assessment,67,PR
|
| 644 |
+
HLT004-0000130,os_endpoint,1825,censored
|
| 645 |
+
HLT004-0000131,diagnosis,0,NYHA_IV
|
| 646 |
+
HLT004-0000131,treatment_start_1L,17,lvad
|
| 647 |
+
HLT004-0000131,treatment_end_1L,153,completed_or_discontinued
|
| 648 |
+
HLT004-0000131,response_assessment,38,PR
|
| 649 |
+
HLT004-0000131,os_endpoint,153,other_cause
|
| 650 |
+
HLT004-0000132,diagnosis,0,NYHA_II
|
| 651 |
+
HLT004-0000132,treatment_start_1L,28,ivabradine
|
| 652 |
+
HLT004-0000132,treatment_end_1L,445,completed_or_discontinued
|
| 653 |
+
HLT004-0000132,response_assessment,86,PR
|
| 654 |
+
HLT004-0000132,os_endpoint,445,other_cause
|
| 655 |
+
HLT004-0000133,diagnosis,0,NYHA_II
|
| 656 |
+
HLT004-0000133,treatment_start_1L,14,lvad
|
| 657 |
+
HLT004-0000133,treatment_end_1L,864,completed_or_discontinued
|
| 658 |
+
HLT004-0000133,response_assessment,70,PR
|
| 659 |
+
HLT004-0000133,os_endpoint,864,disease
|
| 660 |
+
HLT004-0000134,diagnosis,0,NYHA_III
|
| 661 |
+
HLT004-0000134,treatment_start_1L,8,ivabradine
|
| 662 |
+
HLT004-0000134,treatment_end_1L,401,completed_or_discontinued
|
| 663 |
+
HLT004-0000134,response_assessment,73,CR
|
| 664 |
+
HLT004-0000134,os_endpoint,401,censored
|
| 665 |
+
HLT004-0000135,diagnosis,0,NYHA_IV
|
| 666 |
+
HLT004-0000135,treatment_start_1L,15,ivabradine
|
| 667 |
+
HLT004-0000135,treatment_end_1L,151,completed_or_discontinued
|
| 668 |
+
HLT004-0000135,response_assessment,57,PR
|
| 669 |
+
HLT004-0000135,os_endpoint,151,other_cause
|
| 670 |
+
HLT004-0000136,diagnosis,0,NYHA_III
|
| 671 |
+
HLT004-0000136,treatment_start_1L,16,gdmt_core
|
| 672 |
+
HLT004-0000136,treatment_end_1L,212,completed_or_discontinued
|
| 673 |
+
HLT004-0000136,response_assessment,36,PR
|
| 674 |
+
HLT004-0000136,os_endpoint,212,other_cause
|
| 675 |
+
HLT004-0000137,diagnosis,0,NYHA_III
|
| 676 |
+
HLT004-0000137,treatment_start_1L,25,ivabradine
|
| 677 |
+
HLT004-0000137,treatment_end_1L,640,completed_or_discontinued
|
| 678 |
+
HLT004-0000137,response_assessment,51,PR
|
| 679 |
+
HLT004-0000137,os_endpoint,640,censored
|
| 680 |
+
HLT004-0000138,diagnosis,0,NYHA_II
|
| 681 |
+
HLT004-0000138,treatment_start_1L,18,gdmt_core
|
| 682 |
+
HLT004-0000138,treatment_end_1L,53,completed_or_discontinued
|
| 683 |
+
HLT004-0000138,response_assessment,88,PR
|
| 684 |
+
HLT004-0000138,os_endpoint,53,disease
|
| 685 |
+
HLT004-0000139,diagnosis,0,NYHA_IV
|
| 686 |
+
HLT004-0000139,treatment_start_1L,8,ivabradine
|
| 687 |
+
HLT004-0000139,treatment_end_1L,176,completed_or_discontinued
|
| 688 |
+
HLT004-0000139,response_assessment,84,PR
|
| 689 |
+
HLT004-0000139,os_endpoint,176,disease
|
| 690 |
+
HLT004-0000140,diagnosis,0,NYHA_II
|
| 691 |
+
HLT004-0000140,treatment_start_1L,23,gdmt_core
|
| 692 |
+
HLT004-0000140,treatment_end_1L,550,completed_or_discontinued
|
| 693 |
+
HLT004-0000140,response_assessment,36,PR
|
| 694 |
+
HLT004-0000140,os_endpoint,550,disease
|
| 695 |
+
HLT004-0000141,diagnosis,0,NYHA_I
|
| 696 |
+
HLT004-0000141,treatment_start_1L,25,ivabradine
|
| 697 |
+
HLT004-0000141,treatment_end_1L,1825,completed_or_discontinued
|
| 698 |
+
HLT004-0000141,response_assessment,54,PR
|
| 699 |
+
HLT004-0000141,os_endpoint,1825,censored
|
| 700 |
+
HLT004-0000142,diagnosis,0,NYHA_IV
|
| 701 |
+
HLT004-0000142,treatment_start_1L,10,ivabradine
|
| 702 |
+
HLT004-0000142,treatment_end_1L,602,completed_or_discontinued
|
| 703 |
+
HLT004-0000142,response_assessment,81,PR
|
| 704 |
+
HLT004-0000142,os_endpoint,602,disease
|
| 705 |
+
HLT004-0000143,diagnosis,0,NYHA_II
|
| 706 |
+
HLT004-0000143,treatment_start_1L,9,gdmt_core
|
| 707 |
+
HLT004-0000143,treatment_end_1L,1825,completed_or_discontinued
|
| 708 |
+
HLT004-0000143,progression,218,radiographic_progression
|
| 709 |
+
HLT004-0000143,os_endpoint,1825,censored
|
| 710 |
+
HLT004-0000144,diagnosis,0,NYHA_I
|
| 711 |
+
HLT004-0000144,treatment_start_1L,15,gdmt_core
|
| 712 |
+
HLT004-0000144,treatment_end_1L,1825,completed_or_discontinued
|
| 713 |
+
HLT004-0000144,response_assessment,53,PR
|
| 714 |
+
HLT004-0000144,os_endpoint,1825,censored
|
| 715 |
+
HLT004-0000145,diagnosis,0,NYHA_III
|
| 716 |
+
HLT004-0000145,treatment_start_1L,24,lvad
|
| 717 |
+
HLT004-0000145,treatment_end_1L,1224,completed_or_discontinued
|
| 718 |
+
HLT004-0000145,progression,780,radiographic_progression
|
| 719 |
+
HLT004-0000145,os_endpoint,1224,disease
|
| 720 |
+
HLT004-0000146,diagnosis,0,NYHA_II
|
| 721 |
+
HLT004-0000146,treatment_start_1L,13,gdmt_core
|
| 722 |
+
HLT004-0000146,treatment_end_1L,798,completed_or_discontinued
|
| 723 |
+
HLT004-0000146,response_assessment,48,PR
|
| 724 |
+
HLT004-0000146,os_endpoint,798,disease
|
| 725 |
+
HLT004-0000147,diagnosis,0,NYHA_I
|
| 726 |
+
HLT004-0000147,treatment_start_1L,26,gdmt_core
|
| 727 |
+
HLT004-0000147,treatment_end_1L,160,completed_or_discontinued
|
| 728 |
+
HLT004-0000147,response_assessment,70,PR
|
| 729 |
+
HLT004-0000147,os_endpoint,160,other_cause
|
| 730 |
+
HLT004-0000148,diagnosis,0,NYHA_III
|
| 731 |
+
HLT004-0000148,treatment_start_1L,21,gdmt_core
|
| 732 |
+
HLT004-0000148,treatment_end_1L,1104,completed_or_discontinued
|
| 733 |
+
HLT004-0000148,response_assessment,39,CR
|
| 734 |
+
HLT004-0000148,os_endpoint,1104,disease
|
| 735 |
+
HLT004-0000149,diagnosis,0,NYHA_III
|
| 736 |
+
HLT004-0000149,treatment_start_1L,7,ivabradine
|
| 737 |
+
HLT004-0000149,treatment_end_1L,582,completed_or_discontinued
|
| 738 |
+
HLT004-0000149,os_endpoint,582,other_cause
|
| 739 |
+
HLT004-0000150,diagnosis,0,NYHA_III
|
| 740 |
+
HLT004-0000150,treatment_start_1L,19,lvad
|
| 741 |
+
HLT004-0000150,treatment_end_1L,1825,completed_or_discontinued
|
| 742 |
+
HLT004-0000150,progression,384,radiographic_progression
|
| 743 |
+
HLT004-0000150,os_endpoint,1825,censored
|
| 744 |
+
HLT004-0000151,diagnosis,0,NYHA_II
|
| 745 |
+
HLT004-0000151,treatment_start_1L,28,gdmt_core
|
| 746 |
+
HLT004-0000151,treatment_end_1L,262,completed_or_discontinued
|
| 747 |
+
HLT004-0000151,response_assessment,59,PR
|
| 748 |
+
HLT004-0000151,os_endpoint,262,censored
|
| 749 |
+
HLT004-0000152,diagnosis,0,NYHA_III
|
| 750 |
+
HLT004-0000152,treatment_start_1L,13,ivabradine
|
| 751 |
+
HLT004-0000152,treatment_end_1L,719,completed_or_discontinued
|
| 752 |
+
HLT004-0000152,progression,288,radiographic_progression
|
| 753 |
+
HLT004-0000152,os_endpoint,719,disease
|
| 754 |
+
HLT004-0000153,diagnosis,0,NYHA_III
|
| 755 |
+
HLT004-0000153,treatment_start_1L,17,ivabradine
|
| 756 |
+
HLT004-0000153,treatment_end_1L,74,completed_or_discontinued
|
| 757 |
+
HLT004-0000153,response_assessment,35,PR
|
| 758 |
+
HLT004-0000153,os_endpoint,74,censored
|
| 759 |
+
HLT004-0000154,diagnosis,0,NYHA_II
|
| 760 |
+
HLT004-0000154,treatment_start_1L,26,ivabradine
|
| 761 |
+
HLT004-0000154,treatment_end_1L,557,completed_or_discontinued
|
| 762 |
+
HLT004-0000154,response_assessment,89,PR
|
| 763 |
+
HLT004-0000154,os_endpoint,557,other_cause
|
| 764 |
+
HLT004-0000155,diagnosis,0,NYHA_II
|
| 765 |
+
HLT004-0000155,treatment_start_1L,23,lvad
|
| 766 |
+
HLT004-0000155,treatment_end_1L,425,completed_or_discontinued
|
| 767 |
+
HLT004-0000155,progression,380,radiographic_progression
|
| 768 |
+
HLT004-0000155,os_endpoint,425,censored
|
| 769 |
+
HLT004-0000156,diagnosis,0,NYHA_I
|
| 770 |
+
HLT004-0000156,treatment_start_1L,9,lvad
|
| 771 |
+
HLT004-0000156,treatment_end_1L,1685,completed_or_discontinued
|
| 772 |
+
HLT004-0000156,progression,1318,radiographic_progression
|
| 773 |
+
HLT004-0000156,os_endpoint,1685,censored
|
| 774 |
+
HLT004-0000157,diagnosis,0,NYHA_II
|
| 775 |
+
HLT004-0000157,treatment_start_1L,11,gdmt_core
|
| 776 |
+
HLT004-0000157,treatment_end_1L,88,completed_or_discontinued
|
| 777 |
+
HLT004-0000157,progression,70,radiographic_progression
|
| 778 |
+
HLT004-0000157,os_endpoint,88,censored
|
| 779 |
+
HLT004-0000158,diagnosis,0,NYHA_II
|
| 780 |
+
HLT004-0000158,treatment_start_1L,10,ivabradine
|
| 781 |
+
HLT004-0000158,treatment_end_1L,13,completed_or_discontinued
|
| 782 |
+
HLT004-0000158,response_assessment,47,PR
|
| 783 |
+
HLT004-0000158,os_endpoint,13,disease
|
| 784 |
+
HLT004-0000159,diagnosis,0,NYHA_III
|
| 785 |
+
HLT004-0000159,treatment_start_1L,9,gdmt_core
|
| 786 |
+
HLT004-0000159,treatment_end_1L,1072,completed_or_discontinued
|
| 787 |
+
HLT004-0000159,response_assessment,45,PR
|
| 788 |
+
HLT004-0000159,os_endpoint,1072,censored
|
| 789 |
+
HLT004-0000160,diagnosis,0,NYHA_IV
|
| 790 |
+
HLT004-0000160,treatment_start_1L,16,gdmt_core
|
| 791 |
+
HLT004-0000160,treatment_end_1L,137,completed_or_discontinued
|
| 792 |
+
HLT004-0000160,response_assessment,38,PR
|
| 793 |
+
HLT004-0000160,os_endpoint,137,disease
|
| 794 |
+
HLT004-0000161,diagnosis,0,NYHA_II
|
| 795 |
+
HLT004-0000161,treatment_start_1L,23,ivabradine
|
| 796 |
+
HLT004-0000161,treatment_end_1L,680,completed_or_discontinued
|
| 797 |
+
HLT004-0000161,progression,458,radiographic_progression
|
| 798 |
+
HLT004-0000161,os_endpoint,680,censored
|
| 799 |
+
HLT004-0000162,diagnosis,0,NYHA_III
|
| 800 |
+
HLT004-0000162,treatment_start_1L,20,lvad
|
| 801 |
+
HLT004-0000162,treatment_end_1L,1079,completed_or_discontinued
|
| 802 |
+
HLT004-0000162,response_assessment,59,PR
|
| 803 |
+
HLT004-0000162,os_endpoint,1079,disease
|
| 804 |
+
HLT004-0000163,diagnosis,0,NYHA_II
|
| 805 |
+
HLT004-0000163,treatment_start_1L,8,ivabradine
|
| 806 |
+
HLT004-0000163,treatment_end_1L,676,completed_or_discontinued
|
| 807 |
+
HLT004-0000163,response_assessment,87,PR
|
| 808 |
+
HLT004-0000163,os_endpoint,676,disease
|
| 809 |
+
HLT004-0000164,diagnosis,0,NYHA_I
|
| 810 |
+
HLT004-0000164,treatment_start_1L,18,gdmt_core
|
| 811 |
+
HLT004-0000164,treatment_end_1L,452,completed_or_discontinued
|
| 812 |
+
HLT004-0000164,response_assessment,51,PR
|
| 813 |
+
HLT004-0000164,os_endpoint,452,other_cause
|
| 814 |
+
HLT004-0000165,diagnosis,0,NYHA_III
|
| 815 |
+
HLT004-0000165,treatment_start_1L,26,gdmt_core
|
| 816 |
+
HLT004-0000165,treatment_end_1L,1049,completed_or_discontinued
|
| 817 |
+
HLT004-0000165,response_assessment,80,CR
|
| 818 |
+
HLT004-0000165,os_endpoint,1049,disease
|
| 819 |
+
HLT004-0000166,diagnosis,0,NYHA_II
|
| 820 |
+
HLT004-0000166,treatment_start_1L,28,lvad
|
| 821 |
+
HLT004-0000166,treatment_end_1L,282,completed_or_discontinued
|
| 822 |
+
HLT004-0000166,progression,204,radiographic_progression
|
| 823 |
+
HLT004-0000166,os_endpoint,282,other_cause
|
| 824 |
+
HLT004-0000167,diagnosis,0,NYHA_IV
|
| 825 |
+
HLT004-0000167,treatment_start_1L,12,lvad
|
| 826 |
+
HLT004-0000167,treatment_end_1L,28,completed_or_discontinued
|
| 827 |
+
HLT004-0000167,response_assessment,74,PR
|
| 828 |
+
HLT004-0000167,os_endpoint,28,disease
|
| 829 |
+
HLT004-0000168,diagnosis,0,NYHA_III
|
| 830 |
+
HLT004-0000168,treatment_start_1L,15,gdmt_core
|
| 831 |
+
HLT004-0000168,treatment_end_1L,570,completed_or_discontinued
|
| 832 |
+
HLT004-0000168,progression,166,radiographic_progression
|
| 833 |
+
HLT004-0000168,os_endpoint,570,disease
|
| 834 |
+
HLT004-0000169,diagnosis,0,NYHA_II
|
| 835 |
+
HLT004-0000169,treatment_start_1L,10,lvad
|
| 836 |
+
HLT004-0000169,treatment_end_1L,143,completed_or_discontinued
|
| 837 |
+
HLT004-0000169,response_assessment,38,PR
|
| 838 |
+
HLT004-0000169,os_endpoint,143,other_cause
|
| 839 |
+
HLT004-0000170,diagnosis,0,NYHA_II
|
| 840 |
+
HLT004-0000170,treatment_start_1L,8,ivabradine
|
| 841 |
+
HLT004-0000170,treatment_end_1L,1808,completed_or_discontinued
|
| 842 |
+
HLT004-0000170,response_assessment,30,PR
|
| 843 |
+
HLT004-0000170,os_endpoint,1825,censored
|
| 844 |
+
HLT004-0000171,diagnosis,0,NYHA_II
|
| 845 |
+
HLT004-0000171,treatment_start_1L,23,lvad
|
| 846 |
+
HLT004-0000171,treatment_end_1L,709,completed_or_discontinued
|
| 847 |
+
HLT004-0000171,progression,634,radiographic_progression
|
| 848 |
+
HLT004-0000171,os_endpoint,709,disease
|
| 849 |
+
HLT004-0000172,diagnosis,0,NYHA_IV
|
| 850 |
+
HLT004-0000172,treatment_start_1L,29,ivabradine
|
| 851 |
+
HLT004-0000172,treatment_end_1L,398,completed_or_discontinued
|
| 852 |
+
HLT004-0000172,progression,135,radiographic_progression
|
| 853 |
+
HLT004-0000172,os_endpoint,398,disease
|
| 854 |
+
HLT004-0000173,diagnosis,0,NYHA_III
|
| 855 |
+
HLT004-0000173,treatment_start_1L,24,lvad
|
| 856 |
+
HLT004-0000173,treatment_end_1L,957,completed_or_discontinued
|
| 857 |
+
HLT004-0000173,progression,413,radiographic_progression
|
| 858 |
+
HLT004-0000173,os_endpoint,957,disease
|
| 859 |
+
HLT004-0000174,diagnosis,0,NYHA_II
|
| 860 |
+
HLT004-0000174,treatment_start_1L,13,gdmt_core
|
| 861 |
+
HLT004-0000174,treatment_end_1L,1720,completed_or_discontinued
|
| 862 |
+
HLT004-0000174,progression,108,radiographic_progression
|
| 863 |
+
HLT004-0000174,os_endpoint,1720,disease
|
| 864 |
+
HLT004-0000175,diagnosis,0,NYHA_II
|
| 865 |
+
HLT004-0000175,treatment_start_1L,14,ivabradine
|
| 866 |
+
HLT004-0000175,treatment_end_1L,157,completed_or_discontinued
|
| 867 |
+
HLT004-0000175,response_assessment,50,PR
|
| 868 |
+
HLT004-0000175,os_endpoint,157,censored
|
| 869 |
+
HLT004-0000176,diagnosis,0,NYHA_III
|
| 870 |
+
HLT004-0000176,treatment_start_1L,10,lvad
|
| 871 |
+
HLT004-0000176,treatment_end_1L,720,completed_or_discontinued
|
| 872 |
+
HLT004-0000176,progression,442,radiographic_progression
|
| 873 |
+
HLT004-0000176,os_endpoint,720,other_cause
|
| 874 |
+
HLT004-0000177,diagnosis,0,NYHA_III
|
| 875 |
+
HLT004-0000177,treatment_start_1L,16,gdmt_core
|
| 876 |
+
HLT004-0000177,treatment_end_1L,17,completed_or_discontinued
|
| 877 |
+
HLT004-0000177,progression,15,radiographic_progression
|
| 878 |
+
HLT004-0000177,os_endpoint,17,disease
|
| 879 |
+
HLT004-0000178,diagnosis,0,NYHA_I
|
| 880 |
+
HLT004-0000178,treatment_start_1L,19,gdmt_core
|
| 881 |
+
HLT004-0000178,treatment_end_1L,1360,completed_or_discontinued
|
| 882 |
+
HLT004-0000178,progression,1134,radiographic_progression
|
| 883 |
+
HLT004-0000178,os_endpoint,1360,other_cause
|
| 884 |
+
HLT004-0000179,diagnosis,0,NYHA_I
|
| 885 |
+
HLT004-0000179,treatment_start_1L,25,lvad
|
| 886 |
+
HLT004-0000179,treatment_end_1L,1096,completed_or_discontinued
|
| 887 |
+
HLT004-0000179,response_assessment,33,PR
|
| 888 |
+
HLT004-0000179,os_endpoint,1096,other_cause
|
| 889 |
+
HLT004-0000180,diagnosis,0,NYHA_I
|
| 890 |
+
HLT004-0000180,treatment_start_1L,12,lvad
|
| 891 |
+
HLT004-0000180,treatment_end_1L,434,completed_or_discontinued
|
| 892 |
+
HLT004-0000180,progression,338,radiographic_progression
|
| 893 |
+
HLT004-0000180,os_endpoint,434,censored
|
| 894 |
+
HLT004-0000181,diagnosis,0,NYHA_II
|
| 895 |
+
HLT004-0000181,treatment_start_1L,22,lvad
|
| 896 |
+
HLT004-0000181,treatment_end_1L,1473,completed_or_discontinued
|
| 897 |
+
HLT004-0000181,progression,249,radiographic_progression
|
| 898 |
+
HLT004-0000181,os_endpoint,1473,disease
|
| 899 |
+
HLT004-0000182,diagnosis,0,NYHA_II
|
| 900 |
+
HLT004-0000182,treatment_start_1L,28,lvad
|
| 901 |
+
HLT004-0000182,treatment_end_1L,567,completed_or_discontinued
|
| 902 |
+
HLT004-0000182,response_assessment,48,CR
|
| 903 |
+
HLT004-0000182,os_endpoint,567,other_cause
|
| 904 |
+
HLT004-0000183,diagnosis,0,NYHA_I
|
| 905 |
+
HLT004-0000183,treatment_start_1L,12,lvad
|
| 906 |
+
HLT004-0000183,treatment_end_1L,219,completed_or_discontinued
|
| 907 |
+
HLT004-0000183,response_assessment,70,PR
|
| 908 |
+
HLT004-0000183,os_endpoint,219,other_cause
|
| 909 |
+
HLT004-0000184,diagnosis,0,NYHA_II
|
| 910 |
+
HLT004-0000184,treatment_start_1L,29,gdmt_core
|
| 911 |
+
HLT004-0000184,treatment_end_1L,1404,completed_or_discontinued
|
| 912 |
+
HLT004-0000184,progression,1247,radiographic_progression
|
| 913 |
+
HLT004-0000184,os_endpoint,1404,other_cause
|
| 914 |
+
HLT004-0000185,diagnosis,0,NYHA_II
|
| 915 |
+
HLT004-0000185,treatment_start_1L,25,ivabradine
|
| 916 |
+
HLT004-0000185,treatment_end_1L,712,completed_or_discontinued
|
| 917 |
+
HLT004-0000185,response_assessment,59,PR
|
| 918 |
+
HLT004-0000185,os_endpoint,712,censored
|
| 919 |
+
HLT004-0000186,diagnosis,0,NYHA_I
|
| 920 |
+
HLT004-0000186,treatment_start_1L,29,lvad
|
| 921 |
+
HLT004-0000186,treatment_end_1L,1825,completed_or_discontinued
|
| 922 |
+
HLT004-0000186,response_assessment,45,CR
|
| 923 |
+
HLT004-0000186,os_endpoint,1825,censored
|
| 924 |
+
HLT004-0000187,diagnosis,0,NYHA_IV
|
| 925 |
+
HLT004-0000187,treatment_start_1L,24,lvad
|
| 926 |
+
HLT004-0000187,treatment_end_1L,762,completed_or_discontinued
|
| 927 |
+
HLT004-0000187,response_assessment,65,PR
|
| 928 |
+
HLT004-0000187,os_endpoint,762,disease
|
| 929 |
+
HLT004-0000188,diagnosis,0,NYHA_III
|
| 930 |
+
HLT004-0000188,treatment_start_1L,26,gdmt_core
|
| 931 |
+
HLT004-0000188,treatment_end_1L,48,completed_or_discontinued
|
| 932 |
+
HLT004-0000188,response_assessment,51,PR
|
| 933 |
+
HLT004-0000188,os_endpoint,48,other_cause
|
| 934 |
+
HLT004-0000189,diagnosis,0,NYHA_II
|
| 935 |
+
HLT004-0000189,treatment_start_1L,21,gdmt_core
|
| 936 |
+
HLT004-0000189,treatment_end_1L,1177,completed_or_discontinued
|
| 937 |
+
HLT004-0000189,progression,998,radiographic_progression
|
| 938 |
+
HLT004-0000189,os_endpoint,1177,censored
|
| 939 |
+
HLT004-0000190,diagnosis,0,NYHA_II
|
| 940 |
+
HLT004-0000190,treatment_start_1L,15,lvad
|
| 941 |
+
HLT004-0000190,treatment_end_1L,845,completed_or_discontinued
|
| 942 |
+
HLT004-0000190,response_assessment,50,PR
|
| 943 |
+
HLT004-0000190,os_endpoint,845,censored
|
| 944 |
+
HLT004-0000191,diagnosis,0,NYHA_II
|
| 945 |
+
HLT004-0000191,treatment_start_1L,13,ivabradine
|
| 946 |
+
HLT004-0000191,treatment_end_1L,203,completed_or_discontinued
|
| 947 |
+
HLT004-0000191,progression,169,radiographic_progression
|
| 948 |
+
HLT004-0000191,os_endpoint,203,censored
|
| 949 |
+
HLT004-0000192,diagnosis,0,NYHA_IV
|
| 950 |
+
HLT004-0000192,treatment_start_1L,13,gdmt_core
|
| 951 |
+
HLT004-0000192,treatment_end_1L,82,completed_or_discontinued
|
| 952 |
+
HLT004-0000192,progression,54,radiographic_progression
|
| 953 |
+
HLT004-0000192,os_endpoint,82,other_cause
|
| 954 |
+
HLT004-0000193,diagnosis,0,NYHA_III
|
| 955 |
+
HLT004-0000193,treatment_start_1L,18,lvad
|
| 956 |
+
HLT004-0000193,treatment_end_1L,61,completed_or_discontinued
|
| 957 |
+
HLT004-0000193,progression,53,radiographic_progression
|
| 958 |
+
HLT004-0000193,os_endpoint,61,other_cause
|
| 959 |
+
HLT004-0000194,diagnosis,0,NYHA_II
|
| 960 |
+
HLT004-0000194,treatment_start_1L,26,ivabradine
|
| 961 |
+
HLT004-0000194,treatment_end_1L,355,completed_or_discontinued
|
| 962 |
+
HLT004-0000194,response_assessment,55,PR
|
| 963 |
+
HLT004-0000194,os_endpoint,355,censored
|
| 964 |
+
HLT004-0000195,diagnosis,0,NYHA_IV
|
| 965 |
+
HLT004-0000195,treatment_start_1L,15,gdmt_core
|
| 966 |
+
HLT004-0000195,treatment_end_1L,337,completed_or_discontinued
|
| 967 |
+
HLT004-0000195,progression,3,radiographic_progression
|
| 968 |
+
HLT004-0000195,os_endpoint,337,disease
|
| 969 |
+
HLT004-0000196,diagnosis,0,NYHA_III
|
| 970 |
+
HLT004-0000196,treatment_start_1L,21,gdmt_core
|
| 971 |
+
HLT004-0000196,treatment_end_1L,1476,completed_or_discontinued
|
| 972 |
+
HLT004-0000196,response_assessment,72,CR
|
| 973 |
+
HLT004-0000196,os_endpoint,1476,disease
|
| 974 |
+
HLT004-0000197,diagnosis,0,NYHA_III
|
| 975 |
+
HLT004-0000197,treatment_start_1L,15,gdmt_core
|
| 976 |
+
HLT004-0000197,treatment_end_1L,151,completed_or_discontinued
|
| 977 |
+
HLT004-0000197,progression,97,radiographic_progression
|
| 978 |
+
HLT004-0000197,os_endpoint,151,disease
|
| 979 |
+
HLT004-0000198,diagnosis,0,NYHA_II
|
| 980 |
+
HLT004-0000198,treatment_start_1L,7,lvad
|
| 981 |
+
HLT004-0000198,treatment_end_1L,728,completed_or_discontinued
|
| 982 |
+
HLT004-0000198,progression,539,radiographic_progression
|
| 983 |
+
HLT004-0000198,os_endpoint,728,other_cause
|
| 984 |
+
HLT004-0000199,diagnosis,0,NYHA_II
|
| 985 |
+
HLT004-0000199,treatment_start_1L,13,ivabradine
|
| 986 |
+
HLT004-0000199,treatment_end_1L,43,completed_or_discontinued
|
| 987 |
+
HLT004-0000199,os_endpoint,43,censored
|
| 988 |
+
HLT004-0000200,diagnosis,0,NYHA_III
|
| 989 |
+
HLT004-0000200,treatment_start_1L,13,gdmt_core
|
| 990 |
+
HLT004-0000200,treatment_end_1L,330,completed_or_discontinued
|
| 991 |
+
HLT004-0000200,progression,203,radiographic_progression
|
| 992 |
+
HLT004-0000200,os_endpoint,330,disease
|
| 993 |
+
HLT004-0000201,diagnosis,0,NYHA_II
|
| 994 |
+
HLT004-0000201,treatment_start_1L,24,ivabradine
|
| 995 |
+
HLT004-0000201,treatment_end_1L,969,completed_or_discontinued
|
| 996 |
+
HLT004-0000201,os_endpoint,969,censored
|
| 997 |
+
HLT004-0000202,diagnosis,0,NYHA_III
|
| 998 |
+
HLT004-0000202,treatment_start_1L,21,gdmt_core
|
| 999 |
+
HLT004-0000202,treatment_end_1L,1414,completed_or_discontinued
|
| 1000 |
+
HLT004-0000202,response_assessment,75,CR
|
| 1001 |
+
HLT004-0000202,os_endpoint,1414,disease
|
| 1002 |
+
HLT004-0000203,diagnosis,0,NYHA_III
|
| 1003 |
+
HLT004-0000203,treatment_start_1L,17,gdmt_core
|
| 1004 |
+
HLT004-0000203,treatment_end_1L,91,completed_or_discontinued
|
| 1005 |
+
HLT004-0000203,os_endpoint,91,other_cause
|
| 1006 |
+
HLT004-0000204,diagnosis,0,NYHA_II
|
| 1007 |
+
HLT004-0000204,treatment_start_1L,10,ivabradine
|
| 1008 |
+
HLT004-0000204,treatment_end_1L,30,completed_or_discontinued
|
| 1009 |
+
HLT004-0000204,progression,23,radiographic_progression
|
| 1010 |
+
HLT004-0000204,os_endpoint,30,censored
|
| 1011 |
+
HLT004-0000205,diagnosis,0,NYHA_II
|
| 1012 |
+
HLT004-0000205,treatment_start_1L,25,ivabradine
|
| 1013 |
+
HLT004-0000205,treatment_end_1L,655,completed_or_discontinued
|
| 1014 |
+
HLT004-0000205,response_assessment,81,CR
|
| 1015 |
+
HLT004-0000205,os_endpoint,655,other_cause
|
| 1016 |
+
HLT004-0000206,diagnosis,0,NYHA_II
|
| 1017 |
+
HLT004-0000206,treatment_start_1L,24,gdmt_core
|
| 1018 |
+
HLT004-0000206,treatment_end_1L,690,completed_or_discontinued
|
| 1019 |
+
HLT004-0000206,response_assessment,48,CR
|
| 1020 |
+
HLT004-0000206,os_endpoint,690,other_cause
|
| 1021 |
+
HLT004-0000207,diagnosis,0,NYHA_II
|
| 1022 |
+
HLT004-0000207,treatment_start_1L,25,ivabradine
|
| 1023 |
+
HLT004-0000207,treatment_end_1L,266,completed_or_discontinued
|
| 1024 |
+
HLT004-0000207,os_endpoint,266,disease
|
| 1025 |
+
HLT004-0000208,diagnosis,0,NYHA_III
|
| 1026 |
+
HLT004-0000208,treatment_start_1L,7,ivabradine
|
| 1027 |
+
HLT004-0000208,treatment_end_1L,590,completed_or_discontinued
|
| 1028 |
+
HLT004-0000208,progression,524,radiographic_progression
|
| 1029 |
+
HLT004-0000208,os_endpoint,590,disease
|
| 1030 |
+
HLT004-0000209,diagnosis,0,NYHA_III
|
| 1031 |
+
HLT004-0000209,treatment_start_1L,8,ivabradine
|
| 1032 |
+
HLT004-0000209,treatment_end_1L,555,completed_or_discontinued
|
| 1033 |
+
HLT004-0000209,os_endpoint,555,disease
|
| 1034 |
+
HLT004-0000210,diagnosis,0,NYHA_II
|
| 1035 |
+
HLT004-0000210,treatment_start_1L,12,gdmt_core
|
| 1036 |
+
HLT004-0000210,treatment_end_1L,1825,completed_or_discontinued
|
| 1037 |
+
HLT004-0000210,response_assessment,40,PR
|
| 1038 |
+
HLT004-0000210,os_endpoint,1825,censored
|
| 1039 |
+
HLT004-0000211,diagnosis,0,NYHA_III
|
| 1040 |
+
HLT004-0000211,treatment_start_1L,9,gdmt_core
|
| 1041 |
+
HLT004-0000211,treatment_end_1L,800,completed_or_discontinued
|
| 1042 |
+
HLT004-0000211,response_assessment,36,PR
|
| 1043 |
+
HLT004-0000211,os_endpoint,800,censored
|
| 1044 |
+
HLT004-0000212,diagnosis,0,NYHA_II
|
| 1045 |
+
HLT004-0000212,treatment_start_1L,29,gdmt_core
|
| 1046 |
+
HLT004-0000212,treatment_end_1L,1537,completed_or_discontinued
|
| 1047 |
+
HLT004-0000212,progression,926,radiographic_progression
|
| 1048 |
+
HLT004-0000212,os_endpoint,1537,disease
|
| 1049 |
+
HLT004-0000213,diagnosis,0,NYHA_III
|
| 1050 |
+
HLT004-0000213,treatment_start_1L,23,ivabradine
|
| 1051 |
+
HLT004-0000213,treatment_end_1L,816,completed_or_discontinued
|
| 1052 |
+
HLT004-0000213,progression,588,radiographic_progression
|
| 1053 |
+
HLT004-0000213,os_endpoint,816,disease
|
| 1054 |
+
HLT004-0000214,diagnosis,0,NYHA_II
|
| 1055 |
+
HLT004-0000214,treatment_start_1L,24,lvad
|
| 1056 |
+
HLT004-0000214,treatment_end_1L,1268,completed_or_discontinued
|
| 1057 |
+
HLT004-0000214,response_assessment,54,CR
|
| 1058 |
+
HLT004-0000214,os_endpoint,1268,disease
|
| 1059 |
+
HLT004-0000215,diagnosis,0,NYHA_III
|
| 1060 |
+
HLT004-0000215,treatment_start_1L,9,gdmt_core
|
| 1061 |
+
HLT004-0000215,treatment_end_1L,451,completed_or_discontinued
|
| 1062 |
+
HLT004-0000215,progression,365,radiographic_progression
|
| 1063 |
+
HLT004-0000215,os_endpoint,451,disease
|
| 1064 |
+
HLT004-0000216,diagnosis,0,NYHA_III
|
| 1065 |
+
HLT004-0000216,treatment_start_1L,12,lvad
|
| 1066 |
+
HLT004-0000216,treatment_end_1L,1825,completed_or_discontinued
|
| 1067 |
+
HLT004-0000216,response_assessment,39,CR
|
| 1068 |
+
HLT004-0000216,os_endpoint,1825,censored
|
| 1069 |
+
HLT004-0000217,diagnosis,0,NYHA_II
|
| 1070 |
+
HLT004-0000217,treatment_start_1L,17,lvad
|
| 1071 |
+
HLT004-0000217,treatment_end_1L,1052,completed_or_discontinued
|
| 1072 |
+
HLT004-0000217,response_assessment,36,PR
|
| 1073 |
+
HLT004-0000217,os_endpoint,1052,disease
|
| 1074 |
+
HLT004-0000218,diagnosis,0,NYHA_III
|
| 1075 |
+
HLT004-0000218,treatment_start_1L,19,gdmt_core
|
| 1076 |
+
HLT004-0000218,treatment_end_1L,214,completed_or_discontinued
|
| 1077 |
+
HLT004-0000218,os_endpoint,214,censored
|
| 1078 |
+
HLT004-0000219,diagnosis,0,NYHA_IV
|
| 1079 |
+
HLT004-0000219,treatment_start_1L,22,gdmt_core
|
| 1080 |
+
HLT004-0000219,treatment_end_1L,258,completed_or_discontinued
|
| 1081 |
+
HLT004-0000219,progression,16,radiographic_progression
|
| 1082 |
+
HLT004-0000219,os_endpoint,258,disease
|
| 1083 |
+
HLT004-0000220,diagnosis,0,NYHA_II
|
| 1084 |
+
HLT004-0000220,treatment_start_1L,25,gdmt_core
|
| 1085 |
+
HLT004-0000220,treatment_end_1L,993,completed_or_discontinued
|
| 1086 |
+
HLT004-0000220,progression,705,radiographic_progression
|
| 1087 |
+
HLT004-0000220,os_endpoint,993,censored
|
| 1088 |
+
HLT004-0000221,diagnosis,0,NYHA_III
|
| 1089 |
+
HLT004-0000221,treatment_start_1L,20,gdmt_core
|
| 1090 |
+
HLT004-0000221,treatment_end_1L,583,completed_or_discontinued
|
| 1091 |
+
HLT004-0000221,response_assessment,64,PR
|
| 1092 |
+
HLT004-0000221,os_endpoint,583,disease
|
| 1093 |
+
HLT004-0000222,diagnosis,0,NYHA_IV
|
| 1094 |
+
HLT004-0000222,treatment_start_1L,17,ivabradine
|
| 1095 |
+
HLT004-0000222,treatment_end_1L,152,completed_or_discontinued
|
| 1096 |
+
HLT004-0000222,response_assessment,57,CR
|
| 1097 |
+
HLT004-0000222,os_endpoint,152,disease
|
| 1098 |
+
HLT004-0000223,diagnosis,0,NYHA_IV
|
| 1099 |
+
HLT004-0000223,treatment_start_1L,16,gdmt_core
|
| 1100 |
+
HLT004-0000223,treatment_end_1L,1165,completed_or_discontinued
|
| 1101 |
+
HLT004-0000223,progression,377,radiographic_progression
|
| 1102 |
+
HLT004-0000223,os_endpoint,1165,disease
|
| 1103 |
+
HLT004-0000224,diagnosis,0,NYHA_II
|
| 1104 |
+
HLT004-0000224,treatment_start_1L,10,lvad
|
| 1105 |
+
HLT004-0000224,treatment_end_1L,786,completed_or_discontinued
|
| 1106 |
+
HLT004-0000224,response_assessment,68,PR
|
| 1107 |
+
HLT004-0000224,os_endpoint,786,censored
|
| 1108 |
+
HLT004-0000225,diagnosis,0,NYHA_III
|
| 1109 |
+
HLT004-0000225,treatment_start_1L,17,ivabradine
|
| 1110 |
+
HLT004-0000225,treatment_end_1L,1366,completed_or_discontinued
|
| 1111 |
+
HLT004-0000225,response_assessment,63,PR
|
| 1112 |
+
HLT004-0000225,os_endpoint,1366,censored
|
| 1113 |
+
HLT004-0000226,diagnosis,0,NYHA_IV
|
| 1114 |
+
HLT004-0000226,treatment_start_1L,16,ivabradine
|
| 1115 |
+
HLT004-0000226,treatment_end_1L,99,completed_or_discontinued
|
| 1116 |
+
HLT004-0000226,response_assessment,64,PR
|
| 1117 |
+
HLT004-0000226,os_endpoint,99,censored
|
| 1118 |
+
HLT004-0000227,diagnosis,0,NYHA_III
|
| 1119 |
+
HLT004-0000227,treatment_start_1L,24,lvad
|
| 1120 |
+
HLT004-0000227,treatment_end_1L,832,completed_or_discontinued
|
| 1121 |
+
HLT004-0000227,response_assessment,86,PR
|
| 1122 |
+
HLT004-0000227,os_endpoint,832,censored
|
| 1123 |
+
HLT004-0000228,diagnosis,0,NYHA_I
|
| 1124 |
+
HLT004-0000228,treatment_start_1L,26,ivabradine
|
| 1125 |
+
HLT004-0000228,treatment_end_1L,117,completed_or_discontinued
|
| 1126 |
+
HLT004-0000228,os_endpoint,117,censored
|
| 1127 |
+
HLT004-0000229,diagnosis,0,NYHA_I
|
| 1128 |
+
HLT004-0000229,treatment_start_1L,27,lvad
|
| 1129 |
+
HLT004-0000229,treatment_end_1L,1825,completed_or_discontinued
|
| 1130 |
+
HLT004-0000229,response_assessment,76,PR
|
| 1131 |
+
HLT004-0000229,os_endpoint,1825,censored
|
| 1132 |
+
HLT004-0000230,diagnosis,0,NYHA_III
|
| 1133 |
+
HLT004-0000230,treatment_start_1L,17,lvad
|
| 1134 |
+
HLT004-0000230,treatment_end_1L,344,completed_or_discontinued
|
| 1135 |
+
HLT004-0000230,response_assessment,74,CR
|
| 1136 |
+
HLT004-0000230,os_endpoint,344,disease
|
| 1137 |
+
HLT004-0000231,diagnosis,0,NYHA_II
|
| 1138 |
+
HLT004-0000231,treatment_start_1L,21,ivabradine
|
| 1139 |
+
HLT004-0000231,treatment_end_1L,1492,completed_or_discontinued
|
| 1140 |
+
HLT004-0000231,response_assessment,38,PR
|
| 1141 |
+
HLT004-0000231,os_endpoint,1492,censored
|
| 1142 |
+
HLT004-0000232,diagnosis,0,NYHA_II
|
| 1143 |
+
HLT004-0000232,treatment_start_1L,22,gdmt_core
|
| 1144 |
+
HLT004-0000232,treatment_end_1L,1601,completed_or_discontinued
|
| 1145 |
+
HLT004-0000232,progression,1186,radiographic_progression
|
| 1146 |
+
HLT004-0000232,os_endpoint,1601,disease
|
| 1147 |
+
HLT004-0000233,diagnosis,0,NYHA_II
|
| 1148 |
+
HLT004-0000233,treatment_start_1L,24,ivabradine
|
| 1149 |
+
HLT004-0000233,treatment_end_1L,606,completed_or_discontinued
|
| 1150 |
+
HLT004-0000233,progression,458,radiographic_progression
|
| 1151 |
+
HLT004-0000233,os_endpoint,606,disease
|
| 1152 |
+
HLT004-0000234,diagnosis,0,NYHA_III
|
| 1153 |
+
HLT004-0000234,treatment_start_1L,26,gdmt_core
|
| 1154 |
+
HLT004-0000234,treatment_end_1L,812,completed_or_discontinued
|
| 1155 |
+
HLT004-0000234,response_assessment,33,CR
|
| 1156 |
+
HLT004-0000234,os_endpoint,812,disease
|
| 1157 |
+
HLT004-0000235,diagnosis,0,NYHA_II
|
| 1158 |
+
HLT004-0000235,treatment_start_1L,10,ivabradine
|
| 1159 |
+
HLT004-0000235,treatment_end_1L,970,completed_or_discontinued
|
| 1160 |
+
HLT004-0000235,progression,763,radiographic_progression
|
| 1161 |
+
HLT004-0000235,os_endpoint,970,disease
|
| 1162 |
+
HLT004-0000236,diagnosis,0,NYHA_IV
|
| 1163 |
+
HLT004-0000236,treatment_start_1L,11,gdmt_core
|
| 1164 |
+
HLT004-0000236,treatment_end_1L,616,completed_or_discontinued
|
| 1165 |
+
HLT004-0000236,response_assessment,52,CR
|
| 1166 |
+
HLT004-0000236,os_endpoint,616,disease
|
| 1167 |
+
HLT004-0000237,diagnosis,0,NYHA_III
|
| 1168 |
+
HLT004-0000237,treatment_start_1L,12,ivabradine
|
| 1169 |
+
HLT004-0000237,treatment_end_1L,824,completed_or_discontinued
|
| 1170 |
+
HLT004-0000237,progression,656,radiographic_progression
|
| 1171 |
+
HLT004-0000237,os_endpoint,824,disease
|
| 1172 |
+
HLT004-0000238,diagnosis,0,NYHA_IV
|
| 1173 |
+
HLT004-0000238,treatment_start_1L,21,lvad
|
| 1174 |
+
HLT004-0000238,treatment_end_1L,507,completed_or_discontinued
|
| 1175 |
+
HLT004-0000238,progression,175,radiographic_progression
|
| 1176 |
+
HLT004-0000238,os_endpoint,507,disease
|
| 1177 |
+
HLT004-0000239,diagnosis,0,NYHA_IV
|
| 1178 |
+
HLT004-0000239,treatment_start_1L,16,gdmt_core
|
| 1179 |
+
HLT004-0000239,treatment_end_1L,441,completed_or_discontinued
|
| 1180 |
+
HLT004-0000239,response_assessment,64,PR
|
| 1181 |
+
HLT004-0000239,os_endpoint,441,disease
|
| 1182 |
+
HLT004-0000240,diagnosis,0,NYHA_II
|
| 1183 |
+
HLT004-0000240,treatment_start_1L,16,ivabradine
|
| 1184 |
+
HLT004-0000240,treatment_end_1L,584,completed_or_discontinued
|
| 1185 |
+
HLT004-0000240,response_assessment,33,PR
|
| 1186 |
+
HLT004-0000240,os_endpoint,584,censored
|
| 1187 |
+
HLT004-0000241,diagnosis,0,NYHA_III
|
| 1188 |
+
HLT004-0000241,treatment_start_1L,13,ivabradine
|
| 1189 |
+
HLT004-0000241,treatment_end_1L,1813,completed_or_discontinued
|
| 1190 |
+
HLT004-0000241,response_assessment,80,CR
|
| 1191 |
+
HLT004-0000241,os_endpoint,1825,censored
|
| 1192 |
+
HLT004-0000242,diagnosis,0,NYHA_I
|
| 1193 |
+
HLT004-0000242,treatment_start_1L,21,lvad
|
| 1194 |
+
HLT004-0000242,treatment_end_1L,1411,completed_or_discontinued
|
| 1195 |
+
HLT004-0000242,response_assessment,67,PR
|
| 1196 |
+
HLT004-0000242,os_endpoint,1411,disease
|
| 1197 |
+
HLT004-0000243,diagnosis,0,NYHA_IV
|
| 1198 |
+
HLT004-0000243,treatment_start_1L,17,lvad
|
| 1199 |
+
HLT004-0000243,treatment_end_1L,231,completed_or_discontinued
|
| 1200 |
+
HLT004-0000243,progression,140,radiographic_progression
|
| 1201 |
+
HLT004-0000243,os_endpoint,231,disease
|
| 1202 |
+
HLT004-0000244,diagnosis,0,NYHA_II
|
| 1203 |
+
HLT004-0000244,treatment_start_1L,12,gdmt_core
|
| 1204 |
+
HLT004-0000244,treatment_end_1L,208,completed_or_discontinued
|
| 1205 |
+
HLT004-0000244,progression,168,radiographic_progression
|
| 1206 |
+
HLT004-0000244,os_endpoint,208,disease
|
| 1207 |
+
HLT004-0000245,diagnosis,0,NYHA_III
|
| 1208 |
+
HLT004-0000245,treatment_start_1L,24,lvad
|
| 1209 |
+
HLT004-0000245,treatment_end_1L,1186,completed_or_discontinued
|
| 1210 |
+
HLT004-0000245,response_assessment,76,CR
|
| 1211 |
+
HLT004-0000245,os_endpoint,1186,disease
|
| 1212 |
+
HLT004-0000246,diagnosis,0,NYHA_III
|
| 1213 |
+
HLT004-0000246,treatment_start_1L,16,gdmt_core
|
| 1214 |
+
HLT004-0000246,treatment_end_1L,204,completed_or_discontinued
|
| 1215 |
+
HLT004-0000246,response_assessment,50,PR
|
| 1216 |
+
HLT004-0000246,os_endpoint,204,censored
|
| 1217 |
+
HLT004-0000247,diagnosis,0,NYHA_II
|
| 1218 |
+
HLT004-0000247,treatment_start_1L,29,lvad
|
| 1219 |
+
HLT004-0000247,treatment_end_1L,1732,completed_or_discontinued
|
| 1220 |
+
HLT004-0000247,progression,72,radiographic_progression
|
| 1221 |
+
HLT004-0000247,os_endpoint,1732,other_cause
|
| 1222 |
+
HLT004-0000248,diagnosis,0,NYHA_III
|
| 1223 |
+
HLT004-0000248,treatment_start_1L,9,ivabradine
|
| 1224 |
+
HLT004-0000248,treatment_end_1L,666,completed_or_discontinued
|
| 1225 |
+
HLT004-0000248,response_assessment,88,PR
|
| 1226 |
+
HLT004-0000248,os_endpoint,666,disease
|
| 1227 |
+
HLT004-0000249,diagnosis,0,NYHA_I
|
| 1228 |
+
HLT004-0000249,treatment_start_1L,9,ivabradine
|
| 1229 |
+
HLT004-0000249,treatment_end_1L,1734,completed_or_discontinued
|
| 1230 |
+
HLT004-0000249,progression,910,radiographic_progression
|
| 1231 |
+
HLT004-0000249,os_endpoint,1734,censored
|
| 1232 |
+
HLT004-0000250,diagnosis,0,NYHA_II
|
| 1233 |
+
HLT004-0000250,treatment_start_1L,13,lvad
|
| 1234 |
+
HLT004-0000250,treatment_end_1L,10,completed_or_discontinued
|
| 1235 |
+
HLT004-0000250,response_assessment,46,CR
|
| 1236 |
+
HLT004-0000250,os_endpoint,10,other_cause
|
| 1237 |
+
HLT004-0000251,diagnosis,0,NYHA_II
|
| 1238 |
+
HLT004-0000251,treatment_start_1L,23,lvad
|
| 1239 |
+
HLT004-0000251,treatment_end_1L,1055,completed_or_discontinued
|
| 1240 |
+
HLT004-0000251,response_assessment,67,PR
|
| 1241 |
+
HLT004-0000251,os_endpoint,1055,censored
|
| 1242 |
+
HLT004-0000252,diagnosis,0,NYHA_II
|
| 1243 |
+
HLT004-0000252,treatment_start_1L,24,lvad
|
| 1244 |
+
HLT004-0000252,treatment_end_1L,1825,completed_or_discontinued
|
| 1245 |
+
HLT004-0000252,response_assessment,75,PR
|
| 1246 |
+
HLT004-0000252,os_endpoint,1825,censored
|
| 1247 |
+
HLT004-0000253,diagnosis,0,NYHA_III
|
| 1248 |
+
HLT004-0000253,treatment_start_1L,29,ivabradine
|
| 1249 |
+
HLT004-0000253,treatment_end_1L,582,completed_or_discontinued
|
| 1250 |
+
HLT004-0000253,response_assessment,72,PR
|
| 1251 |
+
HLT004-0000253,os_endpoint,582,disease
|
| 1252 |
+
HLT004-0000254,diagnosis,0,NYHA_IV
|
| 1253 |
+
HLT004-0000254,treatment_start_1L,18,ivabradine
|
| 1254 |
+
HLT004-0000254,treatment_end_1L,219,completed_or_discontinued
|
| 1255 |
+
HLT004-0000254,progression,181,radiographic_progression
|
| 1256 |
+
HLT004-0000254,os_endpoint,219,censored
|
| 1257 |
+
HLT004-0000255,diagnosis,0,NYHA_II
|
| 1258 |
+
HLT004-0000255,treatment_start_1L,21,ivabradine
|
| 1259 |
+
HLT004-0000255,treatment_end_1L,261,completed_or_discontinued
|
| 1260 |
+
HLT004-0000255,progression,226,radiographic_progression
|
| 1261 |
+
HLT004-0000255,os_endpoint,261,censored
|
| 1262 |
+
HLT004-0000256,diagnosis,0,NYHA_III
|
| 1263 |
+
HLT004-0000256,treatment_start_1L,29,lvad
|
| 1264 |
+
HLT004-0000256,treatment_end_1L,929,completed_or_discontinued
|
| 1265 |
+
HLT004-0000256,response_assessment,71,CR
|
| 1266 |
+
HLT004-0000256,os_endpoint,929,disease
|
| 1267 |
+
HLT004-0000257,diagnosis,0,NYHA_IV
|
| 1268 |
+
HLT004-0000257,treatment_start_1L,27,lvad
|
| 1269 |
+
HLT004-0000257,treatment_end_1L,677,completed_or_discontinued
|
| 1270 |
+
HLT004-0000257,progression,145,radiographic_progression
|
| 1271 |
+
HLT004-0000257,os_endpoint,677,other_cause
|
| 1272 |
+
HLT004-0000258,diagnosis,0,NYHA_III
|
| 1273 |
+
HLT004-0000258,treatment_start_1L,23,gdmt_core
|
| 1274 |
+
HLT004-0000258,treatment_end_1L,1066,completed_or_discontinued
|
| 1275 |
+
HLT004-0000258,progression,160,radiographic_progression
|
| 1276 |
+
HLT004-0000258,os_endpoint,1066,disease
|
| 1277 |
+
HLT004-0000259,diagnosis,0,NYHA_I
|
| 1278 |
+
HLT004-0000259,treatment_start_1L,25,gdmt_core
|
| 1279 |
+
HLT004-0000259,treatment_end_1L,249,completed_or_discontinued
|
| 1280 |
+
HLT004-0000259,os_endpoint,249,censored
|
| 1281 |
+
HLT004-0000260,diagnosis,0,NYHA_IV
|
| 1282 |
+
HLT004-0000260,treatment_start_1L,24,gdmt_core
|
| 1283 |
+
HLT004-0000260,treatment_end_1L,742,completed_or_discontinued
|
| 1284 |
+
HLT004-0000260,response_assessment,50,PR
|
| 1285 |
+
HLT004-0000260,os_endpoint,742,disease
|
| 1286 |
+
HLT004-0000261,diagnosis,0,NYHA_I
|
| 1287 |
+
HLT004-0000261,treatment_start_1L,16,gdmt_core
|
| 1288 |
+
HLT004-0000261,treatment_end_1L,1825,completed_or_discontinued
|
| 1289 |
+
HLT004-0000261,response_assessment,57,PR
|
| 1290 |
+
HLT004-0000261,os_endpoint,1825,censored
|
| 1291 |
+
HLT004-0000262,diagnosis,0,NYHA_III
|
| 1292 |
+
HLT004-0000262,treatment_start_1L,22,ivabradine
|
| 1293 |
+
HLT004-0000262,treatment_end_1L,776,completed_or_discontinued
|
| 1294 |
+
HLT004-0000262,response_assessment,59,PR
|
| 1295 |
+
HLT004-0000262,os_endpoint,776,disease
|
| 1296 |
+
HLT004-0000263,diagnosis,0,NYHA_III
|
| 1297 |
+
HLT004-0000263,treatment_start_1L,18,gdmt_core
|
| 1298 |
+
HLT004-0000263,treatment_end_1L,786,completed_or_discontinued
|
| 1299 |
+
HLT004-0000263,os_endpoint,786,censored
|
| 1300 |
+
HLT004-0000264,diagnosis,0,NYHA_III
|
| 1301 |
+
HLT004-0000264,treatment_start_1L,16,ivabradine
|
| 1302 |
+
HLT004-0000264,treatment_end_1L,1668,completed_or_discontinued
|
| 1303 |
+
HLT004-0000264,response_assessment,60,PR
|
| 1304 |
+
HLT004-0000264,os_endpoint,1668,disease
|
| 1305 |
+
HLT004-0000265,diagnosis,0,NYHA_I
|
| 1306 |
+
HLT004-0000265,treatment_start_1L,25,gdmt_core
|
| 1307 |
+
HLT004-0000265,treatment_end_1L,195,completed_or_discontinued
|
| 1308 |
+
HLT004-0000265,os_endpoint,195,censored
|
| 1309 |
+
HLT004-0000266,diagnosis,0,NYHA_II
|
| 1310 |
+
HLT004-0000266,treatment_start_1L,7,ivabradine
|
| 1311 |
+
HLT004-0000266,treatment_end_1L,134,completed_or_discontinued
|
| 1312 |
+
HLT004-0000266,progression,90,radiographic_progression
|
| 1313 |
+
HLT004-0000266,os_endpoint,134,disease
|
| 1314 |
+
HLT004-0000267,diagnosis,0,NYHA_III
|
| 1315 |
+
HLT004-0000267,treatment_start_1L,9,ivabradine
|
| 1316 |
+
HLT004-0000267,treatment_end_1L,1259,completed_or_discontinued
|
| 1317 |
+
HLT004-0000267,response_assessment,67,CR
|
| 1318 |
+
HLT004-0000267,os_endpoint,1259,disease
|
| 1319 |
+
HLT004-0000268,diagnosis,0,NYHA_I
|
| 1320 |
+
HLT004-0000268,treatment_start_1L,21,ivabradine
|
| 1321 |
+
HLT004-0000268,treatment_end_1L,1821,completed_or_discontinued
|
| 1322 |
+
HLT004-0000268,os_endpoint,1825,censored
|
| 1323 |
+
HLT004-0000269,diagnosis,0,NYHA_II
|
| 1324 |
+
HLT004-0000269,treatment_start_1L,19,ivabradine
|
| 1325 |
+
HLT004-0000269,treatment_end_1L,674,completed_or_discontinued
|
| 1326 |
+
HLT004-0000269,progression,447,radiographic_progression
|
| 1327 |
+
HLT004-0000269,os_endpoint,674,disease
|
| 1328 |
+
HLT004-0000270,diagnosis,0,NYHA_III
|
| 1329 |
+
HLT004-0000270,treatment_start_1L,27,lvad
|
| 1330 |
+
HLT004-0000270,treatment_end_1L,1596,completed_or_discontinued
|
| 1331 |
+
HLT004-0000270,progression,415,radiographic_progression
|
| 1332 |
+
HLT004-0000270,os_endpoint,1596,disease
|
| 1333 |
+
HLT004-0000271,diagnosis,0,NYHA_III
|
| 1334 |
+
HLT004-0000271,treatment_start_1L,15,lvad
|
| 1335 |
+
HLT004-0000271,treatment_end_1L,689,completed_or_discontinued
|
| 1336 |
+
HLT004-0000271,progression,591,radiographic_progression
|
| 1337 |
+
HLT004-0000271,os_endpoint,689,disease
|
| 1338 |
+
HLT004-0000272,diagnosis,0,NYHA_II
|
| 1339 |
+
HLT004-0000272,treatment_start_1L,15,ivabradine
|
| 1340 |
+
HLT004-0000272,treatment_end_1L,940,completed_or_discontinued
|
| 1341 |
+
HLT004-0000272,progression,752,radiographic_progression
|
| 1342 |
+
HLT004-0000272,os_endpoint,940,censored
|
| 1343 |
+
HLT004-0000273,diagnosis,0,NYHA_II
|
| 1344 |
+
HLT004-0000273,treatment_start_1L,7,gdmt_core
|
| 1345 |
+
HLT004-0000273,treatment_end_1L,1825,completed_or_discontinued
|
| 1346 |
+
HLT004-0000273,progression,1457,radiographic_progression
|
| 1347 |
+
HLT004-0000273,os_endpoint,1825,censored
|
| 1348 |
+
HLT004-0000274,diagnosis,0,NYHA_IV
|
| 1349 |
+
HLT004-0000274,treatment_start_1L,19,gdmt_core
|
| 1350 |
+
HLT004-0000274,treatment_end_1L,590,completed_or_discontinued
|
| 1351 |
+
HLT004-0000274,response_assessment,57,PR
|
| 1352 |
+
HLT004-0000274,os_endpoint,590,disease
|
| 1353 |
+
HLT004-0000275,diagnosis,0,NYHA_II
|
| 1354 |
+
HLT004-0000275,treatment_start_1L,15,lvad
|
| 1355 |
+
HLT004-0000275,treatment_end_1L,184,completed_or_discontinued
|
| 1356 |
+
HLT004-0000275,progression,144,radiographic_progression
|
| 1357 |
+
HLT004-0000275,os_endpoint,184,other_cause
|
| 1358 |
+
HLT004-0000276,diagnosis,0,NYHA_I
|
| 1359 |
+
HLT004-0000276,treatment_start_1L,12,lvad
|
| 1360 |
+
HLT004-0000276,treatment_end_1L,1825,completed_or_discontinued
|
| 1361 |
+
HLT004-0000276,response_assessment,37,PR
|
| 1362 |
+
HLT004-0000276,os_endpoint,1825,censored
|
| 1363 |
+
HLT004-0000277,diagnosis,0,NYHA_II
|
| 1364 |
+
HLT004-0000277,treatment_start_1L,14,lvad
|
| 1365 |
+
HLT004-0000277,treatment_end_1L,1825,completed_or_discontinued
|
| 1366 |
+
HLT004-0000277,progression,114,radiographic_progression
|
| 1367 |
+
HLT004-0000277,os_endpoint,1825,censored
|
| 1368 |
+
HLT004-0000278,diagnosis,0,NYHA_II
|
| 1369 |
+
HLT004-0000278,treatment_start_1L,16,lvad
|
| 1370 |
+
HLT004-0000278,treatment_end_1L,527,completed_or_discontinued
|
| 1371 |
+
HLT004-0000278,response_assessment,51,PR
|
| 1372 |
+
HLT004-0000278,os_endpoint,527,other_cause
|
| 1373 |
+
HLT004-0000279,diagnosis,0,NYHA_IV
|
| 1374 |
+
HLT004-0000279,treatment_start_1L,23,gdmt_core
|
| 1375 |
+
HLT004-0000279,treatment_end_1L,229,completed_or_discontinued
|
| 1376 |
+
HLT004-0000279,response_assessment,87,PR
|
| 1377 |
+
HLT004-0000279,os_endpoint,229,disease
|
| 1378 |
+
HLT004-0000280,diagnosis,0,NYHA_II
|
| 1379 |
+
HLT004-0000280,treatment_start_1L,15,ivabradine
|
| 1380 |
+
HLT004-0000280,treatment_end_1L,648,completed_or_discontinued
|
| 1381 |
+
HLT004-0000280,os_endpoint,648,other_cause
|
| 1382 |
+
HLT004-0000281,diagnosis,0,NYHA_I
|
| 1383 |
+
HLT004-0000281,treatment_start_1L,23,lvad
|
| 1384 |
+
HLT004-0000281,treatment_end_1L,216,completed_or_discontinued
|
| 1385 |
+
HLT004-0000281,progression,155,radiographic_progression
|
| 1386 |
+
HLT004-0000281,os_endpoint,216,censored
|
| 1387 |
+
HLT004-0000282,diagnosis,0,NYHA_II
|
| 1388 |
+
HLT004-0000282,treatment_start_1L,12,lvad
|
| 1389 |
+
HLT004-0000282,treatment_end_1L,603,completed_or_discontinued
|
| 1390 |
+
HLT004-0000282,progression,457,radiographic_progression
|
| 1391 |
+
HLT004-0000282,os_endpoint,603,other_cause
|
| 1392 |
+
HLT004-0000283,diagnosis,0,NYHA_I
|
| 1393 |
+
HLT004-0000283,treatment_start_1L,13,gdmt_core
|
| 1394 |
+
HLT004-0000283,treatment_end_1L,1825,completed_or_discontinued
|
| 1395 |
+
HLT004-0000283,os_endpoint,1825,censored
|
| 1396 |
+
HLT004-0000284,diagnosis,0,NYHA_II
|
| 1397 |
+
HLT004-0000284,treatment_start_1L,25,ivabradine
|
| 1398 |
+
HLT004-0000284,treatment_end_1L,1348,completed_or_discontinued
|
| 1399 |
+
HLT004-0000284,response_assessment,32,CR
|
| 1400 |
+
HLT004-0000284,os_endpoint,1348,other_cause
|
| 1401 |
+
HLT004-0000285,diagnosis,0,NYHA_IV
|
| 1402 |
+
HLT004-0000285,treatment_start_1L,14,gdmt_core
|
| 1403 |
+
HLT004-0000285,treatment_end_1L,453,completed_or_discontinued
|
| 1404 |
+
HLT004-0000285,response_assessment,42,PR
|
| 1405 |
+
HLT004-0000285,os_endpoint,453,disease
|
| 1406 |
+
HLT004-0000286,diagnosis,0,NYHA_III
|
| 1407 |
+
HLT004-0000286,treatment_start_1L,29,lvad
|
| 1408 |
+
HLT004-0000286,treatment_end_1L,380,completed_or_discontinued
|
| 1409 |
+
HLT004-0000286,progression,317,radiographic_progression
|
| 1410 |
+
HLT004-0000286,os_endpoint,380,disease
|
| 1411 |
+
HLT004-0000287,diagnosis,0,NYHA_I
|
| 1412 |
+
HLT004-0000287,treatment_start_1L,20,gdmt_core
|
| 1413 |
+
HLT004-0000287,treatment_end_1L,1825,completed_or_discontinued
|
| 1414 |
+
HLT004-0000287,response_assessment,56,PR
|
| 1415 |
+
HLT004-0000287,os_endpoint,1825,censored
|
| 1416 |
+
HLT004-0000288,diagnosis,0,NYHA_II
|
| 1417 |
+
HLT004-0000288,treatment_start_1L,14,lvad
|
| 1418 |
+
HLT004-0000288,treatment_end_1L,246,completed_or_discontinued
|
| 1419 |
+
HLT004-0000288,progression,209,radiographic_progression
|
| 1420 |
+
HLT004-0000288,os_endpoint,246,censored
|
| 1421 |
+
HLT004-0000289,diagnosis,0,NYHA_II
|
| 1422 |
+
HLT004-0000289,treatment_start_1L,18,ivabradine
|
| 1423 |
+
HLT004-0000289,treatment_end_1L,141,completed_or_discontinued
|
| 1424 |
+
HLT004-0000289,progression,93,radiographic_progression
|
| 1425 |
+
HLT004-0000289,os_endpoint,141,censored
|
| 1426 |
+
HLT004-0000290,diagnosis,0,NYHA_I
|
| 1427 |
+
HLT004-0000290,treatment_start_1L,12,ivabradine
|
| 1428 |
+
HLT004-0000290,treatment_end_1L,185,completed_or_discontinued
|
| 1429 |
+
HLT004-0000290,progression,136,radiographic_progression
|
| 1430 |
+
HLT004-0000290,os_endpoint,185,other_cause
|
| 1431 |
+
HLT004-0000291,diagnosis,0,NYHA_III
|
| 1432 |
+
HLT004-0000291,treatment_start_1L,8,lvad
|
| 1433 |
+
HLT004-0000291,treatment_end_1L,1203,completed_or_discontinued
|
| 1434 |
+
HLT004-0000291,progression,922,radiographic_progression
|
| 1435 |
+
HLT004-0000291,os_endpoint,1203,other_cause
|
| 1436 |
+
HLT004-0000292,diagnosis,0,NYHA_II
|
| 1437 |
+
HLT004-0000292,treatment_start_1L,28,gdmt_core
|
| 1438 |
+
HLT004-0000292,treatment_end_1L,1825,completed_or_discontinued
|
| 1439 |
+
HLT004-0000292,response_assessment,75,PR
|
| 1440 |
+
HLT004-0000292,os_endpoint,1825,censored
|
| 1441 |
+
HLT004-0000293,diagnosis,0,NYHA_III
|
| 1442 |
+
HLT004-0000293,treatment_start_1L,17,lvad
|
| 1443 |
+
HLT004-0000293,treatment_end_1L,945,completed_or_discontinued
|
| 1444 |
+
HLT004-0000293,response_assessment,40,PR
|
| 1445 |
+
HLT004-0000293,os_endpoint,945,disease
|
| 1446 |
+
HLT004-0000294,diagnosis,0,NYHA_IV
|
| 1447 |
+
HLT004-0000294,treatment_start_1L,26,lvad
|
| 1448 |
+
HLT004-0000294,treatment_end_1L,211,completed_or_discontinued
|
| 1449 |
+
HLT004-0000294,progression,57,radiographic_progression
|
| 1450 |
+
HLT004-0000294,os_endpoint,211,disease
|
| 1451 |
+
HLT004-0000295,diagnosis,0,NYHA_II
|
| 1452 |
+
HLT004-0000295,treatment_start_1L,28,lvad
|
| 1453 |
+
HLT004-0000295,treatment_end_1L,124,completed_or_discontinued
|
| 1454 |
+
HLT004-0000295,progression,85,radiographic_progression
|
| 1455 |
+
HLT004-0000295,os_endpoint,124,other_cause
|
| 1456 |
+
HLT004-0000296,diagnosis,0,NYHA_IV
|
| 1457 |
+
HLT004-0000296,treatment_start_1L,28,gdmt_core
|
| 1458 |
+
HLT004-0000296,treatment_end_1L,606,completed_or_discontinued
|
| 1459 |
+
HLT004-0000296,progression,414,radiographic_progression
|
| 1460 |
+
HLT004-0000296,os_endpoint,606,disease
|
| 1461 |
+
HLT004-0000297,diagnosis,0,NYHA_II
|
| 1462 |
+
HLT004-0000297,treatment_start_1L,21,lvad
|
| 1463 |
+
HLT004-0000297,treatment_end_1L,1258,completed_or_discontinued
|
| 1464 |
+
HLT004-0000297,progression,953,radiographic_progression
|
| 1465 |
+
HLT004-0000297,os_endpoint,1258,censored
|
| 1466 |
+
HLT004-0000298,diagnosis,0,NYHA_II
|
| 1467 |
+
HLT004-0000298,treatment_start_1L,12,lvad
|
| 1468 |
+
HLT004-0000298,treatment_end_1L,1534,completed_or_discontinued
|
| 1469 |
+
HLT004-0000298,response_assessment,50,PR
|
| 1470 |
+
HLT004-0000298,os_endpoint,1534,disease
|
| 1471 |
+
HLT004-0000299,diagnosis,0,NYHA_III
|
| 1472 |
+
HLT004-0000299,treatment_start_1L,27,lvad
|
| 1473 |
+
HLT004-0000299,treatment_end_1L,296,completed_or_discontinued
|
| 1474 |
+
HLT004-0000299,os_endpoint,296,disease
|
| 1475 |
+
HLT004-0000300,diagnosis,0,NYHA_I
|
| 1476 |
+
HLT004-0000300,treatment_start_1L,26,ivabradine
|
| 1477 |
+
HLT004-0000300,treatment_end_1L,230,completed_or_discontinued
|
| 1478 |
+
HLT004-0000300,response_assessment,78,PR
|
| 1479 |
+
HLT004-0000300,os_endpoint,230,censored
|
| 1480 |
+
HLT004-0000301,diagnosis,0,NYHA_III
|
| 1481 |
+
HLT004-0000301,treatment_start_1L,20,ivabradine
|
| 1482 |
+
HLT004-0000301,treatment_end_1L,1484,completed_or_discontinued
|
| 1483 |
+
HLT004-0000301,progression,254,radiographic_progression
|
| 1484 |
+
HLT004-0000301,os_endpoint,1484,disease
|
| 1485 |
+
HLT004-0000302,diagnosis,0,NYHA_III
|
| 1486 |
+
HLT004-0000302,treatment_start_1L,18,gdmt_core
|
| 1487 |
+
HLT004-0000302,treatment_end_1L,910,completed_or_discontinued
|
| 1488 |
+
HLT004-0000302,response_assessment,42,PR
|
| 1489 |
+
HLT004-0000302,os_endpoint,910,disease
|
| 1490 |
+
HLT004-0000303,diagnosis,0,NYHA_II
|
| 1491 |
+
HLT004-0000303,treatment_start_1L,13,ivabradine
|
| 1492 |
+
HLT004-0000303,treatment_end_1L,1208,completed_or_discontinued
|
| 1493 |
+
HLT004-0000303,response_assessment,65,PR
|
| 1494 |
+
HLT004-0000303,os_endpoint,1208,censored
|
| 1495 |
+
HLT004-0000304,diagnosis,0,NYHA_IV
|
| 1496 |
+
HLT004-0000304,treatment_start_1L,20,gdmt_core
|
| 1497 |
+
HLT004-0000304,treatment_end_1L,381,completed_or_discontinued
|
| 1498 |
+
HLT004-0000304,progression,208,radiographic_progression
|
| 1499 |
+
HLT004-0000304,os_endpoint,381,disease
|
| 1500 |
+
HLT004-0000305,diagnosis,0,NYHA_II
|
| 1501 |
+
HLT004-0000305,treatment_start_1L,14,gdmt_core
|
| 1502 |
+
HLT004-0000305,treatment_end_1L,1825,completed_or_discontinued
|
| 1503 |
+
HLT004-0000305,progression,211,radiographic_progression
|
| 1504 |
+
HLT004-0000305,os_endpoint,1825,censored
|
| 1505 |
+
HLT004-0000306,diagnosis,0,NYHA_III
|
| 1506 |
+
HLT004-0000306,treatment_start_1L,27,gdmt_core
|
| 1507 |
+
HLT004-0000306,treatment_end_1L,875,completed_or_discontinued
|
| 1508 |
+
HLT004-0000306,response_assessment,46,CR
|
| 1509 |
+
HLT004-0000306,os_endpoint,875,disease
|
| 1510 |
+
HLT004-0000307,diagnosis,0,NYHA_I
|
| 1511 |
+
HLT004-0000307,treatment_start_1L,23,gdmt_core
|
| 1512 |
+
HLT004-0000307,treatment_end_1L,456,completed_or_discontinued
|
| 1513 |
+
HLT004-0000307,response_assessment,88,PR
|
| 1514 |
+
HLT004-0000307,os_endpoint,456,other_cause
|
| 1515 |
+
HLT004-0000308,diagnosis,0,NYHA_II
|
| 1516 |
+
HLT004-0000308,treatment_start_1L,18,lvad
|
| 1517 |
+
HLT004-0000308,treatment_end_1L,594,completed_or_discontinued
|
| 1518 |
+
HLT004-0000308,response_assessment,42,PR
|
| 1519 |
+
HLT004-0000308,os_endpoint,594,disease
|
| 1520 |
+
HLT004-0000309,diagnosis,0,NYHA_II
|
| 1521 |
+
HLT004-0000309,treatment_start_1L,13,ivabradine
|
| 1522 |
+
HLT004-0000309,treatment_end_1L,1593,completed_or_discontinued
|
| 1523 |
+
HLT004-0000309,progression,1221,radiographic_progression
|
| 1524 |
+
HLT004-0000309,os_endpoint,1593,disease
|
| 1525 |
+
HLT004-0000310,diagnosis,0,NYHA_IV
|
| 1526 |
+
HLT004-0000310,treatment_start_1L,9,gdmt_core
|
| 1527 |
+
HLT004-0000310,treatment_end_1L,31,completed_or_discontinued
|
| 1528 |
+
HLT004-0000310,response_assessment,70,PR
|
| 1529 |
+
HLT004-0000310,os_endpoint,31,disease
|
| 1530 |
+
HLT004-0000311,diagnosis,0,NYHA_I
|
| 1531 |
+
HLT004-0000311,treatment_start_1L,17,lvad
|
| 1532 |
+
HLT004-0000311,treatment_end_1L,1183,completed_or_discontinued
|
| 1533 |
+
HLT004-0000311,response_assessment,31,CR
|
| 1534 |
+
HLT004-0000311,os_endpoint,1183,disease
|
| 1535 |
+
HLT004-0000312,diagnosis,0,NYHA_IV
|
| 1536 |
+
HLT004-0000312,treatment_start_1L,9,lvad
|
| 1537 |
+
HLT004-0000312,treatment_end_1L,188,completed_or_discontinued
|
| 1538 |
+
HLT004-0000312,response_assessment,51,CR
|
| 1539 |
+
HLT004-0000312,os_endpoint,188,disease
|
| 1540 |
+
HLT004-0000313,diagnosis,0,NYHA_II
|
| 1541 |
+
HLT004-0000313,treatment_start_1L,8,lvad
|
| 1542 |
+
HLT004-0000313,treatment_end_1L,1825,completed_or_discontinued
|
| 1543 |
+
HLT004-0000313,progression,281,radiographic_progression
|
| 1544 |
+
HLT004-0000313,os_endpoint,1825,censored
|
| 1545 |
+
HLT004-0000314,diagnosis,0,NYHA_II
|
| 1546 |
+
HLT004-0000314,treatment_start_1L,21,lvad
|
| 1547 |
+
HLT004-0000314,treatment_end_1L,673,completed_or_discontinued
|
| 1548 |
+
HLT004-0000314,progression,547,radiographic_progression
|
| 1549 |
+
HLT004-0000314,os_endpoint,673,other_cause
|
| 1550 |
+
HLT004-0000315,diagnosis,0,NYHA_II
|
| 1551 |
+
HLT004-0000315,treatment_start_1L,7,lvad
|
| 1552 |
+
HLT004-0000315,treatment_end_1L,1825,completed_or_discontinued
|
| 1553 |
+
HLT004-0000315,response_assessment,73,PR
|
| 1554 |
+
HLT004-0000315,os_endpoint,1825,censored
|
| 1555 |
+
HLT004-0000316,diagnosis,0,NYHA_I
|
| 1556 |
+
HLT004-0000316,treatment_start_1L,12,ivabradine
|
| 1557 |
+
HLT004-0000316,treatment_end_1L,83,completed_or_discontinued
|
| 1558 |
+
HLT004-0000316,os_endpoint,83,disease
|
| 1559 |
+
HLT004-0000317,diagnosis,0,NYHA_IV
|
| 1560 |
+
HLT004-0000317,treatment_start_1L,7,lvad
|
| 1561 |
+
HLT004-0000317,treatment_end_1L,156,completed_or_discontinued
|
| 1562 |
+
HLT004-0000317,response_assessment,89,PR
|
| 1563 |
+
HLT004-0000317,os_endpoint,156,disease
|
| 1564 |
+
HLT004-0000318,diagnosis,0,NYHA_II
|
| 1565 |
+
HLT004-0000318,treatment_start_1L,25,lvad
|
| 1566 |
+
HLT004-0000318,treatment_end_1L,752,completed_or_discontinued
|
| 1567 |
+
HLT004-0000318,progression,620,radiographic_progression
|
| 1568 |
+
HLT004-0000318,os_endpoint,752,other_cause
|
| 1569 |
+
HLT004-0000319,diagnosis,0,NYHA_III
|
| 1570 |
+
HLT004-0000319,treatment_start_1L,13,gdmt_core
|
| 1571 |
+
HLT004-0000319,treatment_end_1L,334,completed_or_discontinued
|
| 1572 |
+
HLT004-0000319,response_assessment,68,PR
|
| 1573 |
+
HLT004-0000319,os_endpoint,334,censored
|
| 1574 |
+
HLT004-0000320,diagnosis,0,NYHA_III
|
| 1575 |
+
HLT004-0000320,treatment_start_1L,20,lvad
|
| 1576 |
+
HLT004-0000320,treatment_end_1L,180,completed_or_discontinued
|
| 1577 |
+
HLT004-0000320,response_assessment,87,PR
|
| 1578 |
+
HLT004-0000320,os_endpoint,180,censored
|
| 1579 |
+
HLT004-0000321,diagnosis,0,NYHA_II
|
| 1580 |
+
HLT004-0000321,treatment_start_1L,14,lvad
|
| 1581 |
+
HLT004-0000321,treatment_end_1L,1825,completed_or_discontinued
|
| 1582 |
+
HLT004-0000321,progression,1740,radiographic_progression
|
| 1583 |
+
HLT004-0000321,os_endpoint,1825,censored
|
| 1584 |
+
HLT004-0000322,diagnosis,0,NYHA_III
|
| 1585 |
+
HLT004-0000322,treatment_start_1L,27,lvad
|
| 1586 |
+
HLT004-0000322,treatment_end_1L,1194,completed_or_discontinued
|
| 1587 |
+
HLT004-0000322,response_assessment,86,PR
|
| 1588 |
+
HLT004-0000322,os_endpoint,1194,disease
|
| 1589 |
+
HLT004-0000323,diagnosis,0,NYHA_IV
|
| 1590 |
+
HLT004-0000323,treatment_start_1L,28,lvad
|
| 1591 |
+
HLT004-0000323,treatment_end_1L,265,completed_or_discontinued
|
| 1592 |
+
HLT004-0000323,os_endpoint,265,censored
|
| 1593 |
+
HLT004-0000324,diagnosis,0,NYHA_III
|
| 1594 |
+
HLT004-0000324,treatment_start_1L,10,ivabradine
|
| 1595 |
+
HLT004-0000324,treatment_end_1L,64,completed_or_discontinued
|
| 1596 |
+
HLT004-0000324,progression,39,radiographic_progression
|
| 1597 |
+
HLT004-0000324,os_endpoint,64,other_cause
|
| 1598 |
+
HLT004-0000325,diagnosis,0,NYHA_III
|
| 1599 |
+
HLT004-0000325,treatment_start_1L,19,ivabradine
|
| 1600 |
+
HLT004-0000325,treatment_end_1L,701,completed_or_discontinued
|
| 1601 |
+
HLT004-0000325,response_assessment,34,PR
|
| 1602 |
+
HLT004-0000325,os_endpoint,701,disease
|
| 1603 |
+
HLT004-0000326,diagnosis,0,NYHA_III
|
| 1604 |
+
HLT004-0000326,treatment_start_1L,15,ivabradine
|
| 1605 |
+
HLT004-0000326,treatment_end_1L,532,completed_or_discontinued
|
| 1606 |
+
HLT004-0000326,response_assessment,88,PR
|
| 1607 |
+
HLT004-0000326,os_endpoint,532,disease
|
| 1608 |
+
HLT004-0000327,diagnosis,0,NYHA_III
|
| 1609 |
+
HLT004-0000327,treatment_start_1L,7,lvad
|
| 1610 |
+
HLT004-0000327,treatment_end_1L,643,completed_or_discontinued
|
| 1611 |
+
HLT004-0000327,response_assessment,71,PR
|
| 1612 |
+
HLT004-0000327,os_endpoint,643,disease
|
| 1613 |
+
HLT004-0000328,diagnosis,0,NYHA_II
|
| 1614 |
+
HLT004-0000328,treatment_start_1L,27,lvad
|
| 1615 |
+
HLT004-0000328,treatment_end_1L,965,completed_or_discontinued
|
| 1616 |
+
HLT004-0000328,progression,761,radiographic_progression
|
| 1617 |
+
HLT004-0000328,os_endpoint,965,other_cause
|
| 1618 |
+
HLT004-0000329,diagnosis,0,NYHA_III
|
| 1619 |
+
HLT004-0000329,treatment_start_1L,19,lvad
|
| 1620 |
+
HLT004-0000329,treatment_end_1L,467,completed_or_discontinued
|
| 1621 |
+
HLT004-0000329,response_assessment,64,PR
|
| 1622 |
+
HLT004-0000329,os_endpoint,467,disease
|
| 1623 |
+
HLT004-0000330,diagnosis,0,NYHA_II
|
| 1624 |
+
HLT004-0000330,treatment_start_1L,11,lvad
|
| 1625 |
+
HLT004-0000330,treatment_end_1L,1825,completed_or_discontinued
|
| 1626 |
+
HLT004-0000330,progression,1407,radiographic_progression
|
| 1627 |
+
HLT004-0000330,os_endpoint,1825,censored
|
| 1628 |
+
HLT004-0000331,diagnosis,0,NYHA_III
|
| 1629 |
+
HLT004-0000331,treatment_start_1L,16,lvad
|
| 1630 |
+
HLT004-0000331,treatment_end_1L,672,completed_or_discontinued
|
| 1631 |
+
HLT004-0000331,response_assessment,73,PR
|
| 1632 |
+
HLT004-0000331,os_endpoint,672,disease
|
| 1633 |
+
HLT004-0000332,diagnosis,0,NYHA_IV
|
| 1634 |
+
HLT004-0000332,treatment_start_1L,25,gdmt_core
|
| 1635 |
+
HLT004-0000332,treatment_end_1L,64,completed_or_discontinued
|
| 1636 |
+
HLT004-0000332,response_assessment,65,CR
|
| 1637 |
+
HLT004-0000332,os_endpoint,64,disease
|
| 1638 |
+
HLT004-0000333,diagnosis,0,NYHA_IV
|
| 1639 |
+
HLT004-0000333,treatment_start_1L,7,lvad
|
| 1640 |
+
HLT004-0000333,treatment_end_1L,854,completed_or_discontinued
|
| 1641 |
+
HLT004-0000333,response_assessment,45,PR
|
| 1642 |
+
HLT004-0000333,os_endpoint,854,disease
|
| 1643 |
+
HLT004-0000334,diagnosis,0,NYHA_III
|
| 1644 |
+
HLT004-0000334,treatment_start_1L,9,gdmt_core
|
| 1645 |
+
HLT004-0000334,treatment_end_1L,30,completed_or_discontinued
|
| 1646 |
+
HLT004-0000334,progression,19,radiographic_progression
|
| 1647 |
+
HLT004-0000334,os_endpoint,30,censored
|
| 1648 |
+
HLT004-0000335,diagnosis,0,NYHA_III
|
| 1649 |
+
HLT004-0000335,treatment_start_1L,20,ivabradine
|
| 1650 |
+
HLT004-0000335,treatment_end_1L,1,completed_or_discontinued
|
| 1651 |
+
HLT004-0000335,os_endpoint,1,other_cause
|
| 1652 |
+
HLT004-0000336,diagnosis,0,NYHA_III
|
| 1653 |
+
HLT004-0000336,treatment_start_1L,15,gdmt_core
|
| 1654 |
+
HLT004-0000336,treatment_end_1L,901,completed_or_discontinued
|
| 1655 |
+
HLT004-0000336,progression,895,radiographic_progression
|
| 1656 |
+
HLT004-0000336,os_endpoint,901,disease
|
| 1657 |
+
HLT004-0000337,diagnosis,0,NYHA_II
|
| 1658 |
+
HLT004-0000337,treatment_start_1L,28,ivabradine
|
| 1659 |
+
HLT004-0000337,treatment_end_1L,1336,completed_or_discontinued
|
| 1660 |
+
HLT004-0000337,response_assessment,48,PR
|
| 1661 |
+
HLT004-0000337,os_endpoint,1336,disease
|
| 1662 |
+
HLT004-0000338,diagnosis,0,NYHA_II
|
| 1663 |
+
HLT004-0000338,treatment_start_1L,10,ivabradine
|
| 1664 |
+
HLT004-0000338,treatment_end_1L,286,completed_or_discontinued
|
| 1665 |
+
HLT004-0000338,response_assessment,84,PR
|
| 1666 |
+
HLT004-0000338,os_endpoint,286,censored
|
| 1667 |
+
HLT004-0000339,diagnosis,0,NYHA_II
|
| 1668 |
+
HLT004-0000339,treatment_start_1L,18,gdmt_core
|
| 1669 |
+
HLT004-0000339,treatment_end_1L,1303,completed_or_discontinued
|
| 1670 |
+
HLT004-0000339,progression,794,radiographic_progression
|
| 1671 |
+
HLT004-0000339,os_endpoint,1303,censored
|
| 1672 |
+
HLT004-0000340,diagnosis,0,NYHA_I
|
| 1673 |
+
HLT004-0000340,treatment_start_1L,28,lvad
|
| 1674 |
+
HLT004-0000340,treatment_end_1L,1529,completed_or_discontinued
|
| 1675 |
+
HLT004-0000340,response_assessment,35,PR
|
| 1676 |
+
HLT004-0000340,os_endpoint,1529,censored
|
| 1677 |
+
HLT004-0000341,diagnosis,0,NYHA_IV
|
| 1678 |
+
HLT004-0000341,treatment_start_1L,10,lvad
|
| 1679 |
+
HLT004-0000341,treatment_end_1L,346,completed_or_discontinued
|
| 1680 |
+
HLT004-0000341,progression,124,radiographic_progression
|
| 1681 |
+
HLT004-0000341,os_endpoint,346,disease
|
| 1682 |
+
HLT004-0000342,diagnosis,0,NYHA_IV
|
| 1683 |
+
HLT004-0000342,treatment_start_1L,29,gdmt_core
|
| 1684 |
+
HLT004-0000342,treatment_end_1L,307,completed_or_discontinued
|
| 1685 |
+
HLT004-0000342,response_assessment,78,CR
|
| 1686 |
+
HLT004-0000342,os_endpoint,307,disease
|
| 1687 |
+
HLT004-0000343,diagnosis,0,NYHA_II
|
| 1688 |
+
HLT004-0000343,treatment_start_1L,25,lvad
|
| 1689 |
+
HLT004-0000343,treatment_end_1L,24,completed_or_discontinued
|
| 1690 |
+
HLT004-0000343,response_assessment,62,PR
|
| 1691 |
+
HLT004-0000343,os_endpoint,24,disease
|
| 1692 |
+
HLT004-0000344,diagnosis,0,NYHA_II
|
| 1693 |
+
HLT004-0000344,treatment_start_1L,8,ivabradine
|
| 1694 |
+
HLT004-0000344,treatment_end_1L,1273,completed_or_discontinued
|
| 1695 |
+
HLT004-0000344,progression,1131,radiographic_progression
|
| 1696 |
+
HLT004-0000344,os_endpoint,1273,disease
|
| 1697 |
+
HLT004-0000345,diagnosis,0,NYHA_III
|
| 1698 |
+
HLT004-0000345,treatment_start_1L,29,gdmt_core
|
| 1699 |
+
HLT004-0000345,treatment_end_1L,1297,completed_or_discontinued
|
| 1700 |
+
HLT004-0000345,response_assessment,85,PR
|
| 1701 |
+
HLT004-0000345,os_endpoint,1297,disease
|
| 1702 |
+
HLT004-0000346,diagnosis,0,NYHA_II
|
| 1703 |
+
HLT004-0000346,treatment_start_1L,11,gdmt_core
|
| 1704 |
+
HLT004-0000346,treatment_end_1L,146,completed_or_discontinued
|
| 1705 |
+
HLT004-0000346,response_assessment,81,PR
|
| 1706 |
+
HLT004-0000346,os_endpoint,146,disease
|
| 1707 |
+
HLT004-0000347,diagnosis,0,NYHA_III
|
| 1708 |
+
HLT004-0000347,treatment_start_1L,23,lvad
|
| 1709 |
+
HLT004-0000347,treatment_end_1L,366,completed_or_discontinued
|
| 1710 |
+
HLT004-0000347,response_assessment,72,PR
|
| 1711 |
+
HLT004-0000347,os_endpoint,366,censored
|
| 1712 |
+
HLT004-0000348,diagnosis,0,NYHA_IV
|
| 1713 |
+
HLT004-0000348,treatment_start_1L,23,lvad
|
| 1714 |
+
HLT004-0000348,treatment_end_1L,374,completed_or_discontinued
|
| 1715 |
+
HLT004-0000348,response_assessment,89,CR
|
| 1716 |
+
HLT004-0000348,os_endpoint,374,disease
|
| 1717 |
+
HLT004-0000349,diagnosis,0,NYHA_II
|
| 1718 |
+
HLT004-0000349,treatment_start_1L,17,lvad
|
| 1719 |
+
HLT004-0000349,treatment_end_1L,30,completed_or_discontinued
|
| 1720 |
+
HLT004-0000349,os_endpoint,30,censored
|
| 1721 |
+
HLT004-0000350,diagnosis,0,NYHA_II
|
| 1722 |
+
HLT004-0000350,treatment_start_1L,16,lvad
|
| 1723 |
+
HLT004-0000350,treatment_end_1L,1591,completed_or_discontinued
|
| 1724 |
+
HLT004-0000350,response_assessment,61,PR
|
| 1725 |
+
HLT004-0000350,os_endpoint,1591,censored
|
| 1726 |
+
HLT004-0000351,diagnosis,0,NYHA_II
|
| 1727 |
+
HLT004-0000351,treatment_start_1L,22,ivabradine
|
| 1728 |
+
HLT004-0000351,treatment_end_1L,1822,completed_or_discontinued
|
| 1729 |
+
HLT004-0000351,progression,1245,radiographic_progression
|
| 1730 |
+
HLT004-0000351,os_endpoint,1825,censored
|
| 1731 |
+
HLT004-0000352,diagnosis,0,NYHA_I
|
| 1732 |
+
HLT004-0000352,treatment_start_1L,11,lvad
|
| 1733 |
+
HLT004-0000352,treatment_end_1L,1825,completed_or_discontinued
|
| 1734 |
+
HLT004-0000352,progression,424,radiographic_progression
|
| 1735 |
+
HLT004-0000352,os_endpoint,1825,censored
|
| 1736 |
+
HLT004-0000353,diagnosis,0,NYHA_II
|
| 1737 |
+
HLT004-0000353,treatment_start_1L,26,lvad
|
| 1738 |
+
HLT004-0000353,treatment_end_1L,772,completed_or_discontinued
|
| 1739 |
+
HLT004-0000353,response_assessment,38,PR
|
| 1740 |
+
HLT004-0000353,os_endpoint,772,disease
|
| 1741 |
+
HLT004-0000354,diagnosis,0,NYHA_I
|
| 1742 |
+
HLT004-0000354,treatment_start_1L,22,ivabradine
|
| 1743 |
+
HLT004-0000354,treatment_end_1L,1005,completed_or_discontinued
|
| 1744 |
+
HLT004-0000354,os_endpoint,1005,disease
|
| 1745 |
+
HLT004-0000355,diagnosis,0,NYHA_I
|
| 1746 |
+
HLT004-0000355,treatment_start_1L,17,gdmt_core
|
| 1747 |
+
HLT004-0000355,treatment_end_1L,7,completed_or_discontinued
|
| 1748 |
+
HLT004-0000355,response_assessment,67,CR
|
| 1749 |
+
HLT004-0000355,os_endpoint,7,other_cause
|
| 1750 |
+
HLT004-0000356,diagnosis,0,NYHA_II
|
| 1751 |
+
HLT004-0000356,treatment_start_1L,14,gdmt_core
|
| 1752 |
+
HLT004-0000356,treatment_end_1L,720,completed_or_discontinued
|
| 1753 |
+
HLT004-0000356,response_assessment,38,CR
|
| 1754 |
+
HLT004-0000356,os_endpoint,720,censored
|
| 1755 |
+
HLT004-0000357,diagnosis,0,NYHA_II
|
| 1756 |
+
HLT004-0000357,treatment_start_1L,23,ivabradine
|
| 1757 |
+
HLT004-0000357,treatment_end_1L,219,completed_or_discontinued
|
| 1758 |
+
HLT004-0000357,response_assessment,51,CR
|
| 1759 |
+
HLT004-0000357,os_endpoint,219,disease
|
| 1760 |
+
HLT004-0000358,diagnosis,0,NYHA_III
|
| 1761 |
+
HLT004-0000358,treatment_start_1L,21,lvad
|
| 1762 |
+
HLT004-0000358,treatment_end_1L,322,completed_or_discontinued
|
| 1763 |
+
HLT004-0000358,progression,61,radiographic_progression
|
| 1764 |
+
HLT004-0000358,os_endpoint,322,censored
|
| 1765 |
+
HLT004-0000359,diagnosis,0,NYHA_I
|
| 1766 |
+
HLT004-0000359,treatment_start_1L,9,gdmt_core
|
| 1767 |
+
HLT004-0000359,treatment_end_1L,289,completed_or_discontinued
|
| 1768 |
+
HLT004-0000359,progression,78,radiographic_progression
|
| 1769 |
+
HLT004-0000359,os_endpoint,289,censored
|
| 1770 |
+
HLT004-0000360,diagnosis,0,NYHA_IV
|
| 1771 |
+
HLT004-0000360,treatment_start_1L,20,lvad
|
| 1772 |
+
HLT004-0000360,treatment_end_1L,259,completed_or_discontinued
|
| 1773 |
+
HLT004-0000360,response_assessment,33,CR
|
| 1774 |
+
HLT004-0000360,os_endpoint,259,disease
|
| 1775 |
+
HLT004-0000361,diagnosis,0,NYHA_II
|
| 1776 |
+
HLT004-0000361,treatment_start_1L,11,lvad
|
| 1777 |
+
HLT004-0000361,treatment_end_1L,1177,completed_or_discontinued
|
| 1778 |
+
HLT004-0000361,progression,936,radiographic_progression
|
| 1779 |
+
HLT004-0000361,os_endpoint,1177,other_cause
|
| 1780 |
+
HLT004-0000362,diagnosis,0,NYHA_I
|
| 1781 |
+
HLT004-0000362,treatment_start_1L,15,ivabradine
|
| 1782 |
+
HLT004-0000362,treatment_end_1L,685,completed_or_discontinued
|
| 1783 |
+
HLT004-0000362,progression,461,radiographic_progression
|
| 1784 |
+
HLT004-0000362,os_endpoint,685,disease
|
| 1785 |
+
HLT004-0000363,diagnosis,0,NYHA_I
|
| 1786 |
+
HLT004-0000363,treatment_start_1L,25,gdmt_core
|
| 1787 |
+
HLT004-0000363,treatment_end_1L,1825,completed_or_discontinued
|
| 1788 |
+
HLT004-0000363,progression,1136,radiographic_progression
|
| 1789 |
+
HLT004-0000363,os_endpoint,1825,censored
|
| 1790 |
+
HLT004-0000364,diagnosis,0,NYHA_III
|
| 1791 |
+
HLT004-0000364,treatment_start_1L,22,gdmt_core
|
| 1792 |
+
HLT004-0000364,treatment_end_1L,258,completed_or_discontinued
|
| 1793 |
+
HLT004-0000364,progression,39,radiographic_progression
|
| 1794 |
+
HLT004-0000364,os_endpoint,258,disease
|
| 1795 |
+
HLT004-0000365,diagnosis,0,NYHA_II
|
| 1796 |
+
HLT004-0000365,treatment_start_1L,11,ivabradine
|
| 1797 |
+
HLT004-0000365,treatment_end_1L,95,completed_or_discontinued
|
| 1798 |
+
HLT004-0000365,progression,68,radiographic_progression
|
| 1799 |
+
HLT004-0000365,os_endpoint,95,disease
|
| 1800 |
+
HLT004-0000366,diagnosis,0,NYHA_II
|
| 1801 |
+
HLT004-0000366,treatment_start_1L,20,lvad
|
| 1802 |
+
HLT004-0000366,treatment_end_1L,349,completed_or_discontinued
|
| 1803 |
+
HLT004-0000366,progression,214,radiographic_progression
|
| 1804 |
+
HLT004-0000366,os_endpoint,349,other_cause
|
| 1805 |
+
HLT004-0000367,diagnosis,0,NYHA_I
|
| 1806 |
+
HLT004-0000367,treatment_start_1L,24,ivabradine
|
| 1807 |
+
HLT004-0000367,treatment_end_1L,552,completed_or_discontinued
|
| 1808 |
+
HLT004-0000367,progression,355,radiographic_progression
|
| 1809 |
+
HLT004-0000367,os_endpoint,552,disease
|
| 1810 |
+
HLT004-0000368,diagnosis,0,NYHA_IV
|
| 1811 |
+
HLT004-0000368,treatment_start_1L,14,gdmt_core
|
| 1812 |
+
HLT004-0000368,treatment_end_1L,518,completed_or_discontinued
|
| 1813 |
+
HLT004-0000368,progression,193,radiographic_progression
|
| 1814 |
+
HLT004-0000368,os_endpoint,518,disease
|
| 1815 |
+
HLT004-0000369,diagnosis,0,NYHA_I
|
| 1816 |
+
HLT004-0000369,treatment_start_1L,7,ivabradine
|
| 1817 |
+
HLT004-0000369,treatment_end_1L,1807,completed_or_discontinued
|
| 1818 |
+
HLT004-0000369,response_assessment,72,CR
|
| 1819 |
+
HLT004-0000369,os_endpoint,1825,censored
|
| 1820 |
+
HLT004-0000370,diagnosis,0,NYHA_II
|
| 1821 |
+
HLT004-0000370,treatment_start_1L,16,gdmt_core
|
| 1822 |
+
HLT004-0000370,treatment_end_1L,1387,completed_or_discontinued
|
| 1823 |
+
HLT004-0000370,response_assessment,43,CR
|
| 1824 |
+
HLT004-0000370,os_endpoint,1387,disease
|
| 1825 |
+
HLT004-0000371,diagnosis,0,NYHA_IV
|
| 1826 |
+
HLT004-0000371,treatment_start_1L,18,gdmt_core
|
| 1827 |
+
HLT004-0000371,treatment_end_1L,240,completed_or_discontinued
|
| 1828 |
+
HLT004-0000371,progression,202,radiographic_progression
|
| 1829 |
+
HLT004-0000371,os_endpoint,240,disease
|
| 1830 |
+
HLT004-0000372,diagnosis,0,NYHA_II
|
| 1831 |
+
HLT004-0000372,treatment_start_1L,26,ivabradine
|
| 1832 |
+
HLT004-0000372,treatment_end_1L,1070,completed_or_discontinued
|
| 1833 |
+
HLT004-0000372,os_endpoint,1070,disease
|
| 1834 |
+
HLT004-0000373,diagnosis,0,NYHA_II
|
| 1835 |
+
HLT004-0000373,treatment_start_1L,17,ivabradine
|
| 1836 |
+
HLT004-0000373,treatment_end_1L,367,completed_or_discontinued
|
| 1837 |
+
HLT004-0000373,response_assessment,61,PR
|
| 1838 |
+
HLT004-0000373,os_endpoint,367,censored
|
| 1839 |
+
HLT004-0000374,diagnosis,0,NYHA_III
|
| 1840 |
+
HLT004-0000374,treatment_start_1L,10,ivabradine
|
| 1841 |
+
HLT004-0000374,treatment_end_1L,912,completed_or_discontinued
|
| 1842 |
+
HLT004-0000374,progression,584,radiographic_progression
|
| 1843 |
+
HLT004-0000374,os_endpoint,912,disease
|
| 1844 |
+
HLT004-0000375,diagnosis,0,NYHA_II
|
| 1845 |
+
HLT004-0000375,treatment_start_1L,22,lvad
|
| 1846 |
+
HLT004-0000375,treatment_end_1L,1821,completed_or_discontinued
|
| 1847 |
+
HLT004-0000375,progression,341,radiographic_progression
|
| 1848 |
+
HLT004-0000375,os_endpoint,1821,disease
|
| 1849 |
+
HLT004-0000376,diagnosis,0,NYHA_I
|
| 1850 |
+
HLT004-0000376,treatment_start_1L,28,gdmt_core
|
| 1851 |
+
HLT004-0000376,treatment_end_1L,551,completed_or_discontinued
|
| 1852 |
+
HLT004-0000376,os_endpoint,551,censored
|
| 1853 |
+
HLT004-0000377,diagnosis,0,NYHA_II
|
| 1854 |
+
HLT004-0000377,treatment_start_1L,10,lvad
|
| 1855 |
+
HLT004-0000377,treatment_end_1L,142,completed_or_discontinued
|
| 1856 |
+
HLT004-0000377,progression,106,radiographic_progression
|
| 1857 |
+
HLT004-0000377,os_endpoint,142,censored
|
| 1858 |
+
HLT004-0000378,diagnosis,0,NYHA_I
|
| 1859 |
+
HLT004-0000378,treatment_start_1L,16,gdmt_core
|
| 1860 |
+
HLT004-0000378,treatment_end_1L,1488,completed_or_discontinued
|
| 1861 |
+
HLT004-0000378,response_assessment,40,PR
|
| 1862 |
+
HLT004-0000378,os_endpoint,1488,censored
|
| 1863 |
+
HLT004-0000379,diagnosis,0,NYHA_IV
|
| 1864 |
+
HLT004-0000379,treatment_start_1L,20,gdmt_core
|
| 1865 |
+
HLT004-0000379,treatment_end_1L,469,completed_or_discontinued
|
| 1866 |
+
HLT004-0000379,response_assessment,73,PR
|
| 1867 |
+
HLT004-0000379,os_endpoint,469,disease
|
| 1868 |
+
HLT004-0000380,diagnosis,0,NYHA_III
|
| 1869 |
+
HLT004-0000380,treatment_start_1L,15,lvad
|
| 1870 |
+
HLT004-0000380,treatment_end_1L,1229,completed_or_discontinued
|
| 1871 |
+
HLT004-0000380,progression,932,radiographic_progression
|
| 1872 |
+
HLT004-0000380,os_endpoint,1229,disease
|
| 1873 |
+
HLT004-0000381,diagnosis,0,NYHA_III
|
| 1874 |
+
HLT004-0000381,treatment_start_1L,22,lvad
|
| 1875 |
+
HLT004-0000381,treatment_end_1L,578,completed_or_discontinued
|
| 1876 |
+
HLT004-0000381,response_assessment,71,PR
|
| 1877 |
+
HLT004-0000381,os_endpoint,578,censored
|
| 1878 |
+
HLT004-0000382,diagnosis,0,NYHA_II
|
| 1879 |
+
HLT004-0000382,treatment_start_1L,10,gdmt_core
|
| 1880 |
+
HLT004-0000382,treatment_end_1L,543,completed_or_discontinued
|
| 1881 |
+
HLT004-0000382,response_assessment,40,PR
|
| 1882 |
+
HLT004-0000382,os_endpoint,543,disease
|
| 1883 |
+
HLT004-0000383,diagnosis,0,NYHA_III
|
| 1884 |
+
HLT004-0000383,treatment_start_1L,10,ivabradine
|
| 1885 |
+
HLT004-0000383,treatment_end_1L,771,completed_or_discontinued
|
| 1886 |
+
HLT004-0000383,progression,441,radiographic_progression
|
| 1887 |
+
HLT004-0000383,os_endpoint,771,disease
|
| 1888 |
+
HLT004-0000384,diagnosis,0,NYHA_III
|
| 1889 |
+
HLT004-0000384,treatment_start_1L,20,lvad
|
| 1890 |
+
HLT004-0000384,treatment_end_1L,280,completed_or_discontinued
|
| 1891 |
+
HLT004-0000384,response_assessment,61,PR
|
| 1892 |
+
HLT004-0000384,os_endpoint,280,censored
|
| 1893 |
+
HLT004-0000385,diagnosis,0,NYHA_I
|
| 1894 |
+
HLT004-0000385,treatment_start_1L,28,lvad
|
| 1895 |
+
HLT004-0000385,treatment_end_1L,555,completed_or_discontinued
|
| 1896 |
+
HLT004-0000385,os_endpoint,555,censored
|
| 1897 |
+
HLT004-0000386,diagnosis,0,NYHA_IV
|
| 1898 |
+
HLT004-0000386,treatment_start_1L,11,ivabradine
|
| 1899 |
+
HLT004-0000386,treatment_end_1L,247,completed_or_discontinued
|
| 1900 |
+
HLT004-0000386,response_assessment,86,PR
|
| 1901 |
+
HLT004-0000386,os_endpoint,247,disease
|
| 1902 |
+
HLT004-0000387,diagnosis,0,NYHA_III
|
| 1903 |
+
HLT004-0000387,treatment_start_1L,29,gdmt_core
|
| 1904 |
+
HLT004-0000387,treatment_end_1L,320,completed_or_discontinued
|
| 1905 |
+
HLT004-0000387,progression,252,radiographic_progression
|
| 1906 |
+
HLT004-0000387,os_endpoint,320,censored
|
| 1907 |
+
HLT004-0000388,diagnosis,0,NYHA_III
|
| 1908 |
+
HLT004-0000388,treatment_start_1L,27,ivabradine
|
| 1909 |
+
HLT004-0000388,treatment_end_1L,1117,completed_or_discontinued
|
| 1910 |
+
HLT004-0000388,response_assessment,33,PR
|
| 1911 |
+
HLT004-0000388,os_endpoint,1117,disease
|
| 1912 |
+
HLT004-0000389,diagnosis,0,NYHA_II
|
| 1913 |
+
HLT004-0000389,treatment_start_1L,15,gdmt_core
|
| 1914 |
+
HLT004-0000389,treatment_end_1L,1825,completed_or_discontinued
|
| 1915 |
+
HLT004-0000389,response_assessment,30,PR
|
| 1916 |
+
HLT004-0000389,os_endpoint,1825,censored
|
| 1917 |
+
HLT004-0000390,diagnosis,0,NYHA_I
|
| 1918 |
+
HLT004-0000390,treatment_start_1L,10,gdmt_core
|
| 1919 |
+
HLT004-0000390,treatment_end_1L,1825,completed_or_discontinued
|
| 1920 |
+
HLT004-0000390,response_assessment,65,CR
|
| 1921 |
+
HLT004-0000390,os_endpoint,1825,censored
|
| 1922 |
+
HLT004-0000391,diagnosis,0,NYHA_III
|
| 1923 |
+
HLT004-0000391,treatment_start_1L,13,lvad
|
| 1924 |
+
HLT004-0000391,treatment_end_1L,378,completed_or_discontinued
|
| 1925 |
+
HLT004-0000391,progression,245,radiographic_progression
|
| 1926 |
+
HLT004-0000391,os_endpoint,378,disease
|
| 1927 |
+
HLT004-0000392,diagnosis,0,NYHA_III
|
| 1928 |
+
HLT004-0000392,treatment_start_1L,23,lvad
|
| 1929 |
+
HLT004-0000392,treatment_end_1L,577,completed_or_discontinued
|
| 1930 |
+
HLT004-0000392,progression,459,radiographic_progression
|
| 1931 |
+
HLT004-0000392,os_endpoint,577,disease
|
| 1932 |
+
HLT004-0000393,diagnosis,0,NYHA_II
|
| 1933 |
+
HLT004-0000393,treatment_start_1L,18,gdmt_core
|
| 1934 |
+
HLT004-0000393,treatment_end_1L,55,completed_or_discontinued
|
| 1935 |
+
HLT004-0000393,progression,45,radiographic_progression
|
| 1936 |
+
HLT004-0000393,os_endpoint,55,other_cause
|
| 1937 |
+
HLT004-0000394,diagnosis,0,NYHA_I
|
| 1938 |
+
HLT004-0000394,treatment_start_1L,23,lvad
|
| 1939 |
+
HLT004-0000394,treatment_end_1L,1641,completed_or_discontinued
|
| 1940 |
+
HLT004-0000394,progression,1095,radiographic_progression
|
| 1941 |
+
HLT004-0000394,os_endpoint,1641,censored
|
| 1942 |
+
HLT004-0000395,diagnosis,0,NYHA_III
|
| 1943 |
+
HLT004-0000395,treatment_start_1L,19,lvad
|
| 1944 |
+
HLT004-0000395,treatment_end_1L,368,completed_or_discontinued
|
| 1945 |
+
HLT004-0000395,response_assessment,86,PR
|
| 1946 |
+
HLT004-0000395,os_endpoint,368,disease
|
| 1947 |
+
HLT004-0000396,diagnosis,0,NYHA_II
|
| 1948 |
+
HLT004-0000396,treatment_start_1L,29,lvad
|
| 1949 |
+
HLT004-0000396,treatment_end_1L,1825,completed_or_discontinued
|
| 1950 |
+
HLT004-0000396,progression,1526,radiographic_progression
|
| 1951 |
+
HLT004-0000396,os_endpoint,1825,censored
|
| 1952 |
+
HLT004-0000397,diagnosis,0,NYHA_II
|
| 1953 |
+
HLT004-0000397,treatment_start_1L,25,ivabradine
|
| 1954 |
+
HLT004-0000397,treatment_end_1L,502,completed_or_discontinued
|
| 1955 |
+
HLT004-0000397,os_endpoint,502,other_cause
|
| 1956 |
+
HLT004-0000398,diagnosis,0,NYHA_III
|
| 1957 |
+
HLT004-0000398,treatment_start_1L,20,ivabradine
|
| 1958 |
+
HLT004-0000398,treatment_end_1L,756,completed_or_discontinued
|
| 1959 |
+
HLT004-0000398,response_assessment,49,PR
|
| 1960 |
+
HLT004-0000398,os_endpoint,756,censored
|
| 1961 |
+
HLT004-0000399,diagnosis,0,NYHA_I
|
| 1962 |
+
HLT004-0000399,treatment_start_1L,10,gdmt_core
|
| 1963 |
+
HLT004-0000399,treatment_end_1L,613,completed_or_discontinued
|
| 1964 |
+
HLT004-0000399,progression,372,radiographic_progression
|
| 1965 |
+
HLT004-0000399,os_endpoint,613,disease
|
| 1966 |
+
HLT004-0000400,diagnosis,0,NYHA_I
|
| 1967 |
+
HLT004-0000400,treatment_start_1L,19,gdmt_core
|
| 1968 |
+
HLT004-0000400,treatment_end_1L,424,completed_or_discontinued
|
| 1969 |
+
HLT004-0000400,progression,357,radiographic_progression
|
| 1970 |
+
HLT004-0000400,os_endpoint,424,censored
|
heart_failure/hlt004_longitudinal.csv
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
nsclc/hlt004_baseline.csv
ADDED
|
@@ -0,0 +1,401 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
patient_id,disease_type,cohort_label,staging_system,diagnosis_date,age_at_dx,sex,race_ethnicity,ecog_ps_baseline,smoking_ever,smoking_pack_years,bmi_at_dx,cci_at_dx,insurance_type,adi_percentile,education_level,stage_at_dx,stage_idx_at_dx,os_days,os_event,pfs_days,pfs_event,censoring_reason,death_cause,last_contact_days,treatment_arm_1L,best_overall_response,response_day_from_dx,progression_day_from_dx
|
| 2 |
+
HLT004-0000001,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-04-01,73,Male,Hispanic_Latino,0,True,6.1,34.0,1,Commercial,40.2,Bachelors_Plus,Stage_IV,3,83,1,83,1,death,disease,83,carbo_taxol,SD,,59.0
|
| 3 |
+
HLT004-0000002,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-06-28,59,Female,White,1,True,8.4,19.6,0,Medicare,3.1,Some_College,Stage_III,2,1312,0,190,1,lost_to_follow_up,censored,1312,docetaxel_2L,SD,,129.0
|
| 4 |
+
HLT004-0000003,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-05-06,77,Male,Black_AA,1,False,0.0,25.9,0,Commercial,4.6,HS_Diploma,Stage_IV,3,187,1,103,1,death,disease,187,carbo_pem_pembro,SD,,68.0
|
| 5 |
+
HLT004-0000004,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-07-20,79,Female,White,0,True,16.0,33.3,2,Commercial,30.2,Bachelors_Plus,Stage_I,0,1825,0,1825,0,administrative,censored,1825,pembro_mono,PD,,1825.0
|
| 6 |
+
HLT004-0000005,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-03-09,50,Female,White,0,True,41.0,25.3,2,Commercial,53.8,Some_College,Stage_IV,3,46,1,46,1,death,disease,46,docetaxel_2L,PD,,46.0
|
| 7 |
+
HLT004-0000006,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-02-25,56,Male,White,0,True,8.3,19.1,3,Medicare,31.7,HS_Diploma,Stage_I,0,50,0,50,0,lost_to_follow_up,censored,50,carbo_pem_pembro,PR,74.0,
|
| 8 |
+
HLT004-0000007,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-11-23,71,Male,White,2,False,0.0,33.2,2,Commercial,61.3,HS_Diploma,Stage_I,0,598,1,598,0,death,other_cause,598,pembro_mono,CR,50.0,
|
| 9 |
+
HLT004-0000008,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-01-21,66,Male,Black_AA,1,True,23.1,36.1,1,Medicare,38.8,Some_College,Stage_III,2,522,1,17,1,death,disease,522,carbo_pem_pembro,PR,58.0,
|
| 10 |
+
HLT004-0000009,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-07-09,69,Female,Hispanic_Latino,0,True,37.7,28.8,0,Commercial,31.4,HS_Diploma,Stage_II,1,1825,0,250,1,administrative,censored,1825,pembro_mono,PD,,250.0
|
| 11 |
+
HLT004-0000010,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-10-08,61,Female,White,2,False,0.0,16.9,1,Commercial,57.6,Less_than_HS,Stage_IV,3,253,1,162,1,death,disease,253,carbo_taxol,PD,,162.0
|
| 12 |
+
HLT004-0000011,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-10-05,78,Male,White,1,True,34.0,33.5,3,Medicare,17.0,HS_Diploma,Stage_I,0,673,0,673,0,lost_to_follow_up,censored,673,docetaxel_2L,SD,,474.0
|
| 13 |
+
HLT004-0000012,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-12-03,77,Female,White,1,True,3.7,18.8,2,Medicare,51.2,HS_Diploma,Stage_I,0,253,0,253,0,lost_to_follow_up,censored,253,carbo_taxol,SD,,173.0
|
| 14 |
+
HLT004-0000013,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-11,70,Male,Hispanic_Latino,3,True,10.8,31.0,1,Medicare,59.3,Some_College,Stage_IV,3,536,1,141,1,death,disease,536,carbo_pem_pembro,PR,87.0,
|
| 15 |
+
HLT004-0000014,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-06-11,81,Female,White,0,True,24.5,23.6,1,Medicare,30.9,Some_College,Stage_II,1,534,1,534,1,death,disease,534,docetaxel_2L,PD,,534.0
|
| 16 |
+
HLT004-0000015,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-02-10,74,Female,Black_AA,0,True,3.0,21.9,2,Medicare,9.0,HS_Diploma,Stage_IV,3,526,1,267,1,death,disease,526,docetaxel_2L,PD,,267.0
|
| 17 |
+
HLT004-0000016,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-03,61,Female,White,1,False,0.0,26.4,0,Medicare,2.4,Some_College,Stage_IV,3,564,1,397,1,death,disease,564,pembro_mono,PR,31.0,
|
| 18 |
+
HLT004-0000017,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-06-13,73,Female,White,0,True,22.8,28.0,0,Medicare,23.6,HS_Diploma,Stage_I,0,423,1,423,1,death,disease,423,pembro_mono,SD,,372.0
|
| 19 |
+
HLT004-0000018,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-03-16,60,Female,Black_AA,1,True,32.2,25.1,1,Medicaid,28.3,HS_Diploma,Stage_IV,3,48,1,48,1,death,disease,48,carbo_pem_pembro,PR,37.0,
|
| 20 |
+
HLT004-0000019,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-05-20,78,Male,Black_AA,0,False,0.0,32.7,1,Commercial,35.3,HS_Diploma,Stage_III,2,778,1,139,1,death,disease,778,pembro_mono,PR,75.0,
|
| 21 |
+
HLT004-0000020,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-02-05,69,Male,White,0,True,8.7,26.3,0,Medicare,36.4,Bachelors_Plus,Stage_III,2,424,1,424,1,death,disease,424,carbo_pem_pembro,PD,,424.0
|
| 22 |
+
HLT004-0000021,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-10-22,68,Male,Hispanic_Latino,0,True,49.4,35.2,1,Commercial,27.8,Bachelors_Plus,Stage_I,0,906,1,805,1,death,other_cause,906,carbo_pem_pembro,SD,,495.0
|
| 23 |
+
HLT004-0000022,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-05-08,63,Male,NHOPI,1,False,0.0,30.8,0,Medicaid,21.6,Some_College,Stage_IV,3,45,1,45,1,death,other_cause,45,docetaxel_2L,PD,,45.0
|
| 24 |
+
HLT004-0000023,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-05-30,82,Female,White,0,True,52.2,24.8,0,Medicare,15.7,Less_than_HS,Stage_IV,3,393,1,255,1,death,disease,393,pembro_mono,SD,,165.0
|
| 25 |
+
HLT004-0000024,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-10-29,68,Female,White,0,False,0.0,23.7,4,Uninsured,11.9,HS_Diploma,Stage_III,2,749,1,396,1,death,disease,749,carbo_taxol,SD,,297.0
|
| 26 |
+
HLT004-0000025,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-06-08,65,Female,White,2,False,0.0,18.9,1,Commercial,43.4,HS_Diploma,Stage_IV,3,219,1,218,1,death,disease,219,carbo_pem_pembro,PR,88.0,
|
| 27 |
+
HLT004-0000026,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-05-16,66,Male,Hispanic_Latino,0,True,5.0,30.9,2,Medicare,58.3,Bachelors_Plus,Stage_III,2,1774,1,65,1,death,disease,1774,docetaxel_2L,SD,,46.0
|
| 28 |
+
HLT004-0000027,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-05-30,75,Female,White,1,True,45.1,26.9,1,Commercial,17.5,Less_than_HS,Stage_IV,3,453,1,159,1,death,disease,453,carbo_pem_pembro,SD,,126.0
|
| 29 |
+
HLT004-0000028,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-05-10,73,Male,White,0,True,19.8,15.0,4,Medicare,52.6,Bachelors_Plus,Stage_IV,3,366,1,115,1,death,disease,366,carbo_pem_pembro,CR,67.0,
|
| 30 |
+
HLT004-0000029,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-12-16,74,Male,White,1,True,16.5,25.8,3,Medicare,27.6,Some_College,Stage_IV,3,39,1,39,1,death,other_cause,39,carbo_pem_pembro,PR,52.0,
|
| 31 |
+
HLT004-0000030,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-29,74,Female,Hispanic_Latino,0,True,9.3,23.5,2,Medicare,54.0,Some_College,Stage_IV,3,92,1,92,1,death,disease,92,carbo_pem_pembro,SD,,70.0
|
| 32 |
+
HLT004-0000031,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-06-26,91,Female,White,1,True,17.2,38.9,1,Commercial,58.5,Bachelors_Plus,Stage_IV,3,502,1,261,1,death,disease,502,carbo_pem_pembro,PR,40.0,
|
| 33 |
+
HLT004-0000032,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-05-12,65,Female,Black_AA,0,False,0.0,18.5,1,Medicare,39.8,Less_than_HS,Stage_I,0,1059,1,1059,1,death,disease,1059,docetaxel_2L,SD,,736.0
|
| 34 |
+
HLT004-0000033,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-01-03,64,Male,White,2,False,0.0,20.2,2,Medicare,14.2,Bachelors_Plus,Stage_IV,3,159,1,159,1,death,disease,159,carbo_taxol,PD,,159.0
|
| 35 |
+
HLT004-0000034,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-07-28,61,Female,Asian,3,False,0.0,36.0,0,Medicaid,13.1,Less_than_HS,Stage_IV,3,520,1,266,1,death,disease,520,pembro_mono,SD,,228.0
|
| 36 |
+
HLT004-0000035,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-11-13,76,Male,White,0,True,1.0,37.5,1,Medicaid,35.1,Bachelors_Plus,Stage_IV,3,79,1,54,1,death,disease,79,pembro_mono,SD,,45.0
|
| 37 |
+
HLT004-0000036,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-08-07,81,Female,White,0,True,65.6,24.5,3,Medicaid,17.7,Some_College,Stage_III,2,116,0,116,0,lost_to_follow_up,censored,116,pembro_mono,PR,47.0,
|
| 38 |
+
HLT004-0000037,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-06-03,68,Female,Hispanic_Latino,0,True,10.1,25.2,2,VA,58.8,Less_than_HS,Stage_IV,3,431,1,296,1,death,disease,431,pembro_mono,PR,31.0,
|
| 39 |
+
HLT004-0000038,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-15,61,Male,Asian,1,True,10.0,32.9,3,Medicare,26.9,Bachelors_Plus,Stage_II,1,358,1,358,1,death,disease,358,pembro_mono,PD,,358.0
|
| 40 |
+
HLT004-0000039,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-12-06,61,Male,White,0,False,0.0,15.0,1,Uninsured,43.8,Less_than_HS,Stage_III,2,358,1,330,1,death,disease,358,pembro_mono,PD,,330.0
|
| 41 |
+
HLT004-0000040,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-12-08,76,Male,White,2,True,58.9,17.6,1,Commercial,43.8,HS_Diploma,Stage_IV,3,45,0,45,0,lost_to_follow_up,censored,45,pembro_mono,SD,,34.0
|
| 42 |
+
HLT004-0000041,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-05-24,77,Female,Hispanic_Latino,2,True,24.5,27.4,2,Uninsured,71.0,Bachelors_Plus,Stage_I,0,1077,0,305,1,lost_to_follow_up,censored,1077,docetaxel_2L,PD,,305.0
|
| 43 |
+
HLT004-0000042,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-03-29,75,Male,Hispanic_Latino,2,False,0.0,38.7,0,Medicare,25.1,Some_College,Stage_IV,3,279,1,279,1,death,disease,279,docetaxel_2L,PD,,279.0
|
| 44 |
+
HLT004-0000043,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-06-06,63,Female,White,1,True,3.3,26.4,1,Commercial,38.4,Bachelors_Plus,Stage_I,0,445,1,445,1,death,other_cause,445,docetaxel_2L,PD,,445.0
|
| 45 |
+
HLT004-0000044,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-03-23,72,Female,White,4,True,16.2,29.7,4,Commercial,43.7,Some_College,Stage_IV,3,426,1,194,1,death,disease,426,carbo_pem_pembro,SD,,159.0
|
| 46 |
+
HLT004-0000045,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-03-09,71,Female,Hispanic_Latino,0,True,2.3,36.1,1,Commercial,30.0,Some_College,Stage_IV,3,258,1,150,1,death,disease,258,pembro_mono,PR,88.0,
|
| 47 |
+
HLT004-0000046,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-07-11,72,Male,Hispanic_Latino,1,True,57.1,42.2,2,Medicare,30.2,HS_Diploma,Stage_III,2,559,1,476,1,death,disease,559,pembro_mono,PR,53.0,
|
| 48 |
+
HLT004-0000047,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-04-09,78,Female,Hispanic_Latino,0,False,0.0,25.5,0,VA,21.4,HS_Diploma,Stage_IV,3,490,1,43,1,death,disease,490,carbo_pem_pembro,PD,,43.0
|
| 49 |
+
HLT004-0000048,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-06-01,72,Male,White,3,True,38.8,29.0,0,Uninsured,47.9,Bachelors_Plus,Stage_I,0,1694,1,898,1,death,other_cause,1694,docetaxel_2L,SD,,576.0
|
| 50 |
+
HLT004-0000049,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-01-09,76,Female,White,1,False,0.0,40.4,2,VA,47.0,Less_than_HS,Stage_IV,3,1015,1,183,1,death,other_cause,1015,carbo_pem_pembro,PR,55.0,
|
| 51 |
+
HLT004-0000050,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-08,70,Female,Hispanic_Latino,2,False,0.0,19.7,1,Commercial,46.4,Some_College,Stage_IV,3,583,1,163,1,death,disease,583,carbo_pem_pembro,PD,,163.0
|
| 52 |
+
HLT004-0000051,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-07-14,72,Female,Hispanic_Latino,0,False,0.0,35.5,1,Commercial,76.3,HS_Diploma,Stage_I,0,1825,0,1825,0,administrative,censored,1825,docetaxel_2L,PD,,1825.0
|
| 53 |
+
HLT004-0000052,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-07-30,76,Female,Hispanic_Latino,3,True,25.0,22.8,1,Medicare,45.8,HS_Diploma,Stage_IV,3,1143,1,171,1,death,disease,1143,carbo_pem_pembro,SD,,152.0
|
| 54 |
+
HLT004-0000053,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-07-31,55,Male,White,1,True,12.8,29.7,0,Medicaid,18.3,Some_College,Stage_III,2,378,1,246,1,death,disease,378,carbo_taxol,SD,,212.0
|
| 55 |
+
HLT004-0000054,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-10-02,66,Male,White,1,False,0.0,27.6,1,Commercial,33.6,Bachelors_Plus,Stage_IV,3,374,1,127,1,death,disease,374,carbo_pem_pembro,PR,59.0,
|
| 56 |
+
HLT004-0000055,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-11-20,65,Male,Hispanic_Latino,3,True,35.0,23.2,2,Medicare,13.3,Bachelors_Plus,Stage_IV,3,346,1,205,1,death,disease,346,docetaxel_2L,PR,30.0,
|
| 57 |
+
HLT004-0000056,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-07-05,63,Male,White,1,True,4.6,23.0,3,Medicare,26.0,Bachelors_Plus,Stage_III,2,740,0,123,1,lost_to_follow_up,censored,740,carbo_taxol,PD,,123.0
|
| 58 |
+
HLT004-0000057,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-09-23,67,Male,AIAN,1,False,0.0,30.8,4,Commercial,73.2,HS_Diploma,Stage_IV,3,505,1,108,1,death,disease,505,pembro_mono,PR,62.0,
|
| 59 |
+
HLT004-0000058,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-08-03,84,Male,White,1,True,13.5,35.3,0,Commercial,48.6,Some_College,Stage_II,1,1545,0,574,1,lost_to_follow_up,censored,1545,docetaxel_2L,PD,,574.0
|
| 60 |
+
HLT004-0000059,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-12-05,61,Male,Black_AA,0,False,0.0,28.3,1,Medicare,22.8,Less_than_HS,Stage_III,2,263,1,263,1,death,disease,263,pembro_mono,PR,56.0,
|
| 61 |
+
HLT004-0000060,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-12-02,79,Male,Hispanic_Latino,0,False,0.0,29.5,1,Medicare,77.7,Bachelors_Plus,Stage_IV,3,401,1,111,1,death,disease,401,docetaxel_2L,PD,,111.0
|
| 62 |
+
HLT004-0000061,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-10-26,53,Male,White,0,False,0.0,32.6,1,Medicaid,13.4,HS_Diploma,Stage_I,0,1212,0,1040,1,lost_to_follow_up,censored,1212,docetaxel_2L,PD,,1040.0
|
| 63 |
+
HLT004-0000062,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-03-06,66,Female,White,0,True,28.1,23.1,3,Medicaid,36.9,Some_College,Stage_IV,3,156,1,64,1,death,disease,156,carbo_taxol,SD,,57.0
|
| 64 |
+
HLT004-0000063,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-07,71,Female,Black_AA,2,False,0.0,33.7,2,Medicaid,62.6,HS_Diploma,Stage_II,1,559,1,559,1,death,disease,559,docetaxel_2L,PD,,559.0
|
| 65 |
+
HLT004-0000064,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-07-24,75,Male,White,1,True,20.2,34.2,1,Commercial,60.1,Bachelors_Plus,Stage_IV,3,55,1,22,1,death,other_cause,55,carbo_taxol,SD,,15.0
|
| 66 |
+
HLT004-0000065,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-04-03,77,Male,White,1,False,0.0,45.2,1,Commercial,17.1,Bachelors_Plus,Stage_IV,3,260,1,208,1,death,disease,260,carbo_pem_pembro,SD,,175.0
|
| 67 |
+
HLT004-0000066,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-10-16,77,Male,Black_AA,1,False,0.0,26.8,2,Medicare,20.6,Bachelors_Plus,Stage_III,2,599,1,490,1,death,other_cause,599,carbo_taxol,SD,,439.0
|
| 68 |
+
HLT004-0000067,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-04-05,66,Female,Asian,1,False,0.0,26.3,1,Medicare,26.8,Less_than_HS,Stage_II,1,793,1,287,1,death,other_cause,793,pembro_mono,PD,,287.0
|
| 69 |
+
HLT004-0000068,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-06-05,65,Male,White,1,True,120.0,33.9,2,Commercial,29.3,Bachelors_Plus,Stage_III,2,705,1,40,1,death,disease,705,carbo_pem_pembro,SD,,32.0
|
| 70 |
+
HLT004-0000069,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-10-19,78,Male,White,3,True,4.5,34.2,0,Commercial,51.2,HS_Diploma,Stage_IV,3,488,1,113,1,death,disease,488,pembro_mono,SD,,93.0
|
| 71 |
+
HLT004-0000070,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-03-26,68,Male,White,3,True,2.7,25.8,1,Commercial,21.8,HS_Diploma,Stage_III,2,169,0,169,0,lost_to_follow_up,censored,169,carbo_taxol,PD,,169.0
|
| 72 |
+
HLT004-0000071,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-12-17,57,Male,White,1,True,18.0,26.6,3,Medicare,30.3,HS_Diploma,Stage_III,2,521,1,521,1,death,disease,521,pembro_mono,CR,34.0,
|
| 73 |
+
HLT004-0000072,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-03-19,58,Male,White,0,True,12.0,32.5,2,Commercial,24.0,HS_Diploma,Stage_IV,3,8,1,8,1,death,other_cause,8,carbo_pem_pembro,PR,85.0,
|
| 74 |
+
HLT004-0000073,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-09-20,60,Female,White,1,True,31.1,24.0,1,Medicare,44.5,Some_College,Stage_III,2,1065,1,655,1,death,other_cause,1065,docetaxel_2L,SD,,567.0
|
| 75 |
+
HLT004-0000074,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-07-25,74,Female,Black_AA,1,True,8.4,26.6,2,Medicare,30.6,HS_Diploma,Stage_III,2,374,0,374,0,lost_to_follow_up,censored,374,carbo_taxol,SD,,256.0
|
| 76 |
+
HLT004-0000075,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-02-21,71,Female,White,1,False,0.0,29.7,1,Commercial,30.7,HS_Diploma,Stage_III,2,152,1,152,1,death,disease,152,carbo_pem_pembro,PD,,152.0
|
| 77 |
+
HLT004-0000076,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-05-04,76,Female,Asian,1,False,0.0,35.3,0,Medicare,68.2,Some_College,Stage_I,0,1825,0,1667,1,administrative,censored,1825,carbo_taxol,SD,,1180.0
|
| 78 |
+
HLT004-0000077,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-12-28,65,Female,White,1,True,6.2,25.4,1,Medicare,9.9,Bachelors_Plus,Stage_IV,3,76,1,76,1,death,other_cause,76,carbo_taxol,PR,36.0,
|
| 79 |
+
HLT004-0000078,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-03-23,71,Male,White,0,False,0.0,17.7,2,Medicare,18.8,Some_College,Stage_IV,3,374,1,93,1,death,disease,374,pembro_mono,PR,51.0,
|
| 80 |
+
HLT004-0000079,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-10-19,76,Female,Hispanic_Latino,0,True,34.0,17.2,0,Medicare,42.3,Some_College,Stage_IV,3,328,1,328,1,death,disease,328,carbo_taxol,SD,,227.0
|
| 81 |
+
HLT004-0000080,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-10-15,66,Female,Hispanic_Latino,1,True,1.0,21.3,1,Medicare,19.9,HS_Diploma,Stage_IV,3,386,1,204,1,death,disease,386,carbo_pem_pembro,PR,45.0,
|
| 82 |
+
HLT004-0000081,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-08-06,74,Male,White,0,True,9.2,21.0,3,Commercial,30.7,Bachelors_Plus,Stage_III,2,796,1,413,1,death,disease,796,docetaxel_2L,SD,,370.0
|
| 83 |
+
HLT004-0000082,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-03-23,63,Female,White,0,False,0.0,28.1,0,Medicare,47.3,Less_than_HS,Stage_III,2,836,1,262,1,death,disease,836,carbo_taxol,SD,,164.0
|
| 84 |
+
HLT004-0000083,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-06-02,66,Male,White,1,False,0.0,21.7,1,Medicaid,53.0,HS_Diploma,Stage_IV,3,264,0,43,1,lost_to_follow_up,censored,264,carbo_pem_pembro,SD,,37.0
|
| 85 |
+
HLT004-0000084,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-08-01,66,Male,White,1,False,0.0,24.7,3,Commercial,33.6,Less_than_HS,Stage_IV,3,564,1,227,1,death,disease,564,pembro_mono,PD,,227.0
|
| 86 |
+
HLT004-0000085,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-25,58,Female,White,0,False,0.0,24.3,3,Medicare,46.3,Some_College,Stage_IV,3,635,1,246,1,death,disease,635,pembro_mono,PD,,246.0
|
| 87 |
+
HLT004-0000086,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-12-09,74,Female,White,1,False,0.0,26.4,2,Commercial,24.4,HS_Diploma,Stage_III,2,529,1,529,1,death,disease,529,pembro_mono,PD,,529.0
|
| 88 |
+
HLT004-0000087,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-05-15,65,Female,White,2,True,13.7,37.3,3,Medicaid,34.5,Some_College,Stage_IV,3,907,1,191,1,death,disease,907,carbo_taxol,SD,,171.0
|
| 89 |
+
HLT004-0000088,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-09-01,70,Male,White,0,True,50.9,33.2,1,Medicare,42.8,HS_Diploma,Stage_IV,3,235,0,219,1,lost_to_follow_up,censored,235,carbo_taxol,PR,80.0,
|
| 90 |
+
HLT004-0000089,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-05-05,74,Female,Asian,2,True,70.8,29.2,1,Medicare,47.1,Some_College,Stage_IV,3,230,1,230,1,death,disease,230,pembro_mono,PD,,230.0
|
| 91 |
+
HLT004-0000090,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-04-25,74,Female,Black_AA,3,False,0.0,26.2,2,Commercial,41.4,Some_College,Stage_IV,3,814,1,194,1,death,disease,814,carbo_pem_pembro,PD,,194.0
|
| 92 |
+
HLT004-0000091,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-11-01,76,Male,White,1,True,19.5,26.4,2,Medicaid,7.0,Less_than_HS,Stage_III,2,807,1,261,1,death,disease,807,carbo_taxol,SD,,218.0
|
| 93 |
+
HLT004-0000092,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-01-21,69,Female,White,1,True,22.3,31.1,1,Commercial,45.5,Some_College,Stage_III,2,740,1,401,1,death,disease,740,docetaxel_2L,SD,,313.0
|
| 94 |
+
HLT004-0000093,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-04-18,65,Male,White,0,False,0.0,32.7,2,Medicare,77.9,Some_College,Stage_III,2,267,1,160,1,death,disease,267,pembro_mono,SD,,124.0
|
| 95 |
+
HLT004-0000094,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-07-29,69,Male,White,3,True,52.4,23.5,5,Medicare,51.8,Some_College,Stage_III,2,727,1,153,1,death,disease,727,pembro_mono,PD,,153.0
|
| 96 |
+
HLT004-0000095,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-07-12,53,Male,Hispanic_Latino,1,False,0.0,29.3,2,Medicare,16.1,Less_than_HS,Stage_IV,3,318,1,318,1,death,disease,318,carbo_pem_pembro,PR,42.0,
|
| 97 |
+
HLT004-0000096,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-07-19,55,Female,Hispanic_Latino,3,True,8.1,16.5,0,Uninsured,67.2,Some_College,Stage_III,2,172,0,165,1,lost_to_follow_up,censored,172,docetaxel_2L,SD,,131.0
|
| 98 |
+
HLT004-0000097,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-03-07,56,Male,Hispanic_Latino,1,False,0.0,30.4,0,Medicare,47.4,HS_Diploma,Stage_III,2,1102,1,334,1,death,disease,1102,carbo_taxol,PD,,334.0
|
| 99 |
+
HLT004-0000098,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-07-23,60,Male,NHOPI,0,False,0.0,33.8,3,Medicare,60.4,Less_than_HS,Stage_III,2,662,1,333,1,death,disease,662,carbo_pem_pembro,SD,,212.0
|
| 100 |
+
HLT004-0000099,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-10-29,73,Male,NHOPI,0,True,7.8,27.4,0,Medicare,25.0,HS_Diploma,Stage_IV,3,465,1,179,1,death,other_cause,465,carbo_pem_pembro,PD,,179.0
|
| 101 |
+
HLT004-0000100,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-02-10,60,Male,Asian,1,False,0.0,40.4,1,Commercial,69.9,Some_College,Stage_IV,3,343,1,343,1,death,disease,343,pembro_mono,PD,,343.0
|
| 102 |
+
HLT004-0000101,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-10-18,66,Male,White,1,True,11.8,23.6,6,Medicare,40.7,HS_Diploma,Stage_I,0,660,1,660,1,death,disease,660,pembro_mono,PR,50.0,
|
| 103 |
+
HLT004-0000102,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-04-19,82,Female,White,0,True,0.9,30.4,0,Medicaid,46.5,Some_College,Stage_IV,3,568,0,24,1,lost_to_follow_up,censored,568,carbo_pem_pembro,SD,,16.0
|
| 104 |
+
HLT004-0000103,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-05-21,66,Male,White,2,True,21.8,28.9,1,Uninsured,20.7,HS_Diploma,Stage_III,2,723,1,266,1,death,disease,723,carbo_taxol,PR,42.0,
|
| 105 |
+
HLT004-0000104,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-04-06,77,Female,White,2,False,0.0,28.5,0,Medicaid,31.1,Bachelors_Plus,Stage_III,2,419,1,271,1,death,disease,419,pembro_mono,CR,35.0,
|
| 106 |
+
HLT004-0000105,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-10-30,60,Female,White,1,True,15.9,28.4,1,Medicaid,66.2,HS_Diploma,Stage_II,1,1825,0,335,1,administrative,censored,1825,pembro_mono,PR,79.0,
|
| 107 |
+
HLT004-0000106,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-05-21,67,Male,Hispanic_Latino,1,True,19.6,29.8,4,Medicare,61.1,Some_College,Stage_IV,3,763,1,17,1,death,disease,763,pembro_mono,SD,,12.0
|
| 108 |
+
HLT004-0000107,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-04-01,60,Male,Black_AA,0,False,0.0,34.4,1,Medicaid,43.0,Bachelors_Plus,Stage_IV,3,622,1,100,1,death,disease,622,carbo_pem_pembro,SD,,76.0
|
| 109 |
+
HLT004-0000108,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-05-24,66,Female,White,2,True,14.3,37.6,2,Commercial,37.2,HS_Diploma,Stage_IV,3,278,0,194,1,lost_to_follow_up,censored,278,docetaxel_2L,PR,43.0,
|
| 110 |
+
HLT004-0000109,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-01-20,78,Male,White,0,True,2.6,29.1,3,Medicaid,0.4,Less_than_HS,Stage_I,0,254,0,191,1,lost_to_follow_up,censored,254,docetaxel_2L,SD,,148.0
|
| 111 |
+
HLT004-0000110,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-05-27,52,Male,White,2,True,0.4,34.2,0,Medicaid,23.2,Some_College,Stage_IV,3,753,1,133,1,death,disease,753,pembro_mono,SD,,95.0
|
| 112 |
+
HLT004-0000111,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-04-01,74,Female,White,1,True,15.0,24.7,1,Commercial,30.6,Bachelors_Plus,Stage_IV,3,362,1,148,1,death,disease,362,carbo_pem_pembro,SD,,131.0
|
| 113 |
+
HLT004-0000112,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-04-01,72,Female,Hispanic_Latino,1,False,0.0,33.8,1,Medicare,27.8,Bachelors_Plus,Stage_III,2,83,1,83,1,death,disease,83,pembro_mono,PR,61.0,
|
| 114 |
+
HLT004-0000113,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-08-09,64,Female,White,0,True,105.0,24.4,1,Medicare,30.0,HS_Diploma,Stage_II,1,620,1,620,1,death,disease,620,carbo_taxol,SD,,505.0
|
| 115 |
+
HLT004-0000114,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-06-29,55,Male,Hispanic_Latino,0,True,39.4,35.9,1,Commercial,26.8,Bachelors_Plus,Stage_III,2,110,1,110,1,death,disease,110,carbo_pem_pembro,SD,,90.0
|
| 116 |
+
HLT004-0000115,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-05-25,70,Female,White,2,False,0.0,42.8,0,Commercial,10.9,HS_Diploma,Stage_IV,3,515,1,129,1,death,disease,515,carbo_taxol,PR,56.0,
|
| 117 |
+
HLT004-0000116,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-12-07,64,Female,White,1,True,80.2,28.3,1,Commercial,67.3,HS_Diploma,Stage_III,2,153,1,153,1,death,other_cause,153,docetaxel_2L,PD,,153.0
|
| 118 |
+
HLT004-0000117,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-03-20,72,Male,White,1,False,0.0,15.5,4,Uninsured,33.4,Some_College,Stage_III,2,445,1,246,1,death,other_cause,445,carbo_taxol,SD,,220.0
|
| 119 |
+
HLT004-0000118,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-10-15,70,Female,Hispanic_Latino,3,True,43.6,25.7,0,Medicare,23.1,Some_College,Stage_IV,3,172,1,145,1,death,disease,172,docetaxel_2L,SD,,108.0
|
| 120 |
+
HLT004-0000119,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-12-01,86,Male,Hispanic_Latino,3,False,0.0,36.7,3,VA,31.9,Some_College,Stage_IV,3,401,0,243,1,lost_to_follow_up,censored,401,pembro_mono,SD,,177.0
|
| 121 |
+
HLT004-0000120,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-03-08,67,Male,White,2,False,0.0,32.5,2,Commercial,26.3,Bachelors_Plus,Stage_IV,3,151,1,151,1,death,other_cause,151,pembro_mono,PD,,151.0
|
| 122 |
+
HLT004-0000121,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-09-15,59,Female,Asian,0,False,0.0,30.6,0,Medicaid,13.6,HS_Diploma,Stage_IV,3,212,1,17,1,death,other_cause,212,carbo_pem_pembro,PR,64.0,
|
| 123 |
+
HLT004-0000122,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-04-17,71,Male,White,1,True,46.5,35.4,1,Medicare,12.9,Some_College,Stage_I,0,640,0,640,0,lost_to_follow_up,censored,640,pembro_mono,SD,,547.0
|
| 124 |
+
HLT004-0000123,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-03-28,72,Male,Hispanic_Latino,2,True,29.8,32.1,5,Medicare,15.3,HS_Diploma,Stage_IV,3,10,1,10,1,death,disease,10,carbo_pem_pembro,SD,,8.0
|
| 125 |
+
HLT004-0000124,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-03-28,83,Female,White,1,False,0.0,36.6,0,Medicaid,27.3,Less_than_HS,Stage_III,2,294,1,294,1,death,disease,294,carbo_taxol,PD,,294.0
|
| 126 |
+
HLT004-0000125,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-04-16,78,Female,White,0,True,7.4,34.8,2,Commercial,34.7,HS_Diploma,Stage_I,0,770,1,390,1,death,disease,770,carbo_taxol,SD,,334.0
|
| 127 |
+
HLT004-0000126,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-11-22,73,Female,Hispanic_Latino,2,True,4.5,38.5,0,Medicare,43.9,Bachelors_Plus,Stage_IV,3,425,1,425,1,death,disease,425,carbo_taxol,PD,,425.0
|
| 128 |
+
HLT004-0000127,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-03-14,84,Female,White,1,True,18.3,31.3,1,Medicare,32.8,Some_College,Stage_II,1,972,0,972,0,lost_to_follow_up,censored,972,pembro_mono,PR,66.0,
|
| 129 |
+
HLT004-0000128,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-05-07,58,Female,White,1,False,0.0,34.7,0,Medicaid,26.6,Less_than_HS,Stage_I,0,1825,0,403,1,administrative,censored,1825,carbo_pem_pembro,PR,68.0,
|
| 130 |
+
HLT004-0000129,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-07-02,63,Male,White,4,False,0.0,27.2,4,Medicare,27.4,Some_College,Stage_IV,3,762,1,253,1,death,disease,762,carbo_pem_pembro,PR,74.0,
|
| 131 |
+
HLT004-0000130,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-10-01,60,Male,White,1,True,34.0,25.4,3,Medicaid,33.4,Bachelors_Plus,Stage_III,2,816,1,737,1,death,disease,816,docetaxel_2L,SD,,572.0
|
| 132 |
+
HLT004-0000131,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-06-08,66,Male,Black_AA,1,False,0.0,39.7,0,Medicare,22.9,Bachelors_Plus,Stage_I,0,1117,1,1117,1,death,disease,1117,carbo_pem_pembro,PR,71.0,
|
| 133 |
+
HLT004-0000132,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-07-07,56,Male,Hispanic_Latino,1,True,105.0,30.4,0,Medicaid,31.3,Some_College,Stage_IV,3,160,1,87,1,death,other_cause,160,carbo_pem_pembro,SD,,68.0
|
| 134 |
+
HLT004-0000133,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-09-22,76,Female,Hispanic_Latino,1,True,11.4,34.1,5,Commercial,55.7,HS_Diploma,Stage_IV,3,441,1,120,1,death,disease,441,carbo_pem_pembro,PR,38.0,
|
| 135 |
+
HLT004-0000134,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-11,67,Male,White,0,True,14.5,29.9,0,Medicaid,42.5,Some_College,Stage_IV,3,349,1,207,1,death,disease,349,carbo_pem_pembro,PR,86.0,
|
| 136 |
+
HLT004-0000135,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-08-25,55,Male,White,2,True,13.1,25.5,2,Medicare,42.5,Bachelors_Plus,Stage_I,0,1825,0,1154,1,administrative,censored,1825,docetaxel_2L,SD,,926.0
|
| 137 |
+
HLT004-0000136,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-01-21,59,Male,White,2,True,1.4,29.2,2,Medicaid,25.2,Bachelors_Plus,Stage_IV,3,262,0,49,1,lost_to_follow_up,censored,262,carbo_pem_pembro,PR,73.0,
|
| 138 |
+
HLT004-0000137,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-06-15,73,Male,White,0,False,0.0,38.0,1,Uninsured,44.3,Bachelors_Plus,Stage_IV,3,287,1,129,1,death,disease,287,carbo_taxol,PR,57.0,
|
| 139 |
+
HLT004-0000138,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-06-04,78,Female,White,0,False,0.0,32.5,0,Medicaid,61.1,Some_College,Stage_I,0,74,0,74,0,lost_to_follow_up,censored,74,pembro_mono,SD,,46.0
|
| 140 |
+
HLT004-0000139,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-08-08,89,Male,Asian,2,True,24.7,18.5,0,Uninsured,72.8,Less_than_HS,Stage_II,1,557,1,557,1,death,other_cause,557,carbo_taxol,SD,,392.0
|
| 141 |
+
HLT004-0000140,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-07-15,95,Male,Hispanic_Latino,0,True,16.8,27.8,2,Medicaid,47.3,Some_College,Stage_I,0,425,0,425,0,lost_to_follow_up,censored,425,docetaxel_2L,PD,,425.0
|
| 142 |
+
HLT004-0000141,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-02-09,74,Male,Hispanic_Latino,1,True,84.3,40.2,1,Medicare,22.5,HS_Diploma,Stage_IV,3,557,1,138,1,death,disease,557,docetaxel_2L,PD,,138.0
|
| 143 |
+
HLT004-0000142,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-12-15,60,Male,White,1,False,0.0,27.8,0,Commercial,45.1,Less_than_HS,Stage_II,1,88,0,88,0,lost_to_follow_up,censored,88,carbo_pem_pembro,SD,,76.0
|
| 144 |
+
HLT004-0000143,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-08-15,48,Female,White,1,False,0.0,17.9,2,Medicaid,36.4,Some_College,Stage_IV,3,2,1,2,1,death,disease,2,carbo_pem_pembro,SD,,1.0
|
| 145 |
+
HLT004-0000144,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-12-25,72,Male,White,0,False,0.0,40.8,2,Medicare,81.4,Some_College,Stage_IV,3,464,1,160,1,death,disease,464,carbo_pem_pembro,PR,54.0,
|
| 146 |
+
HLT004-0000145,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-02-14,61,Male,White,1,True,27.3,33.3,0,Medicare,44.9,Bachelors_Plus,Stage_II,1,549,1,549,1,death,disease,549,carbo_pem_pembro,PR,81.0,
|
| 147 |
+
HLT004-0000146,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-10-07,65,Male,White,1,True,7.9,28.7,6,Medicare,19.4,Bachelors_Plus,Stage_IV,3,261,1,261,1,death,disease,261,carbo_taxol,PD,,261.0
|
| 148 |
+
HLT004-0000147,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-05-29,63,Female,White,1,True,11.2,26.8,0,Medicare,66.1,Bachelors_Plus,Stage_II,1,1727,1,1263,1,death,disease,1727,pembro_mono,SD,,943.0
|
| 149 |
+
HLT004-0000148,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-02-23,68,Female,White,0,True,8.0,35.8,0,Uninsured,49.2,Bachelors_Plus,Stage_I,0,947,1,501,1,death,disease,947,carbo_taxol,SD,,392.0
|
| 150 |
+
HLT004-0000149,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-02-28,80,Female,Asian,1,True,34.5,25.7,0,Medicaid,1.6,Some_College,Stage_IV,3,452,1,20,1,death,other_cause,452,carbo_pem_pembro,PR,39.0,
|
| 151 |
+
HLT004-0000150,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-12-19,71,Female,White,1,True,7.9,36.2,0,Medicare,48.0,Less_than_HS,Stage_III,2,699,1,638,1,death,disease,699,carbo_taxol,SD,,415.0
|
| 152 |
+
HLT004-0000151,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-03-10,68,Female,Asian,0,False,0.0,32.5,2,VA,46.7,Some_College,Stage_IV,3,74,1,49,1,death,disease,74,docetaxel_2L,PD,,49.0
|
| 153 |
+
HLT004-0000152,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-12-02,59,Male,White,0,True,37.5,30.6,1,VA,75.9,HS_Diploma,Stage_IV,3,28,1,28,1,death,disease,28,docetaxel_2L,PR,39.0,
|
| 154 |
+
HLT004-0000153,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-12-07,53,Male,White,0,True,22.8,30.0,1,VA,16.7,Less_than_HS,Stage_I,0,1598,1,499,1,death,disease,1598,carbo_pem_pembro,PD,,499.0
|
| 155 |
+
HLT004-0000154,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-04-26,65,Female,White,0,False,0.0,28.0,0,Medicare,34.9,HS_Diploma,Stage_III,2,143,1,143,1,death,other_cause,143,pembro_mono,PD,,143.0
|
| 156 |
+
HLT004-0000155,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-11-23,69,Male,White,0,True,3.5,35.6,1,Medicaid,26.0,Bachelors_Plus,Stage_II,1,1731,1,664,1,death,disease,1731,carbo_taxol,SD,,497.0
|
| 157 |
+
HLT004-0000156,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-12-25,87,Female,White,3,False,0.0,23.7,3,Medicare,12.9,Bachelors_Plus,Stage_IV,3,141,1,141,1,death,disease,141,pembro_mono,PD,,141.0
|
| 158 |
+
HLT004-0000157,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-05-07,71,Male,White,1,True,33.7,19.0,0,Medicare,26.2,Bachelors_Plus,Stage_IV,3,398,1,92,1,death,disease,398,carbo_taxol,PR,55.0,
|
| 159 |
+
HLT004-0000158,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-08-14,79,Female,Asian,2,False,0.0,32.9,2,Uninsured,58.2,Bachelors_Plus,Stage_III,2,638,1,383,1,death,disease,638,docetaxel_2L,PR,54.0,
|
| 160 |
+
HLT004-0000159,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-01-18,65,Female,White,3,True,11.2,33.0,2,Medicaid,37.4,Bachelors_Plus,Stage_IV,3,344,1,14,1,death,disease,344,carbo_pem_pembro,PD,,14.0
|
| 161 |
+
HLT004-0000160,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-08-10,58,Male,Black_AA,0,True,4.3,32.1,0,Medicare,73.5,HS_Diploma,Stage_IV,3,157,0,95,1,lost_to_follow_up,censored,157,carbo_pem_pembro,SD,,85.0
|
| 162 |
+
HLT004-0000161,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-08-17,60,Female,White,1,False,0.0,31.6,1,Medicare,11.3,Bachelors_Plus,Stage_IV,3,397,1,261,1,death,disease,397,docetaxel_2L,PD,,261.0
|
| 163 |
+
HLT004-0000162,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-01-31,62,Female,White,2,True,66.5,27.1,0,Medicaid,57.9,Bachelors_Plus,Stage_I,0,47,1,47,1,death,disease,47,carbo_taxol,SD,,38.0
|
| 164 |
+
HLT004-0000163,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-08-04,91,Female,White,1,True,20.6,34.0,0,Commercial,72.5,Bachelors_Plus,Stage_I,0,1360,1,1360,1,death,other_cause,1360,carbo_pem_pembro,SD,,1005.0
|
| 165 |
+
HLT004-0000164,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-12-13,61,Male,White,1,True,10.6,28.8,2,Medicare,24.7,HS_Diploma,Stage_I,0,771,1,771,1,death,disease,771,pembro_mono,PR,61.0,
|
| 166 |
+
HLT004-0000165,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-07-31,78,Male,Two_Plus,1,True,17.6,26.1,2,Commercial,71.3,Less_than_HS,Stage_III,2,434,0,204,1,lost_to_follow_up,censored,434,docetaxel_2L,SD,,152.0
|
| 167 |
+
HLT004-0000166,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-12-26,60,Female,Hispanic_Latino,0,False,0.0,27.2,1,Medicare,31.1,Bachelors_Plus,Stage_III,2,491,1,71,1,death,disease,491,pembro_mono,PR,63.0,
|
| 168 |
+
HLT004-0000167,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-01,79,Male,Hispanic_Latino,1,True,16.6,41.6,0,Medicare,51.2,HS_Diploma,Stage_I,0,567,1,567,1,death,other_cause,567,docetaxel_2L,SD,,390.0
|
| 169 |
+
HLT004-0000168,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-02-08,73,Male,White,4,True,29.2,18.3,1,Medicaid,59.8,HS_Diploma,Stage_III,2,219,1,219,1,death,other_cause,219,docetaxel_2L,SD,,142.0
|
| 170 |
+
HLT004-0000169,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-11-16,68,Female,White,3,True,7.7,32.2,4,Medicare,46.0,Some_College,Stage_III,2,981,1,417,1,death,disease,981,carbo_pem_pembro,PD,,417.0
|
| 171 |
+
HLT004-0000170,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-04-04,69,Female,Asian,0,False,0.0,18.7,1,Medicaid,13.4,HS_Diploma,Stage_I,0,712,0,712,0,lost_to_follow_up,censored,712,pembro_mono,SD,,502.0
|
| 172 |
+
HLT004-0000171,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-09-18,63,Male,White,1,True,47.4,28.4,0,Medicaid,27.1,Less_than_HS,Stage_IV,3,321,1,321,1,death,disease,321,pembro_mono,CR,80.0,
|
| 173 |
+
HLT004-0000172,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-07-21,74,Male,White,0,True,4.3,26.4,1,Commercial,35.7,Bachelors_Plus,Stage_IV,3,762,1,321,1,death,disease,762,docetaxel_2L,PD,,321.0
|
| 174 |
+
HLT004-0000173,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-02-15,65,Male,White,2,False,0.0,16.2,1,Medicare,59.4,Bachelors_Plus,Stage_III,2,48,1,48,1,death,other_cause,48,carbo_taxol,SD,,32.0
|
| 175 |
+
HLT004-0000174,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-11-30,57,Male,Hispanic_Latino,0,True,17.0,31.5,0,Medicaid,16.2,Bachelors_Plus,Stage_III,2,636,1,600,1,death,disease,636,carbo_pem_pembro,SD,,530.0
|
| 176 |
+
HLT004-0000175,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-11-12,57,Female,Black_AA,3,False,0.0,26.7,0,Commercial,58.8,HS_Diploma,Stage_III,2,419,1,419,1,death,disease,419,docetaxel_2L,SD,,268.0
|
| 177 |
+
HLT004-0000176,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-03-03,71,Male,Hispanic_Latino,2,True,13.5,16.1,1,Uninsured,79.0,HS_Diploma,Stage_IV,3,203,0,166,1,lost_to_follow_up,censored,203,carbo_taxol,PR,30.0,
|
| 178 |
+
HLT004-0000177,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-05-14,85,Male,Hispanic_Latino,0,True,120.0,34.3,1,Medicare,43.6,Some_College,Stage_IV,3,82,1,82,1,death,other_cause,82,carbo_pem_pembro,SD,,73.0
|
| 179 |
+
HLT004-0000178,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-09-16,71,Female,White,0,True,49.4,38.0,1,Medicare,3.5,Some_College,Stage_III,2,61,1,61,1,death,other_cause,61,docetaxel_2L,PD,,61.0
|
| 180 |
+
HLT004-0000179,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-04-14,68,Male,Asian,2,False,0.0,38.3,2,Medicare,69.0,Less_than_HS,Stage_IV,3,278,1,127,1,death,disease,278,pembro_mono,PD,,127.0
|
| 181 |
+
HLT004-0000180,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-10-08,72,Male,White,0,True,26.3,31.3,4,Medicare,26.7,Bachelors_Plus,Stage_IV,3,337,1,2,1,death,disease,337,carbo_pem_pembro,PR,88.0,
|
| 182 |
+
HLT004-0000181,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-12-30,83,Female,Black_AA,1,True,39.8,29.4,3,Medicaid,28.9,Bachelors_Plus,Stage_IV,3,590,1,242,1,death,disease,590,carbo_pem_pembro,PR,50.0,
|
| 183 |
+
HLT004-0000182,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-02-04,72,Female,White,3,True,4.1,37.3,0,Commercial,72.0,Some_College,Stage_II,1,243,1,243,1,death,disease,243,carbo_pem_pembro,SD,,149.0
|
| 184 |
+
HLT004-0000183,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-10-20,65,Female,Two_Plus,1,True,56.7,39.5,1,Medicaid,17.5,HS_Diploma,Stage_I,0,728,1,728,1,death,other_cause,728,docetaxel_2L,PD,,728.0
|
| 185 |
+
HLT004-0000184,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-05-19,81,Female,White,1,True,7.4,36.1,1,Medicaid,8.0,HS_Diploma,Stage_IV,3,43,0,43,0,lost_to_follow_up,censored,43,carbo_taxol,PD,,43.0
|
| 186 |
+
HLT004-0000185,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-06-03,74,Male,White,1,True,7.0,23.3,0,Medicare,34.9,Less_than_HS,Stage_III,2,220,1,122,1,death,disease,220,carbo_pem_pembro,SD,,101.0
|
| 187 |
+
HLT004-0000186,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-10-25,85,Female,White,0,True,28.2,30.3,3,Commercial,84.4,HS_Diploma,Stage_IV,3,385,1,295,1,death,disease,385,carbo_pem_pembro,PR,33.0,
|
| 188 |
+
HLT004-0000187,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-08-13,71,Female,White,3,True,2.0,31.8,1,Commercial,26.1,Some_College,Stage_IV,3,565,1,121,1,death,disease,565,carbo_pem_pembro,PD,,121.0
|
| 189 |
+
HLT004-0000188,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-12-25,57,Female,White,0,True,31.3,17.9,2,Commercial,46.9,Some_College,Stage_III,2,91,1,91,1,death,other_cause,91,carbo_pem_pembro,SD,,79.0
|
| 190 |
+
HLT004-0000189,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-12-03,56,Female,Black_AA,0,True,8.4,32.0,3,Commercial,37.5,Some_College,Stage_III,2,30,0,30,0,lost_to_follow_up,censored,30,carbo_taxol,PR,48.0,
|
| 191 |
+
HLT004-0000190,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-05,86,Female,White,0,True,7.2,43.2,1,Commercial,43.0,Bachelors_Plus,Stage_III,2,655,1,195,1,death,other_cause,655,pembro_mono,SD,,156.0
|
| 192 |
+
HLT004-0000191,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-11-02,87,Female,Asian,3,True,36.1,33.1,2,Medicare,28.3,HS_Diploma,Stage_III,2,395,1,217,1,death,disease,395,carbo_taxol,PD,,217.0
|
| 193 |
+
HLT004-0000192,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-02-18,68,Male,White,0,True,20.5,38.2,2,Commercial,28.9,Less_than_HS,Stage_IV,3,53,1,53,1,death,disease,53,carbo_pem_pembro,PD,,53.0
|
| 194 |
+
HLT004-0000193,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-12-20,66,Female,Black_AA,2,True,38.0,30.2,0,Medicare,44.7,Less_than_HS,Stage_IV,3,236,1,144,1,death,disease,236,carbo_taxol,SD,,107.0
|
| 195 |
+
HLT004-0000194,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-06-07,84,Male,White,1,True,23.5,28.6,0,Medicare,17.9,HS_Diploma,Stage_III,2,370,1,370,1,death,disease,370,carbo_taxol,PR,45.0,
|
| 196 |
+
HLT004-0000195,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-09-04,58,Female,Black_AA,2,True,64.3,31.5,1,Commercial,60.2,Some_College,Stage_IV,3,463,1,215,1,death,disease,463,carbo_pem_pembro,PR,65.0,
|
| 197 |
+
HLT004-0000196,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-06-10,61,Female,White,3,True,47.8,24.0,4,Medicare,20.6,Bachelors_Plus,Stage_III,2,800,0,619,1,lost_to_follow_up,censored,800,carbo_pem_pembro,SD,,439.0
|
| 198 |
+
HLT004-0000197,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-08-28,76,Female,White,2,False,0.0,23.1,0,Medicaid,83.8,Bachelors_Plus,Stage_IV,3,307,1,121,1,death,disease,307,carbo_pem_pembro,SD,,102.0
|
| 199 |
+
HLT004-0000198,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-11-28,66,Female,Asian,3,True,31.4,37.0,1,Medicare,48.9,Some_College,Stage_II,1,1306,1,1306,1,death,disease,1306,carbo_taxol,PR,50.0,
|
| 200 |
+
HLT004-0000199,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-12-09,69,Male,White,0,False,0.0,37.6,0,Medicare,66.7,Some_College,Stage_IV,3,253,1,253,1,death,disease,253,pembro_mono,PD,,253.0
|
| 201 |
+
HLT004-0000200,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-02-04,68,Female,White,2,True,36.1,23.0,1,Commercial,38.7,HS_Diploma,Stage_IV,3,180,1,180,1,death,disease,180,carbo_pem_pembro,SD,,152.0
|
| 202 |
+
HLT004-0000201,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-08-05,73,Female,Black_AA,1,False,0.0,35.1,3,Medicare,29.1,Some_College,Stage_III,2,1393,1,237,1,death,disease,1393,docetaxel_2L,SD,,180.0
|
| 203 |
+
HLT004-0000202,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-10-10,84,Male,Hispanic_Latino,1,True,0.5,28.6,3,Commercial,28.1,HS_Diploma,Stage_IV,3,210,1,36,1,death,disease,210,pembro_mono,PD,,36.0
|
| 204 |
+
HLT004-0000203,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-08-05,70,Male,White,2,True,15.5,31.2,0,Medicare,45.3,Bachelors_Plus,Stage_IV,3,214,0,171,1,lost_to_follow_up,censored,214,carbo_pem_pembro,PR,55.0,
|
| 205 |
+
HLT004-0000204,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-03-03,76,Male,White,3,True,13.1,32.0,2,Commercial,35.9,Some_College,Stage_II,1,692,0,107,1,lost_to_follow_up,censored,692,carbo_pem_pembro,PD,,107.0
|
| 206 |
+
HLT004-0000205,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-01-19,49,Female,Hispanic_Latino,1,False,0.0,35.3,0,Medicaid,61.4,HS_Diploma,Stage_IV,3,993,0,396,1,lost_to_follow_up,censored,993,carbo_pem_pembro,PR,72.0,
|
| 207 |
+
HLT004-0000206,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-06-04,69,Male,Hispanic_Latino,1,True,2.6,29.6,1,Commercial,58.6,HS_Diploma,Stage_IV,3,233,1,36,1,death,disease,233,carbo_pem_pembro,PD,,36.0
|
| 208 |
+
HLT004-0000207,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-03-29,61,Female,Two_Plus,1,True,68.7,37.8,2,Medicare,56.1,HS_Diploma,Stage_IV,3,152,1,152,1,death,disease,152,carbo_taxol,PR,72.0,
|
| 209 |
+
HLT004-0000208,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-04-26,57,Male,White,1,True,55.0,31.0,1,Medicare,60.0,Bachelors_Plus,Stage_III,2,1666,0,645,1,lost_to_follow_up,censored,1666,carbo_pem_pembro,SD,,552.0
|
| 210 |
+
HLT004-0000209,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-08-05,61,Female,Black_AA,1,False,0.0,33.0,1,Medicare,53.7,Less_than_HS,Stage_IV,3,562,1,119,1,death,disease,562,docetaxel_2L,PD,,119.0
|
| 211 |
+
HLT004-0000210,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-10-03,66,Male,White,1,True,3.0,23.9,0,Medicare,35.6,Less_than_HS,Stage_IV,3,587,1,271,1,death,disease,587,carbo_taxol,PD,,271.0
|
| 212 |
+
HLT004-0000211,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-11-10,79,Female,Asian,0,True,12.9,42.5,3,Medicare,23.8,HS_Diploma,Stage_IV,3,99,0,99,0,lost_to_follow_up,censored,99,pembro_mono,PR,75.0,
|
| 213 |
+
HLT004-0000212,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-03-12,56,Male,White,0,True,5.6,32.0,2,Commercial,28.4,Bachelors_Plus,Stage_I,0,832,0,651,1,lost_to_follow_up,censored,832,docetaxel_2L,PD,,651.0
|
| 214 |
+
HLT004-0000213,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-09-04,70,Female,Hispanic_Latino,2,False,0.0,33.5,0,Commercial,48.9,Some_College,Stage_I,0,117,0,117,0,lost_to_follow_up,censored,117,pembro_mono,SD,,91.0
|
| 215 |
+
HLT004-0000214,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-12-01,65,Female,White,1,True,17.5,19.1,0,Commercial,23.6,Some_College,Stage_IV,3,337,1,142,1,death,disease,337,docetaxel_2L,PR,81.0,
|
| 216 |
+
HLT004-0000215,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-05-23,66,Female,White,3,True,9.2,24.0,1,Medicare,53.4,HS_Diploma,Stage_III,2,229,1,229,1,death,disease,229,docetaxel_2L,PR,48.0,
|
| 217 |
+
HLT004-0000216,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-06-26,80,Female,Black_AA,1,False,0.0,36.8,2,Medicare,16.1,Less_than_HS,Stage_II,1,1492,0,1308,1,lost_to_follow_up,censored,1492,carbo_taxol,PD,,1308.0
|
| 218 |
+
HLT004-0000217,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-11-19,75,Male,White,0,True,13.3,30.9,2,Commercial,51.6,Bachelors_Plus,Stage_III,2,533,1,533,1,death,disease,533,carbo_pem_pembro,PD,,533.0
|
| 219 |
+
HLT004-0000218,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-29,83,Male,Hispanic_Latino,0,True,22.9,17.2,2,Commercial,43.3,HS_Diploma,Stage_IV,3,121,1,121,1,death,disease,121,carbo_pem_pembro,PD,,121.0
|
| 220 |
+
HLT004-0000219,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-12-05,68,Male,White,0,True,5.5,35.5,1,Medicare,23.1,Less_than_HS,Stage_III,2,541,1,541,1,death,disease,541,carbo_pem_pembro,SD,,353.0
|
| 221 |
+
HLT004-0000220,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-08-24,63,Male,Black_AA,3,True,12.2,25.7,2,Commercial,16.9,Some_College,Stage_IV,3,194,1,194,1,death,disease,194,pembro_mono,SD,,122.0
|
| 222 |
+
HLT004-0000221,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-02-12,67,Female,White,0,True,18.9,37.9,2,Medicare,75.0,Less_than_HS,Stage_IV,3,616,1,223,1,death,disease,616,carbo_pem_pembro,PD,,223.0
|
| 223 |
+
HLT004-0000222,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-10-07,72,Female,White,1,True,62.0,28.6,1,Commercial,45.0,Less_than_HS,Stage_IV,3,329,1,235,1,death,disease,329,carbo_taxol,SD,,169.0
|
| 224 |
+
HLT004-0000223,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-07-16,71,Female,White,3,False,0.0,30.4,1,VA,19.9,Bachelors_Plus,Stage_IV,3,507,1,166,1,death,disease,507,docetaxel_2L,PR,54.0,
|
| 225 |
+
HLT004-0000224,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-02-28,59,Female,White,3,False,0.0,36.4,0,Commercial,73.0,Some_College,Stage_II,1,663,1,663,1,death,other_cause,663,carbo_taxol,PD,,663.0
|
| 226 |
+
HLT004-0000225,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-04-13,70,Female,White,0,True,89.7,23.5,3,Medicaid,70.1,HS_Diploma,Stage_IV,3,183,1,54,1,death,disease,183,carbo_taxol,PD,,54.0
|
| 227 |
+
HLT004-0000226,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-11-06,72,Female,Black_AA,0,True,6.5,22.9,3,Medicare,53.5,HS_Diploma,Stage_I,0,1825,0,1825,0,administrative,censored,1825,carbo_taxol,PR,39.0,
|
| 228 |
+
HLT004-0000227,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-04-20,95,Male,Black_AA,0,True,2.9,27.9,4,Medicaid,19.9,Bachelors_Plus,Stage_IV,3,141,1,90,1,death,disease,141,pembro_mono,SD,,56.0
|
| 229 |
+
HLT004-0000228,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-12-12,88,Male,Black_AA,0,False,0.0,34.2,0,Commercial,28.0,Less_than_HS,Stage_III,2,385,1,292,1,death,disease,385,pembro_mono,PD,,292.0
|
| 230 |
+
HLT004-0000229,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-07-21,61,Female,White,0,True,72.7,20.8,2,Medicare,4.3,Less_than_HS,Stage_IV,3,41,1,41,1,death,disease,41,carbo_pem_pembro,SD,,25.0
|
| 231 |
+
HLT004-0000230,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-06-23,67,Female,White,1,True,120.0,18.8,2,Commercial,20.2,Some_College,Stage_IV,3,474,1,200,1,death,disease,474,pembro_mono,PD,,200.0
|
| 232 |
+
HLT004-0000231,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-01-07,55,Male,White,3,True,42.8,34.2,0,Commercial,31.7,Some_College,Stage_I,0,204,0,204,0,lost_to_follow_up,censored,204,carbo_taxol,SD,,137.0
|
| 233 |
+
HLT004-0000232,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-07-19,64,Male,Hispanic_Latino,1,True,3.2,25.4,2,Medicaid,43.2,Bachelors_Plus,Stage_IV,3,580,1,11,1,death,disease,580,pembro_mono,SD,,6.0
|
| 234 |
+
HLT004-0000233,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-01-06,73,Female,Hispanic_Latino,1,True,28.4,26.7,5,Medicare,57.6,HS_Diploma,Stage_I,0,1825,0,577,1,administrative,censored,1825,pembro_mono,SD,,492.0
|
| 235 |
+
HLT004-0000234,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-03-23,82,Male,White,0,False,0.0,17.6,1,Commercial,24.0,Less_than_HS,Stage_III,2,415,1,145,1,death,disease,415,carbo_taxol,PD,,145.0
|
| 236 |
+
HLT004-0000235,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-10-12,62,Male,Black_AA,2,True,52.5,24.9,0,Medicare,8.3,Some_College,Stage_III,2,10,1,10,1,death,other_cause,10,docetaxel_2L,SD,,7.0
|
| 237 |
+
HLT004-0000236,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-10-21,63,Female,White,1,False,0.0,29.1,1,Medicaid,13.5,Some_College,Stage_III,2,1055,0,375,1,lost_to_follow_up,censored,1055,docetaxel_2L,SD,,288.0
|
| 238 |
+
HLT004-0000237,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-09-05,48,Female,White,2,True,5.7,34.9,1,Uninsured,53.0,HS_Diploma,Stage_IV,3,1111,1,130,1,death,disease,1111,docetaxel_2L,SD,,100.0
|
| 239 |
+
HLT004-0000238,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-11-03,68,Male,White,3,False,0.0,24.3,1,Medicare,68.9,Some_College,Stage_IV,3,232,1,141,1,death,disease,232,pembro_mono,PR,86.0,
|
| 240 |
+
HLT004-0000239,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-19,59,Female,White,0,False,0.0,39.4,2,Commercial,31.0,HS_Diploma,Stage_III,2,219,0,219,0,lost_to_follow_up,censored,219,pembro_mono,PD,,219.0
|
| 241 |
+
HLT004-0000240,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-03-01,64,Male,Black_AA,0,False,0.0,24.9,2,Medicare,42.6,Bachelors_Plus,Stage_IV,3,261,0,224,1,lost_to_follow_up,censored,261,carbo_taxol,SD,,186.0
|
| 242 |
+
HLT004-0000241,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-12-06,61,Female,Asian,0,True,69.4,24.9,1,Medicaid,67.2,Bachelors_Plus,Stage_IV,3,371,1,161,1,death,disease,371,pembro_mono,PR,74.0,
|
| 243 |
+
HLT004-0000242,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-08-11,69,Male,White,1,True,82.0,38.6,0,Medicare,33.3,Some_College,Stage_IV,3,677,1,99,1,death,other_cause,677,docetaxel_2L,SD,,63.0
|
| 244 |
+
HLT004-0000243,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-09,52,Female,White,3,True,62.0,30.4,1,Medicare,32.8,Bachelors_Plus,Stage_I,0,1825,0,727,1,administrative,censored,1825,carbo_pem_pembro,SD,,538.0
|
| 245 |
+
HLT004-0000244,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-07-20,55,Male,Black_AA,1,True,39.3,25.7,4,Medicare,55.5,Bachelors_Plus,Stage_IV,3,249,0,65,1,lost_to_follow_up,censored,249,carbo_pem_pembro,SD,,49.0
|
| 246 |
+
HLT004-0000245,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-11-07,91,Male,Asian,2,True,11.8,28.1,2,Commercial,57.8,HS_Diploma,Stage_I,0,1825,0,1825,0,administrative,censored,1825,carbo_taxol,PR,33.0,
|
| 247 |
+
HLT004-0000246,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-01-18,57,Female,Black_AA,1,False,0.0,37.5,1,Medicare,34.8,HS_Diploma,Stage_IV,3,315,1,41,1,death,disease,315,carbo_pem_pembro,SD,,32.0
|
| 248 |
+
HLT004-0000247,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-12-14,59,Male,White,0,False,0.0,38.2,1,Medicare,53.4,Some_College,Stage_IV,3,310,1,204,1,death,disease,310,carbo_pem_pembro,PR,52.0,
|
| 249 |
+
HLT004-0000248,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-07-12,88,Male,Black_AA,0,True,105.0,24.0,2,Commercial,23.5,Less_than_HS,Stage_IV,3,587,1,328,1,death,disease,587,carbo_pem_pembro,SD,,261.0
|
| 250 |
+
HLT004-0000249,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-05-28,95,Male,White,1,True,0.2,28.8,0,Medicare,40.0,HS_Diploma,Stage_I,0,1825,0,1289,1,administrative,censored,1825,pembro_mono,PD,,1289.0
|
| 251 |
+
HLT004-0000250,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-03-10,58,Female,AIAN,1,False,0.0,29.7,2,Commercial,43.1,HS_Diploma,Stage_I,0,195,0,195,0,lost_to_follow_up,censored,195,carbo_pem_pembro,PR,62.0,
|
| 252 |
+
HLT004-0000251,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-02-18,66,Female,White,1,False,0.0,23.0,2,Uninsured,21.3,Bachelors_Plus,Stage_IV,3,26,1,26,1,death,disease,26,carbo_pem_pembro,SD,,18.0
|
| 253 |
+
HLT004-0000252,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-07-30,73,Female,Black_AA,0,True,52.9,28.8,3,Medicaid,23.8,Some_College,Stage_I,0,1825,0,1455,1,administrative,censored,1825,pembro_mono,PR,30.0,
|
| 254 |
+
HLT004-0000253,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-05-30,87,Male,White,1,True,7.2,29.1,0,Medicaid,30.1,Bachelors_Plus,Stage_III,2,1120,1,1120,1,death,disease,1120,carbo_taxol,PD,,1120.0
|
| 255 |
+
HLT004-0000254,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-06-16,60,Male,White,0,False,0.0,36.2,4,Commercial,59.6,HS_Diploma,Stage_IV,3,134,1,128,1,death,disease,134,carbo_taxol,PR,67.0,
|
| 256 |
+
HLT004-0000255,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-06-30,67,Male,Hispanic_Latino,3,True,30.9,36.6,3,Commercial,63.6,HS_Diploma,Stage_IV,3,638,1,142,1,death,disease,638,docetaxel_2L,PD,,142.0
|
| 257 |
+
HLT004-0000256,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-30,77,Female,Black_AA,0,True,8.3,27.1,2,Medicaid,63.5,Bachelors_Plus,Stage_II,1,1103,1,1103,1,death,disease,1103,docetaxel_2L,SD,,937.0
|
| 258 |
+
HLT004-0000257,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-11-14,74,Female,White,0,False,0.0,27.8,1,Medicaid,60.5,Less_than_HS,Stage_III,2,401,1,401,1,death,disease,401,pembro_mono,PD,,401.0
|
| 259 |
+
HLT004-0000258,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-04-08,66,Female,Asian,1,False,0.0,33.2,2,Medicare,27.6,Less_than_HS,Stage_IV,3,403,1,250,1,death,disease,403,carbo_pem_pembro,PR,76.0,
|
| 260 |
+
HLT004-0000259,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-10-01,68,Female,Hispanic_Latino,1,False,0.0,25.5,2,Medicare,76.7,HS_Diploma,Stage_III,2,984,1,399,1,death,disease,984,carbo_pem_pembro,SD,,280.0
|
| 261 |
+
HLT004-0000260,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-02-20,56,Male,White,1,False,0.0,32.7,1,Commercial,4.6,Some_College,Stage_I,0,184,1,184,0,death,other_cause,184,docetaxel_2L,PD,,184.0
|
| 262 |
+
HLT004-0000261,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-08-13,67,Female,White,1,True,49.5,28.6,4,Commercial,58.0,HS_Diploma,Stage_II,1,1276,1,306,1,death,disease,1276,pembro_mono,PD,,306.0
|
| 263 |
+
HLT004-0000262,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-25,67,Male,White,4,True,14.1,23.1,3,Commercial,43.4,Less_than_HS,Stage_III,2,730,1,41,1,death,disease,730,docetaxel_2L,SD,,36.0
|
| 264 |
+
HLT004-0000263,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-06-07,72,Male,Black_AA,1,True,19.2,23.2,3,Medicare,13.9,HS_Diploma,Stage_IV,3,527,1,200,1,death,other_cause,527,pembro_mono,SD,,156.0
|
| 265 |
+
HLT004-0000264,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-04-25,64,Male,White,1,True,32.7,38.1,2,Commercial,32.2,HS_Diploma,Stage_III,2,383,1,383,1,death,disease,383,carbo_pem_pembro,PR,46.0,
|
| 266 |
+
HLT004-0000265,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-12-26,74,Male,White,1,True,48.3,28.1,2,Medicare,42.6,Less_than_HS,Stage_I,0,648,1,648,1,death,other_cause,648,carbo_taxol,SD,,511.0
|
| 267 |
+
HLT004-0000266,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-07-21,80,Male,Asian,0,True,14.2,39.3,3,Medicare,15.3,Some_College,Stage_III,2,216,0,97,1,lost_to_follow_up,censored,216,docetaxel_2L,SD,,80.0
|
| 268 |
+
HLT004-0000267,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-01-28,71,Male,Asian,1,True,30.6,25.9,2,Commercial,35.8,Less_than_HS,Stage_I,0,603,1,603,1,death,other_cause,603,docetaxel_2L,SD,,488.0
|
| 269 |
+
HLT004-0000268,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-09-21,73,Male,Hispanic_Latino,0,False,0.0,30.9,0,Medicaid,19.6,HS_Diploma,Stage_III,2,453,1,266,1,death,disease,453,carbo_pem_pembro,PD,,266.0
|
| 270 |
+
HLT004-0000269,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-10-05,70,Female,AIAN,1,True,1.0,43.9,3,Commercial,49.2,Some_College,Stage_IV,3,589,1,50,1,death,disease,589,carbo_taxol,PD,,50.0
|
| 271 |
+
HLT004-0000270,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-11-25,70,Male,Hispanic_Latino,0,True,54.3,22.5,2,Commercial,50.7,Bachelors_Plus,Stage_IV,3,453,1,138,1,death,disease,453,carbo_pem_pembro,SD,,119.0
|
| 272 |
+
HLT004-0000271,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-02-23,62,Male,Hispanic_Latino,4,True,3.3,17.3,7,Commercial,10.3,HS_Diploma,Stage_I,0,1064,1,1064,1,death,disease,1064,docetaxel_2L,PR,71.0,
|
| 273 |
+
HLT004-0000272,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-07-22,73,Female,Hispanic_Latino,1,True,0.6,37.1,3,Medicare,41.2,HS_Diploma,Stage_III,2,1825,0,758,1,administrative,censored,1825,carbo_taxol,PD,,758.0
|
| 274 |
+
HLT004-0000273,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-07-07,69,Female,White,2,False,0.0,24.0,0,Medicare,49.8,HS_Diploma,Stage_I,0,246,0,246,0,lost_to_follow_up,censored,246,docetaxel_2L,PD,,246.0
|
| 275 |
+
HLT004-0000274,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-08-01,90,Female,White,1,True,69.2,29.0,2,Commercial,5.5,Bachelors_Plus,Stage_I,0,141,0,141,0,lost_to_follow_up,censored,141,carbo_pem_pembro,PR,89.0,
|
| 276 |
+
HLT004-0000275,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-11-14,85,Male,White,0,True,17.9,25.5,0,Commercial,49.7,HS_Diploma,Stage_IV,3,185,1,46,1,death,other_cause,185,pembro_mono,PR,50.0,
|
| 277 |
+
HLT004-0000276,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-01-26,73,Female,Black_AA,2,False,0.0,30.8,0,Medicare,61.1,HS_Diploma,Stage_III,2,1203,1,937,1,death,other_cause,1203,docetaxel_2L,SD,,692.0
|
| 278 |
+
HLT004-0000277,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-03-06,62,Male,White,1,True,13.4,23.2,2,Commercial,72.1,Some_College,Stage_IV,3,585,1,226,1,death,disease,585,carbo_pem_pembro,PR,59.0,
|
| 279 |
+
HLT004-0000278,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-08-20,58,Male,White,2,True,15.9,28.0,0,Medicare,47.4,HS_Diploma,Stage_IV,3,378,1,378,1,death,disease,378,docetaxel_2L,PD,,378.0
|
| 280 |
+
HLT004-0000279,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-12-14,81,Female,White,1,True,8.3,31.9,1,Medicare,17.8,HS_Diploma,Stage_II,1,621,1,262,1,death,other_cause,621,docetaxel_2L,SD,,197.0
|
| 281 |
+
HLT004-0000280,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-12-05,72,Female,White,1,True,7.4,22.8,2,Commercial,44.6,Less_than_HS,Stage_IV,3,124,1,63,1,death,other_cause,124,docetaxel_2L,PD,,63.0
|
| 282 |
+
HLT004-0000281,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-06-13,74,Female,White,2,True,12.4,24.8,1,Medicare,45.8,Some_College,Stage_III,2,1010,1,1010,1,death,disease,1010,carbo_taxol,PD,,1010.0
|
| 283 |
+
HLT004-0000282,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-10-17,52,Female,Hispanic_Latino,1,True,53.8,26.9,0,Medicare,54.5,Some_College,Stage_II,1,1258,0,1258,0,lost_to_follow_up,censored,1258,pembro_mono,PR,30.0,
|
| 284 |
+
HLT004-0000283,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-03-19,79,Female,Hispanic_Latino,0,True,96.2,20.2,3,Commercial,72.5,Some_College,Stage_IV,3,306,1,267,1,death,disease,306,carbo_taxol,SD,,227.0
|
| 285 |
+
HLT004-0000284,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-05,74,Male,White,1,True,48.4,26.5,1,Commercial,40.6,Bachelors_Plus,Stage_I,0,364,0,364,0,lost_to_follow_up,censored,364,pembro_mono,SD,,241.0
|
| 286 |
+
HLT004-0000285,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-09-28,58,Male,White,1,True,36.9,29.8,2,Commercial,43.9,HS_Diploma,Stage_IV,3,230,0,53,1,lost_to_follow_up,censored,230,carbo_taxol,PD,,53.0
|
| 287 |
+
HLT004-0000286,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-09-21,65,Male,White,3,True,19.6,26.6,3,Medicare,39.3,Bachelors_Plus,Stage_IV,3,593,1,92,1,death,disease,593,pembro_mono,PD,,92.0
|
| 288 |
+
HLT004-0000287,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-08-16,72,Male,Hispanic_Latino,1,False,0.0,27.4,1,VA,36.4,Bachelors_Plus,Stage_III,2,607,1,15,1,death,disease,607,carbo_pem_pembro,SD,,12.0
|
| 289 |
+
HLT004-0000288,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-04-05,70,Female,Hispanic_Latino,1,True,30.1,29.0,4,Medicaid,47.7,Bachelors_Plus,Stage_IV,3,314,1,314,1,death,disease,314,carbo_taxol,PD,,314.0
|
| 290 |
+
HLT004-0000289,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-11-17,67,Male,White,2,True,2.0,25.0,3,Medicare,21.6,Bachelors_Plus,Stage_II,1,1527,1,832,1,death,disease,1527,carbo_taxol,SD,,665.0
|
| 291 |
+
HLT004-0000290,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-06-30,68,Female,Hispanic_Latino,1,True,115.9,33.4,5,Medicare,59.8,HS_Diploma,Stage_IV,3,947,1,27,1,death,disease,947,carbo_pem_pembro,SD,,20.0
|
| 292 |
+
HLT004-0000291,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-10-21,67,Female,White,2,True,37.0,38.0,1,Commercial,47.3,HS_Diploma,Stage_I,0,1825,0,109,1,administrative,censored,1825,carbo_pem_pembro,SD,,88.0
|
| 293 |
+
HLT004-0000292,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-03-29,71,Female,White,1,True,63.1,26.2,1,Commercial,43.0,Some_College,Stage_I,0,456,1,456,0,death,other_cause,456,carbo_pem_pembro,SD,,340.0
|
| 294 |
+
HLT004-0000293,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-07-14,84,Male,Two_Plus,0,False,0.0,32.1,1,Commercial,18.8,Less_than_HS,Stage_III,2,198,1,182,1,death,disease,198,docetaxel_2L,PR,72.0,
|
| 295 |
+
HLT004-0000294,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-11-16,44,Male,White,2,False,0.0,27.6,1,Commercial,15.7,Some_College,Stage_IV,3,318,1,318,1,death,disease,318,pembro_mono,SD,,223.0
|
| 296 |
+
HLT004-0000295,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-08-07,67,Female,White,0,True,42.7,31.4,1,Medicare,60.8,Less_than_HS,Stage_I,0,217,1,217,1,death,disease,217,carbo_pem_pembro,PR,44.0,
|
| 297 |
+
HLT004-0000296,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-09-05,71,Female,White,0,True,0.8,38.8,3,Medicare,75.0,Less_than_HS,Stage_IV,3,118,1,118,1,death,disease,118,pembro_mono,PD,,118.0
|
| 298 |
+
HLT004-0000297,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-04-28,72,Female,Black_AA,1,False,0.0,32.3,3,Medicare,47.6,Bachelors_Plus,Stage_II,1,320,0,320,0,lost_to_follow_up,censored,320,docetaxel_2L,PD,,320.0
|
| 299 |
+
HLT004-0000298,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-11-09,66,Female,Asian,2,True,7.6,18.1,1,Uninsured,82.8,Some_College,Stage_III,2,657,1,80,1,death,disease,657,docetaxel_2L,PD,,80.0
|
| 300 |
+
HLT004-0000299,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-10-14,52,Female,NHOPI,2,True,11.3,31.9,1,Medicare,61.2,Some_College,Stage_III,2,673,1,189,1,death,other_cause,673,docetaxel_2L,SD,,155.0
|
| 301 |
+
HLT004-0000300,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-05-19,73,Male,White,0,True,37.4,36.7,1,Commercial,18.4,HS_Diploma,Stage_I,0,1825,0,1825,0,administrative,censored,1825,docetaxel_2L,PD,,1825.0
|
| 302 |
+
HLT004-0000301,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-01-15,87,Female,White,0,True,8.2,27.7,0,Commercial,42.2,Some_College,Stage_IV,3,8,1,8,1,death,disease,8,carbo_taxol,PD,,8.0
|
| 303 |
+
HLT004-0000302,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-01-22,54,Male,Hispanic_Latino,3,False,0.0,35.3,5,Commercial,29.9,Bachelors_Plus,Stage_III,2,260,1,260,1,death,disease,260,docetaxel_2L,PR,32.0,
|
| 304 |
+
HLT004-0000303,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-04-07,78,Female,White,0,True,28.9,24.8,0,Medicare,47.6,Some_College,Stage_IV,3,752,1,360,1,death,other_cause,752,docetaxel_2L,PD,,360.0
|
| 305 |
+
HLT004-0000304,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-01-06,66,Female,Hispanic_Latino,0,False,0.0,19.9,1,Medicare,40.1,Some_College,Stage_IV,3,334,0,146,1,lost_to_follow_up,censored,334,carbo_pem_pembro,PR,66.0,
|
| 306 |
+
HLT004-0000305,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-12-23,69,Male,Black_AA,0,True,36.6,30.0,1,Uninsured,57.4,Some_College,Stage_III,2,180,0,180,0,lost_to_follow_up,censored,180,docetaxel_2L,PD,,180.0
|
| 307 |
+
HLT004-0000306,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-12-03,59,Male,White,1,True,56.5,18.2,0,Medicare,56.6,HS_Diploma,Stage_IV,3,689,1,227,1,death,disease,689,pembro_mono,PR,56.0,
|
| 308 |
+
HLT004-0000307,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-09-14,66,Male,Hispanic_Latino,2,True,71.8,27.6,1,Medicare,24.6,Some_College,Stage_IV,3,477,1,151,1,death,disease,477,docetaxel_2L,PD,,151.0
|
| 309 |
+
HLT004-0000308,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-05-03,83,Female,White,2,True,22.6,37.1,1,Medicare,39.4,Bachelors_Plus,Stage_IV,3,265,0,265,0,lost_to_follow_up,censored,265,docetaxel_2L,PD,,265.0
|
| 310 |
+
HLT004-0000309,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-11-08,75,Male,White,1,True,7.6,17.3,2,Uninsured,46.0,Some_College,Stage_IV,3,64,1,64,1,death,other_cause,64,carbo_taxol,SD,,42.0
|
| 311 |
+
HLT004-0000310,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-11-25,87,Male,White,0,True,5.5,21.2,2,Commercial,45.8,HS_Diploma,Stage_IV,3,280,1,156,1,death,disease,280,carbo_taxol,SD,,114.0
|
| 312 |
+
HLT004-0000311,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-03-27,81,Male,White,1,True,5.4,22.7,0,Medicare,61.8,Some_College,Stage_IV,3,212,1,187,1,death,disease,212,pembro_mono,PD,,187.0
|
| 313 |
+
HLT004-0000312,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-03-27,74,Male,Black_AA,1,False,0.0,28.7,2,Medicare,18.2,Some_College,Stage_III,2,428,1,259,1,death,disease,428,pembro_mono,SD,,177.0
|
| 314 |
+
HLT004-0000313,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-04-02,87,Male,Black_AA,0,True,40.5,26.8,1,Medicare,21.8,Bachelors_Plus,Stage_IV,3,739,1,171,1,death,disease,739,docetaxel_2L,PD,,171.0
|
| 315 |
+
HLT004-0000314,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-09-08,74,Male,Two_Plus,0,True,20.1,37.8,4,Medicare,22.1,Some_College,Stage_III,2,311,1,311,1,death,disease,311,docetaxel_2L,SD,,203.0
|
| 316 |
+
HLT004-0000315,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-04,78,Male,Two_Plus,0,True,65.7,35.0,1,Medicare,61.6,HS_Diploma,Stage_IV,3,948,1,261,1,death,disease,948,pembro_mono,SD,,230.0
|
| 317 |
+
HLT004-0000316,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-07-30,67,Male,White,0,True,3.8,32.2,0,Medicare,58.5,HS_Diploma,Stage_IV,3,268,1,24,1,death,disease,268,docetaxel_2L,PD,,24.0
|
| 318 |
+
HLT004-0000317,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-10-26,70,Male,White,1,False,0.0,30.0,3,Medicare,23.5,Some_College,Stage_IV,3,64,1,64,1,death,disease,64,carbo_pem_pembro,PR,72.0,
|
| 319 |
+
HLT004-0000318,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-05-12,63,Male,Black_AA,1,False,0.0,31.5,0,Uninsured,38.1,Less_than_HS,Stage_IV,3,854,1,83,1,death,disease,854,docetaxel_2L,SD,,63.0
|
| 320 |
+
HLT004-0000319,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-03-16,79,Male,AIAN,0,False,0.0,23.8,1,Commercial,11.0,Some_College,Stage_IV,3,30,0,30,0,lost_to_follow_up,censored,30,carbo_pem_pembro,SD,,20.0
|
| 321 |
+
HLT004-0000320,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-11-24,58,Female,White,1,True,0.6,34.4,2,Uninsured,13.4,Bachelors_Plus,Stage_IV,3,1,1,1,0,death,other_cause,1,pembro_mono,PR,86.0,
|
| 322 |
+
HLT004-0000321,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-08-18,77,Male,White,2,True,6.6,22.2,0,Medicare,21.4,Some_College,Stage_I,0,1825,0,1825,0,administrative,censored,1825,carbo_pem_pembro,PR,78.0,
|
| 323 |
+
HLT004-0000322,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-05-02,68,Male,White,2,True,56.9,34.3,1,Medicaid,60.5,HS_Diploma,Stage_III,2,445,1,197,1,death,disease,445,pembro_mono,PD,,197.0
|
| 324 |
+
HLT004-0000323,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-09-05,81,Male,White,2,True,6.6,36.5,0,Medicare,52.0,Bachelors_Plus,Stage_II,1,286,0,286,0,lost_to_follow_up,censored,286,carbo_taxol,SD,,183.0
|
| 325 |
+
HLT004-0000324,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-09-28,77,Male,Black_AA,1,True,36.8,30.4,2,Medicare,23.0,Some_College,Stage_I,0,1303,0,1303,0,lost_to_follow_up,censored,1303,carbo_pem_pembro,PR,40.0,
|
| 326 |
+
HLT004-0000325,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-17,88,Male,White,2,True,2.4,28.0,2,Commercial,26.5,HS_Diploma,Stage_IV,3,284,1,85,1,death,disease,284,pembro_mono,SD,,75.0
|
| 327 |
+
HLT004-0000326,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-07-31,77,Male,Hispanic_Latino,0,True,17.5,31.6,1,Medicare,16.6,Some_College,Stage_IV,3,346,1,114,1,death,disease,346,pembro_mono,PD,,114.0
|
| 328 |
+
HLT004-0000327,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-05-08,54,Female,Hispanic_Latino,1,True,29.4,15.0,0,Commercial,23.2,Some_College,Stage_III,2,513,1,219,1,death,disease,513,carbo_pem_pembro,PR,46.0,
|
| 329 |
+
HLT004-0000328,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-02-24,69,Male,Hispanic_Latino,0,True,52.5,31.0,1,Medicare,28.5,Bachelors_Plus,Stage_II,1,19,1,19,1,death,disease,19,pembro_mono,PR,88.0,
|
| 330 |
+
HLT004-0000329,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-06-16,58,Male,White,1,False,0.0,28.4,0,Uninsured,44.4,HS_Diploma,Stage_IV,3,254,1,254,1,death,disease,254,carbo_pem_pembro,PR,42.0,
|
| 331 |
+
HLT004-0000330,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-08-10,64,Male,White,1,False,0.0,28.8,2,Medicare,35.6,HS_Diploma,Stage_III,2,864,1,864,1,death,disease,864,carbo_pem_pembro,SD,,662.0
|
| 332 |
+
HLT004-0000331,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-04-05,85,Male,Hispanic_Latino,0,True,45.2,33.5,3,Medicare,5.9,Some_College,Stage_IV,3,29,1,29,1,death,disease,29,carbo_pem_pembro,PR,70.0,
|
| 333 |
+
HLT004-0000332,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-03-12,76,Male,Hispanic_Latino,2,False,0.0,28.6,1,Medicare,17.5,Less_than_HS,Stage_IV,3,341,1,114,1,death,disease,341,pembro_mono,PR,31.0,
|
| 334 |
+
HLT004-0000333,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-11-27,63,Female,White,0,True,6.0,22.0,0,VA,58.3,Some_College,Stage_III,2,623,1,240,1,death,disease,623,docetaxel_2L,PR,51.0,
|
| 335 |
+
HLT004-0000334,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-06-11,59,Female,Hispanic_Latino,0,False,0.0,28.2,0,Commercial,41.4,Bachelors_Plus,Stage_II,1,30,0,30,0,lost_to_follow_up,censored,30,pembro_mono,PD,,30.0
|
| 336 |
+
HLT004-0000335,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-07-02,70,Male,White,0,False,0.0,29.5,1,VA,31.7,HS_Diploma,Stage_III,2,841,1,376,1,death,disease,841,docetaxel_2L,PD,,376.0
|
| 337 |
+
HLT004-0000336,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-12-08,57,Male,Hispanic_Latino,1,True,35.1,29.8,1,Medicare,47.0,Some_College,Stage_I,0,1825,0,1825,0,administrative,censored,1825,pembro_mono,PD,,1825.0
|
| 338 |
+
HLT004-0000337,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-28,63,Male,White,0,False,0.0,30.1,1,Commercial,27.2,Bachelors_Plus,Stage_III,2,1488,1,65,1,death,disease,1488,docetaxel_2L,SD,,53.0
|
| 339 |
+
HLT004-0000338,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-03-07,73,Male,White,1,False,0.0,35.5,3,Medicare,58.1,Some_College,Stage_I,0,1081,1,1081,1,death,disease,1081,docetaxel_2L,PD,,1081.0
|
| 340 |
+
HLT004-0000339,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-03-19,81,Female,White,0,False,0.0,22.4,1,Commercial,44.1,Some_College,Stage_I,0,703,1,703,1,death,disease,703,carbo_taxol,SD,,632.0
|
| 341 |
+
HLT004-0000340,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-07-28,76,Male,White,2,False,0.0,30.2,1,VA,28.6,Some_College,Stage_III,2,7,1,7,0,death,other_cause,7,carbo_pem_pembro,SD,,5.0
|
| 342 |
+
HLT004-0000341,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-12-01,47,Male,White,3,True,13.3,37.1,1,Commercial,80.3,HS_Diploma,Stage_I,0,720,0,720,0,lost_to_follow_up,censored,720,carbo_pem_pembro,PR,68.0,
|
| 343 |
+
HLT004-0000342,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-09-25,73,Female,White,1,True,11.8,18.3,0,Commercial,36.7,HS_Diploma,Stage_IV,3,43,1,43,1,death,disease,43,carbo_taxol,SD,,38.0
|
| 344 |
+
HLT004-0000343,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-09-12,70,Male,White,1,False,0.0,30.2,0,Commercial,61.7,Some_College,Stage_I,0,322,0,243,1,lost_to_follow_up,censored,322,pembro_mono,PD,,243.0
|
| 345 |
+
HLT004-0000344,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-01-02,74,Male,Hispanic_Latino,2,True,8.7,25.5,2,Medicaid,58.9,HS_Diploma,Stage_IV,3,159,1,5,1,death,disease,159,carbo_pem_pembro,PR,86.0,
|
| 346 |
+
HLT004-0000345,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-02-23,86,Female,White,4,True,28.8,26.8,1,Commercial,18.1,HS_Diploma,Stage_II,1,1038,1,1038,1,death,disease,1038,docetaxel_2L,PD,,1038.0
|
| 347 |
+
HLT004-0000346,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-08-16,49,Male,Black_AA,1,True,15.7,23.5,1,Medicare,26.9,Less_than_HS,Stage_I,0,1177,1,1177,0,death,other_cause,1177,docetaxel_2L,PD,,1177.0
|
| 348 |
+
HLT004-0000347,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-08-11,64,Male,Hispanic_Latino,2,True,120.0,28.0,2,Commercial,72.3,Bachelors_Plus,Stage_I,0,479,1,479,1,death,disease,479,carbo_taxol,PR,39.0,
|
| 349 |
+
HLT004-0000348,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-07-24,75,Male,White,2,True,8.0,40.5,1,Commercial,30.0,Less_than_HS,Stage_IV,3,400,1,197,1,death,disease,400,carbo_pem_pembro,PR,36.0,
|
| 350 |
+
HLT004-0000349,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-05-06,54,Female,White,2,False,0.0,21.3,0,Medicaid,42.8,Bachelors_Plus,Stage_II,1,275,1,99,1,death,other_cause,275,carbo_taxol,PD,,99.0
|
| 351 |
+
HLT004-0000350,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-05-11,84,Male,Hispanic_Latino,1,True,66.5,21.8,2,Medicaid,25.5,HS_Diploma,Stage_III,2,31,1,31,1,death,disease,31,carbo_taxol,PR,71.0,
|
| 352 |
+
HLT004-0000351,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-06-25,73,Male,Hispanic_Latino,0,False,0.0,21.0,2,Uninsured,50.2,Some_College,Stage_I,0,349,1,349,1,death,other_cause,349,docetaxel_2L,PD,,349.0
|
| 353 |
+
HLT004-0000352,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-10-30,78,Male,White,0,False,0.0,39.8,0,Medicare,25.7,HS_Diploma,Stage_IV,3,55,1,55,1,death,disease,55,carbo_taxol,SD,,36.0
|
| 354 |
+
HLT004-0000353,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-11-29,64,Male,Hispanic_Latino,1,True,1.4,26.2,1,Medicaid,59.9,HS_Diploma,Stage_I,0,1825,0,1825,0,administrative,censored,1825,carbo_pem_pembro,SD,,1437.0
|
| 355 |
+
HLT004-0000354,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-12-14,78,Female,White,1,True,0.5,28.9,5,Commercial,46.5,Some_College,Stage_III,2,363,1,336,1,death,disease,363,carbo_taxol,SD,,220.0
|
| 356 |
+
HLT004-0000355,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-04-05,80,Male,White,1,True,3.2,26.6,6,Medicare,50.1,Some_College,Stage_IV,3,277,1,7,1,death,disease,277,carbo_pem_pembro,SD,,4.0
|
| 357 |
+
HLT004-0000356,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-01-06,72,Female,Hispanic_Latino,1,False,0.0,23.2,2,Commercial,60.6,HS_Diploma,Stage_II,1,961,1,961,1,death,disease,961,carbo_taxol,SD,,702.0
|
| 358 |
+
HLT004-0000357,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-02-04,72,Female,White,1,False,0.0,27.6,3,Medicare,42.9,Some_College,Stage_III,2,356,1,356,1,death,disease,356,carbo_taxol,PR,78.0,
|
| 359 |
+
HLT004-0000358,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-11-25,72,Female,Hispanic_Latino,2,True,4.6,44.3,5,Medicare,32.0,Some_College,Stage_IV,3,367,0,214,1,lost_to_follow_up,censored,367,pembro_mono,PR,85.0,
|
| 360 |
+
HLT004-0000359,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-12-15,61,Male,White,0,True,5.2,37.7,0,Medicaid,14.0,HS_Diploma,Stage_III,2,608,1,608,1,death,disease,608,pembro_mono,PD,,608.0
|
| 361 |
+
HLT004-0000360,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-03-23,68,Female,Hispanic_Latino,0,True,6.5,23.8,2,Commercial,59.2,Some_College,Stage_I,0,1825,0,776,1,administrative,censored,1825,docetaxel_2L,SD,,536.0
|
| 362 |
+
HLT004-0000361,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-05-27,68,Female,White,2,True,58.4,33.1,2,Medicaid,62.2,HS_Diploma,Stage_III,2,551,0,551,0,lost_to_follow_up,censored,551,carbo_pem_pembro,PR,84.0,
|
| 363 |
+
HLT004-0000362,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-05-23,73,Male,White,2,False,0.0,23.9,0,Medicaid,78.4,Some_College,Stage_I,0,142,0,142,0,lost_to_follow_up,censored,142,docetaxel_2L,PD,,142.0
|
| 364 |
+
HLT004-0000363,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-07-22,79,Female,White,4,False,0.0,18.1,2,Medicaid,51.4,Less_than_HS,Stage_IV,3,310,1,32,1,death,disease,310,carbo_pem_pembro,PR,60.0,
|
| 365 |
+
HLT004-0000364,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-01-04,59,Female,White,2,True,0.3,35.4,1,Commercial,19.2,Some_College,Stage_IV,3,469,1,377,1,death,disease,469,carbo_taxol,PR,64.0,
|
| 366 |
+
HLT004-0000365,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-11-13,68,Male,Hispanic_Latino,2,False,0.0,36.3,2,Medicaid,70.5,HS_Diploma,Stage_IV,3,491,1,413,1,death,disease,491,docetaxel_2L,SD,,258.0
|
| 367 |
+
HLT004-0000366,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-10-19,84,Female,White,0,True,20.1,35.6,0,Commercial,30.5,Some_College,Stage_II,1,578,0,347,1,lost_to_follow_up,censored,578,pembro_mono,PD,,347.0
|
| 368 |
+
HLT004-0000367,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2020-01-06,62,Male,White,1,False,0.0,26.2,1,Commercial,28.0,Some_College,Stage_IV,3,108,1,95,1,death,disease,108,carbo_pem_pembro,PR,62.0,
|
| 369 |
+
HLT004-0000368,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-03-20,61,Female,White,0,True,1.4,28.1,2,Commercial,49.6,Bachelors_Plus,Stage_IV,3,308,1,121,1,death,disease,308,carbo_taxol,SD,,107.0
|
| 370 |
+
HLT004-0000369,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-10-09,72,Female,White,1,True,31.8,33.7,1,Medicaid,24.2,Some_College,Stage_I,0,280,0,280,0,lost_to_follow_up,censored,280,pembro_mono,SD,,245.0
|
| 371 |
+
HLT004-0000370,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-03-05,78,Male,Hispanic_Latino,3,False,0.0,31.5,1,Uninsured,51.0,Bachelors_Plus,Stage_IV,3,488,1,315,1,death,disease,488,docetaxel_2L,SD,,270.0
|
| 372 |
+
HLT004-0000371,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-23,70,Female,White,0,True,10.9,26.7,2,Medicare,31.4,HS_Diploma,Stage_IV,3,247,1,110,1,death,disease,247,pembro_mono,PR,72.0,
|
| 373 |
+
HLT004-0000372,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-01-07,83,Male,Two_Plus,1,True,53.3,19.1,1,Medicaid,65.0,HS_Diploma,Stage_IV,3,320,0,277,1,lost_to_follow_up,censored,320,carbo_pem_pembro,PR,89.0,
|
| 374 |
+
HLT004-0000373,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-11-23,78,Female,White,0,False,0.0,29.8,2,Commercial,53.5,Less_than_HS,Stage_III,2,745,1,51,1,death,disease,745,carbo_taxol,PD,,51.0
|
| 375 |
+
HLT004-0000374,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-07-13,78,Female,Black_AA,0,True,39.5,35.8,6,Medicare,15.5,Some_College,Stage_I,0,1825,0,970,1,administrative,censored,1825,carbo_pem_pembro,PR,61.0,
|
| 376 |
+
HLT004-0000375,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-06-19,75,Male,White,0,True,19.0,21.7,2,Medicare,57.8,Some_College,Stage_IV,3,347,1,172,1,death,disease,347,carbo_pem_pembro,SD,,117.0
|
| 377 |
+
HLT004-0000376,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-12-13,93,Male,White,0,True,120.0,33.1,2,Medicaid,32.8,Bachelors_Plus,Stage_IV,3,151,1,151,1,death,disease,151,carbo_taxol,PD,,151.0
|
| 378 |
+
HLT004-0000377,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-05-03,67,Male,Hispanic_Latino,3,True,8.9,31.2,2,Medicare,82.9,Some_College,Stage_III,2,384,1,311,1,death,disease,384,docetaxel_2L,PD,,311.0
|
| 379 |
+
HLT004-0000378,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-15,49,Male,AIAN,1,True,19.4,33.8,3,Medicaid,32.3,Some_College,Stage_I,0,55,1,55,1,death,other_cause,55,carbo_pem_pembro,SD,,35.0
|
| 380 |
+
HLT004-0000379,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-10-07,86,Male,Hispanic_Latino,2,True,58.6,34.5,2,Commercial,51.6,HS_Diploma,Stage_IV,3,411,1,297,1,death,disease,411,docetaxel_2L,PD,,297.0
|
| 381 |
+
HLT004-0000380,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-02-01,65,Male,White,1,False,0.0,24.8,1,Uninsured,35.4,Less_than_HS,Stage_II,1,590,1,476,1,death,disease,590,pembro_mono,PR,67.0,
|
| 382 |
+
HLT004-0000381,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-08-23,71,Male,White,0,True,20.8,19.1,0,VA,31.5,Bachelors_Plus,Stage_III,2,1307,1,634,1,death,disease,1307,docetaxel_2L,PR,38.0,
|
| 383 |
+
HLT004-0000382,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2018-01-28,83,Male,Black_AA,0,True,27.8,25.8,4,Commercial,34.9,HS_Diploma,Stage_IV,3,206,1,206,1,death,disease,206,carbo_pem_pembro,PR,51.0,
|
| 384 |
+
HLT004-0000383,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-04-18,53,Female,White,2,False,0.0,34.6,0,Medicaid,64.4,Less_than_HS,Stage_I,0,756,0,756,0,lost_to_follow_up,censored,756,carbo_taxol,SD,,571.0
|
| 385 |
+
HLT004-0000384,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-05-25,57,Female,Hispanic_Latino,0,True,18.6,25.7,0,Uninsured,33.5,Bachelors_Plus,Stage_I,0,429,1,429,1,death,disease,429,carbo_pem_pembro,SD,,344.0
|
| 386 |
+
HLT004-0000385,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-04-01,53,Female,White,3,False,0.0,24.8,0,Medicare,22.4,Bachelors_Plus,Stage_I,0,424,0,424,0,lost_to_follow_up,censored,424,carbo_taxol,PR,33.0,
|
| 387 |
+
HLT004-0000386,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-05-14,62,Male,White,0,True,7.5,17.8,1,Medicaid,54.8,Some_College,Stage_IV,3,55,1,55,1,death,disease,55,carbo_pem_pembro,SD,,43.0
|
| 388 |
+
HLT004-0000387,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2021-12-14,74,Female,Hispanic_Latino,1,False,0.0,40.0,0,Medicaid,27.9,HS_Diploma,Stage_III,2,765,1,318,1,death,disease,765,carbo_taxol,SD,,214.0
|
| 389 |
+
HLT004-0000388,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-05-01,75,Female,Black_AA,2,True,1.6,34.2,0,Commercial,62.1,Bachelors_Plus,Stage_IV,3,73,0,73,0,lost_to_follow_up,censored,73,carbo_pem_pembro,PD,,73.0
|
| 390 |
+
HLT004-0000389,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-10-19,72,Male,White,0,True,32.2,33.9,4,Medicare,51.2,HS_Diploma,Stage_IV,3,41,0,41,0,lost_to_follow_up,censored,41,carbo_pem_pembro,PR,67.0,
|
| 391 |
+
HLT004-0000390,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-04-12,55,Male,White,0,False,0.0,35.1,0,Medicaid,47.5,Some_College,Stage_IV,3,316,1,228,1,death,disease,316,docetaxel_2L,PR,69.0,
|
| 392 |
+
HLT004-0000391,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2019-12-26,46,Female,Black_AA,3,True,12.5,32.7,1,Medicare,54.6,HS_Diploma,Stage_IV,3,243,1,26,1,death,other_cause,243,docetaxel_2L,SD,,21.0
|
| 393 |
+
HLT004-0000392,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-02-24,70,Male,White,0,True,31.0,27.6,1,Medicare,70.1,Bachelors_Plus,Stage_IV,3,372,1,139,1,death,disease,372,carbo_pem_pembro,PR,63.0,
|
| 394 |
+
HLT004-0000393,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-03-15,65,Male,White,1,True,5.8,28.1,1,VA,46.3,Bachelors_Plus,Stage_III,2,88,1,88,1,death,other_cause,88,docetaxel_2L,PR,70.0,
|
| 395 |
+
HLT004-0000394,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2015-02-15,74,Female,White,1,True,21.9,26.4,4,Uninsured,30.8,Some_College,Stage_IV,3,189,1,189,1,death,disease,189,carbo_pem_pembro,PR,34.0,
|
| 396 |
+
HLT004-0000395,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-04-27,77,Male,Hispanic_Latino,0,True,120.0,45.4,0,Commercial,65.5,Less_than_HS,Stage_IV,3,331,1,331,1,death,disease,331,carbo_taxol,PD,,331.0
|
| 397 |
+
HLT004-0000396,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2016-03-04,71,Male,Hispanic_Latino,2,True,2.1,32.5,2,Commercial,53.2,Some_College,Stage_IV,3,939,1,131,1,death,disease,939,docetaxel_2L,PR,43.0,
|
| 398 |
+
HLT004-0000397,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2022-04-22,77,Female,White,2,True,29.5,26.2,2,Uninsured,47.8,HS_Diploma,Stage_III,2,326,1,33,1,death,other_cause,326,pembro_mono,PD,,33.0
|
| 399 |
+
HLT004-0000398,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2023-01-20,72,Female,White,1,True,32.4,32.0,2,Medicaid,12.5,Bachelors_Plus,Stage_III,2,1235,1,715,1,death,disease,1235,carbo_pem_pembro,PD,,715.0
|
| 400 |
+
HLT004-0000399,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2017-09-14,75,Male,White,2,True,33.0,22.8,1,Medicare,53.7,HS_Diploma,Stage_IV,3,504,1,168,1,death,disease,504,carbo_taxol,PD,,168.0
|
| 401 |
+
HLT004-0000400,nsclc,Non-Small Cell Lung Cancer,TNM 8th Edition,2014-11-08,62,Female,White,0,True,89.7,38.4,2,Commercial,36.6,Less_than_HS,Stage_I,0,1825,0,1053,1,administrative,censored,1825,pembro_mono,PR,61.0,
|
nsclc/hlt004_events.csv
ADDED
|
@@ -0,0 +1,1944 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
patient_id,event_type,event_day,event_detail
|
| 2 |
+
HLT004-0000001,diagnosis,0,Stage_IV
|
| 3 |
+
HLT004-0000001,treatment_start_1L,26,carbo_taxol
|
| 4 |
+
HLT004-0000001,treatment_end_1L,83,completed_or_discontinued
|
| 5 |
+
HLT004-0000001,progression,59,radiographic_progression
|
| 6 |
+
HLT004-0000001,os_endpoint,83,disease
|
| 7 |
+
HLT004-0000002,diagnosis,0,Stage_III
|
| 8 |
+
HLT004-0000002,treatment_start_1L,9,docetaxel_2L
|
| 9 |
+
HLT004-0000002,treatment_end_1L,135,completed_or_discontinued
|
| 10 |
+
HLT004-0000002,progression,129,radiographic_progression
|
| 11 |
+
HLT004-0000002,os_endpoint,1312,censored
|
| 12 |
+
HLT004-0000003,diagnosis,0,Stage_IV
|
| 13 |
+
HLT004-0000003,treatment_start_1L,11,carbo_pem_pembro
|
| 14 |
+
HLT004-0000003,treatment_end_1L,137,completed_or_discontinued
|
| 15 |
+
HLT004-0000003,progression,68,radiographic_progression
|
| 16 |
+
HLT004-0000003,os_endpoint,187,disease
|
| 17 |
+
HLT004-0000004,diagnosis,0,Stage_I
|
| 18 |
+
HLT004-0000004,treatment_start_1L,28,pembro_mono
|
| 19 |
+
HLT004-0000004,treatment_end_1L,763,completed_or_discontinued
|
| 20 |
+
HLT004-0000004,os_endpoint,1825,censored
|
| 21 |
+
HLT004-0000005,diagnosis,0,Stage_IV
|
| 22 |
+
HLT004-0000005,treatment_start_1L,25,docetaxel_2L
|
| 23 |
+
HLT004-0000005,treatment_end_1L,46,completed_or_discontinued
|
| 24 |
+
HLT004-0000005,os_endpoint,46,disease
|
| 25 |
+
HLT004-0000006,diagnosis,0,Stage_I
|
| 26 |
+
HLT004-0000006,treatment_start_1L,21,carbo_pem_pembro
|
| 27 |
+
HLT004-0000006,treatment_end_1L,50,completed_or_discontinued
|
| 28 |
+
HLT004-0000006,response_assessment,74,PR
|
| 29 |
+
HLT004-0000006,os_endpoint,50,censored
|
| 30 |
+
HLT004-0000007,diagnosis,0,Stage_I
|
| 31 |
+
HLT004-0000007,treatment_start_1L,23,pembro_mono
|
| 32 |
+
HLT004-0000007,treatment_end_1L,598,completed_or_discontinued
|
| 33 |
+
HLT004-0000007,response_assessment,50,CR
|
| 34 |
+
HLT004-0000007,os_endpoint,598,other_cause
|
| 35 |
+
HLT004-0000008,diagnosis,0,Stage_III
|
| 36 |
+
HLT004-0000008,treatment_start_1L,27,carbo_pem_pembro
|
| 37 |
+
HLT004-0000008,treatment_end_1L,153,completed_or_discontinued
|
| 38 |
+
HLT004-0000008,response_assessment,58,PR
|
| 39 |
+
HLT004-0000008,os_endpoint,522,disease
|
| 40 |
+
HLT004-0000009,diagnosis,0,Stage_II
|
| 41 |
+
HLT004-0000009,treatment_start_1L,14,pembro_mono
|
| 42 |
+
HLT004-0000009,treatment_end_1L,749,completed_or_discontinued
|
| 43 |
+
HLT004-0000009,progression,250,radiographic_progression
|
| 44 |
+
HLT004-0000009,os_endpoint,1825,censored
|
| 45 |
+
HLT004-0000010,diagnosis,0,Stage_IV
|
| 46 |
+
HLT004-0000010,treatment_start_1L,23,carbo_taxol
|
| 47 |
+
HLT004-0000010,treatment_end_1L,149,completed_or_discontinued
|
| 48 |
+
HLT004-0000010,progression,162,radiographic_progression
|
| 49 |
+
HLT004-0000010,os_endpoint,253,disease
|
| 50 |
+
HLT004-0000011,diagnosis,0,Stage_I
|
| 51 |
+
HLT004-0000011,treatment_start_1L,7,docetaxel_2L
|
| 52 |
+
HLT004-0000011,treatment_end_1L,133,completed_or_discontinued
|
| 53 |
+
HLT004-0000011,progression,474,radiographic_progression
|
| 54 |
+
HLT004-0000011,os_endpoint,673,censored
|
| 55 |
+
HLT004-0000012,diagnosis,0,Stage_I
|
| 56 |
+
HLT004-0000012,treatment_start_1L,21,carbo_taxol
|
| 57 |
+
HLT004-0000012,treatment_end_1L,147,completed_or_discontinued
|
| 58 |
+
HLT004-0000012,progression,173,radiographic_progression
|
| 59 |
+
HLT004-0000012,os_endpoint,253,censored
|
| 60 |
+
HLT004-0000013,diagnosis,0,Stage_IV
|
| 61 |
+
HLT004-0000013,treatment_start_1L,21,carbo_pem_pembro
|
| 62 |
+
HLT004-0000013,treatment_end_1L,147,completed_or_discontinued
|
| 63 |
+
HLT004-0000013,response_assessment,87,PR
|
| 64 |
+
HLT004-0000013,os_endpoint,536,disease
|
| 65 |
+
HLT004-0000014,diagnosis,0,Stage_II
|
| 66 |
+
HLT004-0000014,treatment_start_1L,8,docetaxel_2L
|
| 67 |
+
HLT004-0000014,treatment_end_1L,134,completed_or_discontinued
|
| 68 |
+
HLT004-0000014,os_endpoint,534,disease
|
| 69 |
+
HLT004-0000015,diagnosis,0,Stage_IV
|
| 70 |
+
HLT004-0000015,treatment_start_1L,8,docetaxel_2L
|
| 71 |
+
HLT004-0000015,treatment_end_1L,134,completed_or_discontinued
|
| 72 |
+
HLT004-0000015,progression,267,radiographic_progression
|
| 73 |
+
HLT004-0000015,os_endpoint,526,disease
|
| 74 |
+
HLT004-0000016,diagnosis,0,Stage_IV
|
| 75 |
+
HLT004-0000016,treatment_start_1L,23,pembro_mono
|
| 76 |
+
HLT004-0000016,treatment_end_1L,564,completed_or_discontinued
|
| 77 |
+
HLT004-0000016,response_assessment,31,PR
|
| 78 |
+
HLT004-0000016,os_endpoint,564,disease
|
| 79 |
+
HLT004-0000017,diagnosis,0,Stage_I
|
| 80 |
+
HLT004-0000017,treatment_start_1L,8,pembro_mono
|
| 81 |
+
HLT004-0000017,treatment_end_1L,423,completed_or_discontinued
|
| 82 |
+
HLT004-0000017,progression,372,radiographic_progression
|
| 83 |
+
HLT004-0000017,os_endpoint,423,disease
|
| 84 |
+
HLT004-0000018,diagnosis,0,Stage_IV
|
| 85 |
+
HLT004-0000018,treatment_start_1L,22,carbo_pem_pembro
|
| 86 |
+
HLT004-0000018,treatment_end_1L,48,completed_or_discontinued
|
| 87 |
+
HLT004-0000018,response_assessment,37,PR
|
| 88 |
+
HLT004-0000018,os_endpoint,48,disease
|
| 89 |
+
HLT004-0000019,diagnosis,0,Stage_III
|
| 90 |
+
HLT004-0000019,treatment_start_1L,11,pembro_mono
|
| 91 |
+
HLT004-0000019,treatment_end_1L,746,completed_or_discontinued
|
| 92 |
+
HLT004-0000019,response_assessment,75,PR
|
| 93 |
+
HLT004-0000019,os_endpoint,778,disease
|
| 94 |
+
HLT004-0000020,diagnosis,0,Stage_III
|
| 95 |
+
HLT004-0000020,treatment_start_1L,8,carbo_pem_pembro
|
| 96 |
+
HLT004-0000020,treatment_end_1L,134,completed_or_discontinued
|
| 97 |
+
HLT004-0000020,os_endpoint,424,disease
|
| 98 |
+
HLT004-0000021,diagnosis,0,Stage_I
|
| 99 |
+
HLT004-0000021,treatment_start_1L,12,carbo_pem_pembro
|
| 100 |
+
HLT004-0000021,treatment_end_1L,138,completed_or_discontinued
|
| 101 |
+
HLT004-0000021,progression,495,radiographic_progression
|
| 102 |
+
HLT004-0000021,os_endpoint,906,other_cause
|
| 103 |
+
HLT004-0000022,diagnosis,0,Stage_IV
|
| 104 |
+
HLT004-0000022,treatment_start_1L,26,docetaxel_2L
|
| 105 |
+
HLT004-0000022,treatment_end_1L,45,completed_or_discontinued
|
| 106 |
+
HLT004-0000022,os_endpoint,45,other_cause
|
| 107 |
+
HLT004-0000023,diagnosis,0,Stage_IV
|
| 108 |
+
HLT004-0000023,treatment_start_1L,17,pembro_mono
|
| 109 |
+
HLT004-0000023,treatment_end_1L,393,completed_or_discontinued
|
| 110 |
+
HLT004-0000023,progression,165,radiographic_progression
|
| 111 |
+
HLT004-0000023,os_endpoint,393,disease
|
| 112 |
+
HLT004-0000024,diagnosis,0,Stage_III
|
| 113 |
+
HLT004-0000024,treatment_start_1L,15,carbo_taxol
|
| 114 |
+
HLT004-0000024,treatment_end_1L,141,completed_or_discontinued
|
| 115 |
+
HLT004-0000024,progression,297,radiographic_progression
|
| 116 |
+
HLT004-0000024,os_endpoint,749,disease
|
| 117 |
+
HLT004-0000025,diagnosis,0,Stage_IV
|
| 118 |
+
HLT004-0000025,treatment_start_1L,12,carbo_pem_pembro
|
| 119 |
+
HLT004-0000025,treatment_end_1L,138,completed_or_discontinued
|
| 120 |
+
HLT004-0000025,response_assessment,88,PR
|
| 121 |
+
HLT004-0000025,os_endpoint,219,disease
|
| 122 |
+
HLT004-0000026,diagnosis,0,Stage_III
|
| 123 |
+
HLT004-0000026,treatment_start_1L,20,docetaxel_2L
|
| 124 |
+
HLT004-0000026,treatment_end_1L,146,completed_or_discontinued
|
| 125 |
+
HLT004-0000026,progression,46,radiographic_progression
|
| 126 |
+
HLT004-0000026,os_endpoint,1774,disease
|
| 127 |
+
HLT004-0000027,diagnosis,0,Stage_IV
|
| 128 |
+
HLT004-0000027,treatment_start_1L,10,carbo_pem_pembro
|
| 129 |
+
HLT004-0000027,treatment_end_1L,136,completed_or_discontinued
|
| 130 |
+
HLT004-0000027,progression,126,radiographic_progression
|
| 131 |
+
HLT004-0000027,os_endpoint,453,disease
|
| 132 |
+
HLT004-0000028,diagnosis,0,Stage_IV
|
| 133 |
+
HLT004-0000028,treatment_start_1L,16,carbo_pem_pembro
|
| 134 |
+
HLT004-0000028,treatment_end_1L,142,completed_or_discontinued
|
| 135 |
+
HLT004-0000028,response_assessment,67,CR
|
| 136 |
+
HLT004-0000028,os_endpoint,366,disease
|
| 137 |
+
HLT004-0000029,diagnosis,0,Stage_IV
|
| 138 |
+
HLT004-0000029,treatment_start_1L,25,carbo_pem_pembro
|
| 139 |
+
HLT004-0000029,treatment_end_1L,39,completed_or_discontinued
|
| 140 |
+
HLT004-0000029,response_assessment,52,PR
|
| 141 |
+
HLT004-0000029,os_endpoint,39,other_cause
|
| 142 |
+
HLT004-0000030,diagnosis,0,Stage_IV
|
| 143 |
+
HLT004-0000030,treatment_start_1L,21,carbo_pem_pembro
|
| 144 |
+
HLT004-0000030,treatment_end_1L,92,completed_or_discontinued
|
| 145 |
+
HLT004-0000030,progression,70,radiographic_progression
|
| 146 |
+
HLT004-0000030,os_endpoint,92,disease
|
| 147 |
+
HLT004-0000031,diagnosis,0,Stage_IV
|
| 148 |
+
HLT004-0000031,treatment_start_1L,29,carbo_pem_pembro
|
| 149 |
+
HLT004-0000031,treatment_end_1L,155,completed_or_discontinued
|
| 150 |
+
HLT004-0000031,response_assessment,40,PR
|
| 151 |
+
HLT004-0000031,os_endpoint,502,disease
|
| 152 |
+
HLT004-0000032,diagnosis,0,Stage_I
|
| 153 |
+
HLT004-0000032,treatment_start_1L,7,docetaxel_2L
|
| 154 |
+
HLT004-0000032,treatment_end_1L,133,completed_or_discontinued
|
| 155 |
+
HLT004-0000032,progression,736,radiographic_progression
|
| 156 |
+
HLT004-0000032,os_endpoint,1059,disease
|
| 157 |
+
HLT004-0000033,diagnosis,0,Stage_IV
|
| 158 |
+
HLT004-0000033,treatment_start_1L,11,carbo_taxol
|
| 159 |
+
HLT004-0000033,treatment_end_1L,137,completed_or_discontinued
|
| 160 |
+
HLT004-0000033,os_endpoint,159,disease
|
| 161 |
+
HLT004-0000034,diagnosis,0,Stage_IV
|
| 162 |
+
HLT004-0000034,treatment_start_1L,16,pembro_mono
|
| 163 |
+
HLT004-0000034,treatment_end_1L,520,completed_or_discontinued
|
| 164 |
+
HLT004-0000034,progression,228,radiographic_progression
|
| 165 |
+
HLT004-0000034,os_endpoint,520,disease
|
| 166 |
+
HLT004-0000035,diagnosis,0,Stage_IV
|
| 167 |
+
HLT004-0000035,treatment_start_1L,20,pembro_mono
|
| 168 |
+
HLT004-0000035,treatment_end_1L,79,completed_or_discontinued
|
| 169 |
+
HLT004-0000035,progression,45,radiographic_progression
|
| 170 |
+
HLT004-0000035,os_endpoint,79,disease
|
| 171 |
+
HLT004-0000036,diagnosis,0,Stage_III
|
| 172 |
+
HLT004-0000036,treatment_start_1L,20,pembro_mono
|
| 173 |
+
HLT004-0000036,treatment_end_1L,116,completed_or_discontinued
|
| 174 |
+
HLT004-0000036,response_assessment,47,PR
|
| 175 |
+
HLT004-0000036,os_endpoint,116,censored
|
| 176 |
+
HLT004-0000037,diagnosis,0,Stage_IV
|
| 177 |
+
HLT004-0000037,treatment_start_1L,27,pembro_mono
|
| 178 |
+
HLT004-0000037,treatment_end_1L,431,completed_or_discontinued
|
| 179 |
+
HLT004-0000037,response_assessment,31,PR
|
| 180 |
+
HLT004-0000037,os_endpoint,431,disease
|
| 181 |
+
HLT004-0000038,diagnosis,0,Stage_II
|
| 182 |
+
HLT004-0000038,treatment_start_1L,17,pembro_mono
|
| 183 |
+
HLT004-0000038,treatment_end_1L,358,completed_or_discontinued
|
| 184 |
+
HLT004-0000038,os_endpoint,358,disease
|
| 185 |
+
HLT004-0000039,diagnosis,0,Stage_III
|
| 186 |
+
HLT004-0000039,treatment_start_1L,23,pembro_mono
|
| 187 |
+
HLT004-0000039,treatment_end_1L,358,completed_or_discontinued
|
| 188 |
+
HLT004-0000039,progression,330,radiographic_progression
|
| 189 |
+
HLT004-0000039,os_endpoint,358,disease
|
| 190 |
+
HLT004-0000040,diagnosis,0,Stage_IV
|
| 191 |
+
HLT004-0000040,treatment_start_1L,25,pembro_mono
|
| 192 |
+
HLT004-0000040,treatment_end_1L,45,completed_or_discontinued
|
| 193 |
+
HLT004-0000040,progression,34,radiographic_progression
|
| 194 |
+
HLT004-0000040,os_endpoint,45,censored
|
| 195 |
+
HLT004-0000041,diagnosis,0,Stage_I
|
| 196 |
+
HLT004-0000041,treatment_start_1L,17,docetaxel_2L
|
| 197 |
+
HLT004-0000041,treatment_end_1L,143,completed_or_discontinued
|
| 198 |
+
HLT004-0000041,progression,305,radiographic_progression
|
| 199 |
+
HLT004-0000041,os_endpoint,1077,censored
|
| 200 |
+
HLT004-0000042,diagnosis,0,Stage_IV
|
| 201 |
+
HLT004-0000042,treatment_start_1L,8,docetaxel_2L
|
| 202 |
+
HLT004-0000042,treatment_end_1L,134,completed_or_discontinued
|
| 203 |
+
HLT004-0000042,os_endpoint,279,disease
|
| 204 |
+
HLT004-0000043,diagnosis,0,Stage_I
|
| 205 |
+
HLT004-0000043,treatment_start_1L,22,docetaxel_2L
|
| 206 |
+
HLT004-0000043,treatment_end_1L,148,completed_or_discontinued
|
| 207 |
+
HLT004-0000043,os_endpoint,445,other_cause
|
| 208 |
+
HLT004-0000044,diagnosis,0,Stage_IV
|
| 209 |
+
HLT004-0000044,treatment_start_1L,13,carbo_pem_pembro
|
| 210 |
+
HLT004-0000044,treatment_end_1L,139,completed_or_discontinued
|
| 211 |
+
HLT004-0000044,progression,159,radiographic_progression
|
| 212 |
+
HLT004-0000044,os_endpoint,426,disease
|
| 213 |
+
HLT004-0000045,diagnosis,0,Stage_IV
|
| 214 |
+
HLT004-0000045,treatment_start_1L,10,pembro_mono
|
| 215 |
+
HLT004-0000045,treatment_end_1L,258,completed_or_discontinued
|
| 216 |
+
HLT004-0000045,response_assessment,88,PR
|
| 217 |
+
HLT004-0000045,os_endpoint,258,disease
|
| 218 |
+
HLT004-0000046,diagnosis,0,Stage_III
|
| 219 |
+
HLT004-0000046,treatment_start_1L,10,pembro_mono
|
| 220 |
+
HLT004-0000046,treatment_end_1L,559,completed_or_discontinued
|
| 221 |
+
HLT004-0000046,response_assessment,53,PR
|
| 222 |
+
HLT004-0000046,os_endpoint,559,disease
|
| 223 |
+
HLT004-0000047,diagnosis,0,Stage_IV
|
| 224 |
+
HLT004-0000047,treatment_start_1L,19,carbo_pem_pembro
|
| 225 |
+
HLT004-0000047,treatment_end_1L,145,completed_or_discontinued
|
| 226 |
+
HLT004-0000047,progression,43,radiographic_progression
|
| 227 |
+
HLT004-0000047,os_endpoint,490,disease
|
| 228 |
+
HLT004-0000048,diagnosis,0,Stage_I
|
| 229 |
+
HLT004-0000048,treatment_start_1L,16,docetaxel_2L
|
| 230 |
+
HLT004-0000048,treatment_end_1L,142,completed_or_discontinued
|
| 231 |
+
HLT004-0000048,progression,576,radiographic_progression
|
| 232 |
+
HLT004-0000048,os_endpoint,1694,other_cause
|
| 233 |
+
HLT004-0000049,diagnosis,0,Stage_IV
|
| 234 |
+
HLT004-0000049,treatment_start_1L,25,carbo_pem_pembro
|
| 235 |
+
HLT004-0000049,treatment_end_1L,151,completed_or_discontinued
|
| 236 |
+
HLT004-0000049,response_assessment,55,PR
|
| 237 |
+
HLT004-0000049,os_endpoint,1015,other_cause
|
| 238 |
+
HLT004-0000050,diagnosis,0,Stage_IV
|
| 239 |
+
HLT004-0000050,treatment_start_1L,8,carbo_pem_pembro
|
| 240 |
+
HLT004-0000050,treatment_end_1L,134,completed_or_discontinued
|
| 241 |
+
HLT004-0000050,progression,163,radiographic_progression
|
| 242 |
+
HLT004-0000050,os_endpoint,583,disease
|
| 243 |
+
HLT004-0000051,diagnosis,0,Stage_I
|
| 244 |
+
HLT004-0000051,treatment_start_1L,18,docetaxel_2L
|
| 245 |
+
HLT004-0000051,treatment_end_1L,144,completed_or_discontinued
|
| 246 |
+
HLT004-0000051,os_endpoint,1825,censored
|
| 247 |
+
HLT004-0000052,diagnosis,0,Stage_IV
|
| 248 |
+
HLT004-0000052,treatment_start_1L,16,carbo_pem_pembro
|
| 249 |
+
HLT004-0000052,treatment_end_1L,142,completed_or_discontinued
|
| 250 |
+
HLT004-0000052,progression,152,radiographic_progression
|
| 251 |
+
HLT004-0000052,os_endpoint,1143,disease
|
| 252 |
+
HLT004-0000053,diagnosis,0,Stage_III
|
| 253 |
+
HLT004-0000053,treatment_start_1L,29,carbo_taxol
|
| 254 |
+
HLT004-0000053,treatment_end_1L,155,completed_or_discontinued
|
| 255 |
+
HLT004-0000053,progression,212,radiographic_progression
|
| 256 |
+
HLT004-0000053,os_endpoint,378,disease
|
| 257 |
+
HLT004-0000054,diagnosis,0,Stage_IV
|
| 258 |
+
HLT004-0000054,treatment_start_1L,16,carbo_pem_pembro
|
| 259 |
+
HLT004-0000054,treatment_end_1L,142,completed_or_discontinued
|
| 260 |
+
HLT004-0000054,response_assessment,59,PR
|
| 261 |
+
HLT004-0000054,os_endpoint,374,disease
|
| 262 |
+
HLT004-0000055,diagnosis,0,Stage_IV
|
| 263 |
+
HLT004-0000055,treatment_start_1L,8,docetaxel_2L
|
| 264 |
+
HLT004-0000055,treatment_end_1L,134,completed_or_discontinued
|
| 265 |
+
HLT004-0000055,response_assessment,30,PR
|
| 266 |
+
HLT004-0000055,os_endpoint,346,disease
|
| 267 |
+
HLT004-0000056,diagnosis,0,Stage_III
|
| 268 |
+
HLT004-0000056,treatment_start_1L,7,carbo_taxol
|
| 269 |
+
HLT004-0000056,treatment_end_1L,133,completed_or_discontinued
|
| 270 |
+
HLT004-0000056,progression,123,radiographic_progression
|
| 271 |
+
HLT004-0000056,os_endpoint,740,censored
|
| 272 |
+
HLT004-0000057,diagnosis,0,Stage_IV
|
| 273 |
+
HLT004-0000057,treatment_start_1L,10,pembro_mono
|
| 274 |
+
HLT004-0000057,treatment_end_1L,505,completed_or_discontinued
|
| 275 |
+
HLT004-0000057,response_assessment,62,PR
|
| 276 |
+
HLT004-0000057,os_endpoint,505,disease
|
| 277 |
+
HLT004-0000058,diagnosis,0,Stage_II
|
| 278 |
+
HLT004-0000058,treatment_start_1L,10,docetaxel_2L
|
| 279 |
+
HLT004-0000058,treatment_end_1L,136,completed_or_discontinued
|
| 280 |
+
HLT004-0000058,progression,574,radiographic_progression
|
| 281 |
+
HLT004-0000058,os_endpoint,1545,censored
|
| 282 |
+
HLT004-0000059,diagnosis,0,Stage_III
|
| 283 |
+
HLT004-0000059,treatment_start_1L,13,pembro_mono
|
| 284 |
+
HLT004-0000059,treatment_end_1L,263,completed_or_discontinued
|
| 285 |
+
HLT004-0000059,response_assessment,56,PR
|
| 286 |
+
HLT004-0000059,os_endpoint,263,disease
|
| 287 |
+
HLT004-0000060,diagnosis,0,Stage_IV
|
| 288 |
+
HLT004-0000060,treatment_start_1L,11,docetaxel_2L
|
| 289 |
+
HLT004-0000060,treatment_end_1L,137,completed_or_discontinued
|
| 290 |
+
HLT004-0000060,progression,111,radiographic_progression
|
| 291 |
+
HLT004-0000060,os_endpoint,401,disease
|
| 292 |
+
HLT004-0000061,diagnosis,0,Stage_I
|
| 293 |
+
HLT004-0000061,treatment_start_1L,19,docetaxel_2L
|
| 294 |
+
HLT004-0000061,treatment_end_1L,145,completed_or_discontinued
|
| 295 |
+
HLT004-0000061,progression,1040,radiographic_progression
|
| 296 |
+
HLT004-0000061,os_endpoint,1212,censored
|
| 297 |
+
HLT004-0000062,diagnosis,0,Stage_IV
|
| 298 |
+
HLT004-0000062,treatment_start_1L,28,carbo_taxol
|
| 299 |
+
HLT004-0000062,treatment_end_1L,154,completed_or_discontinued
|
| 300 |
+
HLT004-0000062,progression,57,radiographic_progression
|
| 301 |
+
HLT004-0000062,os_endpoint,156,disease
|
| 302 |
+
HLT004-0000063,diagnosis,0,Stage_II
|
| 303 |
+
HLT004-0000063,treatment_start_1L,9,docetaxel_2L
|
| 304 |
+
HLT004-0000063,treatment_end_1L,135,completed_or_discontinued
|
| 305 |
+
HLT004-0000063,os_endpoint,559,disease
|
| 306 |
+
HLT004-0000064,diagnosis,0,Stage_IV
|
| 307 |
+
HLT004-0000064,treatment_start_1L,22,carbo_taxol
|
| 308 |
+
HLT004-0000064,treatment_end_1L,55,completed_or_discontinued
|
| 309 |
+
HLT004-0000064,progression,15,radiographic_progression
|
| 310 |
+
HLT004-0000064,os_endpoint,55,other_cause
|
| 311 |
+
HLT004-0000065,diagnosis,0,Stage_IV
|
| 312 |
+
HLT004-0000065,treatment_start_1L,21,carbo_pem_pembro
|
| 313 |
+
HLT004-0000065,treatment_end_1L,147,completed_or_discontinued
|
| 314 |
+
HLT004-0000065,progression,175,radiographic_progression
|
| 315 |
+
HLT004-0000065,os_endpoint,260,disease
|
| 316 |
+
HLT004-0000066,diagnosis,0,Stage_III
|
| 317 |
+
HLT004-0000066,treatment_start_1L,12,carbo_taxol
|
| 318 |
+
HLT004-0000066,treatment_end_1L,138,completed_or_discontinued
|
| 319 |
+
HLT004-0000066,progression,439,radiographic_progression
|
| 320 |
+
HLT004-0000066,os_endpoint,599,other_cause
|
| 321 |
+
HLT004-0000067,diagnosis,0,Stage_II
|
| 322 |
+
HLT004-0000067,treatment_start_1L,13,pembro_mono
|
| 323 |
+
HLT004-0000067,treatment_end_1L,748,completed_or_discontinued
|
| 324 |
+
HLT004-0000067,progression,287,radiographic_progression
|
| 325 |
+
HLT004-0000067,os_endpoint,793,other_cause
|
| 326 |
+
HLT004-0000068,diagnosis,0,Stage_III
|
| 327 |
+
HLT004-0000068,treatment_start_1L,18,carbo_pem_pembro
|
| 328 |
+
HLT004-0000068,treatment_end_1L,144,completed_or_discontinued
|
| 329 |
+
HLT004-0000068,progression,32,radiographic_progression
|
| 330 |
+
HLT004-0000068,os_endpoint,705,disease
|
| 331 |
+
HLT004-0000069,diagnosis,0,Stage_IV
|
| 332 |
+
HLT004-0000069,treatment_start_1L,28,pembro_mono
|
| 333 |
+
HLT004-0000069,treatment_end_1L,488,completed_or_discontinued
|
| 334 |
+
HLT004-0000069,progression,93,radiographic_progression
|
| 335 |
+
HLT004-0000069,os_endpoint,488,disease
|
| 336 |
+
HLT004-0000070,diagnosis,0,Stage_III
|
| 337 |
+
HLT004-0000070,treatment_start_1L,7,carbo_taxol
|
| 338 |
+
HLT004-0000070,treatment_end_1L,133,completed_or_discontinued
|
| 339 |
+
HLT004-0000070,os_endpoint,169,censored
|
| 340 |
+
HLT004-0000071,diagnosis,0,Stage_III
|
| 341 |
+
HLT004-0000071,treatment_start_1L,22,pembro_mono
|
| 342 |
+
HLT004-0000071,treatment_end_1L,521,completed_or_discontinued
|
| 343 |
+
HLT004-0000071,response_assessment,34,CR
|
| 344 |
+
HLT004-0000071,os_endpoint,521,disease
|
| 345 |
+
HLT004-0000072,diagnosis,0,Stage_IV
|
| 346 |
+
HLT004-0000072,treatment_start_1L,15,carbo_pem_pembro
|
| 347 |
+
HLT004-0000072,treatment_end_1L,8,completed_or_discontinued
|
| 348 |
+
HLT004-0000072,response_assessment,85,PR
|
| 349 |
+
HLT004-0000072,os_endpoint,8,other_cause
|
| 350 |
+
HLT004-0000073,diagnosis,0,Stage_III
|
| 351 |
+
HLT004-0000073,treatment_start_1L,17,docetaxel_2L
|
| 352 |
+
HLT004-0000073,treatment_end_1L,143,completed_or_discontinued
|
| 353 |
+
HLT004-0000073,progression,567,radiographic_progression
|
| 354 |
+
HLT004-0000073,os_endpoint,1065,other_cause
|
| 355 |
+
HLT004-0000074,diagnosis,0,Stage_III
|
| 356 |
+
HLT004-0000074,treatment_start_1L,17,carbo_taxol
|
| 357 |
+
HLT004-0000074,treatment_end_1L,143,completed_or_discontinued
|
| 358 |
+
HLT004-0000074,progression,256,radiographic_progression
|
| 359 |
+
HLT004-0000074,os_endpoint,374,censored
|
| 360 |
+
HLT004-0000075,diagnosis,0,Stage_III
|
| 361 |
+
HLT004-0000075,treatment_start_1L,10,carbo_pem_pembro
|
| 362 |
+
HLT004-0000075,treatment_end_1L,136,completed_or_discontinued
|
| 363 |
+
HLT004-0000075,os_endpoint,152,disease
|
| 364 |
+
HLT004-0000076,diagnosis,0,Stage_I
|
| 365 |
+
HLT004-0000076,treatment_start_1L,18,carbo_taxol
|
| 366 |
+
HLT004-0000076,treatment_end_1L,144,completed_or_discontinued
|
| 367 |
+
HLT004-0000076,progression,1180,radiographic_progression
|
| 368 |
+
HLT004-0000076,os_endpoint,1825,censored
|
| 369 |
+
HLT004-0000077,diagnosis,0,Stage_IV
|
| 370 |
+
HLT004-0000077,treatment_start_1L,25,carbo_taxol
|
| 371 |
+
HLT004-0000077,treatment_end_1L,76,completed_or_discontinued
|
| 372 |
+
HLT004-0000077,response_assessment,36,PR
|
| 373 |
+
HLT004-0000077,os_endpoint,76,other_cause
|
| 374 |
+
HLT004-0000078,diagnosis,0,Stage_IV
|
| 375 |
+
HLT004-0000078,treatment_start_1L,28,pembro_mono
|
| 376 |
+
HLT004-0000078,treatment_end_1L,374,completed_or_discontinued
|
| 377 |
+
HLT004-0000078,response_assessment,51,PR
|
| 378 |
+
HLT004-0000078,os_endpoint,374,disease
|
| 379 |
+
HLT004-0000079,diagnosis,0,Stage_IV
|
| 380 |
+
HLT004-0000079,treatment_start_1L,22,carbo_taxol
|
| 381 |
+
HLT004-0000079,treatment_end_1L,148,completed_or_discontinued
|
| 382 |
+
HLT004-0000079,progression,227,radiographic_progression
|
| 383 |
+
HLT004-0000079,os_endpoint,328,disease
|
| 384 |
+
HLT004-0000080,diagnosis,0,Stage_IV
|
| 385 |
+
HLT004-0000080,treatment_start_1L,10,carbo_pem_pembro
|
| 386 |
+
HLT004-0000080,treatment_end_1L,136,completed_or_discontinued
|
| 387 |
+
HLT004-0000080,response_assessment,45,PR
|
| 388 |
+
HLT004-0000080,os_endpoint,386,disease
|
| 389 |
+
HLT004-0000081,diagnosis,0,Stage_III
|
| 390 |
+
HLT004-0000081,treatment_start_1L,13,docetaxel_2L
|
| 391 |
+
HLT004-0000081,treatment_end_1L,139,completed_or_discontinued
|
| 392 |
+
HLT004-0000081,progression,370,radiographic_progression
|
| 393 |
+
HLT004-0000081,os_endpoint,796,disease
|
| 394 |
+
HLT004-0000082,diagnosis,0,Stage_III
|
| 395 |
+
HLT004-0000082,treatment_start_1L,18,carbo_taxol
|
| 396 |
+
HLT004-0000082,treatment_end_1L,144,completed_or_discontinued
|
| 397 |
+
HLT004-0000082,progression,164,radiographic_progression
|
| 398 |
+
HLT004-0000082,os_endpoint,836,disease
|
| 399 |
+
HLT004-0000083,diagnosis,0,Stage_IV
|
| 400 |
+
HLT004-0000083,treatment_start_1L,20,carbo_pem_pembro
|
| 401 |
+
HLT004-0000083,treatment_end_1L,146,completed_or_discontinued
|
| 402 |
+
HLT004-0000083,progression,37,radiographic_progression
|
| 403 |
+
HLT004-0000083,os_endpoint,264,censored
|
| 404 |
+
HLT004-0000084,diagnosis,0,Stage_IV
|
| 405 |
+
HLT004-0000084,treatment_start_1L,20,pembro_mono
|
| 406 |
+
HLT004-0000084,treatment_end_1L,564,completed_or_discontinued
|
| 407 |
+
HLT004-0000084,progression,227,radiographic_progression
|
| 408 |
+
HLT004-0000084,os_endpoint,564,disease
|
| 409 |
+
HLT004-0000085,diagnosis,0,Stage_IV
|
| 410 |
+
HLT004-0000085,treatment_start_1L,22,pembro_mono
|
| 411 |
+
HLT004-0000085,treatment_end_1L,635,completed_or_discontinued
|
| 412 |
+
HLT004-0000085,progression,246,radiographic_progression
|
| 413 |
+
HLT004-0000085,os_endpoint,635,disease
|
| 414 |
+
HLT004-0000086,diagnosis,0,Stage_III
|
| 415 |
+
HLT004-0000086,treatment_start_1L,18,pembro_mono
|
| 416 |
+
HLT004-0000086,treatment_end_1L,529,completed_or_discontinued
|
| 417 |
+
HLT004-0000086,os_endpoint,529,disease
|
| 418 |
+
HLT004-0000087,diagnosis,0,Stage_IV
|
| 419 |
+
HLT004-0000087,treatment_start_1L,8,carbo_taxol
|
| 420 |
+
HLT004-0000087,treatment_end_1L,134,completed_or_discontinued
|
| 421 |
+
HLT004-0000087,progression,171,radiographic_progression
|
| 422 |
+
HLT004-0000087,os_endpoint,907,disease
|
| 423 |
+
HLT004-0000088,diagnosis,0,Stage_IV
|
| 424 |
+
HLT004-0000088,treatment_start_1L,9,carbo_taxol
|
| 425 |
+
HLT004-0000088,treatment_end_1L,135,completed_or_discontinued
|
| 426 |
+
HLT004-0000088,response_assessment,80,PR
|
| 427 |
+
HLT004-0000088,os_endpoint,235,censored
|
| 428 |
+
HLT004-0000089,diagnosis,0,Stage_IV
|
| 429 |
+
HLT004-0000089,treatment_start_1L,28,pembro_mono
|
| 430 |
+
HLT004-0000089,treatment_end_1L,230,completed_or_discontinued
|
| 431 |
+
HLT004-0000089,os_endpoint,230,disease
|
| 432 |
+
HLT004-0000090,diagnosis,0,Stage_IV
|
| 433 |
+
HLT004-0000090,treatment_start_1L,13,carbo_pem_pembro
|
| 434 |
+
HLT004-0000090,treatment_end_1L,139,completed_or_discontinued
|
| 435 |
+
HLT004-0000090,progression,194,radiographic_progression
|
| 436 |
+
HLT004-0000090,os_endpoint,814,disease
|
| 437 |
+
HLT004-0000091,diagnosis,0,Stage_III
|
| 438 |
+
HLT004-0000091,treatment_start_1L,29,carbo_taxol
|
| 439 |
+
HLT004-0000091,treatment_end_1L,155,completed_or_discontinued
|
| 440 |
+
HLT004-0000091,progression,218,radiographic_progression
|
| 441 |
+
HLT004-0000091,os_endpoint,807,disease
|
| 442 |
+
HLT004-0000092,diagnosis,0,Stage_III
|
| 443 |
+
HLT004-0000092,treatment_start_1L,16,docetaxel_2L
|
| 444 |
+
HLT004-0000092,treatment_end_1L,142,completed_or_discontinued
|
| 445 |
+
HLT004-0000092,progression,313,radiographic_progression
|
| 446 |
+
HLT004-0000092,os_endpoint,740,disease
|
| 447 |
+
HLT004-0000093,diagnosis,0,Stage_III
|
| 448 |
+
HLT004-0000093,treatment_start_1L,22,pembro_mono
|
| 449 |
+
HLT004-0000093,treatment_end_1L,267,completed_or_discontinued
|
| 450 |
+
HLT004-0000093,progression,124,radiographic_progression
|
| 451 |
+
HLT004-0000093,os_endpoint,267,disease
|
| 452 |
+
HLT004-0000094,diagnosis,0,Stage_III
|
| 453 |
+
HLT004-0000094,treatment_start_1L,28,pembro_mono
|
| 454 |
+
HLT004-0000094,treatment_end_1L,727,completed_or_discontinued
|
| 455 |
+
HLT004-0000094,progression,153,radiographic_progression
|
| 456 |
+
HLT004-0000094,os_endpoint,727,disease
|
| 457 |
+
HLT004-0000095,diagnosis,0,Stage_IV
|
| 458 |
+
HLT004-0000095,treatment_start_1L,17,carbo_pem_pembro
|
| 459 |
+
HLT004-0000095,treatment_end_1L,143,completed_or_discontinued
|
| 460 |
+
HLT004-0000095,response_assessment,42,PR
|
| 461 |
+
HLT004-0000095,os_endpoint,318,disease
|
| 462 |
+
HLT004-0000096,diagnosis,0,Stage_III
|
| 463 |
+
HLT004-0000096,treatment_start_1L,15,docetaxel_2L
|
| 464 |
+
HLT004-0000096,treatment_end_1L,141,completed_or_discontinued
|
| 465 |
+
HLT004-0000096,progression,131,radiographic_progression
|
| 466 |
+
HLT004-0000096,os_endpoint,172,censored
|
| 467 |
+
HLT004-0000097,diagnosis,0,Stage_III
|
| 468 |
+
HLT004-0000097,treatment_start_1L,14,carbo_taxol
|
| 469 |
+
HLT004-0000097,treatment_end_1L,140,completed_or_discontinued
|
| 470 |
+
HLT004-0000097,progression,334,radiographic_progression
|
| 471 |
+
HLT004-0000097,os_endpoint,1102,disease
|
| 472 |
+
HLT004-0000098,diagnosis,0,Stage_III
|
| 473 |
+
HLT004-0000098,treatment_start_1L,12,carbo_pem_pembro
|
| 474 |
+
HLT004-0000098,treatment_end_1L,138,completed_or_discontinued
|
| 475 |
+
HLT004-0000098,progression,212,radiographic_progression
|
| 476 |
+
HLT004-0000098,os_endpoint,662,disease
|
| 477 |
+
HLT004-0000099,diagnosis,0,Stage_IV
|
| 478 |
+
HLT004-0000099,treatment_start_1L,20,carbo_pem_pembro
|
| 479 |
+
HLT004-0000099,treatment_end_1L,146,completed_or_discontinued
|
| 480 |
+
HLT004-0000099,progression,179,radiographic_progression
|
| 481 |
+
HLT004-0000099,os_endpoint,465,other_cause
|
| 482 |
+
HLT004-0000100,diagnosis,0,Stage_IV
|
| 483 |
+
HLT004-0000100,treatment_start_1L,28,pembro_mono
|
| 484 |
+
HLT004-0000100,treatment_end_1L,343,completed_or_discontinued
|
| 485 |
+
HLT004-0000100,os_endpoint,343,disease
|
| 486 |
+
HLT004-0000101,diagnosis,0,Stage_I
|
| 487 |
+
HLT004-0000101,treatment_start_1L,13,pembro_mono
|
| 488 |
+
HLT004-0000101,treatment_end_1L,660,completed_or_discontinued
|
| 489 |
+
HLT004-0000101,response_assessment,50,PR
|
| 490 |
+
HLT004-0000101,os_endpoint,660,disease
|
| 491 |
+
HLT004-0000102,diagnosis,0,Stage_IV
|
| 492 |
+
HLT004-0000102,treatment_start_1L,10,carbo_pem_pembro
|
| 493 |
+
HLT004-0000102,treatment_end_1L,136,completed_or_discontinued
|
| 494 |
+
HLT004-0000102,progression,16,radiographic_progression
|
| 495 |
+
HLT004-0000102,os_endpoint,568,censored
|
| 496 |
+
HLT004-0000103,diagnosis,0,Stage_III
|
| 497 |
+
HLT004-0000103,treatment_start_1L,21,carbo_taxol
|
| 498 |
+
HLT004-0000103,treatment_end_1L,147,completed_or_discontinued
|
| 499 |
+
HLT004-0000103,response_assessment,42,PR
|
| 500 |
+
HLT004-0000103,os_endpoint,723,disease
|
| 501 |
+
HLT004-0000104,diagnosis,0,Stage_III
|
| 502 |
+
HLT004-0000104,treatment_start_1L,27,pembro_mono
|
| 503 |
+
HLT004-0000104,treatment_end_1L,419,completed_or_discontinued
|
| 504 |
+
HLT004-0000104,response_assessment,35,CR
|
| 505 |
+
HLT004-0000104,os_endpoint,419,disease
|
| 506 |
+
HLT004-0000105,diagnosis,0,Stage_II
|
| 507 |
+
HLT004-0000105,treatment_start_1L,18,pembro_mono
|
| 508 |
+
HLT004-0000105,treatment_end_1L,753,completed_or_discontinued
|
| 509 |
+
HLT004-0000105,response_assessment,79,PR
|
| 510 |
+
HLT004-0000105,os_endpoint,1825,censored
|
| 511 |
+
HLT004-0000106,diagnosis,0,Stage_IV
|
| 512 |
+
HLT004-0000106,treatment_start_1L,23,pembro_mono
|
| 513 |
+
HLT004-0000106,treatment_end_1L,758,completed_or_discontinued
|
| 514 |
+
HLT004-0000106,progression,12,radiographic_progression
|
| 515 |
+
HLT004-0000106,os_endpoint,763,disease
|
| 516 |
+
HLT004-0000107,diagnosis,0,Stage_IV
|
| 517 |
+
HLT004-0000107,treatment_start_1L,23,carbo_pem_pembro
|
| 518 |
+
HLT004-0000107,treatment_end_1L,149,completed_or_discontinued
|
| 519 |
+
HLT004-0000107,progression,76,radiographic_progression
|
| 520 |
+
HLT004-0000107,os_endpoint,622,disease
|
| 521 |
+
HLT004-0000108,diagnosis,0,Stage_IV
|
| 522 |
+
HLT004-0000108,treatment_start_1L,8,docetaxel_2L
|
| 523 |
+
HLT004-0000108,treatment_end_1L,134,completed_or_discontinued
|
| 524 |
+
HLT004-0000108,response_assessment,43,PR
|
| 525 |
+
HLT004-0000108,os_endpoint,278,censored
|
| 526 |
+
HLT004-0000109,diagnosis,0,Stage_I
|
| 527 |
+
HLT004-0000109,treatment_start_1L,25,docetaxel_2L
|
| 528 |
+
HLT004-0000109,treatment_end_1L,151,completed_or_discontinued
|
| 529 |
+
HLT004-0000109,progression,148,radiographic_progression
|
| 530 |
+
HLT004-0000109,os_endpoint,254,censored
|
| 531 |
+
HLT004-0000110,diagnosis,0,Stage_IV
|
| 532 |
+
HLT004-0000110,treatment_start_1L,10,pembro_mono
|
| 533 |
+
HLT004-0000110,treatment_end_1L,745,completed_or_discontinued
|
| 534 |
+
HLT004-0000110,progression,95,radiographic_progression
|
| 535 |
+
HLT004-0000110,os_endpoint,753,disease
|
| 536 |
+
HLT004-0000111,diagnosis,0,Stage_IV
|
| 537 |
+
HLT004-0000111,treatment_start_1L,25,carbo_pem_pembro
|
| 538 |
+
HLT004-0000111,treatment_end_1L,151,completed_or_discontinued
|
| 539 |
+
HLT004-0000111,progression,131,radiographic_progression
|
| 540 |
+
HLT004-0000111,os_endpoint,362,disease
|
| 541 |
+
HLT004-0000112,diagnosis,0,Stage_III
|
| 542 |
+
HLT004-0000112,treatment_start_1L,12,pembro_mono
|
| 543 |
+
HLT004-0000112,treatment_end_1L,83,completed_or_discontinued
|
| 544 |
+
HLT004-0000112,response_assessment,61,PR
|
| 545 |
+
HLT004-0000112,os_endpoint,83,disease
|
| 546 |
+
HLT004-0000113,diagnosis,0,Stage_II
|
| 547 |
+
HLT004-0000113,treatment_start_1L,8,carbo_taxol
|
| 548 |
+
HLT004-0000113,treatment_end_1L,134,completed_or_discontinued
|
| 549 |
+
HLT004-0000113,progression,505,radiographic_progression
|
| 550 |
+
HLT004-0000113,os_endpoint,620,disease
|
| 551 |
+
HLT004-0000114,diagnosis,0,Stage_III
|
| 552 |
+
HLT004-0000114,treatment_start_1L,12,carbo_pem_pembro
|
| 553 |
+
HLT004-0000114,treatment_end_1L,110,completed_or_discontinued
|
| 554 |
+
HLT004-0000114,progression,90,radiographic_progression
|
| 555 |
+
HLT004-0000114,os_endpoint,110,disease
|
| 556 |
+
HLT004-0000115,diagnosis,0,Stage_IV
|
| 557 |
+
HLT004-0000115,treatment_start_1L,8,carbo_taxol
|
| 558 |
+
HLT004-0000115,treatment_end_1L,134,completed_or_discontinued
|
| 559 |
+
HLT004-0000115,response_assessment,56,PR
|
| 560 |
+
HLT004-0000115,os_endpoint,515,disease
|
| 561 |
+
HLT004-0000116,diagnosis,0,Stage_III
|
| 562 |
+
HLT004-0000116,treatment_start_1L,8,docetaxel_2L
|
| 563 |
+
HLT004-0000116,treatment_end_1L,134,completed_or_discontinued
|
| 564 |
+
HLT004-0000116,os_endpoint,153,other_cause
|
| 565 |
+
HLT004-0000117,diagnosis,0,Stage_III
|
| 566 |
+
HLT004-0000117,treatment_start_1L,22,carbo_taxol
|
| 567 |
+
HLT004-0000117,treatment_end_1L,148,completed_or_discontinued
|
| 568 |
+
HLT004-0000117,progression,220,radiographic_progression
|
| 569 |
+
HLT004-0000117,os_endpoint,445,other_cause
|
| 570 |
+
HLT004-0000118,diagnosis,0,Stage_IV
|
| 571 |
+
HLT004-0000118,treatment_start_1L,17,docetaxel_2L
|
| 572 |
+
HLT004-0000118,treatment_end_1L,143,completed_or_discontinued
|
| 573 |
+
HLT004-0000118,progression,108,radiographic_progression
|
| 574 |
+
HLT004-0000118,os_endpoint,172,disease
|
| 575 |
+
HLT004-0000119,diagnosis,0,Stage_IV
|
| 576 |
+
HLT004-0000119,treatment_start_1L,25,pembro_mono
|
| 577 |
+
HLT004-0000119,treatment_end_1L,401,completed_or_discontinued
|
| 578 |
+
HLT004-0000119,progression,177,radiographic_progression
|
| 579 |
+
HLT004-0000119,os_endpoint,401,censored
|
| 580 |
+
HLT004-0000120,diagnosis,0,Stage_IV
|
| 581 |
+
HLT004-0000120,treatment_start_1L,18,pembro_mono
|
| 582 |
+
HLT004-0000120,treatment_end_1L,151,completed_or_discontinued
|
| 583 |
+
HLT004-0000120,os_endpoint,151,other_cause
|
| 584 |
+
HLT004-0000121,diagnosis,0,Stage_IV
|
| 585 |
+
HLT004-0000121,treatment_start_1L,21,carbo_pem_pembro
|
| 586 |
+
HLT004-0000121,treatment_end_1L,147,completed_or_discontinued
|
| 587 |
+
HLT004-0000121,response_assessment,64,PR
|
| 588 |
+
HLT004-0000121,os_endpoint,212,other_cause
|
| 589 |
+
HLT004-0000122,diagnosis,0,Stage_I
|
| 590 |
+
HLT004-0000122,treatment_start_1L,23,pembro_mono
|
| 591 |
+
HLT004-0000122,treatment_end_1L,640,completed_or_discontinued
|
| 592 |
+
HLT004-0000122,progression,547,radiographic_progression
|
| 593 |
+
HLT004-0000122,os_endpoint,640,censored
|
| 594 |
+
HLT004-0000123,diagnosis,0,Stage_IV
|
| 595 |
+
HLT004-0000123,treatment_start_1L,12,carbo_pem_pembro
|
| 596 |
+
HLT004-0000123,treatment_end_1L,10,completed_or_discontinued
|
| 597 |
+
HLT004-0000123,progression,8,radiographic_progression
|
| 598 |
+
HLT004-0000123,os_endpoint,10,disease
|
| 599 |
+
HLT004-0000124,diagnosis,0,Stage_III
|
| 600 |
+
HLT004-0000124,treatment_start_1L,21,carbo_taxol
|
| 601 |
+
HLT004-0000124,treatment_end_1L,147,completed_or_discontinued
|
| 602 |
+
HLT004-0000124,os_endpoint,294,disease
|
| 603 |
+
HLT004-0000125,diagnosis,0,Stage_I
|
| 604 |
+
HLT004-0000125,treatment_start_1L,14,carbo_taxol
|
| 605 |
+
HLT004-0000125,treatment_end_1L,140,completed_or_discontinued
|
| 606 |
+
HLT004-0000125,progression,334,radiographic_progression
|
| 607 |
+
HLT004-0000125,os_endpoint,770,disease
|
| 608 |
+
HLT004-0000126,diagnosis,0,Stage_IV
|
| 609 |
+
HLT004-0000126,treatment_start_1L,28,carbo_taxol
|
| 610 |
+
HLT004-0000126,treatment_end_1L,154,completed_or_discontinued
|
| 611 |
+
HLT004-0000126,os_endpoint,425,disease
|
| 612 |
+
HLT004-0000127,diagnosis,0,Stage_II
|
| 613 |
+
HLT004-0000127,treatment_start_1L,16,pembro_mono
|
| 614 |
+
HLT004-0000127,treatment_end_1L,751,completed_or_discontinued
|
| 615 |
+
HLT004-0000127,response_assessment,66,PR
|
| 616 |
+
HLT004-0000127,os_endpoint,972,censored
|
| 617 |
+
HLT004-0000128,diagnosis,0,Stage_I
|
| 618 |
+
HLT004-0000128,treatment_start_1L,19,carbo_pem_pembro
|
| 619 |
+
HLT004-0000128,treatment_end_1L,145,completed_or_discontinued
|
| 620 |
+
HLT004-0000128,response_assessment,68,PR
|
| 621 |
+
HLT004-0000128,os_endpoint,1825,censored
|
| 622 |
+
HLT004-0000129,diagnosis,0,Stage_IV
|
| 623 |
+
HLT004-0000129,treatment_start_1L,20,carbo_pem_pembro
|
| 624 |
+
HLT004-0000129,treatment_end_1L,146,completed_or_discontinued
|
| 625 |
+
HLT004-0000129,response_assessment,74,PR
|
| 626 |
+
HLT004-0000129,os_endpoint,762,disease
|
| 627 |
+
HLT004-0000130,diagnosis,0,Stage_III
|
| 628 |
+
HLT004-0000130,treatment_start_1L,12,docetaxel_2L
|
| 629 |
+
HLT004-0000130,treatment_end_1L,138,completed_or_discontinued
|
| 630 |
+
HLT004-0000130,progression,572,radiographic_progression
|
| 631 |
+
HLT004-0000130,os_endpoint,816,disease
|
| 632 |
+
HLT004-0000131,diagnosis,0,Stage_I
|
| 633 |
+
HLT004-0000131,treatment_start_1L,29,carbo_pem_pembro
|
| 634 |
+
HLT004-0000131,treatment_end_1L,155,completed_or_discontinued
|
| 635 |
+
HLT004-0000131,response_assessment,71,PR
|
| 636 |
+
HLT004-0000131,os_endpoint,1117,disease
|
| 637 |
+
HLT004-0000132,diagnosis,0,Stage_IV
|
| 638 |
+
HLT004-0000132,treatment_start_1L,27,carbo_pem_pembro
|
| 639 |
+
HLT004-0000132,treatment_end_1L,153,completed_or_discontinued
|
| 640 |
+
HLT004-0000132,progression,68,radiographic_progression
|
| 641 |
+
HLT004-0000132,os_endpoint,160,other_cause
|
| 642 |
+
HLT004-0000133,diagnosis,0,Stage_IV
|
| 643 |
+
HLT004-0000133,treatment_start_1L,25,carbo_pem_pembro
|
| 644 |
+
HLT004-0000133,treatment_end_1L,151,completed_or_discontinued
|
| 645 |
+
HLT004-0000133,response_assessment,38,PR
|
| 646 |
+
HLT004-0000133,os_endpoint,441,disease
|
| 647 |
+
HLT004-0000134,diagnosis,0,Stage_IV
|
| 648 |
+
HLT004-0000134,treatment_start_1L,24,carbo_pem_pembro
|
| 649 |
+
HLT004-0000134,treatment_end_1L,150,completed_or_discontinued
|
| 650 |
+
HLT004-0000134,response_assessment,86,PR
|
| 651 |
+
HLT004-0000134,os_endpoint,349,disease
|
| 652 |
+
HLT004-0000135,diagnosis,0,Stage_I
|
| 653 |
+
HLT004-0000135,treatment_start_1L,20,docetaxel_2L
|
| 654 |
+
HLT004-0000135,treatment_end_1L,146,completed_or_discontinued
|
| 655 |
+
HLT004-0000135,progression,926,radiographic_progression
|
| 656 |
+
HLT004-0000135,os_endpoint,1825,censored
|
| 657 |
+
HLT004-0000136,diagnosis,0,Stage_IV
|
| 658 |
+
HLT004-0000136,treatment_start_1L,17,carbo_pem_pembro
|
| 659 |
+
HLT004-0000136,treatment_end_1L,143,completed_or_discontinued
|
| 660 |
+
HLT004-0000136,response_assessment,73,PR
|
| 661 |
+
HLT004-0000136,os_endpoint,262,censored
|
| 662 |
+
HLT004-0000137,diagnosis,0,Stage_IV
|
| 663 |
+
HLT004-0000137,treatment_start_1L,20,carbo_taxol
|
| 664 |
+
HLT004-0000137,treatment_end_1L,146,completed_or_discontinued
|
| 665 |
+
HLT004-0000137,response_assessment,57,PR
|
| 666 |
+
HLT004-0000137,os_endpoint,287,disease
|
| 667 |
+
HLT004-0000138,diagnosis,0,Stage_I
|
| 668 |
+
HLT004-0000138,treatment_start_1L,23,pembro_mono
|
| 669 |
+
HLT004-0000138,treatment_end_1L,74,completed_or_discontinued
|
| 670 |
+
HLT004-0000138,progression,46,radiographic_progression
|
| 671 |
+
HLT004-0000138,os_endpoint,74,censored
|
| 672 |
+
HLT004-0000139,diagnosis,0,Stage_II
|
| 673 |
+
HLT004-0000139,treatment_start_1L,22,carbo_taxol
|
| 674 |
+
HLT004-0000139,treatment_end_1L,148,completed_or_discontinued
|
| 675 |
+
HLT004-0000139,progression,392,radiographic_progression
|
| 676 |
+
HLT004-0000139,os_endpoint,557,other_cause
|
| 677 |
+
HLT004-0000140,diagnosis,0,Stage_I
|
| 678 |
+
HLT004-0000140,treatment_start_1L,8,docetaxel_2L
|
| 679 |
+
HLT004-0000140,treatment_end_1L,134,completed_or_discontinued
|
| 680 |
+
HLT004-0000140,os_endpoint,425,censored
|
| 681 |
+
HLT004-0000141,diagnosis,0,Stage_IV
|
| 682 |
+
HLT004-0000141,treatment_start_1L,19,docetaxel_2L
|
| 683 |
+
HLT004-0000141,treatment_end_1L,145,completed_or_discontinued
|
| 684 |
+
HLT004-0000141,progression,138,radiographic_progression
|
| 685 |
+
HLT004-0000141,os_endpoint,557,disease
|
| 686 |
+
HLT004-0000142,diagnosis,0,Stage_II
|
| 687 |
+
HLT004-0000142,treatment_start_1L,27,carbo_pem_pembro
|
| 688 |
+
HLT004-0000142,treatment_end_1L,88,completed_or_discontinued
|
| 689 |
+
HLT004-0000142,progression,76,radiographic_progression
|
| 690 |
+
HLT004-0000142,os_endpoint,88,censored
|
| 691 |
+
HLT004-0000143,diagnosis,0,Stage_IV
|
| 692 |
+
HLT004-0000143,treatment_start_1L,21,carbo_pem_pembro
|
| 693 |
+
HLT004-0000143,treatment_end_1L,2,completed_or_discontinued
|
| 694 |
+
HLT004-0000143,progression,1,radiographic_progression
|
| 695 |
+
HLT004-0000143,os_endpoint,2,disease
|
| 696 |
+
HLT004-0000144,diagnosis,0,Stage_IV
|
| 697 |
+
HLT004-0000144,treatment_start_1L,10,carbo_pem_pembro
|
| 698 |
+
HLT004-0000144,treatment_end_1L,136,completed_or_discontinued
|
| 699 |
+
HLT004-0000144,response_assessment,54,PR
|
| 700 |
+
HLT004-0000144,os_endpoint,464,disease
|
| 701 |
+
HLT004-0000145,diagnosis,0,Stage_II
|
| 702 |
+
HLT004-0000145,treatment_start_1L,26,carbo_pem_pembro
|
| 703 |
+
HLT004-0000145,treatment_end_1L,152,completed_or_discontinued
|
| 704 |
+
HLT004-0000145,response_assessment,81,PR
|
| 705 |
+
HLT004-0000145,os_endpoint,549,disease
|
| 706 |
+
HLT004-0000146,diagnosis,0,Stage_IV
|
| 707 |
+
HLT004-0000146,treatment_start_1L,16,carbo_taxol
|
| 708 |
+
HLT004-0000146,treatment_end_1L,142,completed_or_discontinued
|
| 709 |
+
HLT004-0000146,os_endpoint,261,disease
|
| 710 |
+
HLT004-0000147,diagnosis,0,Stage_II
|
| 711 |
+
HLT004-0000147,treatment_start_1L,19,pembro_mono
|
| 712 |
+
HLT004-0000147,treatment_end_1L,754,completed_or_discontinued
|
| 713 |
+
HLT004-0000147,progression,943,radiographic_progression
|
| 714 |
+
HLT004-0000147,os_endpoint,1727,disease
|
| 715 |
+
HLT004-0000148,diagnosis,0,Stage_I
|
| 716 |
+
HLT004-0000148,treatment_start_1L,10,carbo_taxol
|
| 717 |
+
HLT004-0000148,treatment_end_1L,136,completed_or_discontinued
|
| 718 |
+
HLT004-0000148,progression,392,radiographic_progression
|
| 719 |
+
HLT004-0000148,os_endpoint,947,disease
|
| 720 |
+
HLT004-0000149,diagnosis,0,Stage_IV
|
| 721 |
+
HLT004-0000149,treatment_start_1L,22,carbo_pem_pembro
|
| 722 |
+
HLT004-0000149,treatment_end_1L,148,completed_or_discontinued
|
| 723 |
+
HLT004-0000149,response_assessment,39,PR
|
| 724 |
+
HLT004-0000149,os_endpoint,452,other_cause
|
| 725 |
+
HLT004-0000150,diagnosis,0,Stage_III
|
| 726 |
+
HLT004-0000150,treatment_start_1L,26,carbo_taxol
|
| 727 |
+
HLT004-0000150,treatment_end_1L,152,completed_or_discontinued
|
| 728 |
+
HLT004-0000150,progression,415,radiographic_progression
|
| 729 |
+
HLT004-0000150,os_endpoint,699,disease
|
| 730 |
+
HLT004-0000151,diagnosis,0,Stage_IV
|
| 731 |
+
HLT004-0000151,treatment_start_1L,9,docetaxel_2L
|
| 732 |
+
HLT004-0000151,treatment_end_1L,74,completed_or_discontinued
|
| 733 |
+
HLT004-0000151,progression,49,radiographic_progression
|
| 734 |
+
HLT004-0000151,os_endpoint,74,disease
|
| 735 |
+
HLT004-0000152,diagnosis,0,Stage_IV
|
| 736 |
+
HLT004-0000152,treatment_start_1L,21,docetaxel_2L
|
| 737 |
+
HLT004-0000152,treatment_end_1L,28,completed_or_discontinued
|
| 738 |
+
HLT004-0000152,response_assessment,39,PR
|
| 739 |
+
HLT004-0000152,os_endpoint,28,disease
|
| 740 |
+
HLT004-0000153,diagnosis,0,Stage_I
|
| 741 |
+
HLT004-0000153,treatment_start_1L,21,carbo_pem_pembro
|
| 742 |
+
HLT004-0000153,treatment_end_1L,147,completed_or_discontinued
|
| 743 |
+
HLT004-0000153,progression,499,radiographic_progression
|
| 744 |
+
HLT004-0000153,os_endpoint,1598,disease
|
| 745 |
+
HLT004-0000154,diagnosis,0,Stage_III
|
| 746 |
+
HLT004-0000154,treatment_start_1L,14,pembro_mono
|
| 747 |
+
HLT004-0000154,treatment_end_1L,143,completed_or_discontinued
|
| 748 |
+
HLT004-0000154,os_endpoint,143,other_cause
|
| 749 |
+
HLT004-0000155,diagnosis,0,Stage_II
|
| 750 |
+
HLT004-0000155,treatment_start_1L,26,carbo_taxol
|
| 751 |
+
HLT004-0000155,treatment_end_1L,152,completed_or_discontinued
|
| 752 |
+
HLT004-0000155,progression,497,radiographic_progression
|
| 753 |
+
HLT004-0000155,os_endpoint,1731,disease
|
| 754 |
+
HLT004-0000156,diagnosis,0,Stage_IV
|
| 755 |
+
HLT004-0000156,treatment_start_1L,24,pembro_mono
|
| 756 |
+
HLT004-0000156,treatment_end_1L,141,completed_or_discontinued
|
| 757 |
+
HLT004-0000156,os_endpoint,141,disease
|
| 758 |
+
HLT004-0000157,diagnosis,0,Stage_IV
|
| 759 |
+
HLT004-0000157,treatment_start_1L,24,carbo_taxol
|
| 760 |
+
HLT004-0000157,treatment_end_1L,150,completed_or_discontinued
|
| 761 |
+
HLT004-0000157,response_assessment,55,PR
|
| 762 |
+
HLT004-0000157,os_endpoint,398,disease
|
| 763 |
+
HLT004-0000158,diagnosis,0,Stage_III
|
| 764 |
+
HLT004-0000158,treatment_start_1L,27,docetaxel_2L
|
| 765 |
+
HLT004-0000158,treatment_end_1L,153,completed_or_discontinued
|
| 766 |
+
HLT004-0000158,response_assessment,54,PR
|
| 767 |
+
HLT004-0000158,os_endpoint,638,disease
|
| 768 |
+
HLT004-0000159,diagnosis,0,Stage_IV
|
| 769 |
+
HLT004-0000159,treatment_start_1L,22,carbo_pem_pembro
|
| 770 |
+
HLT004-0000159,treatment_end_1L,148,completed_or_discontinued
|
| 771 |
+
HLT004-0000159,progression,14,radiographic_progression
|
| 772 |
+
HLT004-0000159,os_endpoint,344,disease
|
| 773 |
+
HLT004-0000160,diagnosis,0,Stage_IV
|
| 774 |
+
HLT004-0000160,treatment_start_1L,13,carbo_pem_pembro
|
| 775 |
+
HLT004-0000160,treatment_end_1L,139,completed_or_discontinued
|
| 776 |
+
HLT004-0000160,progression,85,radiographic_progression
|
| 777 |
+
HLT004-0000160,os_endpoint,157,censored
|
| 778 |
+
HLT004-0000161,diagnosis,0,Stage_IV
|
| 779 |
+
HLT004-0000161,treatment_start_1L,25,docetaxel_2L
|
| 780 |
+
HLT004-0000161,treatment_end_1L,151,completed_or_discontinued
|
| 781 |
+
HLT004-0000161,progression,261,radiographic_progression
|
| 782 |
+
HLT004-0000161,os_endpoint,397,disease
|
| 783 |
+
HLT004-0000162,diagnosis,0,Stage_I
|
| 784 |
+
HLT004-0000162,treatment_start_1L,19,carbo_taxol
|
| 785 |
+
HLT004-0000162,treatment_end_1L,47,completed_or_discontinued
|
| 786 |
+
HLT004-0000162,progression,38,radiographic_progression
|
| 787 |
+
HLT004-0000162,os_endpoint,47,disease
|
| 788 |
+
HLT004-0000163,diagnosis,0,Stage_I
|
| 789 |
+
HLT004-0000163,treatment_start_1L,13,carbo_pem_pembro
|
| 790 |
+
HLT004-0000163,treatment_end_1L,139,completed_or_discontinued
|
| 791 |
+
HLT004-0000163,progression,1005,radiographic_progression
|
| 792 |
+
HLT004-0000163,os_endpoint,1360,other_cause
|
| 793 |
+
HLT004-0000164,diagnosis,0,Stage_I
|
| 794 |
+
HLT004-0000164,treatment_start_1L,11,pembro_mono
|
| 795 |
+
HLT004-0000164,treatment_end_1L,746,completed_or_discontinued
|
| 796 |
+
HLT004-0000164,response_assessment,61,PR
|
| 797 |
+
HLT004-0000164,os_endpoint,771,disease
|
| 798 |
+
HLT004-0000165,diagnosis,0,Stage_III
|
| 799 |
+
HLT004-0000165,treatment_start_1L,12,docetaxel_2L
|
| 800 |
+
HLT004-0000165,treatment_end_1L,138,completed_or_discontinued
|
| 801 |
+
HLT004-0000165,progression,152,radiographic_progression
|
| 802 |
+
HLT004-0000165,os_endpoint,434,censored
|
| 803 |
+
HLT004-0000166,diagnosis,0,Stage_III
|
| 804 |
+
HLT004-0000166,treatment_start_1L,10,pembro_mono
|
| 805 |
+
HLT004-0000166,treatment_end_1L,491,completed_or_discontinued
|
| 806 |
+
HLT004-0000166,response_assessment,63,PR
|
| 807 |
+
HLT004-0000166,os_endpoint,491,disease
|
| 808 |
+
HLT004-0000167,diagnosis,0,Stage_I
|
| 809 |
+
HLT004-0000167,treatment_start_1L,23,docetaxel_2L
|
| 810 |
+
HLT004-0000167,treatment_end_1L,149,completed_or_discontinued
|
| 811 |
+
HLT004-0000167,progression,390,radiographic_progression
|
| 812 |
+
HLT004-0000167,os_endpoint,567,other_cause
|
| 813 |
+
HLT004-0000168,diagnosis,0,Stage_III
|
| 814 |
+
HLT004-0000168,treatment_start_1L,10,docetaxel_2L
|
| 815 |
+
HLT004-0000168,treatment_end_1L,136,completed_or_discontinued
|
| 816 |
+
HLT004-0000168,progression,142,radiographic_progression
|
| 817 |
+
HLT004-0000168,os_endpoint,219,other_cause
|
| 818 |
+
HLT004-0000169,diagnosis,0,Stage_III
|
| 819 |
+
HLT004-0000169,treatment_start_1L,26,carbo_pem_pembro
|
| 820 |
+
HLT004-0000169,treatment_end_1L,152,completed_or_discontinued
|
| 821 |
+
HLT004-0000169,progression,417,radiographic_progression
|
| 822 |
+
HLT004-0000169,os_endpoint,981,disease
|
| 823 |
+
HLT004-0000170,diagnosis,0,Stage_I
|
| 824 |
+
HLT004-0000170,treatment_start_1L,12,pembro_mono
|
| 825 |
+
HLT004-0000170,treatment_end_1L,712,completed_or_discontinued
|
| 826 |
+
HLT004-0000170,progression,502,radiographic_progression
|
| 827 |
+
HLT004-0000170,os_endpoint,712,censored
|
| 828 |
+
HLT004-0000171,diagnosis,0,Stage_IV
|
| 829 |
+
HLT004-0000171,treatment_start_1L,9,pembro_mono
|
| 830 |
+
HLT004-0000171,treatment_end_1L,321,completed_or_discontinued
|
| 831 |
+
HLT004-0000171,response_assessment,80,CR
|
| 832 |
+
HLT004-0000171,os_endpoint,321,disease
|
| 833 |
+
HLT004-0000172,diagnosis,0,Stage_IV
|
| 834 |
+
HLT004-0000172,treatment_start_1L,25,docetaxel_2L
|
| 835 |
+
HLT004-0000172,treatment_end_1L,151,completed_or_discontinued
|
| 836 |
+
HLT004-0000172,progression,321,radiographic_progression
|
| 837 |
+
HLT004-0000172,os_endpoint,762,disease
|
| 838 |
+
HLT004-0000173,diagnosis,0,Stage_III
|
| 839 |
+
HLT004-0000173,treatment_start_1L,14,carbo_taxol
|
| 840 |
+
HLT004-0000173,treatment_end_1L,48,completed_or_discontinued
|
| 841 |
+
HLT004-0000173,progression,32,radiographic_progression
|
| 842 |
+
HLT004-0000173,os_endpoint,48,other_cause
|
| 843 |
+
HLT004-0000174,diagnosis,0,Stage_III
|
| 844 |
+
HLT004-0000174,treatment_start_1L,25,carbo_pem_pembro
|
| 845 |
+
HLT004-0000174,treatment_end_1L,151,completed_or_discontinued
|
| 846 |
+
HLT004-0000174,progression,530,radiographic_progression
|
| 847 |
+
HLT004-0000174,os_endpoint,636,disease
|
| 848 |
+
HLT004-0000175,diagnosis,0,Stage_III
|
| 849 |
+
HLT004-0000175,treatment_start_1L,7,docetaxel_2L
|
| 850 |
+
HLT004-0000175,treatment_end_1L,133,completed_or_discontinued
|
| 851 |
+
HLT004-0000175,progression,268,radiographic_progression
|
| 852 |
+
HLT004-0000175,os_endpoint,419,disease
|
| 853 |
+
HLT004-0000176,diagnosis,0,Stage_IV
|
| 854 |
+
HLT004-0000176,treatment_start_1L,19,carbo_taxol
|
| 855 |
+
HLT004-0000176,treatment_end_1L,145,completed_or_discontinued
|
| 856 |
+
HLT004-0000176,response_assessment,30,PR
|
| 857 |
+
HLT004-0000176,os_endpoint,203,censored
|
| 858 |
+
HLT004-0000177,diagnosis,0,Stage_IV
|
| 859 |
+
HLT004-0000177,treatment_start_1L,20,carbo_pem_pembro
|
| 860 |
+
HLT004-0000177,treatment_end_1L,82,completed_or_discontinued
|
| 861 |
+
HLT004-0000177,progression,73,radiographic_progression
|
| 862 |
+
HLT004-0000177,os_endpoint,82,other_cause
|
| 863 |
+
HLT004-0000178,diagnosis,0,Stage_III
|
| 864 |
+
HLT004-0000178,treatment_start_1L,22,docetaxel_2L
|
| 865 |
+
HLT004-0000178,treatment_end_1L,61,completed_or_discontinued
|
| 866 |
+
HLT004-0000178,os_endpoint,61,other_cause
|
| 867 |
+
HLT004-0000179,diagnosis,0,Stage_IV
|
| 868 |
+
HLT004-0000179,treatment_start_1L,8,pembro_mono
|
| 869 |
+
HLT004-0000179,treatment_end_1L,278,completed_or_discontinued
|
| 870 |
+
HLT004-0000179,progression,127,radiographic_progression
|
| 871 |
+
HLT004-0000179,os_endpoint,278,disease
|
| 872 |
+
HLT004-0000180,diagnosis,0,Stage_IV
|
| 873 |
+
HLT004-0000180,treatment_start_1L,8,carbo_pem_pembro
|
| 874 |
+
HLT004-0000180,treatment_end_1L,134,completed_or_discontinued
|
| 875 |
+
HLT004-0000180,response_assessment,88,PR
|
| 876 |
+
HLT004-0000180,os_endpoint,337,disease
|
| 877 |
+
HLT004-0000181,diagnosis,0,Stage_IV
|
| 878 |
+
HLT004-0000181,treatment_start_1L,13,carbo_pem_pembro
|
| 879 |
+
HLT004-0000181,treatment_end_1L,139,completed_or_discontinued
|
| 880 |
+
HLT004-0000181,response_assessment,50,PR
|
| 881 |
+
HLT004-0000181,os_endpoint,590,disease
|
| 882 |
+
HLT004-0000182,diagnosis,0,Stage_II
|
| 883 |
+
HLT004-0000182,treatment_start_1L,13,carbo_pem_pembro
|
| 884 |
+
HLT004-0000182,treatment_end_1L,139,completed_or_discontinued
|
| 885 |
+
HLT004-0000182,progression,149,radiographic_progression
|
| 886 |
+
HLT004-0000182,os_endpoint,243,disease
|
| 887 |
+
HLT004-0000183,diagnosis,0,Stage_I
|
| 888 |
+
HLT004-0000183,treatment_start_1L,26,docetaxel_2L
|
| 889 |
+
HLT004-0000183,treatment_end_1L,152,completed_or_discontinued
|
| 890 |
+
HLT004-0000183,os_endpoint,728,other_cause
|
| 891 |
+
HLT004-0000184,diagnosis,0,Stage_IV
|
| 892 |
+
HLT004-0000184,treatment_start_1L,23,carbo_taxol
|
| 893 |
+
HLT004-0000184,treatment_end_1L,43,completed_or_discontinued
|
| 894 |
+
HLT004-0000184,os_endpoint,43,censored
|
| 895 |
+
HLT004-0000185,diagnosis,0,Stage_III
|
| 896 |
+
HLT004-0000185,treatment_start_1L,26,carbo_pem_pembro
|
| 897 |
+
HLT004-0000185,treatment_end_1L,152,completed_or_discontinued
|
| 898 |
+
HLT004-0000185,progression,101,radiographic_progression
|
| 899 |
+
HLT004-0000185,os_endpoint,220,disease
|
| 900 |
+
HLT004-0000186,diagnosis,0,Stage_IV
|
| 901 |
+
HLT004-0000186,treatment_start_1L,23,carbo_pem_pembro
|
| 902 |
+
HLT004-0000186,treatment_end_1L,149,completed_or_discontinued
|
| 903 |
+
HLT004-0000186,response_assessment,33,PR
|
| 904 |
+
HLT004-0000186,os_endpoint,385,disease
|
| 905 |
+
HLT004-0000187,diagnosis,0,Stage_IV
|
| 906 |
+
HLT004-0000187,treatment_start_1L,12,carbo_pem_pembro
|
| 907 |
+
HLT004-0000187,treatment_end_1L,138,completed_or_discontinued
|
| 908 |
+
HLT004-0000187,progression,121,radiographic_progression
|
| 909 |
+
HLT004-0000187,os_endpoint,565,disease
|
| 910 |
+
HLT004-0000188,diagnosis,0,Stage_III
|
| 911 |
+
HLT004-0000188,treatment_start_1L,9,carbo_pem_pembro
|
| 912 |
+
HLT004-0000188,treatment_end_1L,91,completed_or_discontinued
|
| 913 |
+
HLT004-0000188,progression,79,radiographic_progression
|
| 914 |
+
HLT004-0000188,os_endpoint,91,other_cause
|
| 915 |
+
HLT004-0000189,diagnosis,0,Stage_III
|
| 916 |
+
HLT004-0000189,treatment_start_1L,8,carbo_taxol
|
| 917 |
+
HLT004-0000189,treatment_end_1L,30,completed_or_discontinued
|
| 918 |
+
HLT004-0000189,response_assessment,48,PR
|
| 919 |
+
HLT004-0000189,os_endpoint,30,censored
|
| 920 |
+
HLT004-0000190,diagnosis,0,Stage_III
|
| 921 |
+
HLT004-0000190,treatment_start_1L,27,pembro_mono
|
| 922 |
+
HLT004-0000190,treatment_end_1L,655,completed_or_discontinued
|
| 923 |
+
HLT004-0000190,progression,156,radiographic_progression
|
| 924 |
+
HLT004-0000190,os_endpoint,655,other_cause
|
| 925 |
+
HLT004-0000191,diagnosis,0,Stage_III
|
| 926 |
+
HLT004-0000191,treatment_start_1L,21,carbo_taxol
|
| 927 |
+
HLT004-0000191,treatment_end_1L,147,completed_or_discontinued
|
| 928 |
+
HLT004-0000191,progression,217,radiographic_progression
|
| 929 |
+
HLT004-0000191,os_endpoint,395,disease
|
| 930 |
+
HLT004-0000192,diagnosis,0,Stage_IV
|
| 931 |
+
HLT004-0000192,treatment_start_1L,23,carbo_pem_pembro
|
| 932 |
+
HLT004-0000192,treatment_end_1L,53,completed_or_discontinued
|
| 933 |
+
HLT004-0000192,os_endpoint,53,disease
|
| 934 |
+
HLT004-0000193,diagnosis,0,Stage_IV
|
| 935 |
+
HLT004-0000193,treatment_start_1L,27,carbo_taxol
|
| 936 |
+
HLT004-0000193,treatment_end_1L,153,completed_or_discontinued
|
| 937 |
+
HLT004-0000193,progression,107,radiographic_progression
|
| 938 |
+
HLT004-0000193,os_endpoint,236,disease
|
| 939 |
+
HLT004-0000194,diagnosis,0,Stage_III
|
| 940 |
+
HLT004-0000194,treatment_start_1L,13,carbo_taxol
|
| 941 |
+
HLT004-0000194,treatment_end_1L,139,completed_or_discontinued
|
| 942 |
+
HLT004-0000194,response_assessment,45,PR
|
| 943 |
+
HLT004-0000194,os_endpoint,370,disease
|
| 944 |
+
HLT004-0000195,diagnosis,0,Stage_IV
|
| 945 |
+
HLT004-0000195,treatment_start_1L,24,carbo_pem_pembro
|
| 946 |
+
HLT004-0000195,treatment_end_1L,150,completed_or_discontinued
|
| 947 |
+
HLT004-0000195,response_assessment,65,PR
|
| 948 |
+
HLT004-0000195,os_endpoint,463,disease
|
| 949 |
+
HLT004-0000196,diagnosis,0,Stage_III
|
| 950 |
+
HLT004-0000196,treatment_start_1L,24,carbo_pem_pembro
|
| 951 |
+
HLT004-0000196,treatment_end_1L,150,completed_or_discontinued
|
| 952 |
+
HLT004-0000196,progression,439,radiographic_progression
|
| 953 |
+
HLT004-0000196,os_endpoint,800,censored
|
| 954 |
+
HLT004-0000197,diagnosis,0,Stage_IV
|
| 955 |
+
HLT004-0000197,treatment_start_1L,24,carbo_pem_pembro
|
| 956 |
+
HLT004-0000197,treatment_end_1L,150,completed_or_discontinued
|
| 957 |
+
HLT004-0000197,progression,102,radiographic_progression
|
| 958 |
+
HLT004-0000197,os_endpoint,307,disease
|
| 959 |
+
HLT004-0000198,diagnosis,0,Stage_II
|
| 960 |
+
HLT004-0000198,treatment_start_1L,9,carbo_taxol
|
| 961 |
+
HLT004-0000198,treatment_end_1L,135,completed_or_discontinued
|
| 962 |
+
HLT004-0000198,response_assessment,50,PR
|
| 963 |
+
HLT004-0000198,os_endpoint,1306,disease
|
| 964 |
+
HLT004-0000199,diagnosis,0,Stage_IV
|
| 965 |
+
HLT004-0000199,treatment_start_1L,18,pembro_mono
|
| 966 |
+
HLT004-0000199,treatment_end_1L,253,completed_or_discontinued
|
| 967 |
+
HLT004-0000199,os_endpoint,253,disease
|
| 968 |
+
HLT004-0000200,diagnosis,0,Stage_IV
|
| 969 |
+
HLT004-0000200,treatment_start_1L,7,carbo_pem_pembro
|
| 970 |
+
HLT004-0000200,treatment_end_1L,133,completed_or_discontinued
|
| 971 |
+
HLT004-0000200,progression,152,radiographic_progression
|
| 972 |
+
HLT004-0000200,os_endpoint,180,disease
|
| 973 |
+
HLT004-0000201,diagnosis,0,Stage_III
|
| 974 |
+
HLT004-0000201,treatment_start_1L,28,docetaxel_2L
|
| 975 |
+
HLT004-0000201,treatment_end_1L,154,completed_or_discontinued
|
| 976 |
+
HLT004-0000201,progression,180,radiographic_progression
|
| 977 |
+
HLT004-0000201,os_endpoint,1393,disease
|
| 978 |
+
HLT004-0000202,diagnosis,0,Stage_IV
|
| 979 |
+
HLT004-0000202,treatment_start_1L,25,pembro_mono
|
| 980 |
+
HLT004-0000202,treatment_end_1L,210,completed_or_discontinued
|
| 981 |
+
HLT004-0000202,progression,36,radiographic_progression
|
| 982 |
+
HLT004-0000202,os_endpoint,210,disease
|
| 983 |
+
HLT004-0000203,diagnosis,0,Stage_IV
|
| 984 |
+
HLT004-0000203,treatment_start_1L,27,carbo_pem_pembro
|
| 985 |
+
HLT004-0000203,treatment_end_1L,153,completed_or_discontinued
|
| 986 |
+
HLT004-0000203,response_assessment,55,PR
|
| 987 |
+
HLT004-0000203,os_endpoint,214,censored
|
| 988 |
+
HLT004-0000204,diagnosis,0,Stage_II
|
| 989 |
+
HLT004-0000204,treatment_start_1L,11,carbo_pem_pembro
|
| 990 |
+
HLT004-0000204,treatment_end_1L,137,completed_or_discontinued
|
| 991 |
+
HLT004-0000204,progression,107,radiographic_progression
|
| 992 |
+
HLT004-0000204,os_endpoint,692,censored
|
| 993 |
+
HLT004-0000205,diagnosis,0,Stage_IV
|
| 994 |
+
HLT004-0000205,treatment_start_1L,16,carbo_pem_pembro
|
| 995 |
+
HLT004-0000205,treatment_end_1L,142,completed_or_discontinued
|
| 996 |
+
HLT004-0000205,response_assessment,72,PR
|
| 997 |
+
HLT004-0000205,os_endpoint,993,censored
|
| 998 |
+
HLT004-0000206,diagnosis,0,Stage_IV
|
| 999 |
+
HLT004-0000206,treatment_start_1L,10,carbo_pem_pembro
|
| 1000 |
+
HLT004-0000206,treatment_end_1L,136,completed_or_discontinued
|
| 1001 |
+
HLT004-0000206,progression,36,radiographic_progression
|
| 1002 |
+
HLT004-0000206,os_endpoint,233,disease
|
| 1003 |
+
HLT004-0000207,diagnosis,0,Stage_IV
|
| 1004 |
+
HLT004-0000207,treatment_start_1L,23,carbo_taxol
|
| 1005 |
+
HLT004-0000207,treatment_end_1L,149,completed_or_discontinued
|
| 1006 |
+
HLT004-0000207,response_assessment,72,PR
|
| 1007 |
+
HLT004-0000207,os_endpoint,152,disease
|
| 1008 |
+
HLT004-0000208,diagnosis,0,Stage_III
|
| 1009 |
+
HLT004-0000208,treatment_start_1L,11,carbo_pem_pembro
|
| 1010 |
+
HLT004-0000208,treatment_end_1L,137,completed_or_discontinued
|
| 1011 |
+
HLT004-0000208,progression,552,radiographic_progression
|
| 1012 |
+
HLT004-0000208,os_endpoint,1666,censored
|
| 1013 |
+
HLT004-0000209,diagnosis,0,Stage_IV
|
| 1014 |
+
HLT004-0000209,treatment_start_1L,27,docetaxel_2L
|
| 1015 |
+
HLT004-0000209,treatment_end_1L,153,completed_or_discontinued
|
| 1016 |
+
HLT004-0000209,progression,119,radiographic_progression
|
| 1017 |
+
HLT004-0000209,os_endpoint,562,disease
|
| 1018 |
+
HLT004-0000210,diagnosis,0,Stage_IV
|
| 1019 |
+
HLT004-0000210,treatment_start_1L,17,carbo_taxol
|
| 1020 |
+
HLT004-0000210,treatment_end_1L,143,completed_or_discontinued
|
| 1021 |
+
HLT004-0000210,progression,271,radiographic_progression
|
| 1022 |
+
HLT004-0000210,os_endpoint,587,disease
|
| 1023 |
+
HLT004-0000211,diagnosis,0,Stage_IV
|
| 1024 |
+
HLT004-0000211,treatment_start_1L,10,pembro_mono
|
| 1025 |
+
HLT004-0000211,treatment_end_1L,99,completed_or_discontinued
|
| 1026 |
+
HLT004-0000211,response_assessment,75,PR
|
| 1027 |
+
HLT004-0000211,os_endpoint,99,censored
|
| 1028 |
+
HLT004-0000212,diagnosis,0,Stage_I
|
| 1029 |
+
HLT004-0000212,treatment_start_1L,16,docetaxel_2L
|
| 1030 |
+
HLT004-0000212,treatment_end_1L,142,completed_or_discontinued
|
| 1031 |
+
HLT004-0000212,progression,651,radiographic_progression
|
| 1032 |
+
HLT004-0000212,os_endpoint,832,censored
|
| 1033 |
+
HLT004-0000213,diagnosis,0,Stage_I
|
| 1034 |
+
HLT004-0000213,treatment_start_1L,17,pembro_mono
|
| 1035 |
+
HLT004-0000213,treatment_end_1L,117,completed_or_discontinued
|
| 1036 |
+
HLT004-0000213,progression,91,radiographic_progression
|
| 1037 |
+
HLT004-0000213,os_endpoint,117,censored
|
| 1038 |
+
HLT004-0000214,diagnosis,0,Stage_IV
|
| 1039 |
+
HLT004-0000214,treatment_start_1L,18,docetaxel_2L
|
| 1040 |
+
HLT004-0000214,treatment_end_1L,144,completed_or_discontinued
|
| 1041 |
+
HLT004-0000214,response_assessment,81,PR
|
| 1042 |
+
HLT004-0000214,os_endpoint,337,disease
|
| 1043 |
+
HLT004-0000215,diagnosis,0,Stage_III
|
| 1044 |
+
HLT004-0000215,treatment_start_1L,17,docetaxel_2L
|
| 1045 |
+
HLT004-0000215,treatment_end_1L,143,completed_or_discontinued
|
| 1046 |
+
HLT004-0000215,response_assessment,48,PR
|
| 1047 |
+
HLT004-0000215,os_endpoint,229,disease
|
| 1048 |
+
HLT004-0000216,diagnosis,0,Stage_II
|
| 1049 |
+
HLT004-0000216,treatment_start_1L,13,carbo_taxol
|
| 1050 |
+
HLT004-0000216,treatment_end_1L,139,completed_or_discontinued
|
| 1051 |
+
HLT004-0000216,progression,1308,radiographic_progression
|
| 1052 |
+
HLT004-0000216,os_endpoint,1492,censored
|
| 1053 |
+
HLT004-0000217,diagnosis,0,Stage_III
|
| 1054 |
+
HLT004-0000217,treatment_start_1L,29,carbo_pem_pembro
|
| 1055 |
+
HLT004-0000217,treatment_end_1L,155,completed_or_discontinued
|
| 1056 |
+
HLT004-0000217,os_endpoint,533,disease
|
| 1057 |
+
HLT004-0000218,diagnosis,0,Stage_IV
|
| 1058 |
+
HLT004-0000218,treatment_start_1L,7,carbo_pem_pembro
|
| 1059 |
+
HLT004-0000218,treatment_end_1L,121,completed_or_discontinued
|
| 1060 |
+
HLT004-0000218,os_endpoint,121,disease
|
| 1061 |
+
HLT004-0000219,diagnosis,0,Stage_III
|
| 1062 |
+
HLT004-0000219,treatment_start_1L,23,carbo_pem_pembro
|
| 1063 |
+
HLT004-0000219,treatment_end_1L,149,completed_or_discontinued
|
| 1064 |
+
HLT004-0000219,progression,353,radiographic_progression
|
| 1065 |
+
HLT004-0000219,os_endpoint,541,disease
|
| 1066 |
+
HLT004-0000220,diagnosis,0,Stage_IV
|
| 1067 |
+
HLT004-0000220,treatment_start_1L,11,pembro_mono
|
| 1068 |
+
HLT004-0000220,treatment_end_1L,194,completed_or_discontinued
|
| 1069 |
+
HLT004-0000220,progression,122,radiographic_progression
|
| 1070 |
+
HLT004-0000220,os_endpoint,194,disease
|
| 1071 |
+
HLT004-0000221,diagnosis,0,Stage_IV
|
| 1072 |
+
HLT004-0000221,treatment_start_1L,20,carbo_pem_pembro
|
| 1073 |
+
HLT004-0000221,treatment_end_1L,146,completed_or_discontinued
|
| 1074 |
+
HLT004-0000221,progression,223,radiographic_progression
|
| 1075 |
+
HLT004-0000221,os_endpoint,616,disease
|
| 1076 |
+
HLT004-0000222,diagnosis,0,Stage_IV
|
| 1077 |
+
HLT004-0000222,treatment_start_1L,21,carbo_taxol
|
| 1078 |
+
HLT004-0000222,treatment_end_1L,147,completed_or_discontinued
|
| 1079 |
+
HLT004-0000222,progression,169,radiographic_progression
|
| 1080 |
+
HLT004-0000222,os_endpoint,329,disease
|
| 1081 |
+
HLT004-0000223,diagnosis,0,Stage_IV
|
| 1082 |
+
HLT004-0000223,treatment_start_1L,24,docetaxel_2L
|
| 1083 |
+
HLT004-0000223,treatment_end_1L,150,completed_or_discontinued
|
| 1084 |
+
HLT004-0000223,response_assessment,54,PR
|
| 1085 |
+
HLT004-0000223,os_endpoint,507,disease
|
| 1086 |
+
HLT004-0000224,diagnosis,0,Stage_II
|
| 1087 |
+
HLT004-0000224,treatment_start_1L,9,carbo_taxol
|
| 1088 |
+
HLT004-0000224,treatment_end_1L,135,completed_or_discontinued
|
| 1089 |
+
HLT004-0000224,os_endpoint,663,other_cause
|
| 1090 |
+
HLT004-0000225,diagnosis,0,Stage_IV
|
| 1091 |
+
HLT004-0000225,treatment_start_1L,13,carbo_taxol
|
| 1092 |
+
HLT004-0000225,treatment_end_1L,139,completed_or_discontinued
|
| 1093 |
+
HLT004-0000225,progression,54,radiographic_progression
|
| 1094 |
+
HLT004-0000225,os_endpoint,183,disease
|
| 1095 |
+
HLT004-0000226,diagnosis,0,Stage_I
|
| 1096 |
+
HLT004-0000226,treatment_start_1L,11,carbo_taxol
|
| 1097 |
+
HLT004-0000226,treatment_end_1L,137,completed_or_discontinued
|
| 1098 |
+
HLT004-0000226,response_assessment,39,PR
|
| 1099 |
+
HLT004-0000226,os_endpoint,1825,censored
|
| 1100 |
+
HLT004-0000227,diagnosis,0,Stage_IV
|
| 1101 |
+
HLT004-0000227,treatment_start_1L,10,pembro_mono
|
| 1102 |
+
HLT004-0000227,treatment_end_1L,141,completed_or_discontinued
|
| 1103 |
+
HLT004-0000227,progression,56,radiographic_progression
|
| 1104 |
+
HLT004-0000227,os_endpoint,141,disease
|
| 1105 |
+
HLT004-0000228,diagnosis,0,Stage_III
|
| 1106 |
+
HLT004-0000228,treatment_start_1L,27,pembro_mono
|
| 1107 |
+
HLT004-0000228,treatment_end_1L,385,completed_or_discontinued
|
| 1108 |
+
HLT004-0000228,progression,292,radiographic_progression
|
| 1109 |
+
HLT004-0000228,os_endpoint,385,disease
|
| 1110 |
+
HLT004-0000229,diagnosis,0,Stage_IV
|
| 1111 |
+
HLT004-0000229,treatment_start_1L,26,carbo_pem_pembro
|
| 1112 |
+
HLT004-0000229,treatment_end_1L,41,completed_or_discontinued
|
| 1113 |
+
HLT004-0000229,progression,25,radiographic_progression
|
| 1114 |
+
HLT004-0000229,os_endpoint,41,disease
|
| 1115 |
+
HLT004-0000230,diagnosis,0,Stage_IV
|
| 1116 |
+
HLT004-0000230,treatment_start_1L,8,pembro_mono
|
| 1117 |
+
HLT004-0000230,treatment_end_1L,474,completed_or_discontinued
|
| 1118 |
+
HLT004-0000230,progression,200,radiographic_progression
|
| 1119 |
+
HLT004-0000230,os_endpoint,474,disease
|
| 1120 |
+
HLT004-0000231,diagnosis,0,Stage_I
|
| 1121 |
+
HLT004-0000231,treatment_start_1L,23,carbo_taxol
|
| 1122 |
+
HLT004-0000231,treatment_end_1L,149,completed_or_discontinued
|
| 1123 |
+
HLT004-0000231,progression,137,radiographic_progression
|
| 1124 |
+
HLT004-0000231,os_endpoint,204,censored
|
| 1125 |
+
HLT004-0000232,diagnosis,0,Stage_IV
|
| 1126 |
+
HLT004-0000232,treatment_start_1L,24,pembro_mono
|
| 1127 |
+
HLT004-0000232,treatment_end_1L,580,completed_or_discontinued
|
| 1128 |
+
HLT004-0000232,progression,6,radiographic_progression
|
| 1129 |
+
HLT004-0000232,os_endpoint,580,disease
|
| 1130 |
+
HLT004-0000233,diagnosis,0,Stage_I
|
| 1131 |
+
HLT004-0000233,treatment_start_1L,9,pembro_mono
|
| 1132 |
+
HLT004-0000233,treatment_end_1L,744,completed_or_discontinued
|
| 1133 |
+
HLT004-0000233,progression,492,radiographic_progression
|
| 1134 |
+
HLT004-0000233,os_endpoint,1825,censored
|
| 1135 |
+
HLT004-0000234,diagnosis,0,Stage_III
|
| 1136 |
+
HLT004-0000234,treatment_start_1L,20,carbo_taxol
|
| 1137 |
+
HLT004-0000234,treatment_end_1L,146,completed_or_discontinued
|
| 1138 |
+
HLT004-0000234,progression,145,radiographic_progression
|
| 1139 |
+
HLT004-0000234,os_endpoint,415,disease
|
| 1140 |
+
HLT004-0000235,diagnosis,0,Stage_III
|
| 1141 |
+
HLT004-0000235,treatment_start_1L,16,docetaxel_2L
|
| 1142 |
+
HLT004-0000235,treatment_end_1L,10,completed_or_discontinued
|
| 1143 |
+
HLT004-0000235,progression,7,radiographic_progression
|
| 1144 |
+
HLT004-0000235,os_endpoint,10,other_cause
|
| 1145 |
+
HLT004-0000236,diagnosis,0,Stage_III
|
| 1146 |
+
HLT004-0000236,treatment_start_1L,10,docetaxel_2L
|
| 1147 |
+
HLT004-0000236,treatment_end_1L,136,completed_or_discontinued
|
| 1148 |
+
HLT004-0000236,progression,288,radiographic_progression
|
| 1149 |
+
HLT004-0000236,os_endpoint,1055,censored
|
| 1150 |
+
HLT004-0000237,diagnosis,0,Stage_IV
|
| 1151 |
+
HLT004-0000237,treatment_start_1L,17,docetaxel_2L
|
| 1152 |
+
HLT004-0000237,treatment_end_1L,143,completed_or_discontinued
|
| 1153 |
+
HLT004-0000237,progression,100,radiographic_progression
|
| 1154 |
+
HLT004-0000237,os_endpoint,1111,disease
|
| 1155 |
+
HLT004-0000238,diagnosis,0,Stage_IV
|
| 1156 |
+
HLT004-0000238,treatment_start_1L,19,pembro_mono
|
| 1157 |
+
HLT004-0000238,treatment_end_1L,232,completed_or_discontinued
|
| 1158 |
+
HLT004-0000238,response_assessment,86,PR
|
| 1159 |
+
HLT004-0000238,os_endpoint,232,disease
|
| 1160 |
+
HLT004-0000239,diagnosis,0,Stage_III
|
| 1161 |
+
HLT004-0000239,treatment_start_1L,16,pembro_mono
|
| 1162 |
+
HLT004-0000239,treatment_end_1L,219,completed_or_discontinued
|
| 1163 |
+
HLT004-0000239,os_endpoint,219,censored
|
| 1164 |
+
HLT004-0000240,diagnosis,0,Stage_IV
|
| 1165 |
+
HLT004-0000240,treatment_start_1L,26,carbo_taxol
|
| 1166 |
+
HLT004-0000240,treatment_end_1L,152,completed_or_discontinued
|
| 1167 |
+
HLT004-0000240,progression,186,radiographic_progression
|
| 1168 |
+
HLT004-0000240,os_endpoint,261,censored
|
| 1169 |
+
HLT004-0000241,diagnosis,0,Stage_IV
|
| 1170 |
+
HLT004-0000241,treatment_start_1L,24,pembro_mono
|
| 1171 |
+
HLT004-0000241,treatment_end_1L,371,completed_or_discontinued
|
| 1172 |
+
HLT004-0000241,response_assessment,74,PR
|
| 1173 |
+
HLT004-0000241,os_endpoint,371,disease
|
| 1174 |
+
HLT004-0000242,diagnosis,0,Stage_IV
|
| 1175 |
+
HLT004-0000242,treatment_start_1L,24,docetaxel_2L
|
| 1176 |
+
HLT004-0000242,treatment_end_1L,150,completed_or_discontinued
|
| 1177 |
+
HLT004-0000242,progression,63,radiographic_progression
|
| 1178 |
+
HLT004-0000242,os_endpoint,677,other_cause
|
| 1179 |
+
HLT004-0000243,diagnosis,0,Stage_I
|
| 1180 |
+
HLT004-0000243,treatment_start_1L,20,carbo_pem_pembro
|
| 1181 |
+
HLT004-0000243,treatment_end_1L,146,completed_or_discontinued
|
| 1182 |
+
HLT004-0000243,progression,538,radiographic_progression
|
| 1183 |
+
HLT004-0000243,os_endpoint,1825,censored
|
| 1184 |
+
HLT004-0000244,diagnosis,0,Stage_IV
|
| 1185 |
+
HLT004-0000244,treatment_start_1L,22,carbo_pem_pembro
|
| 1186 |
+
HLT004-0000244,treatment_end_1L,148,completed_or_discontinued
|
| 1187 |
+
HLT004-0000244,progression,49,radiographic_progression
|
| 1188 |
+
HLT004-0000244,os_endpoint,249,censored
|
| 1189 |
+
HLT004-0000245,diagnosis,0,Stage_I
|
| 1190 |
+
HLT004-0000245,treatment_start_1L,24,carbo_taxol
|
| 1191 |
+
HLT004-0000245,treatment_end_1L,150,completed_or_discontinued
|
| 1192 |
+
HLT004-0000245,response_assessment,33,PR
|
| 1193 |
+
HLT004-0000245,os_endpoint,1825,censored
|
| 1194 |
+
HLT004-0000246,diagnosis,0,Stage_IV
|
| 1195 |
+
HLT004-0000246,treatment_start_1L,25,carbo_pem_pembro
|
| 1196 |
+
HLT004-0000246,treatment_end_1L,151,completed_or_discontinued
|
| 1197 |
+
HLT004-0000246,progression,32,radiographic_progression
|
| 1198 |
+
HLT004-0000246,os_endpoint,315,disease
|
| 1199 |
+
HLT004-0000247,diagnosis,0,Stage_IV
|
| 1200 |
+
HLT004-0000247,treatment_start_1L,14,carbo_pem_pembro
|
| 1201 |
+
HLT004-0000247,treatment_end_1L,140,completed_or_discontinued
|
| 1202 |
+
HLT004-0000247,response_assessment,52,PR
|
| 1203 |
+
HLT004-0000247,os_endpoint,310,disease
|
| 1204 |
+
HLT004-0000248,diagnosis,0,Stage_IV
|
| 1205 |
+
HLT004-0000248,treatment_start_1L,12,carbo_pem_pembro
|
| 1206 |
+
HLT004-0000248,treatment_end_1L,138,completed_or_discontinued
|
| 1207 |
+
HLT004-0000248,progression,261,radiographic_progression
|
| 1208 |
+
HLT004-0000248,os_endpoint,587,disease
|
| 1209 |
+
HLT004-0000249,diagnosis,0,Stage_I
|
| 1210 |
+
HLT004-0000249,treatment_start_1L,17,pembro_mono
|
| 1211 |
+
HLT004-0000249,treatment_end_1L,752,completed_or_discontinued
|
| 1212 |
+
HLT004-0000249,progression,1289,radiographic_progression
|
| 1213 |
+
HLT004-0000249,os_endpoint,1825,censored
|
| 1214 |
+
HLT004-0000250,diagnosis,0,Stage_I
|
| 1215 |
+
HLT004-0000250,treatment_start_1L,19,carbo_pem_pembro
|
| 1216 |
+
HLT004-0000250,treatment_end_1L,145,completed_or_discontinued
|
| 1217 |
+
HLT004-0000250,response_assessment,62,PR
|
| 1218 |
+
HLT004-0000250,os_endpoint,195,censored
|
| 1219 |
+
HLT004-0000251,diagnosis,0,Stage_IV
|
| 1220 |
+
HLT004-0000251,treatment_start_1L,13,carbo_pem_pembro
|
| 1221 |
+
HLT004-0000251,treatment_end_1L,26,completed_or_discontinued
|
| 1222 |
+
HLT004-0000251,progression,18,radiographic_progression
|
| 1223 |
+
HLT004-0000251,os_endpoint,26,disease
|
| 1224 |
+
HLT004-0000252,diagnosis,0,Stage_I
|
| 1225 |
+
HLT004-0000252,treatment_start_1L,23,pembro_mono
|
| 1226 |
+
HLT004-0000252,treatment_end_1L,758,completed_or_discontinued
|
| 1227 |
+
HLT004-0000252,response_assessment,30,PR
|
| 1228 |
+
HLT004-0000252,os_endpoint,1825,censored
|
| 1229 |
+
HLT004-0000253,diagnosis,0,Stage_III
|
| 1230 |
+
HLT004-0000253,treatment_start_1L,18,carbo_taxol
|
| 1231 |
+
HLT004-0000253,treatment_end_1L,144,completed_or_discontinued
|
| 1232 |
+
HLT004-0000253,os_endpoint,1120,disease
|
| 1233 |
+
HLT004-0000254,diagnosis,0,Stage_IV
|
| 1234 |
+
HLT004-0000254,treatment_start_1L,10,carbo_taxol
|
| 1235 |
+
HLT004-0000254,treatment_end_1L,134,completed_or_discontinued
|
| 1236 |
+
HLT004-0000254,response_assessment,67,PR
|
| 1237 |
+
HLT004-0000254,os_endpoint,134,disease
|
| 1238 |
+
HLT004-0000255,diagnosis,0,Stage_IV
|
| 1239 |
+
HLT004-0000255,treatment_start_1L,13,docetaxel_2L
|
| 1240 |
+
HLT004-0000255,treatment_end_1L,139,completed_or_discontinued
|
| 1241 |
+
HLT004-0000255,progression,142,radiographic_progression
|
| 1242 |
+
HLT004-0000255,os_endpoint,638,disease
|
| 1243 |
+
HLT004-0000256,diagnosis,0,Stage_II
|
| 1244 |
+
HLT004-0000256,treatment_start_1L,19,docetaxel_2L
|
| 1245 |
+
HLT004-0000256,treatment_end_1L,145,completed_or_discontinued
|
| 1246 |
+
HLT004-0000256,progression,937,radiographic_progression
|
| 1247 |
+
HLT004-0000256,os_endpoint,1103,disease
|
| 1248 |
+
HLT004-0000257,diagnosis,0,Stage_III
|
| 1249 |
+
HLT004-0000257,treatment_start_1L,20,pembro_mono
|
| 1250 |
+
HLT004-0000257,treatment_end_1L,401,completed_or_discontinued
|
| 1251 |
+
HLT004-0000257,os_endpoint,401,disease
|
| 1252 |
+
HLT004-0000258,diagnosis,0,Stage_IV
|
| 1253 |
+
HLT004-0000258,treatment_start_1L,21,carbo_pem_pembro
|
| 1254 |
+
HLT004-0000258,treatment_end_1L,147,completed_or_discontinued
|
| 1255 |
+
HLT004-0000258,response_assessment,76,PR
|
| 1256 |
+
HLT004-0000258,os_endpoint,403,disease
|
| 1257 |
+
HLT004-0000259,diagnosis,0,Stage_III
|
| 1258 |
+
HLT004-0000259,treatment_start_1L,8,carbo_pem_pembro
|
| 1259 |
+
HLT004-0000259,treatment_end_1L,134,completed_or_discontinued
|
| 1260 |
+
HLT004-0000259,progression,280,radiographic_progression
|
| 1261 |
+
HLT004-0000259,os_endpoint,984,disease
|
| 1262 |
+
HLT004-0000260,diagnosis,0,Stage_I
|
| 1263 |
+
HLT004-0000260,treatment_start_1L,13,docetaxel_2L
|
| 1264 |
+
HLT004-0000260,treatment_end_1L,139,completed_or_discontinued
|
| 1265 |
+
HLT004-0000260,os_endpoint,184,other_cause
|
| 1266 |
+
HLT004-0000261,diagnosis,0,Stage_II
|
| 1267 |
+
HLT004-0000261,treatment_start_1L,29,pembro_mono
|
| 1268 |
+
HLT004-0000261,treatment_end_1L,764,completed_or_discontinued
|
| 1269 |
+
HLT004-0000261,progression,306,radiographic_progression
|
| 1270 |
+
HLT004-0000261,os_endpoint,1276,disease
|
| 1271 |
+
HLT004-0000262,diagnosis,0,Stage_III
|
| 1272 |
+
HLT004-0000262,treatment_start_1L,23,docetaxel_2L
|
| 1273 |
+
HLT004-0000262,treatment_end_1L,149,completed_or_discontinued
|
| 1274 |
+
HLT004-0000262,progression,36,radiographic_progression
|
| 1275 |
+
HLT004-0000262,os_endpoint,730,disease
|
| 1276 |
+
HLT004-0000263,diagnosis,0,Stage_IV
|
| 1277 |
+
HLT004-0000263,treatment_start_1L,17,pembro_mono
|
| 1278 |
+
HLT004-0000263,treatment_end_1L,527,completed_or_discontinued
|
| 1279 |
+
HLT004-0000263,progression,156,radiographic_progression
|
| 1280 |
+
HLT004-0000263,os_endpoint,527,other_cause
|
| 1281 |
+
HLT004-0000264,diagnosis,0,Stage_III
|
| 1282 |
+
HLT004-0000264,treatment_start_1L,25,carbo_pem_pembro
|
| 1283 |
+
HLT004-0000264,treatment_end_1L,151,completed_or_discontinued
|
| 1284 |
+
HLT004-0000264,response_assessment,46,PR
|
| 1285 |
+
HLT004-0000264,os_endpoint,383,disease
|
| 1286 |
+
HLT004-0000265,diagnosis,0,Stage_I
|
| 1287 |
+
HLT004-0000265,treatment_start_1L,17,carbo_taxol
|
| 1288 |
+
HLT004-0000265,treatment_end_1L,143,completed_or_discontinued
|
| 1289 |
+
HLT004-0000265,progression,511,radiographic_progression
|
| 1290 |
+
HLT004-0000265,os_endpoint,648,other_cause
|
| 1291 |
+
HLT004-0000266,diagnosis,0,Stage_III
|
| 1292 |
+
HLT004-0000266,treatment_start_1L,9,docetaxel_2L
|
| 1293 |
+
HLT004-0000266,treatment_end_1L,135,completed_or_discontinued
|
| 1294 |
+
HLT004-0000266,progression,80,radiographic_progression
|
| 1295 |
+
HLT004-0000266,os_endpoint,216,censored
|
| 1296 |
+
HLT004-0000267,diagnosis,0,Stage_I
|
| 1297 |
+
HLT004-0000267,treatment_start_1L,15,docetaxel_2L
|
| 1298 |
+
HLT004-0000267,treatment_end_1L,141,completed_or_discontinued
|
| 1299 |
+
HLT004-0000267,progression,488,radiographic_progression
|
| 1300 |
+
HLT004-0000267,os_endpoint,603,other_cause
|
| 1301 |
+
HLT004-0000268,diagnosis,0,Stage_III
|
| 1302 |
+
HLT004-0000268,treatment_start_1L,20,carbo_pem_pembro
|
| 1303 |
+
HLT004-0000268,treatment_end_1L,146,completed_or_discontinued
|
| 1304 |
+
HLT004-0000268,progression,266,radiographic_progression
|
| 1305 |
+
HLT004-0000268,os_endpoint,453,disease
|
| 1306 |
+
HLT004-0000269,diagnosis,0,Stage_IV
|
| 1307 |
+
HLT004-0000269,treatment_start_1L,7,carbo_taxol
|
| 1308 |
+
HLT004-0000269,treatment_end_1L,133,completed_or_discontinued
|
| 1309 |
+
HLT004-0000269,progression,50,radiographic_progression
|
| 1310 |
+
HLT004-0000269,os_endpoint,589,disease
|
| 1311 |
+
HLT004-0000270,diagnosis,0,Stage_IV
|
| 1312 |
+
HLT004-0000270,treatment_start_1L,7,carbo_pem_pembro
|
| 1313 |
+
HLT004-0000270,treatment_end_1L,133,completed_or_discontinued
|
| 1314 |
+
HLT004-0000270,progression,119,radiographic_progression
|
| 1315 |
+
HLT004-0000270,os_endpoint,453,disease
|
| 1316 |
+
HLT004-0000271,diagnosis,0,Stage_I
|
| 1317 |
+
HLT004-0000271,treatment_start_1L,11,docetaxel_2L
|
| 1318 |
+
HLT004-0000271,treatment_end_1L,137,completed_or_discontinued
|
| 1319 |
+
HLT004-0000271,response_assessment,71,PR
|
| 1320 |
+
HLT004-0000271,os_endpoint,1064,disease
|
| 1321 |
+
HLT004-0000272,diagnosis,0,Stage_III
|
| 1322 |
+
HLT004-0000272,treatment_start_1L,14,carbo_taxol
|
| 1323 |
+
HLT004-0000272,treatment_end_1L,140,completed_or_discontinued
|
| 1324 |
+
HLT004-0000272,progression,758,radiographic_progression
|
| 1325 |
+
HLT004-0000272,os_endpoint,1825,censored
|
| 1326 |
+
HLT004-0000273,diagnosis,0,Stage_I
|
| 1327 |
+
HLT004-0000273,treatment_start_1L,25,docetaxel_2L
|
| 1328 |
+
HLT004-0000273,treatment_end_1L,151,completed_or_discontinued
|
| 1329 |
+
HLT004-0000273,os_endpoint,246,censored
|
| 1330 |
+
HLT004-0000274,diagnosis,0,Stage_I
|
| 1331 |
+
HLT004-0000274,treatment_start_1L,14,carbo_pem_pembro
|
| 1332 |
+
HLT004-0000274,treatment_end_1L,140,completed_or_discontinued
|
| 1333 |
+
HLT004-0000274,response_assessment,89,PR
|
| 1334 |
+
HLT004-0000274,os_endpoint,141,censored
|
| 1335 |
+
HLT004-0000275,diagnosis,0,Stage_IV
|
| 1336 |
+
HLT004-0000275,treatment_start_1L,10,pembro_mono
|
| 1337 |
+
HLT004-0000275,treatment_end_1L,185,completed_or_discontinued
|
| 1338 |
+
HLT004-0000275,response_assessment,50,PR
|
| 1339 |
+
HLT004-0000275,os_endpoint,185,other_cause
|
| 1340 |
+
HLT004-0000276,diagnosis,0,Stage_III
|
| 1341 |
+
HLT004-0000276,treatment_start_1L,15,docetaxel_2L
|
| 1342 |
+
HLT004-0000276,treatment_end_1L,141,completed_or_discontinued
|
| 1343 |
+
HLT004-0000276,progression,692,radiographic_progression
|
| 1344 |
+
HLT004-0000276,os_endpoint,1203,other_cause
|
| 1345 |
+
HLT004-0000277,diagnosis,0,Stage_IV
|
| 1346 |
+
HLT004-0000277,treatment_start_1L,14,carbo_pem_pembro
|
| 1347 |
+
HLT004-0000277,treatment_end_1L,140,completed_or_discontinued
|
| 1348 |
+
HLT004-0000277,response_assessment,59,PR
|
| 1349 |
+
HLT004-0000277,os_endpoint,585,disease
|
| 1350 |
+
HLT004-0000278,diagnosis,0,Stage_IV
|
| 1351 |
+
HLT004-0000278,treatment_start_1L,22,docetaxel_2L
|
| 1352 |
+
HLT004-0000278,treatment_end_1L,148,completed_or_discontinued
|
| 1353 |
+
HLT004-0000278,os_endpoint,378,disease
|
| 1354 |
+
HLT004-0000279,diagnosis,0,Stage_II
|
| 1355 |
+
HLT004-0000279,treatment_start_1L,17,docetaxel_2L
|
| 1356 |
+
HLT004-0000279,treatment_end_1L,143,completed_or_discontinued
|
| 1357 |
+
HLT004-0000279,progression,197,radiographic_progression
|
| 1358 |
+
HLT004-0000279,os_endpoint,621,other_cause
|
| 1359 |
+
HLT004-0000280,diagnosis,0,Stage_IV
|
| 1360 |
+
HLT004-0000280,treatment_start_1L,16,docetaxel_2L
|
| 1361 |
+
HLT004-0000280,treatment_end_1L,124,completed_or_discontinued
|
| 1362 |
+
HLT004-0000280,progression,63,radiographic_progression
|
| 1363 |
+
HLT004-0000280,os_endpoint,124,other_cause
|
| 1364 |
+
HLT004-0000281,diagnosis,0,Stage_III
|
| 1365 |
+
HLT004-0000281,treatment_start_1L,16,carbo_taxol
|
| 1366 |
+
HLT004-0000281,treatment_end_1L,142,completed_or_discontinued
|
| 1367 |
+
HLT004-0000281,os_endpoint,1010,disease
|
| 1368 |
+
HLT004-0000282,diagnosis,0,Stage_II
|
| 1369 |
+
HLT004-0000282,treatment_start_1L,7,pembro_mono
|
| 1370 |
+
HLT004-0000282,treatment_end_1L,742,completed_or_discontinued
|
| 1371 |
+
HLT004-0000282,response_assessment,30,PR
|
| 1372 |
+
HLT004-0000282,os_endpoint,1258,censored
|
| 1373 |
+
HLT004-0000283,diagnosis,0,Stage_IV
|
| 1374 |
+
HLT004-0000283,treatment_start_1L,8,carbo_taxol
|
| 1375 |
+
HLT004-0000283,treatment_end_1L,134,completed_or_discontinued
|
| 1376 |
+
HLT004-0000283,progression,227,radiographic_progression
|
| 1377 |
+
HLT004-0000283,os_endpoint,306,disease
|
| 1378 |
+
HLT004-0000284,diagnosis,0,Stage_I
|
| 1379 |
+
HLT004-0000284,treatment_start_1L,18,pembro_mono
|
| 1380 |
+
HLT004-0000284,treatment_end_1L,364,completed_or_discontinued
|
| 1381 |
+
HLT004-0000284,progression,241,radiographic_progression
|
| 1382 |
+
HLT004-0000284,os_endpoint,364,censored
|
| 1383 |
+
HLT004-0000285,diagnosis,0,Stage_IV
|
| 1384 |
+
HLT004-0000285,treatment_start_1L,27,carbo_taxol
|
| 1385 |
+
HLT004-0000285,treatment_end_1L,153,completed_or_discontinued
|
| 1386 |
+
HLT004-0000285,progression,53,radiographic_progression
|
| 1387 |
+
HLT004-0000285,os_endpoint,230,censored
|
| 1388 |
+
HLT004-0000286,diagnosis,0,Stage_IV
|
| 1389 |
+
HLT004-0000286,treatment_start_1L,27,pembro_mono
|
| 1390 |
+
HLT004-0000286,treatment_end_1L,593,completed_or_discontinued
|
| 1391 |
+
HLT004-0000286,progression,92,radiographic_progression
|
| 1392 |
+
HLT004-0000286,os_endpoint,593,disease
|
| 1393 |
+
HLT004-0000287,diagnosis,0,Stage_III
|
| 1394 |
+
HLT004-0000287,treatment_start_1L,26,carbo_pem_pembro
|
| 1395 |
+
HLT004-0000287,treatment_end_1L,152,completed_or_discontinued
|
| 1396 |
+
HLT004-0000287,progression,12,radiographic_progression
|
| 1397 |
+
HLT004-0000287,os_endpoint,607,disease
|
| 1398 |
+
HLT004-0000288,diagnosis,0,Stage_IV
|
| 1399 |
+
HLT004-0000288,treatment_start_1L,28,carbo_taxol
|
| 1400 |
+
HLT004-0000288,treatment_end_1L,154,completed_or_discontinued
|
| 1401 |
+
HLT004-0000288,os_endpoint,314,disease
|
| 1402 |
+
HLT004-0000289,diagnosis,0,Stage_II
|
| 1403 |
+
HLT004-0000289,treatment_start_1L,12,carbo_taxol
|
| 1404 |
+
HLT004-0000289,treatment_end_1L,138,completed_or_discontinued
|
| 1405 |
+
HLT004-0000289,progression,665,radiographic_progression
|
| 1406 |
+
HLT004-0000289,os_endpoint,1527,disease
|
| 1407 |
+
HLT004-0000290,diagnosis,0,Stage_IV
|
| 1408 |
+
HLT004-0000290,treatment_start_1L,12,carbo_pem_pembro
|
| 1409 |
+
HLT004-0000290,treatment_end_1L,138,completed_or_discontinued
|
| 1410 |
+
HLT004-0000290,progression,20,radiographic_progression
|
| 1411 |
+
HLT004-0000290,os_endpoint,947,disease
|
| 1412 |
+
HLT004-0000291,diagnosis,0,Stage_I
|
| 1413 |
+
HLT004-0000291,treatment_start_1L,7,carbo_pem_pembro
|
| 1414 |
+
HLT004-0000291,treatment_end_1L,133,completed_or_discontinued
|
| 1415 |
+
HLT004-0000291,progression,88,radiographic_progression
|
| 1416 |
+
HLT004-0000291,os_endpoint,1825,censored
|
| 1417 |
+
HLT004-0000292,diagnosis,0,Stage_I
|
| 1418 |
+
HLT004-0000292,treatment_start_1L,20,carbo_pem_pembro
|
| 1419 |
+
HLT004-0000292,treatment_end_1L,146,completed_or_discontinued
|
| 1420 |
+
HLT004-0000292,progression,340,radiographic_progression
|
| 1421 |
+
HLT004-0000292,os_endpoint,456,other_cause
|
| 1422 |
+
HLT004-0000293,diagnosis,0,Stage_III
|
| 1423 |
+
HLT004-0000293,treatment_start_1L,18,docetaxel_2L
|
| 1424 |
+
HLT004-0000293,treatment_end_1L,144,completed_or_discontinued
|
| 1425 |
+
HLT004-0000293,response_assessment,72,PR
|
| 1426 |
+
HLT004-0000293,os_endpoint,198,disease
|
| 1427 |
+
HLT004-0000294,diagnosis,0,Stage_IV
|
| 1428 |
+
HLT004-0000294,treatment_start_1L,22,pembro_mono
|
| 1429 |
+
HLT004-0000294,treatment_end_1L,318,completed_or_discontinued
|
| 1430 |
+
HLT004-0000294,progression,223,radiographic_progression
|
| 1431 |
+
HLT004-0000294,os_endpoint,318,disease
|
| 1432 |
+
HLT004-0000295,diagnosis,0,Stage_I
|
| 1433 |
+
HLT004-0000295,treatment_start_1L,22,carbo_pem_pembro
|
| 1434 |
+
HLT004-0000295,treatment_end_1L,148,completed_or_discontinued
|
| 1435 |
+
HLT004-0000295,response_assessment,44,PR
|
| 1436 |
+
HLT004-0000295,os_endpoint,217,disease
|
| 1437 |
+
HLT004-0000296,diagnosis,0,Stage_IV
|
| 1438 |
+
HLT004-0000296,treatment_start_1L,20,pembro_mono
|
| 1439 |
+
HLT004-0000296,treatment_end_1L,118,completed_or_discontinued
|
| 1440 |
+
HLT004-0000296,os_endpoint,118,disease
|
| 1441 |
+
HLT004-0000297,diagnosis,0,Stage_II
|
| 1442 |
+
HLT004-0000297,treatment_start_1L,24,docetaxel_2L
|
| 1443 |
+
HLT004-0000297,treatment_end_1L,150,completed_or_discontinued
|
| 1444 |
+
HLT004-0000297,os_endpoint,320,censored
|
| 1445 |
+
HLT004-0000298,diagnosis,0,Stage_III
|
| 1446 |
+
HLT004-0000298,treatment_start_1L,27,docetaxel_2L
|
| 1447 |
+
HLT004-0000298,treatment_end_1L,153,completed_or_discontinued
|
| 1448 |
+
HLT004-0000298,progression,80,radiographic_progression
|
| 1449 |
+
HLT004-0000298,os_endpoint,657,disease
|
| 1450 |
+
HLT004-0000299,diagnosis,0,Stage_III
|
| 1451 |
+
HLT004-0000299,treatment_start_1L,11,docetaxel_2L
|
| 1452 |
+
HLT004-0000299,treatment_end_1L,137,completed_or_discontinued
|
| 1453 |
+
HLT004-0000299,progression,155,radiographic_progression
|
| 1454 |
+
HLT004-0000299,os_endpoint,673,other_cause
|
| 1455 |
+
HLT004-0000300,diagnosis,0,Stage_I
|
| 1456 |
+
HLT004-0000300,treatment_start_1L,19,docetaxel_2L
|
| 1457 |
+
HLT004-0000300,treatment_end_1L,145,completed_or_discontinued
|
| 1458 |
+
HLT004-0000300,os_endpoint,1825,censored
|
| 1459 |
+
HLT004-0000301,diagnosis,0,Stage_IV
|
| 1460 |
+
HLT004-0000301,treatment_start_1L,9,carbo_taxol
|
| 1461 |
+
HLT004-0000301,treatment_end_1L,8,completed_or_discontinued
|
| 1462 |
+
HLT004-0000301,os_endpoint,8,disease
|
| 1463 |
+
HLT004-0000302,diagnosis,0,Stage_III
|
| 1464 |
+
HLT004-0000302,treatment_start_1L,24,docetaxel_2L
|
| 1465 |
+
HLT004-0000302,treatment_end_1L,150,completed_or_discontinued
|
| 1466 |
+
HLT004-0000302,response_assessment,32,PR
|
| 1467 |
+
HLT004-0000302,os_endpoint,260,disease
|
| 1468 |
+
HLT004-0000303,diagnosis,0,Stage_IV
|
| 1469 |
+
HLT004-0000303,treatment_start_1L,29,docetaxel_2L
|
| 1470 |
+
HLT004-0000303,treatment_end_1L,155,completed_or_discontinued
|
| 1471 |
+
HLT004-0000303,progression,360,radiographic_progression
|
| 1472 |
+
HLT004-0000303,os_endpoint,752,other_cause
|
| 1473 |
+
HLT004-0000304,diagnosis,0,Stage_IV
|
| 1474 |
+
HLT004-0000304,treatment_start_1L,10,carbo_pem_pembro
|
| 1475 |
+
HLT004-0000304,treatment_end_1L,136,completed_or_discontinued
|
| 1476 |
+
HLT004-0000304,response_assessment,66,PR
|
| 1477 |
+
HLT004-0000304,os_endpoint,334,censored
|
| 1478 |
+
HLT004-0000305,diagnosis,0,Stage_III
|
| 1479 |
+
HLT004-0000305,treatment_start_1L,10,docetaxel_2L
|
| 1480 |
+
HLT004-0000305,treatment_end_1L,136,completed_or_discontinued
|
| 1481 |
+
HLT004-0000305,os_endpoint,180,censored
|
| 1482 |
+
HLT004-0000306,diagnosis,0,Stage_IV
|
| 1483 |
+
HLT004-0000306,treatment_start_1L,25,pembro_mono
|
| 1484 |
+
HLT004-0000306,treatment_end_1L,689,completed_or_discontinued
|
| 1485 |
+
HLT004-0000306,response_assessment,56,PR
|
| 1486 |
+
HLT004-0000306,os_endpoint,689,disease
|
| 1487 |
+
HLT004-0000307,diagnosis,0,Stage_IV
|
| 1488 |
+
HLT004-0000307,treatment_start_1L,26,docetaxel_2L
|
| 1489 |
+
HLT004-0000307,treatment_end_1L,152,completed_or_discontinued
|
| 1490 |
+
HLT004-0000307,progression,151,radiographic_progression
|
| 1491 |
+
HLT004-0000307,os_endpoint,477,disease
|
| 1492 |
+
HLT004-0000308,diagnosis,0,Stage_IV
|
| 1493 |
+
HLT004-0000308,treatment_start_1L,20,docetaxel_2L
|
| 1494 |
+
HLT004-0000308,treatment_end_1L,146,completed_or_discontinued
|
| 1495 |
+
HLT004-0000308,os_endpoint,265,censored
|
| 1496 |
+
HLT004-0000309,diagnosis,0,Stage_IV
|
| 1497 |
+
HLT004-0000309,treatment_start_1L,17,carbo_taxol
|
| 1498 |
+
HLT004-0000309,treatment_end_1L,64,completed_or_discontinued
|
| 1499 |
+
HLT004-0000309,progression,42,radiographic_progression
|
| 1500 |
+
HLT004-0000309,os_endpoint,64,other_cause
|
| 1501 |
+
HLT004-0000310,diagnosis,0,Stage_IV
|
| 1502 |
+
HLT004-0000310,treatment_start_1L,14,carbo_taxol
|
| 1503 |
+
HLT004-0000310,treatment_end_1L,140,completed_or_discontinued
|
| 1504 |
+
HLT004-0000310,progression,114,radiographic_progression
|
| 1505 |
+
HLT004-0000310,os_endpoint,280,disease
|
| 1506 |
+
HLT004-0000311,diagnosis,0,Stage_IV
|
| 1507 |
+
HLT004-0000311,treatment_start_1L,20,pembro_mono
|
| 1508 |
+
HLT004-0000311,treatment_end_1L,212,completed_or_discontinued
|
| 1509 |
+
HLT004-0000311,progression,187,radiographic_progression
|
| 1510 |
+
HLT004-0000311,os_endpoint,212,disease
|
| 1511 |
+
HLT004-0000312,diagnosis,0,Stage_III
|
| 1512 |
+
HLT004-0000312,treatment_start_1L,7,pembro_mono
|
| 1513 |
+
HLT004-0000312,treatment_end_1L,428,completed_or_discontinued
|
| 1514 |
+
HLT004-0000312,progression,177,radiographic_progression
|
| 1515 |
+
HLT004-0000312,os_endpoint,428,disease
|
| 1516 |
+
HLT004-0000313,diagnosis,0,Stage_IV
|
| 1517 |
+
HLT004-0000313,treatment_start_1L,19,docetaxel_2L
|
| 1518 |
+
HLT004-0000313,treatment_end_1L,145,completed_or_discontinued
|
| 1519 |
+
HLT004-0000313,progression,171,radiographic_progression
|
| 1520 |
+
HLT004-0000313,os_endpoint,739,disease
|
| 1521 |
+
HLT004-0000314,diagnosis,0,Stage_III
|
| 1522 |
+
HLT004-0000314,treatment_start_1L,26,docetaxel_2L
|
| 1523 |
+
HLT004-0000314,treatment_end_1L,152,completed_or_discontinued
|
| 1524 |
+
HLT004-0000314,progression,203,radiographic_progression
|
| 1525 |
+
HLT004-0000314,os_endpoint,311,disease
|
| 1526 |
+
HLT004-0000315,diagnosis,0,Stage_IV
|
| 1527 |
+
HLT004-0000315,treatment_start_1L,13,pembro_mono
|
| 1528 |
+
HLT004-0000315,treatment_end_1L,748,completed_or_discontinued
|
| 1529 |
+
HLT004-0000315,progression,230,radiographic_progression
|
| 1530 |
+
HLT004-0000315,os_endpoint,948,disease
|
| 1531 |
+
HLT004-0000316,diagnosis,0,Stage_IV
|
| 1532 |
+
HLT004-0000316,treatment_start_1L,8,docetaxel_2L
|
| 1533 |
+
HLT004-0000316,treatment_end_1L,134,completed_or_discontinued
|
| 1534 |
+
HLT004-0000316,progression,24,radiographic_progression
|
| 1535 |
+
HLT004-0000316,os_endpoint,268,disease
|
| 1536 |
+
HLT004-0000317,diagnosis,0,Stage_IV
|
| 1537 |
+
HLT004-0000317,treatment_start_1L,9,carbo_pem_pembro
|
| 1538 |
+
HLT004-0000317,treatment_end_1L,64,completed_or_discontinued
|
| 1539 |
+
HLT004-0000317,response_assessment,72,PR
|
| 1540 |
+
HLT004-0000317,os_endpoint,64,disease
|
| 1541 |
+
HLT004-0000318,diagnosis,0,Stage_IV
|
| 1542 |
+
HLT004-0000318,treatment_start_1L,27,docetaxel_2L
|
| 1543 |
+
HLT004-0000318,treatment_end_1L,153,completed_or_discontinued
|
| 1544 |
+
HLT004-0000318,progression,63,radiographic_progression
|
| 1545 |
+
HLT004-0000318,os_endpoint,854,disease
|
| 1546 |
+
HLT004-0000319,diagnosis,0,Stage_IV
|
| 1547 |
+
HLT004-0000319,treatment_start_1L,18,carbo_pem_pembro
|
| 1548 |
+
HLT004-0000319,treatment_end_1L,30,completed_or_discontinued
|
| 1549 |
+
HLT004-0000319,progression,20,radiographic_progression
|
| 1550 |
+
HLT004-0000319,os_endpoint,30,censored
|
| 1551 |
+
HLT004-0000320,diagnosis,0,Stage_IV
|
| 1552 |
+
HLT004-0000320,treatment_start_1L,19,pembro_mono
|
| 1553 |
+
HLT004-0000320,treatment_end_1L,1,completed_or_discontinued
|
| 1554 |
+
HLT004-0000320,response_assessment,86,PR
|
| 1555 |
+
HLT004-0000320,os_endpoint,1,other_cause
|
| 1556 |
+
HLT004-0000321,diagnosis,0,Stage_I
|
| 1557 |
+
HLT004-0000321,treatment_start_1L,22,carbo_pem_pembro
|
| 1558 |
+
HLT004-0000321,treatment_end_1L,148,completed_or_discontinued
|
| 1559 |
+
HLT004-0000321,response_assessment,78,PR
|
| 1560 |
+
HLT004-0000321,os_endpoint,1825,censored
|
| 1561 |
+
HLT004-0000322,diagnosis,0,Stage_III
|
| 1562 |
+
HLT004-0000322,treatment_start_1L,22,pembro_mono
|
| 1563 |
+
HLT004-0000322,treatment_end_1L,445,completed_or_discontinued
|
| 1564 |
+
HLT004-0000322,progression,197,radiographic_progression
|
| 1565 |
+
HLT004-0000322,os_endpoint,445,disease
|
| 1566 |
+
HLT004-0000323,diagnosis,0,Stage_II
|
| 1567 |
+
HLT004-0000323,treatment_start_1L,12,carbo_taxol
|
| 1568 |
+
HLT004-0000323,treatment_end_1L,138,completed_or_discontinued
|
| 1569 |
+
HLT004-0000323,progression,183,radiographic_progression
|
| 1570 |
+
HLT004-0000323,os_endpoint,286,censored
|
| 1571 |
+
HLT004-0000324,diagnosis,0,Stage_I
|
| 1572 |
+
HLT004-0000324,treatment_start_1L,10,carbo_pem_pembro
|
| 1573 |
+
HLT004-0000324,treatment_end_1L,136,completed_or_discontinued
|
| 1574 |
+
HLT004-0000324,response_assessment,40,PR
|
| 1575 |
+
HLT004-0000324,os_endpoint,1303,censored
|
| 1576 |
+
HLT004-0000325,diagnosis,0,Stage_IV
|
| 1577 |
+
HLT004-0000325,treatment_start_1L,28,pembro_mono
|
| 1578 |
+
HLT004-0000325,treatment_end_1L,284,completed_or_discontinued
|
| 1579 |
+
HLT004-0000325,progression,75,radiographic_progression
|
| 1580 |
+
HLT004-0000325,os_endpoint,284,disease
|
| 1581 |
+
HLT004-0000326,diagnosis,0,Stage_IV
|
| 1582 |
+
HLT004-0000326,treatment_start_1L,22,pembro_mono
|
| 1583 |
+
HLT004-0000326,treatment_end_1L,346,completed_or_discontinued
|
| 1584 |
+
HLT004-0000326,progression,114,radiographic_progression
|
| 1585 |
+
HLT004-0000326,os_endpoint,346,disease
|
| 1586 |
+
HLT004-0000327,diagnosis,0,Stage_III
|
| 1587 |
+
HLT004-0000327,treatment_start_1L,10,carbo_pem_pembro
|
| 1588 |
+
HLT004-0000327,treatment_end_1L,136,completed_or_discontinued
|
| 1589 |
+
HLT004-0000327,response_assessment,46,PR
|
| 1590 |
+
HLT004-0000327,os_endpoint,513,disease
|
| 1591 |
+
HLT004-0000328,diagnosis,0,Stage_II
|
| 1592 |
+
HLT004-0000328,treatment_start_1L,9,pembro_mono
|
| 1593 |
+
HLT004-0000328,treatment_end_1L,19,completed_or_discontinued
|
| 1594 |
+
HLT004-0000328,response_assessment,88,PR
|
| 1595 |
+
HLT004-0000328,os_endpoint,19,disease
|
| 1596 |
+
HLT004-0000329,diagnosis,0,Stage_IV
|
| 1597 |
+
HLT004-0000329,treatment_start_1L,26,carbo_pem_pembro
|
| 1598 |
+
HLT004-0000329,treatment_end_1L,152,completed_or_discontinued
|
| 1599 |
+
HLT004-0000329,response_assessment,42,PR
|
| 1600 |
+
HLT004-0000329,os_endpoint,254,disease
|
| 1601 |
+
HLT004-0000330,diagnosis,0,Stage_III
|
| 1602 |
+
HLT004-0000330,treatment_start_1L,9,carbo_pem_pembro
|
| 1603 |
+
HLT004-0000330,treatment_end_1L,135,completed_or_discontinued
|
| 1604 |
+
HLT004-0000330,progression,662,radiographic_progression
|
| 1605 |
+
HLT004-0000330,os_endpoint,864,disease
|
| 1606 |
+
HLT004-0000331,diagnosis,0,Stage_IV
|
| 1607 |
+
HLT004-0000331,treatment_start_1L,12,carbo_pem_pembro
|
| 1608 |
+
HLT004-0000331,treatment_end_1L,29,completed_or_discontinued
|
| 1609 |
+
HLT004-0000331,response_assessment,70,PR
|
| 1610 |
+
HLT004-0000331,os_endpoint,29,disease
|
| 1611 |
+
HLT004-0000332,diagnosis,0,Stage_IV
|
| 1612 |
+
HLT004-0000332,treatment_start_1L,20,pembro_mono
|
| 1613 |
+
HLT004-0000332,treatment_end_1L,341,completed_or_discontinued
|
| 1614 |
+
HLT004-0000332,response_assessment,31,PR
|
| 1615 |
+
HLT004-0000332,os_endpoint,341,disease
|
| 1616 |
+
HLT004-0000333,diagnosis,0,Stage_III
|
| 1617 |
+
HLT004-0000333,treatment_start_1L,27,docetaxel_2L
|
| 1618 |
+
HLT004-0000333,treatment_end_1L,153,completed_or_discontinued
|
| 1619 |
+
HLT004-0000333,response_assessment,51,PR
|
| 1620 |
+
HLT004-0000333,os_endpoint,623,disease
|
| 1621 |
+
HLT004-0000334,diagnosis,0,Stage_II
|
| 1622 |
+
HLT004-0000334,treatment_start_1L,12,pembro_mono
|
| 1623 |
+
HLT004-0000334,treatment_end_1L,30,completed_or_discontinued
|
| 1624 |
+
HLT004-0000334,os_endpoint,30,censored
|
| 1625 |
+
HLT004-0000335,diagnosis,0,Stage_III
|
| 1626 |
+
HLT004-0000335,treatment_start_1L,22,docetaxel_2L
|
| 1627 |
+
HLT004-0000335,treatment_end_1L,148,completed_or_discontinued
|
| 1628 |
+
HLT004-0000335,progression,376,radiographic_progression
|
| 1629 |
+
HLT004-0000335,os_endpoint,841,disease
|
| 1630 |
+
HLT004-0000336,diagnosis,0,Stage_I
|
| 1631 |
+
HLT004-0000336,treatment_start_1L,15,pembro_mono
|
| 1632 |
+
HLT004-0000336,treatment_end_1L,750,completed_or_discontinued
|
| 1633 |
+
HLT004-0000336,os_endpoint,1825,censored
|
| 1634 |
+
HLT004-0000337,diagnosis,0,Stage_III
|
| 1635 |
+
HLT004-0000337,treatment_start_1L,22,docetaxel_2L
|
| 1636 |
+
HLT004-0000337,treatment_end_1L,148,completed_or_discontinued
|
| 1637 |
+
HLT004-0000337,progression,53,radiographic_progression
|
| 1638 |
+
HLT004-0000337,os_endpoint,1488,disease
|
| 1639 |
+
HLT004-0000338,diagnosis,0,Stage_I
|
| 1640 |
+
HLT004-0000338,treatment_start_1L,24,docetaxel_2L
|
| 1641 |
+
HLT004-0000338,treatment_end_1L,150,completed_or_discontinued
|
| 1642 |
+
HLT004-0000338,os_endpoint,1081,disease
|
| 1643 |
+
HLT004-0000339,diagnosis,0,Stage_I
|
| 1644 |
+
HLT004-0000339,treatment_start_1L,12,carbo_taxol
|
| 1645 |
+
HLT004-0000339,treatment_end_1L,138,completed_or_discontinued
|
| 1646 |
+
HLT004-0000339,progression,632,radiographic_progression
|
| 1647 |
+
HLT004-0000339,os_endpoint,703,disease
|
| 1648 |
+
HLT004-0000340,diagnosis,0,Stage_III
|
| 1649 |
+
HLT004-0000340,treatment_start_1L,17,carbo_pem_pembro
|
| 1650 |
+
HLT004-0000340,treatment_end_1L,7,completed_or_discontinued
|
| 1651 |
+
HLT004-0000340,progression,5,radiographic_progression
|
| 1652 |
+
HLT004-0000340,os_endpoint,7,other_cause
|
| 1653 |
+
HLT004-0000341,diagnosis,0,Stage_I
|
| 1654 |
+
HLT004-0000341,treatment_start_1L,16,carbo_pem_pembro
|
| 1655 |
+
HLT004-0000341,treatment_end_1L,142,completed_or_discontinued
|
| 1656 |
+
HLT004-0000341,response_assessment,68,PR
|
| 1657 |
+
HLT004-0000341,os_endpoint,720,censored
|
| 1658 |
+
HLT004-0000342,diagnosis,0,Stage_IV
|
| 1659 |
+
HLT004-0000342,treatment_start_1L,27,carbo_taxol
|
| 1660 |
+
HLT004-0000342,treatment_end_1L,43,completed_or_discontinued
|
| 1661 |
+
HLT004-0000342,progression,38,radiographic_progression
|
| 1662 |
+
HLT004-0000342,os_endpoint,43,disease
|
| 1663 |
+
HLT004-0000343,diagnosis,0,Stage_I
|
| 1664 |
+
HLT004-0000343,treatment_start_1L,22,pembro_mono
|
| 1665 |
+
HLT004-0000343,treatment_end_1L,322,completed_or_discontinued
|
| 1666 |
+
HLT004-0000343,progression,243,radiographic_progression
|
| 1667 |
+
HLT004-0000343,os_endpoint,322,censored
|
| 1668 |
+
HLT004-0000344,diagnosis,0,Stage_IV
|
| 1669 |
+
HLT004-0000344,treatment_start_1L,29,carbo_pem_pembro
|
| 1670 |
+
HLT004-0000344,treatment_end_1L,155,completed_or_discontinued
|
| 1671 |
+
HLT004-0000344,response_assessment,86,PR
|
| 1672 |
+
HLT004-0000344,os_endpoint,159,disease
|
| 1673 |
+
HLT004-0000345,diagnosis,0,Stage_II
|
| 1674 |
+
HLT004-0000345,treatment_start_1L,29,docetaxel_2L
|
| 1675 |
+
HLT004-0000345,treatment_end_1L,155,completed_or_discontinued
|
| 1676 |
+
HLT004-0000345,os_endpoint,1038,disease
|
| 1677 |
+
HLT004-0000346,diagnosis,0,Stage_I
|
| 1678 |
+
HLT004-0000346,treatment_start_1L,18,docetaxel_2L
|
| 1679 |
+
HLT004-0000346,treatment_end_1L,144,completed_or_discontinued
|
| 1680 |
+
HLT004-0000346,os_endpoint,1177,other_cause
|
| 1681 |
+
HLT004-0000347,diagnosis,0,Stage_I
|
| 1682 |
+
HLT004-0000347,treatment_start_1L,15,carbo_taxol
|
| 1683 |
+
HLT004-0000347,treatment_end_1L,141,completed_or_discontinued
|
| 1684 |
+
HLT004-0000347,response_assessment,39,PR
|
| 1685 |
+
HLT004-0000347,os_endpoint,479,disease
|
| 1686 |
+
HLT004-0000348,diagnosis,0,Stage_IV
|
| 1687 |
+
HLT004-0000348,treatment_start_1L,24,carbo_pem_pembro
|
| 1688 |
+
HLT004-0000348,treatment_end_1L,150,completed_or_discontinued
|
| 1689 |
+
HLT004-0000348,response_assessment,36,PR
|
| 1690 |
+
HLT004-0000348,os_endpoint,400,disease
|
| 1691 |
+
HLT004-0000349,diagnosis,0,Stage_II
|
| 1692 |
+
HLT004-0000349,treatment_start_1L,16,carbo_taxol
|
| 1693 |
+
HLT004-0000349,treatment_end_1L,142,completed_or_discontinued
|
| 1694 |
+
HLT004-0000349,progression,99,radiographic_progression
|
| 1695 |
+
HLT004-0000349,os_endpoint,275,other_cause
|
| 1696 |
+
HLT004-0000350,diagnosis,0,Stage_III
|
| 1697 |
+
HLT004-0000350,treatment_start_1L,8,carbo_taxol
|
| 1698 |
+
HLT004-0000350,treatment_end_1L,31,completed_or_discontinued
|
| 1699 |
+
HLT004-0000350,response_assessment,71,PR
|
| 1700 |
+
HLT004-0000350,os_endpoint,31,disease
|
| 1701 |
+
HLT004-0000351,diagnosis,0,Stage_I
|
| 1702 |
+
HLT004-0000351,treatment_start_1L,11,docetaxel_2L
|
| 1703 |
+
HLT004-0000351,treatment_end_1L,137,completed_or_discontinued
|
| 1704 |
+
HLT004-0000351,os_endpoint,349,other_cause
|
| 1705 |
+
HLT004-0000352,diagnosis,0,Stage_IV
|
| 1706 |
+
HLT004-0000352,treatment_start_1L,25,carbo_taxol
|
| 1707 |
+
HLT004-0000352,treatment_end_1L,55,completed_or_discontinued
|
| 1708 |
+
HLT004-0000352,progression,36,radiographic_progression
|
| 1709 |
+
HLT004-0000352,os_endpoint,55,disease
|
| 1710 |
+
HLT004-0000353,diagnosis,0,Stage_I
|
| 1711 |
+
HLT004-0000353,treatment_start_1L,20,carbo_pem_pembro
|
| 1712 |
+
HLT004-0000353,treatment_end_1L,146,completed_or_discontinued
|
| 1713 |
+
HLT004-0000353,progression,1437,radiographic_progression
|
| 1714 |
+
HLT004-0000353,os_endpoint,1825,censored
|
| 1715 |
+
HLT004-0000354,diagnosis,0,Stage_III
|
| 1716 |
+
HLT004-0000354,treatment_start_1L,27,carbo_taxol
|
| 1717 |
+
HLT004-0000354,treatment_end_1L,153,completed_or_discontinued
|
| 1718 |
+
HLT004-0000354,progression,220,radiographic_progression
|
| 1719 |
+
HLT004-0000354,os_endpoint,363,disease
|
| 1720 |
+
HLT004-0000355,diagnosis,0,Stage_IV
|
| 1721 |
+
HLT004-0000355,treatment_start_1L,26,carbo_pem_pembro
|
| 1722 |
+
HLT004-0000355,treatment_end_1L,152,completed_or_discontinued
|
| 1723 |
+
HLT004-0000355,progression,4,radiographic_progression
|
| 1724 |
+
HLT004-0000355,os_endpoint,277,disease
|
| 1725 |
+
HLT004-0000356,diagnosis,0,Stage_II
|
| 1726 |
+
HLT004-0000356,treatment_start_1L,26,carbo_taxol
|
| 1727 |
+
HLT004-0000356,treatment_end_1L,152,completed_or_discontinued
|
| 1728 |
+
HLT004-0000356,progression,702,radiographic_progression
|
| 1729 |
+
HLT004-0000356,os_endpoint,961,disease
|
| 1730 |
+
HLT004-0000357,diagnosis,0,Stage_III
|
| 1731 |
+
HLT004-0000357,treatment_start_1L,23,carbo_taxol
|
| 1732 |
+
HLT004-0000357,treatment_end_1L,149,completed_or_discontinued
|
| 1733 |
+
HLT004-0000357,response_assessment,78,PR
|
| 1734 |
+
HLT004-0000357,os_endpoint,356,disease
|
| 1735 |
+
HLT004-0000358,diagnosis,0,Stage_IV
|
| 1736 |
+
HLT004-0000358,treatment_start_1L,10,pembro_mono
|
| 1737 |
+
HLT004-0000358,treatment_end_1L,367,completed_or_discontinued
|
| 1738 |
+
HLT004-0000358,response_assessment,85,PR
|
| 1739 |
+
HLT004-0000358,os_endpoint,367,censored
|
| 1740 |
+
HLT004-0000359,diagnosis,0,Stage_III
|
| 1741 |
+
HLT004-0000359,treatment_start_1L,26,pembro_mono
|
| 1742 |
+
HLT004-0000359,treatment_end_1L,608,completed_or_discontinued
|
| 1743 |
+
HLT004-0000359,os_endpoint,608,disease
|
| 1744 |
+
HLT004-0000360,diagnosis,0,Stage_I
|
| 1745 |
+
HLT004-0000360,treatment_start_1L,23,docetaxel_2L
|
| 1746 |
+
HLT004-0000360,treatment_end_1L,149,completed_or_discontinued
|
| 1747 |
+
HLT004-0000360,progression,536,radiographic_progression
|
| 1748 |
+
HLT004-0000360,os_endpoint,1825,censored
|
| 1749 |
+
HLT004-0000361,diagnosis,0,Stage_III
|
| 1750 |
+
HLT004-0000361,treatment_start_1L,11,carbo_pem_pembro
|
| 1751 |
+
HLT004-0000361,treatment_end_1L,137,completed_or_discontinued
|
| 1752 |
+
HLT004-0000361,response_assessment,84,PR
|
| 1753 |
+
HLT004-0000361,os_endpoint,551,censored
|
| 1754 |
+
HLT004-0000362,diagnosis,0,Stage_I
|
| 1755 |
+
HLT004-0000362,treatment_start_1L,17,docetaxel_2L
|
| 1756 |
+
HLT004-0000362,treatment_end_1L,142,completed_or_discontinued
|
| 1757 |
+
HLT004-0000362,os_endpoint,142,censored
|
| 1758 |
+
HLT004-0000363,diagnosis,0,Stage_IV
|
| 1759 |
+
HLT004-0000363,treatment_start_1L,24,carbo_pem_pembro
|
| 1760 |
+
HLT004-0000363,treatment_end_1L,150,completed_or_discontinued
|
| 1761 |
+
HLT004-0000363,response_assessment,60,PR
|
| 1762 |
+
HLT004-0000363,os_endpoint,310,disease
|
| 1763 |
+
HLT004-0000364,diagnosis,0,Stage_IV
|
| 1764 |
+
HLT004-0000364,treatment_start_1L,13,carbo_taxol
|
| 1765 |
+
HLT004-0000364,treatment_end_1L,139,completed_or_discontinued
|
| 1766 |
+
HLT004-0000364,response_assessment,64,PR
|
| 1767 |
+
HLT004-0000364,os_endpoint,469,disease
|
| 1768 |
+
HLT004-0000365,diagnosis,0,Stage_IV
|
| 1769 |
+
HLT004-0000365,treatment_start_1L,10,docetaxel_2L
|
| 1770 |
+
HLT004-0000365,treatment_end_1L,136,completed_or_discontinued
|
| 1771 |
+
HLT004-0000365,progression,258,radiographic_progression
|
| 1772 |
+
HLT004-0000365,os_endpoint,491,disease
|
| 1773 |
+
HLT004-0000366,diagnosis,0,Stage_II
|
| 1774 |
+
HLT004-0000366,treatment_start_1L,19,pembro_mono
|
| 1775 |
+
HLT004-0000366,treatment_end_1L,578,completed_or_discontinued
|
| 1776 |
+
HLT004-0000366,progression,347,radiographic_progression
|
| 1777 |
+
HLT004-0000366,os_endpoint,578,censored
|
| 1778 |
+
HLT004-0000367,diagnosis,0,Stage_IV
|
| 1779 |
+
HLT004-0000367,treatment_start_1L,11,carbo_pem_pembro
|
| 1780 |
+
HLT004-0000367,treatment_end_1L,108,completed_or_discontinued
|
| 1781 |
+
HLT004-0000367,response_assessment,62,PR
|
| 1782 |
+
HLT004-0000367,os_endpoint,108,disease
|
| 1783 |
+
HLT004-0000368,diagnosis,0,Stage_IV
|
| 1784 |
+
HLT004-0000368,treatment_start_1L,29,carbo_taxol
|
| 1785 |
+
HLT004-0000368,treatment_end_1L,155,completed_or_discontinued
|
| 1786 |
+
HLT004-0000368,progression,107,radiographic_progression
|
| 1787 |
+
HLT004-0000368,os_endpoint,308,disease
|
| 1788 |
+
HLT004-0000369,diagnosis,0,Stage_I
|
| 1789 |
+
HLT004-0000369,treatment_start_1L,19,pembro_mono
|
| 1790 |
+
HLT004-0000369,treatment_end_1L,280,completed_or_discontinued
|
| 1791 |
+
HLT004-0000369,progression,245,radiographic_progression
|
| 1792 |
+
HLT004-0000369,os_endpoint,280,censored
|
| 1793 |
+
HLT004-0000370,diagnosis,0,Stage_IV
|
| 1794 |
+
HLT004-0000370,treatment_start_1L,20,docetaxel_2L
|
| 1795 |
+
HLT004-0000370,treatment_end_1L,146,completed_or_discontinued
|
| 1796 |
+
HLT004-0000370,progression,270,radiographic_progression
|
| 1797 |
+
HLT004-0000370,os_endpoint,488,disease
|
| 1798 |
+
HLT004-0000371,diagnosis,0,Stage_IV
|
| 1799 |
+
HLT004-0000371,treatment_start_1L,22,pembro_mono
|
| 1800 |
+
HLT004-0000371,treatment_end_1L,247,completed_or_discontinued
|
| 1801 |
+
HLT004-0000371,response_assessment,72,PR
|
| 1802 |
+
HLT004-0000371,os_endpoint,247,disease
|
| 1803 |
+
HLT004-0000372,diagnosis,0,Stage_IV
|
| 1804 |
+
HLT004-0000372,treatment_start_1L,10,carbo_pem_pembro
|
| 1805 |
+
HLT004-0000372,treatment_end_1L,136,completed_or_discontinued
|
| 1806 |
+
HLT004-0000372,response_assessment,89,PR
|
| 1807 |
+
HLT004-0000372,os_endpoint,320,censored
|
| 1808 |
+
HLT004-0000373,diagnosis,0,Stage_III
|
| 1809 |
+
HLT004-0000373,treatment_start_1L,25,carbo_taxol
|
| 1810 |
+
HLT004-0000373,treatment_end_1L,151,completed_or_discontinued
|
| 1811 |
+
HLT004-0000373,progression,51,radiographic_progression
|
| 1812 |
+
HLT004-0000373,os_endpoint,745,disease
|
| 1813 |
+
HLT004-0000374,diagnosis,0,Stage_I
|
| 1814 |
+
HLT004-0000374,treatment_start_1L,11,carbo_pem_pembro
|
| 1815 |
+
HLT004-0000374,treatment_end_1L,137,completed_or_discontinued
|
| 1816 |
+
HLT004-0000374,response_assessment,61,PR
|
| 1817 |
+
HLT004-0000374,os_endpoint,1825,censored
|
| 1818 |
+
HLT004-0000375,diagnosis,0,Stage_IV
|
| 1819 |
+
HLT004-0000375,treatment_start_1L,27,carbo_pem_pembro
|
| 1820 |
+
HLT004-0000375,treatment_end_1L,153,completed_or_discontinued
|
| 1821 |
+
HLT004-0000375,progression,117,radiographic_progression
|
| 1822 |
+
HLT004-0000375,os_endpoint,347,disease
|
| 1823 |
+
HLT004-0000376,diagnosis,0,Stage_IV
|
| 1824 |
+
HLT004-0000376,treatment_start_1L,25,carbo_taxol
|
| 1825 |
+
HLT004-0000376,treatment_end_1L,151,completed_or_discontinued
|
| 1826 |
+
HLT004-0000376,os_endpoint,151,disease
|
| 1827 |
+
HLT004-0000377,diagnosis,0,Stage_III
|
| 1828 |
+
HLT004-0000377,treatment_start_1L,15,docetaxel_2L
|
| 1829 |
+
HLT004-0000377,treatment_end_1L,141,completed_or_discontinued
|
| 1830 |
+
HLT004-0000377,progression,311,radiographic_progression
|
| 1831 |
+
HLT004-0000377,os_endpoint,384,disease
|
| 1832 |
+
HLT004-0000378,diagnosis,0,Stage_I
|
| 1833 |
+
HLT004-0000378,treatment_start_1L,7,carbo_pem_pembro
|
| 1834 |
+
HLT004-0000378,treatment_end_1L,55,completed_or_discontinued
|
| 1835 |
+
HLT004-0000378,progression,35,radiographic_progression
|
| 1836 |
+
HLT004-0000378,os_endpoint,55,other_cause
|
| 1837 |
+
HLT004-0000379,diagnosis,0,Stage_IV
|
| 1838 |
+
HLT004-0000379,treatment_start_1L,20,docetaxel_2L
|
| 1839 |
+
HLT004-0000379,treatment_end_1L,146,completed_or_discontinued
|
| 1840 |
+
HLT004-0000379,progression,297,radiographic_progression
|
| 1841 |
+
HLT004-0000379,os_endpoint,411,disease
|
| 1842 |
+
HLT004-0000380,diagnosis,0,Stage_II
|
| 1843 |
+
HLT004-0000380,treatment_start_1L,12,pembro_mono
|
| 1844 |
+
HLT004-0000380,treatment_end_1L,590,completed_or_discontinued
|
| 1845 |
+
HLT004-0000380,response_assessment,67,PR
|
| 1846 |
+
HLT004-0000380,os_endpoint,590,disease
|
| 1847 |
+
HLT004-0000381,diagnosis,0,Stage_III
|
| 1848 |
+
HLT004-0000381,treatment_start_1L,20,docetaxel_2L
|
| 1849 |
+
HLT004-0000381,treatment_end_1L,146,completed_or_discontinued
|
| 1850 |
+
HLT004-0000381,response_assessment,38,PR
|
| 1851 |
+
HLT004-0000381,os_endpoint,1307,disease
|
| 1852 |
+
HLT004-0000382,diagnosis,0,Stage_IV
|
| 1853 |
+
HLT004-0000382,treatment_start_1L,28,carbo_pem_pembro
|
| 1854 |
+
HLT004-0000382,treatment_end_1L,154,completed_or_discontinued
|
| 1855 |
+
HLT004-0000382,response_assessment,51,PR
|
| 1856 |
+
HLT004-0000382,os_endpoint,206,disease
|
| 1857 |
+
HLT004-0000383,diagnosis,0,Stage_I
|
| 1858 |
+
HLT004-0000383,treatment_start_1L,8,carbo_taxol
|
| 1859 |
+
HLT004-0000383,treatment_end_1L,134,completed_or_discontinued
|
| 1860 |
+
HLT004-0000383,progression,571,radiographic_progression
|
| 1861 |
+
HLT004-0000383,os_endpoint,756,censored
|
| 1862 |
+
HLT004-0000384,diagnosis,0,Stage_I
|
| 1863 |
+
HLT004-0000384,treatment_start_1L,22,carbo_pem_pembro
|
| 1864 |
+
HLT004-0000384,treatment_end_1L,148,completed_or_discontinued
|
| 1865 |
+
HLT004-0000384,progression,344,radiographic_progression
|
| 1866 |
+
HLT004-0000384,os_endpoint,429,disease
|
| 1867 |
+
HLT004-0000385,diagnosis,0,Stage_I
|
| 1868 |
+
HLT004-0000385,treatment_start_1L,16,carbo_taxol
|
| 1869 |
+
HLT004-0000385,treatment_end_1L,142,completed_or_discontinued
|
| 1870 |
+
HLT004-0000385,response_assessment,33,PR
|
| 1871 |
+
HLT004-0000385,os_endpoint,424,censored
|
| 1872 |
+
HLT004-0000386,diagnosis,0,Stage_IV
|
| 1873 |
+
HLT004-0000386,treatment_start_1L,29,carbo_pem_pembro
|
| 1874 |
+
HLT004-0000386,treatment_end_1L,55,completed_or_discontinued
|
| 1875 |
+
HLT004-0000386,progression,43,radiographic_progression
|
| 1876 |
+
HLT004-0000386,os_endpoint,55,disease
|
| 1877 |
+
HLT004-0000387,diagnosis,0,Stage_III
|
| 1878 |
+
HLT004-0000387,treatment_start_1L,20,carbo_taxol
|
| 1879 |
+
HLT004-0000387,treatment_end_1L,146,completed_or_discontinued
|
| 1880 |
+
HLT004-0000387,progression,214,radiographic_progression
|
| 1881 |
+
HLT004-0000387,os_endpoint,765,disease
|
| 1882 |
+
HLT004-0000388,diagnosis,0,Stage_IV
|
| 1883 |
+
HLT004-0000388,treatment_start_1L,28,carbo_pem_pembro
|
| 1884 |
+
HLT004-0000388,treatment_end_1L,73,completed_or_discontinued
|
| 1885 |
+
HLT004-0000388,os_endpoint,73,censored
|
| 1886 |
+
HLT004-0000389,diagnosis,0,Stage_IV
|
| 1887 |
+
HLT004-0000389,treatment_start_1L,14,carbo_pem_pembro
|
| 1888 |
+
HLT004-0000389,treatment_end_1L,41,completed_or_discontinued
|
| 1889 |
+
HLT004-0000389,response_assessment,67,PR
|
| 1890 |
+
HLT004-0000389,os_endpoint,41,censored
|
| 1891 |
+
HLT004-0000390,diagnosis,0,Stage_IV
|
| 1892 |
+
HLT004-0000390,treatment_start_1L,11,docetaxel_2L
|
| 1893 |
+
HLT004-0000390,treatment_end_1L,137,completed_or_discontinued
|
| 1894 |
+
HLT004-0000390,response_assessment,69,PR
|
| 1895 |
+
HLT004-0000390,os_endpoint,316,disease
|
| 1896 |
+
HLT004-0000391,diagnosis,0,Stage_IV
|
| 1897 |
+
HLT004-0000391,treatment_start_1L,16,docetaxel_2L
|
| 1898 |
+
HLT004-0000391,treatment_end_1L,142,completed_or_discontinued
|
| 1899 |
+
HLT004-0000391,progression,21,radiographic_progression
|
| 1900 |
+
HLT004-0000391,os_endpoint,243,other_cause
|
| 1901 |
+
HLT004-0000392,diagnosis,0,Stage_IV
|
| 1902 |
+
HLT004-0000392,treatment_start_1L,23,carbo_pem_pembro
|
| 1903 |
+
HLT004-0000392,treatment_end_1L,149,completed_or_discontinued
|
| 1904 |
+
HLT004-0000392,response_assessment,63,PR
|
| 1905 |
+
HLT004-0000392,os_endpoint,372,disease
|
| 1906 |
+
HLT004-0000393,diagnosis,0,Stage_III
|
| 1907 |
+
HLT004-0000393,treatment_start_1L,19,docetaxel_2L
|
| 1908 |
+
HLT004-0000393,treatment_end_1L,88,completed_or_discontinued
|
| 1909 |
+
HLT004-0000393,response_assessment,70,PR
|
| 1910 |
+
HLT004-0000393,os_endpoint,88,other_cause
|
| 1911 |
+
HLT004-0000394,diagnosis,0,Stage_IV
|
| 1912 |
+
HLT004-0000394,treatment_start_1L,28,carbo_pem_pembro
|
| 1913 |
+
HLT004-0000394,treatment_end_1L,154,completed_or_discontinued
|
| 1914 |
+
HLT004-0000394,response_assessment,34,PR
|
| 1915 |
+
HLT004-0000394,os_endpoint,189,disease
|
| 1916 |
+
HLT004-0000395,diagnosis,0,Stage_IV
|
| 1917 |
+
HLT004-0000395,treatment_start_1L,23,carbo_taxol
|
| 1918 |
+
HLT004-0000395,treatment_end_1L,149,completed_or_discontinued
|
| 1919 |
+
HLT004-0000395,os_endpoint,331,disease
|
| 1920 |
+
HLT004-0000396,diagnosis,0,Stage_IV
|
| 1921 |
+
HLT004-0000396,treatment_start_1L,15,docetaxel_2L
|
| 1922 |
+
HLT004-0000396,treatment_end_1L,141,completed_or_discontinued
|
| 1923 |
+
HLT004-0000396,response_assessment,43,PR
|
| 1924 |
+
HLT004-0000396,os_endpoint,939,disease
|
| 1925 |
+
HLT004-0000397,diagnosis,0,Stage_III
|
| 1926 |
+
HLT004-0000397,treatment_start_1L,7,pembro_mono
|
| 1927 |
+
HLT004-0000397,treatment_end_1L,326,completed_or_discontinued
|
| 1928 |
+
HLT004-0000397,progression,33,radiographic_progression
|
| 1929 |
+
HLT004-0000397,os_endpoint,326,other_cause
|
| 1930 |
+
HLT004-0000398,diagnosis,0,Stage_III
|
| 1931 |
+
HLT004-0000398,treatment_start_1L,22,carbo_pem_pembro
|
| 1932 |
+
HLT004-0000398,treatment_end_1L,148,completed_or_discontinued
|
| 1933 |
+
HLT004-0000398,progression,715,radiographic_progression
|
| 1934 |
+
HLT004-0000398,os_endpoint,1235,disease
|
| 1935 |
+
HLT004-0000399,diagnosis,0,Stage_IV
|
| 1936 |
+
HLT004-0000399,treatment_start_1L,22,carbo_taxol
|
| 1937 |
+
HLT004-0000399,treatment_end_1L,148,completed_or_discontinued
|
| 1938 |
+
HLT004-0000399,progression,168,radiographic_progression
|
| 1939 |
+
HLT004-0000399,os_endpoint,504,disease
|
| 1940 |
+
HLT004-0000400,diagnosis,0,Stage_I
|
| 1941 |
+
HLT004-0000400,treatment_start_1L,8,pembro_mono
|
| 1942 |
+
HLT004-0000400,treatment_end_1L,743,completed_or_discontinued
|
| 1943 |
+
HLT004-0000400,response_assessment,61,PR
|
| 1944 |
+
HLT004-0000400,os_endpoint,1825,censored
|
nsclc/hlt004_longitudinal.csv
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|